id,Grupo,Producto_Activo,Cve_Med,Cve_Med,ID_PRODUCTO,GPO,GPO1,ESP,DIF,VAR,CUADRO_BASICO_SAI,PROGRAMA_MEDICO,DESCRIPCION_ARTICULO,UNIDAD_PRESENTACION,CANTIDAD_PRESENTACION,TIPO_PRESENTACION,Unidades,Medida,tot_unidades,med,ANALGESIACOS_ANTIINFLAMATORIOS_ANTIRREUMATICOS,ANALGESICOS_OPIOIDES___,ANALGESICOS_ANTIPIRETICOS,ANESTESICOS_GENERATES,ANESTESICOS_LOCALES,ANSIOLITICOS,ANTIACIDOS,ANTIAGREGANTE_PLAQUETARIO,ANTIANEMICOS,ANTIANGINOSO,ANTIARRITMICOS,ANTIASMATICO__BRONCODILATADOR,ANTIBIOTICOS,ANTICONCEPTIVO_INTRAUTERINO,ANTIDEPRESIVOS,ANTIDIABETICOS,ANTIDIARREICOS,ANTIDOTOS,ANTIEMETICOS,ANTIEPILEPTICOS,ANTIESPASMODICO,ANTIFUNGICOS,ANTIGOTOSOS,ANTIHEMORRAGICOS,ANTIHISTAMINICOS,ANTIPARKINSONIANO,ANTIPSICOTICOS,ANTISEPTICOS_DESINFECTANTES,ANTITROMBITICO_TROMBOTICO_ANTIAGREGANTE,ANTITROMBOTICO_TROMBOLITICO,ANTITUSIVOS,ANTIULCEROSOS_PROTECTOR_GASTRICO,ANTIVIRALES,CARDIOTONICOS,CORTICOIDES,DIURETICOS_ANTIHIPERTENSIVOS,FACTOR_VITAMINICO,HIPNOTICO_SEDANTE,HIPOLIPEMIANTE,INDUCTOR_DEL_PARTO,INHIBIDOR_DEL_PARTO,INMUNOSUPRESORES,LAXANTES,MUCOLITICOS,OTROS_ANTIHIPERTENSIVOS,RELAJANTE_MUSCULAR,TERAPIA_TIROIDEA,TRATAMIENTO_TUBERCULOSIS,g1_ANALGESICOS,g2_ANESTESIA,g3,g4,g5,g6,g7,g8,g9,g10,g11,g12,g13,g14,g15,g16,g17,g18,g19,g20,g21,g22,g23,GRUPO,ANALGESICOS_URINARIOS,ANTIAGREGANTES_PLAQUETARIOS,ANTIALERGICOS,ANTIANDROGENICOS,ANTIARRITMICOS,ANTICOAGULANTES_ORALES,ANTIDEPRESIVOS,ANTIFLAMATORIOS_ESTEROIDEOS,ANTIHIPERTENSIVOS,ANTIINFLAMATORIOS_NO_ESTEROIDEOS,ANTIMICOTICOS_SISTEMICOS_Y_TOPICOS,ANTIMUSCARINICOS,ANTINEURITICOS,ANTITUSIVOS,ANTIULCEROSOS_Y_PROTECTORES_DE_LA_MUCOSA_GASTRICA,ANTIURICOSURICOS,ANTIVERTIGINOSOS,BENZODIAZEPINAS,BLOQUEADORES_ALFA,BRONCODILATADORES_Y_EXPECTORANTES,DISFUNCION_ERECTIL,ELECTROLITOS_ORALES,FARMACOS_INSUFICIENCIA_CARDIACA_Y_ANTIANGINOSOS,FARMACOS_MODIFICADORES_DE_LA_ENFERMEDAD,FARMACOS_OCULARES,FARMACOS_UTILIZADOS_EN_CANCER_DE_MAMA,FARMACOS_UTILIZADOS_EN_HIPERTIROIDISMO,FARMACOS_UTILIZADOS_EN_HIPOTIROIDISMO,FARMACOS_UTILIZADOS_EN_NEFROLOGIA,FARMACOS_UTILIZADOS_EN_NEUROLOGIA,FARMACOS_UTILIZADOS_EN_OSTEOPOROSIS,FARMACOS_UTILIZADOS_EN_PSIQUIATRIA,FORMULAS_NUTRICIONALES_COMPLETAS,HIPOLIPEMIANTES,HORMONALES,METILXANTINAS,VARIOS,VITAMINICOS
230,Grupo Nº 1: Analgesia,IBUPROFENO,5943,5943,1000059430000,010,000,5943,00,00,SI,,IBUPROFENO. SUSPENSION ORAL. CADA 100 ML CONTIENEN: IBUPROFENO 2 G. ENVASE CON 120 ML Y MEDIDA DOSIFICADORA.,ENV,120,ML.,120,mililitros,120,mililitros,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
557,Grupo Nº 1: Analgesia,BUPRENORFINA,6038,6038,4000060380000,040,000,6038,00,00,SI,Sustantiva,BUPRENORFINA PARCHE CADA PARCHE CONTIENE: BUPRENORFINA 5 MG ENVASE CON 4 PARCHES. VELOCIDAD NOMINAL DE LIBERACION: 5 MICROGRAMOS/H (A TRAVES DE UN PERIODO DE 7 DIAS),ENV,4,PCH,5,microgramos,20,microgramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
558,Grupo Nº 1: Analgesia,BUPRENORFINA,6039,6039,4000060390000,040,000,6039,00,00,SI,Sustantiva,BUPRENORFINA PARCHE CADA PARCHE CONTIENE: BUPRENORFINA 10 MG ENVASE CON 4 PARCHES. VELOCIDAD NOMINAL DE LIBERACION: 10 MICROGRAMOS/H (A TRAVES DE UN PERIODO DE 7 DIAS),ENV,4,PCH,10,microgramos,40,microgramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
572,Grupo Nº 1: Analgesia,KETOROLACO,3422,3422,1000034220000,010,000,3422,00,00,SI,Sustantiva,KETOROLACO TROMETAMINA SOLUCION INYECTABLE CADA FRASCO AMPULA O AMPOLLETA CONTIENE: KETOROLACO-TROMETAMINA 30 MG ENVASE CON 3 FRASCOS AMPULA O 3 AMPOLLETAS DE 1 ML.,ENV,3,AFA,30,miligramos,90,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIINFLAMATORIOS_NO_ESTEROIDEOS,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
594,Grupo Nº 1: Analgesia,DEXTROPROPOXIFENO,107,0107,4000001070000,040,000,0107,00,00,SI,Sustantiva,DEXTROPROPOXIFENO CAPSULA O COMPRIMIDO CADA CAPSULA O COMPRIMIDO CONTIENE:  CLORHIDRATO DE DEXTROPROPOXIFENO 65 MG ENVASE CON 20 CAPSULAS O COMPRIMIDOS.,ENV,20,C.C,65,miligramos,1300,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIINFLAMATORIOS_NO_ESTEROIDEOS,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
595,Grupo Nº 1: Analgesia,NALBUFINA,132,0132,4000001320000,040,000,0132,00,00,NO,Sustantiva,NALBUFINA. SOLUCION INYECTABLE. CADA AMPOLLETA CONTIENE: CLORHIDRATO DE NALBUFINA 10 MG. ENVASE CON 3 AMPOLLETAS DE 1 ML.,CJA,3,AMP,10,miligramos,30,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
596,Grupo Nº 1: Analgesia,NALBUFINA,132,0132,4000001320100,040,000,0132,01,00,SI,Sustantiva,NALBUFINA SOLUCION INYECTABLE CADA AMPOLLETA CONTIENE: CLORHIDRATO DE NALBUFINA  10 MG ENVASE CON 5 AMPOLLETAS DE 1 ML.,ENV,5,AMP,10,miligramos,50,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
612,Grupo Nº 1: Analgesia,TRAMADOL-PARACETAMOL,2096,2096,4000020960000,040,000,2096,00,00,SI,"VALES,Sustantiva",TRAMADOL-PARACETAMOL. TABLETA. CADA TABLETA CONTIENE: CLORHIDRATO DE TRAMADOL 37.5 MG. PARACETAMOL 325.0 MG. ENVASE CON 20 TABLETAS.,ENV,20,TAB,362.5,miligramos,7250,miligramos,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIINFLAMATORIOS_NO_ESTEROIDEOS,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
613,Grupo Nº 1: Analgesia,MORFINA,2099,2099,4000020990000,040,000,2099,00,00,SI,Cofepris - Sin CPM_V,MORFINA SOLUCION INYECTABLE CADA AMPOLLETA CONTIENE: SULFATO DE MORFINA  PENTAHIDRATADA 2.5 MG ENVASE CON 5 AMPOLLETAS CON 2.5 ML.,ENV,1,ENV,2.5,miligramos,2.5,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
614,Grupo Nº 1: Analgesia,BUPRENORFINA,2100,2100,4000021000000,040,000,2100,00,00,SI,Sustantiva,BUPRENORFINA TABLETA SUBLINGUAL CADA TABLETA SUBLINGUAL CONTIENE: CLORHIDRATO  DE BUPRENORFINA EQUIVALENTE A 0.2 MG DE BUPRENORFINA. ENVASE CON 10 TABLETAS.,ENV,10,TAB,0.25,MG,2.5,MG,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
615,Grupo Nº 1: Analgesia,BUPRENORFINA,2100,2100,4000021000100,040,000,2100,01,00,NO,Sustantiva,BUPRENORFINA. TABLETA SUBLINGUAL. CADA TABLETA SUBLINGUAL CONTIENE: CLORHIDRATO DE BUPRENORFINA EQUIVALENTE A 0.2 MG DE BUPRENORFINA. ENVASE CON 20 TABLETAS.,CJA,20,TAB,0.25,MG,5,MG,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
616,Grupo Nº 1: Analgesia,MORFINA,2102,2102,4000021020000,040,000,2102,00,00,SI,Cofepris - Sin CPM_V,MORFINA SOLUCION INYECTABLE CADA AMPOLLETA CONTIENE: SULFATO DE MORFINA  PENTAHIDRATADA 50 MG ENVASE CON 1 AMPOLLETA CON 2.0 ML.,ENV,1,ENV,50,miligramos,50,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
617,Grupo Nº 1: Analgesia,MORFINA,2103,2103,4000021030000,040,000,2103,00,00,SI,Cofepris - Sin CPM_V,MORFINA SOLUCION INYECTABLE CADA AMPOLLETA CONTIENE: SULFATO DE MORFINA 10 MG.  ENVASE CON 5 AMPOLLETAS.,ENV,5,AMP,10,miligramos,50,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
618,Grupo Nº 1: Analgesia,TRAMADOL,2106,2106,4000021060000,040,000,2106,00,00,SI,Sustantiva,TRAMADOL. SOLUCION INYECTABLE. CADA AMPOLLETA CONTIENE: CLORHIDRATO DE TRAMADOL 100 MG. ENVASE CON 5 AMPOLLETAS DE 2 ML.,ENV,5,AMP,100,miligramos,500,miligramos,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
649,Grupo Nº 1: Analgesia,BUPRENORFINA,4026,4026,4000040260000,040,000,4026,00,00,SI,Sustantiva,BUPRENORFINA SOLUCION INYECTABLE CADA AMPOLLETA O FRASCO AMPULA CONTIENE:  CLORHIDRATO DE BUPRENORFINA EQUIVALENTE A 0.3 MG DE BUPRENORFINA. ENVASE CON 6  AMPOLLETAS O FRASCOS AMPULA CON 1 ML.,ENV,6,AMP,0.3,miligramos,1.8,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
650,Grupo Nº 1: Analgesia,FENTANILO,4027,4027,4000040270000,040,000,4027,00,00,SI,Cofepris - Sin CPM_V,FENTANILO PARCHE CADA PARCHE CONTIENE: FENTANILO 4.2 MG ENVASE CON 5 PARCHES.,ENV,5,PZA,4.2,miligramos,21,miligramos,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
651,Grupo Nº 1: Analgesia,MORFINA,4029,4029,4000040290000,040,000,4029,00,00,SI,Cofepris - Sin CPM_V,MORFINA TABLETA CADA TABLETA CONTIENE: SULFATO DE MORFINA PENTAHIDRATADO  EQUIVALENTE A 30 MG DE SULFATO DE MORFINA ENVASE CON 20 TABLETAS.,ENV,20,TAB,30,miligramos,600,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
652,Grupo Nº 1: Analgesia,OXICODONA,4032,4032,4000040320000,040,000,4032,00,00,SI,Cofepris - Sin CPM_V,OXICODONA TABLETA DE LIBERACION PROLONGADA CADA TABLETA CONTIENE: CLORHIDRATO DE OXICODONA 20 MG. ENVASE CON 30 TABLETAS DE LIBERACION PROLONGADA.,ENV,30,TAB,20,miligramos,600,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
653,Grupo Nº 1: Analgesia,OXICODONA,4032,4032,4000040320100,040,000,4032,01,00,NO,Cofepris - Sin CPM_V,OXICODONA. TABLETA DE LIBERACION PROLONGADA. CADA TABLETA CONTIENE: CLORHIDRATO DE OXICODONA 20 MG. ENVASE CON 100 TABLETAS DE LIBERACION PROLONGADA.,ENV,100,TAB,20,miligramos,2000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
654,Grupo Nº 1: Analgesia,OXICODONA,4033,4033,4000040330000,040,000,4033,00,00,SI,Cofepris - Sin CPM_V,OXICODONA TABLETA DE LIBERACION PROLONGADA CADA TABLETA CONTIENE: CLORHIDRATO DE OXICODONA 10 MG ENVASE CON 30 TABLETAS DE LIBERACION PROLONGADA.,ENV,30,TAB,10,miligramos,300,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
655,Grupo Nº 1: Analgesia,OXICODONA,4033,4033,4000040330100,040,000,4033,01,00,NO,Cofepris - Sin CPM_V,OXICODONA. TABLETA DE LIBERACION PROLONGADA. CADA TABLETA CONTIENE: CLORHIDRATO DE OXICODONA 10 MG. ENVASE CON 100 TABLETAS DE LIBERACION PROLONGADA.,ENV,100,TAB,10,miligramos,1000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
678,Grupo Nº 1: Analgesia,ÁCIDO ACETILSALICÍLICO,101,0101,1000001010000,010,000,0101,00,00,SI,"VALES,Sustantiva",ACIDO ACETILSALICILICO TABLETA CADA TABLETA CONTIENE: ACIDO ACETILSALICILICO 500 MG. ENVASE CON 20 TABLETAS.,ENV,20,TAB,500,miligramos,10000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIINFLAMATORIOS_NO_ESTEROIDEOS,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
679,Grupo Nº 1: Analgesia,ÁCIDO ACETILSALICÍLICO,103,0103,1000001030000,010,000,0103,00,00,SI,"VALES,Consumo en demanda",ACIDO ACETILSALICILICO TABLETA SOLUBLE O EFERVESCENTE CADA TABLETA SOLUBLE O EFERVESCENTE CONTIENE: ACIDO ACETILSALICILICO 300 MG ENVASE CON 20 TABLETAS SOLUBLES O EFERVESCENTES.,ENV,20,TAB,300,miligramos,6000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
680,Grupo Nº 1: Analgesia,PARACETAMOL,104,0104,1000001040000,010,000,0104,00,00,SI,"VALES,Programa de Planificación Familiar,Consumo en demanda",PARACETAMOL TABLETA CADA TABLETA CONTIENE: PARACETAMOL 500 MG ENVASE CON 10 TABLETAS.,ENV,10,TAB,500,miligramos,5000,miligramos,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIINFLAMATORIOS_NO_ESTEROIDEOS,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
681,Grupo Nº 1: Analgesia,PARACETAMOL,105,0105,1000001050000,010,000,0105,00,00,SI,"VALES,Sustantiva",PARACETAMOL SUPOSITORIO CADA SUPOSITORIO CONTIENE: PARACETAMOL 300 MG ENVASE CON 3 SUPOSITORIOS.,ENV,3,SUP,300,miligramos,900,miligramos,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
682,Grupo Nº 1: Analgesia,PARACETAMOL,106,0106,1000001060000,010,000,0106,00,00,SI,VALES,"PARACETAMOL SOLUCION ORAL CADA ML CONTIENE: PARACETAMOL 100 MG ENVASE CON 15 ML, GOTERO CALIBRADO A 0.5 Y 1 ML, INTEGRADO O ADJUNTO AL ENVASE QUE SIRVE DE TAPA.",FCO,15,ML.,100,miligramos,100,miligramos,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
683,Grupo Nº 1: Analgesia,METAMIZOL SÓDICO,108,0108,1000001080000,010,000,0108,00,00,SI,"VALES,Sustantiva",METAMIZOL SODICO COMPRIMIDO CADA COMPRIMIDO CONTIENE: METAMIZOL SODICO 500 MG ENVASE CON 10 COMPRIMIDOS.,ENV,10,COM,500,miligramos,5000,miligramos,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIINFLAMATORIOS_NO_ESTEROIDEOS,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
684,Grupo Nº 1: Analgesia,METAMIZOL SÓDICO,109,0109,1000001090000,010,000,0109,00,00,SI,Sustantiva,METAMIZOL SODICO SOLUCION INYECTABLE CADA AMPOLLETA CONTIENE: METAMIZOL SODICO 1 G ENVASE CON 3 AMPOLLETAS CON 2 ML.,ENV,3,AMP,1,gramos,3,gramos,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
691,Grupo Nº 1: Analgesia,DEXMEDETOMIDINA,247,0247,1000002470002,010,000,0247,00,02,NO,Sustantiva,"DEXMEDETOMIDINA. SOLUCION INYECTABLE, CADA FRASCO AMPULA CONTIENE: CLORHIDRATO DE DEXMETOMIDINA 200 MICROGRAMOS. ENVASE CON UN FRASCO AMPULA.",ENV,1,F.A,200,microgramos,200,microgramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
692,Grupo Nº 1: Analgesia,DEXMEDETOMIDINA,247,0247,1000002470100,010,000,0247,01,00,SI,Sustantiva,DEXMEDETOMIDINA SOLUCION INYECTABLE CADA FRASCO AMPULA CONTIENE: CLORHIDRATO DE DEXMEDETOMIDINA 200 MICROGRAMOS. ENVASE CON 5 FRASCOS AMPULA.,ENV,5,F.A,200,microgramos,1000,microgramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
693,Grupo Nº 1: Analgesia,DEXMEDETOMIDINA,247,0247,1000002470200,010,000,0247,02,00,NO,Sustantiva,DEXMEDETOMIDINA. SOLUCIÓN INYECTABLE. CADA FRASCO AMPULA CONTIENE: CLORHIDRATO DE DEXMEDETOMIDINA 200 MICROGRAMOS. ENVASE CON 25 FRASCOS AMPULA.,ENV,25,F.A,200,microgramos,5000,microgramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
931,Grupo Nº 1: Analgesia,KETOROLACO,3422,3422,1000034220002,010,000,3422,00,02,NO,Sustantiva,KETOROLACO. SOLUCION INYECTABLE. CADA FRASCO AMPULA O AMPOLLETA CONTIENE: KETOROLACO-TROMETAMINA 30 MG. ENVASE CON 3 FRASCOS AMPULA O 3 AMPOLLETAS DE 1 ML.,ENV,3,AFA,30,miligramos,90,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIINFLAMATORIOS_NO_ESTEROIDEOS,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
998,Grupo Nº 1: Analgesia,CLONIXINATO DE LISINA,4028,4028,1000040280000,010,000,4028,00,00,SI,Sustantiva,CLONIXINATO DE LISINA SOLUCION INYECTABLE CADA AMPOLLETA CONTIENE: CLONIXINATO  DE LISINA 100 MG ENVASE CON 5 AMPOLLETAS DE 2 ML.,ENV,5,AMP,100,miligramos,500,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
999,Grupo Nº 1: Analgesia,CAPSAICINA,4031,4031,1000040310000,010,000,4031,00,00,SI,Sin programa definido,CAPSAICINA CREMA CADA 100 GRAMOS CONTIENE: EXTRACTO DE OLEORESINA DEL CAPSICUM  ANNUUNA EQUIVALENTE A 0.035 G DE CAPSAICINA. ENVASE CON 40 G.,ENV,1,ENV,0.035,gramos,0.035,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1000,Grupo Nº 1: Analgesia,ETOFENAMATO,4036,4036,1000040360000,010,000,4036,00,00,SI,Sustantiva,ETOFENAMATO SOLUCION INYECTABLE CADA AMPOLLETA CONTIENE: ETOFENAMATO 1 G ENVASE  CON UNA AMPOLLETA DE 2 ML.,ENV,1,AMP,1,gramos,1,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
38,Grupo Nº 10: Hematología,ANTITROMBINA III,5340,5340,1000053400000,010,000,5340,00,00,SI,"Sustantiva,Uso Hospitalario, Hematología",ANTITROMBINA III SOLUCION INYECTABLE EL FRASCO AMPULA CON LIOFILIZADO CONTIENE:  ANTITROMBINA III 500 UI ENVASE CON FRASCO AMPULA Y FRASCO AMPULA CON 10 ML DE  DILUYENTE.,ENV,1,JGO,500,UI,500,UI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
39,Grupo Nº 10: Hematología,FACTOR IX,5343,5343,1000053430000,010,000,5343,00,00,NO,"Sustantiva,Uso Hospitalario, Hematología,Uso Hospitalario, Hematología,Entrega hospitalaria,Entrega hospitalaria",FACTOR IX SOLUCION INYECTABLE CADA FRASCO AMPULA CON LIOFILIZADO CONTIENE: FACTOR IX DE COAGULACION RECOMBINANTE 500 UI ENVASE CON FRASCO AMPULA CON LIOFILIZADO Y FRASCO AMPULA CON DILUYENTE.,JGO,1,JGO,500,UI,500,UI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
40,Grupo Nº 10: Hematología,FACTOR IX,5343,5343,1000053430100,010,000,5343,01,00,SI,"Sustantiva,Uso Hospitalario, Hematología,Uso Hospitalario, Hematología,Entrega hospitalaria,Entrega hospitalaria","FACTOR IX SOLUCION INYECTABLE CADA FRASCO AMPULA CON LIOFILIZADO CONTIENE: FACTOR IX DE COAGULACION RECOMBINANTE 500 UI. ENVASE CON FRASCO AMPULA CON LIOFILIZADO, UNA JERINGA CON 5 ML DE DILUYENTE, UN EQUIPO DE INFUSION, UN",JGO,1,JGO,500,UI,500,UI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
41,Grupo Nº 10: Hematología,FACTOR IX,5344,5344,1000053440000,010,000,5344,00,00,NO,"Sustantiva,Uso Hospitalario, Hematología,Uso Hospitalario, Hematología,Entrega hospitalaria,Entrega hospitalaria",FACTOR IX SOLUCION INYECTABLE CADA FRASCO AMPULA CON LIOFILIZADO CONTIENE: FACTOR IX DE COAGULACION RECOMBINANTE 1000 UI ENVASE CON FRASCO AMPULA CON LIOFILIZADO Y FRASCO AMPULA CON DILUYENTE.,JGO,1,JGO,1000,UI,1000,UI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
42,Grupo Nº 10: Hematología,FACTOR IX,5344,5344,1000053440100,010,000,5344,01,00,SI,"Sustantiva,Uso Hospitalario, Hematología,Uso Hospitalario, Hematología,Entrega hospitalaria,Entrega hospitalaria","FACTOR IX SOLUCION INYECTABLE CADA FRASCO AMPULA CON LIOFILIZADO CONTIENE: FACTOR IX DE COAGULACION RECOMBINANTE 1000 UI. ENVASE CON FRASCO AMPULA CON LIOFILIZADO, UNA JERINGA CON 5 ML DE DILUYENTE, UN EQUIPO DE INFUSION, UN",JGO,1,JGO,1000,UI,1000,UI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
176,Grupo Nº 10: Hematología,RIVAROXABÁN,5544,5544,1000055440001,010,000,5544,00,01,SI,Sustantiva,RIVAROXABAN: CADA COMPRIMIDO CONTIENE RIVAROXABAN DE 10 MG.,PZA,10,COM,10,miligramos,100,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
177,Grupo Nº 10: Hematología,RIVAROXABÁN,5544,5544,1000055440002,010,000,5544,00,02,NO,Sustantiva,RIVAROXABAN. COMPRIMIDO. CADA COMPRIMIDO CONTIENE RIVAROXABAN DE 10 MG.,ENV,10,COM,10,miligramos,100,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
178,Grupo Nº 10: Hematología,RIVAROXABÁN,5544,5544,1000055440101,010,000,5544,01,01,NO,Sustantiva,RIVAROXABAN. COMPRIMIDO. CADA COMPRIMIDO CONTIENE RIVAROXABAN DE 10 MG.,ENV,30,COM,10,miligramos,300,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
185,Grupo Nº 10: Hematología,DABIGATRÁN ETEXILATO,5551,5551,1000055510000,010,000,5551,00,00,SI,Sustantiva,DABIGATRAN ETEXILATO CAPSULA. CADA CAPSULA CONTIENE: DABIGATRAN ETEXILATO MESILATO EQUIVALENTE A 75 MG DE DABIGATRAN ETEXILATO. ENVASE CON 30 CAPSULAS.,ENV,30,CAP,75,miligramos,2250,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
186,Grupo Nº 10: Hematología,DABIGATRÁN ETEXILATO,5551,5551,1000055510104,010,000,5551,01,04,NO,Sustantiva,DABIGATRAN ETEXILATO. CAPSULA. CADA CAPSULA CONTIENE: DABIGATRAN ETEXILATO MESILATO EQUIVALENTE A 75 MG DE DABIGATRAN ETEXILATO. ENVASE CON 60 CAPSULAS.,ENV,60,CAP,75,miligramos,4500,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
187,Grupo Nº 10: Hematología,DABIGATRÁN ETEXILATO,5552,5552,1000055520000,010,000,5552,00,00,SI,Sustantiva,DABIGATRAN ETEXILATO CAPSULA. CADA CAPSULA CONTIENE: DABIGATRAN ETEXILATO MESILATO EQUIVALENTE A 110 MG DE DABIGATRAN ETEXILATO. ENVASE CON 30 CAPSULAS.,ENV,30,CAP,110,miligramos,3300,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
188,Grupo Nº 10: Hematología,DABIGATRÁN ETEXILATO,5552,5552,1000055520102,010,000,5552,01,02,NO,Sustantiva,DABIGATRAN ETEXILATO. CAPSULA. CADA CAPSULA CONTIENE: DABIGATRAN ETEXILATO MESILATO EQUIVALENTE A 110 MG DE DABIGATRAN ETEXILATO. ENVASE CON 60 CAPSULAS.,ENV,60,CAP,110,miligramos,6600,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
195,Grupo Nº 10: Hematología,DARBEPOETINA ALFA,5632,5632,1000056320000,010,000,5632,00,00,SI,Entrega hospitalaria,DARBEPOETINA ALFA. SOLUCION INYECTABLE CADA JERINGA PRELLENADA CONTIENE: DARBEPOETINA ALFA 300 MICROGRAMOS. ENVASE CON 1 MICROJERINGA CON 0.6 ML.,ENV,1,JGA,300,microgramos,300,microgramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
196,Grupo Nº 10: Hematología,DARBEPOETINA ALFA,5633,5633,1000056330000,010,000,5633,00,00,SI,Entrega hospitalaria,DARBEPOETINA ALFA. SOLUCION INYECTABLE CADA JERINGA PRELLENADA CONTIENE: DARBEPOETINA ALFA 500 MICROGRAMOS. ENVASE CON 1 MICROJERINGA CON 1.0 ML.,ENV,1,JGA,500,microgramos,500,microgramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
198,Grupo Nº 10: Hematología,FACTOR VIII DE LA COAGULACIÓN SANGUÍNEA HUMANO/FACTOR DE VON WILLEBRAND,5643,5643,1000056430000,010,000,5643,00,00,SI,"Sustantiva,Uso Hospitalario, Hematología",FACTOR VIII DE LA COAGULACION SANGUINEA HUMANO/FACTOR DE VON WILLEBRAND. SOLUCION INYECTABLE. CADA FRASCO AMPULA CON LIOFILIZADO CONTIENE: FACTOR VIII DE LA COAGULACION SANGUINEA HUMANO 250 UI FACTOR DE VON WILLEBRAND 600 UI.,ENV,1,ENV,850,UI,850,UI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
199,Grupo Nº 10: Hematología,FACTOR VIII DE LA COAGULACIÓN SANGUÍNEA HUMANO/FACTOR DE VON WILLEBRAND,5644,5644,1000056440000,010,000,5644,00,00,SI,"Entrega hospitalaria,Uso Hospitalario, Hematología",FACTOR VIII DE LA COAGULACION SANGUINEA HUMANO/FACTOR DE VON WILLEBRAND. SOLUCION INYECTABLE. CADA FRASCO AMPULA CON LIOFILIZADO CONTIENE: FACTOR VIII DE LA COAGULACION SANGUINEA HUMANO 500 UI FACTOR DE VON WILLEBRAND 1200 UI.,ENV,1,ENV,1700,UI,1700,UI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
209,Grupo Nº 10: Hematología,APIXABÁN,5731,5731,1000057310000,010,000,5731,00,00,SI,Sustantiva,APIXABAN. TABLETA. CADA TABLETA CONTIENE: APIXABAN 2.5 MG. ENVASE CON 20 TABLETAS.,ENV,20,TAB,2.5,miligramos,50,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
210,Grupo Nº 10: Hematología,APIXABÁN,5731,5731,1000057310100,010,000,5731,01,00,NO,Sustantiva,APIXABAN. TABLETA. CADA TABLETA CONTIENE: APIXABAN 2.5 MG. ENVASE CON 60 TABLETAS.,ENV,60,TAB,2.5,miligramos,150,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
211,Grupo Nº 10: Hematología,APIXABÁN,5732,5732,1000057320000,010,000,5732,00,00,SI,Sustantiva,APIXABAN. TABLETA. CADA TABLETA CONTIENE: APIXABAN 5 MG. ENVASE CON 20 TABLETAS.,ENV,20,TAB,5,miligramos,100,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
212,Grupo Nº 10: Hematología,APIXABÁN,5732,5732,1000057320100,010,000,5732,01,00,NO,Sustantiva,APIXABAN. TABLETA. CADA TABLETA CONTIENE: APIXABAN 5 MG. ENVASE CON 60 TABLETAS.,ENV,60,TAB,5,miligramos,300,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
213,Grupo Nº 10: Hematología,RIVAROXABÁN,5735,5735,1000057350101,010,000,5735,01,01,SI,Sustantiva,RIVAROXABAN. COMPRIMIDO. CADA COMPRIMIDO CONTIENE: RIVAROXABAN 15 MG. ENVASE CON 28 COMPRIMIDOS.,ENV,28,COM,15,miligramos,420,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
214,Grupo Nº 10: Hematología,RIVAROXABÁN,5736,5736,1000057360101,010,000,5736,01,01,SI,Sustantiva,RIVAROXABAN. COMPRIMIDO. CADA COMPRIMIDO CONTIENE: RIVAROXABAN 20 MG. ENVASE CON 28 COMPRIMIDOS.,ENV,28,COM,20,miligramos,560,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
215,Grupo Nº 10: Hematología,MOROCTOCOG ALFA,5760,5760,1000057600000,010,000,5760,00,00,SI,,MOROCTOCOG ALFA. SOLUCION INYECTABLE. CADA FRASCO AMPULA CONTIENE: MOROCTOCOG ALFA 250 UI. ENVASE CON UN FRASCO AMPULA Y UNA JERINGA PRELLENADA CON 4 ML DE DILUYENTE.,ENV,1,ENV,250,UI,250,UI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
216,Grupo Nº 10: Hematología,MOROCTOCOG ALFA,5761,5761,1000057610000,010,000,5761,00,00,SI,,MOROCTOCOG ALFA. SOLUCION INYECTABLE. CADA FRASCO AMPULA CONTIENE: MOROCTOCOG ALFA 500 UI. ENVASE CON UN FRASCO AMPULA Y UNA JERINGA PRELLENADA CON 4 ML DE DILUYENTE.,ENV,1,ENV,500,UI,500,UI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
221,Grupo Nº 10: Hematología,OCTOCOG ALFA (FACTOR VIII DE LA COAGULACIÓN SANGUÍNEA HUMANA RECOMBINANTE ADNr),5850,5850,1000058500000,010,000,5850,00,00,SI,"Entrega hospitalaria,Uso Hospitalario, Hematología","OCTOCOG ALFA (FACTOR VIII DE LA COAGULACION SANGUINEA HUMANA RECOMBINANTE ADNR). SOLUCION INYECTABLE. CADA FRASCO AMPULA CON LIOFILIZADO CONTIENE: OCTOCOG ALFA 250 UI. ENVASE CON UN FRASCO AMPULA CON LIOFILIZADO, UN FRASCO",ENV,1,ENV,250,UI,250,UI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
222,Grupo Nº 10: Hematología,OCTOCOG ALFA (FACTOR VIII DE LA COAGULACIÓN SANGUÍNEA HUMANA RECOMBINANTE ADNr),5851,5851,1000058510000,010,000,5851,00,00,SI,"Entrega hospitalaria,Uso Hospitalario, Hematología","OCTOCOG ALFA (FACTOR VIII DE LA COAGULACION SANGUINEA HUMANA RECOMBINANTE ADNR). SOLUCION INYECTABLE. CADA FRASCO AMPULA CON LIOFILIZADO CONTIENE:  OCTOCOG ALFA 500 UI. ENVASE CON UN FRASCO AMPULA CON LIOFILIZADO, UN FRASCO",ENV,1,ENV,500,UI,500,UI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
245,Grupo Nº 10: Hematología,MOROCTOCOG ALFA,6014,6014,1000060140000,010,000,6014,00,00,SI,,"MOROCTOCOG ALFA. SOLUCION INYECTABLE. CADA FRASCO AMPULA CON LIOFILIZADO CONTIENE: MOROCTOCOG ALFA 1000 UI. ENVASE CON UN FRASCO AMPULA CON LIOFILIZADO, UNA JERINGA PRELLENADA CON 4 ML DE DILUYENTE, UN ADAPTADOR Y UN EQUIPO DE",ENV,1,ENV,1000,UI,1000,UI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
250,Grupo Nº 10: Hematología,CONCENTRADO DE PROTEÍNAS HUMANAS COAGULABLES,6032,6032,1000060320001,010,000,6032,00,01,SI,"Sin programa definido,Entrega hospitalaria",CONCENTRADO DE PROTEINAS HUMANAS COAGULABLES. SOLUCION. CADA ML DE SOLUCION RECONSTITUIDA CONTIENE: FIBINOGENO HUMANO 91 MG (COMO PROTEINA COAGULABLE) APROTININA BOVINA O SINTETICA 3000 UIK TROMBINA HUMANA 500 UI. CLORURO DE,ENV,1,ENV,91,miligramos,91,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
251,Grupo Nº 10: Hematología,CONCENTRADO DE PROTEÍNAS HUMANAS COAGULABLES,6033,6033,1000060330001,010,000,6033,00,01,SI,"Sin programa definido,Entrega hospitalaria",CONCENTRADO DE PROTEINAS HUMANAS COAGULABLES. SOLUCION. CADA ML DE SOLUCION RECONSTITUIDA CONTIENE: FIBINOGENO HUMANO 91 MG (COMO PROTEINA COAGULABLE) APROTININA BOVINA O SINTETICA 3000 UIK TROMBINA HUMANA 500 UI CLORURO DE CALCIO,ENV,1,ENV,91,miligramos,91,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
258,Grupo Nº 10: Hematología,TUROCTOCOG ALFA (FACTOR VIII DE COAGULACIÓN HUMANO DE ORIGEN ADN RECOMBINANTE),6061,6061,1000060610000,010,000,6061,00,00,SI,,"TUROCTOCOG ALFA (FACTOR VIII DE COAGULACION HUMANO DE ORIGEN ADN RECOMBINANTE). SOLUCION INYECTABLE. CADA FRASCO AMPULA CON POLVO LIOFILIZADO CONTIENE: TUROCTOCOG ALFA 250 UI. ENVASE CON UN FRASCO AMPULA CON POLVO LIOFILIZADO, UNA",ENV,1,ENV,250,UI,250,UI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
259,Grupo Nº 10: Hematología,TUROCTOCOG ALFA (FACTOR VIII DE COAGULACIÓN HUMANO DE ORIGEN ADN RECOMBINANTE),6062,6062,1000060620000,010,000,6062,00,00,SI,,"TUROCTOCOG ALFA (FACTOR VIII DE COAGULACION HUMANO DE ORIGEN ADN RECOMBINANTE). SOLUCION INYECTABLE. CADA FRASCO AMPULA CON POLVO LIOFILIZADO CONTIENE: TUROCTOCOG ALFA 500 UI. ENVASE CON UN FRASCO AMPULA CON POLVO LIOFILIZADO, UNA",ENV,1,ENV,500,UI,500,UI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
260,Grupo Nº 10: Hematología,TUROCTOCOG ALFA (FACTOR VIII DE COAGULACIÓN HUMANO DE ORIGEN ADN RECOMBINANTE),6063,6063,1000060630000,010,000,6063,00,00,SI,,"TUROCTOCOG ALFA (FACTOR VIII DE COAGULACION HUMANO DE ORIGEN ADN RECOMBINANTE). SOLUCION INYECTABLE. CADA FRASCO AMPULA CON POLVO LIOFILIZADO CONTIENE: TUROCTOCOG ALFA 1000 UI. ENVASE CON UN FRASCO AMPULA CON POLVO LIOFILIZADO, UNA",ENV,1,ENV,1000,UI,1000,UI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
397,Grupo Nº 10: Hematología,ENOXAPARINA,2154,2154,1000021540000,010,000,2154,00,00,SI,Sustantiva,ENOXAPARINA SOLUCION INYECTABLE CADA JERINGA CONTIENE: ENOXAPARINA SODICA 40 MG  ENVASE CON 2 JERINGAS DE 0.4 ML.,ENV,2,JGA,40,miligramos,80,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
398,Grupo Nº 10: Hematología,ENOXAPARINA,2154,2154,1000021540102,010,000,2154,01,02,NO,Sustantiva,ENOXAPARINA SOLUCION INYECTABLE CADA JERINGA CONTIENE: ENOXAPARINA SODICA 40 MG ENVASE CON 2 JERINGAS CON DISPOSITIVO DE SEGURIDAD DE 0.4 ML.,ENV,2,JGA,40,miligramos,80,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
399,Grupo Nº 10: Hematología,NADROPARINA,2155,2155,1000021550000,010,000,2155,00,00,SI,Sustantiva,NADROPARINA SOLUCION INYECTABLE CADA JERINGA CONTIENE: NADROPARINA CALCICA 2  850 UI AXA ENVASE CON 2 JERINGAS CON 0.3 ML.,ENV,1,JGO,2850,UI,2850,UI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
400,Grupo Nº 10: Hematología,NADROPARINA,2155,2155,1000021550100,010,000,2155,01,00,NO,Sustantiva,NADROPARINA. SOLUCION INYECTABLE CADA JERINGA CONTIENE: NADROPARINA CALCICA 2 850 UI AXA. ENVASE CON 10 JERINGAS CON 0.3 ML.,CJA,10,JGA,2850,UI,28500,UI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
419,Grupo Nº 10: Hematología,DEFERASIROX,2204,2204,1000022040000,010,000,2204,00,00,SI,Catálogo II -- TORRE DE CONTROL,DEFERASIROX COMPRIMIDO CADA COMPRIMIDO CONTIENE: DEFERASIROX 125 MG ENVASE CON  28 COMPRIMIDOS.,ENV,28,COM,125,miligramos,3500,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
420,Grupo Nº 10: Hematología,DEFERASIROX,2206,2206,1000022060000,010,000,2206,00,00,SI,Catálogo II -- TORRE DE CONTROL,DEFERASIROX COMPRIMIDOCADA COMPRIMIDO CONTIENE: DEFERASIROX 500 MG ENVASE CON  28 COMPRIMIDOS.,ENV,28,COM,500,miligramos,14000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
761,Grupo Nº 10: Hematología,HEPARINA,621,0621,1000006210000,010,000,0621,00,00,SI,"Sustantiva,Uso Hospitalario, Hematología",HEPARINA SOLUCION INYECTABLE CADA FRASCO AMPULA CONTIENE: HEPARINA SODICA EQUIVALENTE A 10 000 UI DE HEPARINA. ENVASE CON 50 FRASCOS AMPULA CON 10 ML (1000 UI/ML).,ENV,50,F.A,10,mililitros,500,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
762,Grupo Nº 10: Hematología,HEPARINA,622,0622,1000006220000,010,000,0622,00,00,SI,"Entrega hospitalaria,Uso Hospitalario, Hematología",HEPARINA SOLUCION INYECTABLE CADA FRASCO AMPULA CONTIENE: HEPARINA SODICA EQUIVALENTE A 25 000 UI DE HEPARINA. ENVASE CON 50 FRASCOS AMPULA CON 5 ML (5 000 UI/ML).,ENV,50,F.A,5,mililitros,250,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
763,Grupo Nº 10: Hematología,WARFARINA,623,0623,1000006230000,010,000,0623,00,00,SI,"VALES,Sustantiva",WARFARINA. TABLETA CADA TABLETA CONTIENE: WARFARINA SODICA 5 MG ENVASE CON 25 TABLETAS.,ENV,25,TAB,5,miligramos,125,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
764,Grupo Nº 10: Hematología,ACENOCUMAROL,624,0624,1000006240002,010,000,0624,00,02,NO,"VALES,Sustantiva",ACENOCUMAROL TABLETA CADA TABLETA CONTIENE: ACENOCUMAROL 4 MG ENVASE CON 20 TABLETAS.,ENV,20,TAB,4,miligramos,80,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTICOAGULANTES_ORALES,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
765,Grupo Nº 10: Hematología,ACENOCUMAROL,624,0624,1000006240100,010,000,0624,01,00,SI,"VALES,Sustantiva",ACENOCUMAROL TABLETA CADA TABLETA CONTIENE: ACENOCUMAROL 4 MG ENVASE CON 30 TABLETAS.,ENV,30,TAB,4,miligramos,120,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTICOAGULANTES_ORALES,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
767,Grupo Nº 10: Hematología,FITOMENADIONA,626,0626,1000006260000,010,000,0626,00,00,NO,Sustantiva,FITOMENADIONA. SOLUCION O EMULSION INYECTABLE. CADA AMPOLLETA CONTIENE: FITOMENADIONA 10 MG. ENVASE CON TRES AMPOLLETAS DE 1 ML.,ENV,3,AMP,10,miligramos,30,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
768,Grupo Nº 10: Hematología,FITOMENADIONA,626,0626,1000006260100,010,000,0626,01,00,SI,Sustantiva,FITOMENADIONA SOLUCION O EMULSION INYECTABLE CADA AMPOLLETA CONTIENE: FITOMENADIONA 10 MG ENVASE CON 5 AMPOLLETAS DE 1 ML.,ENV,5,AMP,10,miligramos,50,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
873,Grupo Nº 10: Hematología,FUMARATO FERROSO,1701,1701,1000017010000,010,000,1701,00,00,SI,"VALES,Sustantiva",FUMARATO FERROSO TABLETA CADA TABLETA CONTIENE: FUMARATO FERROSO 200 MG EQUIVALENTE A 65.74 MG DE HIERRO ELEMENTAL. ENVASE CON 50 TABLETAS.,ENV,50,TAB,200,miligramos,10000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,VITAMINICOS,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1
874,Grupo Nº 10: Hematología,FUMARATO FERROSO,1702,1702,1000017020000,010,000,1702,00,00,SI,"VALES,Sustantiva",FUMARATO FERROSO SUSPENSION ORAL CADA ML CONTIENE: FUMARATO FERROSO 29 MG EQUIVALENTE A 9.53 MG DE HIERRO ELEMENTAL. ENVASE CON 120 ML.,ENV,120,ML.,38.53,miligramos,38.53,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
875,Grupo Nº 10: Hematología,SULFATO FERROSO,1703,1703,1000017030000,010,000,1703,00,00,SI,"VALES,Sustantiva",SULFATO FERROSO TABLETA CADA TABLETA CONTIENE: SULFATO FERROSO DESECADO APROXIMADAMENTE 200 MG EQUIVALENTE A 60.27 MG DE HIERRO ELEMENTAL. ENVASE CON 30 TABLETAS.,ENV,30,TAB,200,miligramos,6000,miligramos,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,VITAMINICOS,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1
876,Grupo Nº 10: Hematología,SULFATO FERROSO,1704,1704,1000017040000,010,000,1704,00,00,SI,"VALES,Sustantiva -- Meta médica",SULFATO FERROSO SOLUCION CADA ML CONTIENE: SULFATO FERROSO HEPTAHIDRATADO 125 MG EQUIVALENTE A 25 MG DE HIERRO ELEMENTAL. ENVASE GOTERO CON 15 ML.,ENV,15,ML.,150,miligramos,150,miligramos,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
877,Grupo Nº 10: Hematología,HIERRO DEXTRÁN,1705,1705,1000017050000,010,000,1705,00,00,SI,"VALES,Sustantiva",HIERRO DEXTRAN SOLUCION INYECTABLE CADA AMPOLLETA CONTIENE: HIERRO EN FORMA DE HIERRO DEXTRAN 100 MG ENVASE CON 3 AMPOLLETAS DE 2 ML.,ENV,3,AMP,100,miligramos,300,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,VITAMINICOS,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1
881,Grupo Nº 10: Hematología,HIDROXOCOBALAMINA,1708,1708,1000017080000,010,000,1708,00,00,SI,"VALES,Sustantiva",HIDROXOCOBALAMINA SOLUCION INYECTABLE CADA AMPOLLETA O FRASCO AMPULA CON SOLUCION O LIOFILIZADO CONTIENE: HIDROXOCOBALAMINA 100 MICROGRAMO ENVASE CON 3 AMPOLLETAS DE 2 ML O FRASCO AMPULA Y DILUYENTE.,ENV,3,JGO,100,microgramos,300,microgramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,VITAMINICOS,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1
884,Grupo Nº 10: Hematología,FITOMENADIONA,1732,1732,1000017320000,010,000,1732,00,00,NO,Sustantiva,FITOMENADIONA. SOLUCION O EMULSION INYECTABLE. CADA AMPOLLETA CONTIENE: FITOMENADIONA 2 MG. ENVASE CON 3 AMPOLLETAS DE 0.2 ML.,ENV,3,AMP,2,miligramos,6,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
885,Grupo Nº 10: Hematología,FITOMENADIONA,1732,1732,1000017320100,010,000,1732,01,00,SI,Sustantiva,FITOMENADIONA SOLUCION O EMULSION INYECTABLE CADA AMPOLLETA CONTIENE: FITOMENADIONA 2 MG ENVASE CON 5 AMPOLLETAS DE 0.2 ML.,ENV,5,AMP,2,miligramos,10,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1073,Grupo Nº 10: Hematología,COMPLEJO COAGULANTE ANTI-INHIBIDOR DEL FACTOR VIII,4218,4218,1000042180000,010,000,4218,00,00,SI,"Entrega hospitalaria,Uso Hospitalario, Hematología",COMPLEJO COAGULANTE ANTI-INHIBIDOR DEL FACTOR VIII. SOLUCION INYECTABLE EL  FRASCO AMPULA CON LIOFILIZADO CONTIENE: COMPLEJO COAGULANTE ANTIINHIBIDOR DEL  FACTOR VIII 500U FEIBA PROTEINA PLASMATICA HUMANA 200-600 MG. ENVASE CON,ENV,1,ENV,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1074,Grupo Nº 10: Hematología,COMPLEJO COAGULANTE ANTI-INHIBIDOR DEL FACTOR VIII,4219,4219,1000042190000,010,000,4219,00,00,SI,"Entrega hospitalaria,Uso Hospitalario, Hematología",COMPLEJO COAGULANTE ANTI-INHIBIDOR DEL FACTOR VIII SOLUCION INYECTABLE COMPLEJO COAGULANTE ANTI-INHIBIDOR DEL FACTOR VIII 1000 U FEIBA PROTEINA PLASMATICA HUMANA 400-1200 MG ENVASE CON FRASCO AMPULA CON LIOFILIZADO Y UN FRASCO CON 20,ENV,1,JGO,60,miligramos,60,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1075,Grupo Nº 10: Hematología,NADROPARINA,4222,4222,1000042220000,010,000,4222,00,00,SI,Sustantiva,NADROPARINA SOLUCION INYECTABLE CADA JERINGA PRELLENADA CONTIENE: NADROPARINA CALCICA 5700 UI AXA ENVASE CON 2 JERINGAS PRELLENADAS CON 0.6 ML.,ENV,2,JGA,5700,UI,11400,UI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1076,Grupo Nº 10: Hematología,NADROPARINA,4222,4222,1000042220102,010,000,4222,01,02,NO,Sustantiva,NADROPARINA. SOLUCION INYECTABLE. CADA JERINGA PRELLENADA CONTIENE: NADROPARINA CALCICA 5700 UI AXA. ENVASE CON 10 JERINGAS PRELLENADAS CON 0.6 ML.,ENV,10,JGA,5700,UI,57000,UI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1077,Grupo Nº 10: Hematología,NADROPARINA,4223,4223,1000042230000,010,000,4223,00,00,SI,Sustantiva,NADROPARINA SOLUCION INYECTABLE CADA JERINGA PRELLENADA CONTIENE: NADROPARINA CALCICA 3800 UI AXA ENVASE CON 2 JERINGAS PRELLENADAS CON 0.4 ML.,ENV,2,JGA,3800,UI,7600,UI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1078,Grupo Nº 10: Hematología,NADROPARINA,4223,4223,1000042230102,010,000,4223,01,02,NO,Sustantiva,NADROPARINA. SOLUCION INYECTABLE. CADA JERINGA PRELLENADA CONTIENE: NADROPARINA CALCICA 3800 UI AXA. ENVASE CON 10 JERINGAS PRELLENADAS CON 0.4 ML.,ENV,10,JGA,3800,UI,38000,UI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1079,Grupo Nº 10: Hematología,ENOXAPARINA,4224,4224,1000042240000,010,000,4224,00,00,SI,Sustantiva,ENOXAPARINA SOLUCION INYECTABLE CADA JERINGA CONTIENE ENOXAPARINA SODICA 60 MG ENVASE CON 2 JERINGAS DE 0.6 ML.,ENV,2,JGA,60,miligramos,120,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1080,Grupo Nº 10: Hematología,ENOXAPARINA,4224,4224,1000042240102,010,000,4224,01,02,NO,Sustantiva,ENOXAPARINA SOLUCION INYECTABLE CADA JERINGA CONTIENE ENOXAPARINA SODICA 60 MG ENVASE CON 2 JERINGAS CON DISPOSITIVO DE SEGURIDAD DE 0.6 ML.,ENV,2,JGA,60,miligramos,120,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1091,Grupo Nº 10: Hematología,ÁCIDO AMINOCAPROICO,4237,4237,1000042370000,010,000,4237,00,00,SI,"Sustantiva,Uso Hospitalario, Hematología",ACIDO AMINOCAPROICO SOLUCION INYECTABLE CADA FRASCO AMPULA CONTIENE: ACIDO AMINOCAPROICO 5 G ENVASE CON UN FRASCO AMPULA CON 20 ML.,ENV,1,F.A,5,gramos,5,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1092,Grupo Nº 10: Hematología,EPTACOG ALFA (FACTOR DE COAGULACIÓN VII ALFA RECOMBINANTE),4238,4238,1000042380000,010,000,4238,00,00,NO,"Entrega hospitalaria,Uso Hospitalario, Hematología,Uso Hospitalario, Hematología,Uso Hospitalario, Hematología,Entrega hospitalaria,Entrega hospitalaria",EPTACOG (FACTOR DE COAGULACION VII ALFA RECOMBINANTE). SOLUCION INYECTABLE.  CADA FRASCO AMPULA CON LIOFILIZADO CONTIENE: FACTOR DE COAGULACION VII ALFA  RECOMBINANTE 60 000 UI (1.2 MG) O 1 MG (50 KUI). ENVASE CON UN FRASCO AMPULA,ENV,1,F.A,60000,UI,60000,UI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1093,Grupo Nº 10: Hematología,EPTACOG ALFA (FACTOR DE COAGULACIÓN VII ALFA RECOMBINANTE),4238,4238,1000042380102,010,000,4238,01,02,NO,"Entrega hospitalaria,Uso Hospitalario, Hematología,Uso Hospitalario, Hematología,Uso Hospitalario, Hematología,Entrega hospitalaria,Entrega hospitalaria",EPTACOG ALFA (FACTOR DE COAGULACION VII ALFA RECOMBINANTE). SOLUCION INYECTABLE CADA FRASCO AMPULA CON LIOFILIZADO CONTIENE: FACTOR DE COAGULACION VII ALFA RECOMBINANTE 60 000 UI (1.2 MG) O 1 MG (50 KUI). ENVASE CON UN FRASCO AMPULA,ENV,1,ENV,60000,UI,60000,UI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1094,Grupo Nº 10: Hematología,EPTACOG ALFA (FACTOR DE COAGULACIÓN VII ALFA RECOMBINANTE),4238,4238,1000042380200,010,000,4238,02,00,SI,"Entrega hospitalaria,Uso Hospitalario, Hematología,Uso Hospitalario, Hematología,Uso Hospitalario, Hematología,Entrega hospitalaria,Entrega hospitalaria",EPTACOG ALFA (FACTOR DE COAGULACION VII ALFA RECOMBINANTE). SOLUCION INYECTABLE. CADA FRASCO AMPULA CON LIOFILIZADO CONTIENE: FACTOR DE COAGULACION VII ALFA RECOMBINANTE 60 000 UI (1.2 MG) O 1 MG (50 KUI). ENVASE CON UN FRASCO,ENV,1,ENV,60000,UI,60000,UI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1095,Grupo Nº 10: Hematología,FACTOR ANTIHEMOFÍLICO HUMANO,4239,4239,1000042390000,010,000,4239,00,00,SI,Entrega hospitalaria,"FACTOR ANTIHEMOFILICO HUMANO SOLUCION INYECTABLE CADA FRASCO AMPULA CON LIOFILIZADO CONTIENE: FACTOR ANTIHEMOFILICO HUMANO 250 UI ENVASE CON UN FRASCO AMPULA, FRASCO AMPULA CON DILUYENTE Y EQUIPO PARA ADMINISTRACION.",EQP,1,EQP,250,UI,250,UI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1096,Grupo Nº 10: Hematología,DEXAMETASONA,4241,4241,1000042410000,010,000,4241,00,00,SI,Sustantiva,DEXAMETASONA SOLUCION INYECTABLE CADA FRASCO AMPULA O AMPOLLETA CONTIENE: FOSFATO SODICO DE DEXAMETASONA EQUIVALENTE A 8 MG DE FOSFATO DE DEXAMETASONA. ENVASE CON UN FRASCO AMPULA O AMPOLLETA CON 2 ML.,ENV,1,AFA,8,miligramos,8,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1097,Grupo Nº 10: Hematología,ENOXAPARINA,4242,4242,1000042420000,010,000,4242,00,00,SI,Sustantiva,ENOXAPARINA SOLUCION INYECTABLE CADA JERINGA CONTIENE: ENOXAPARINA SODICA 20 MG ENVASE CON 2 JERINGAS DE 0.2 ML.,CJA,1,CJA,20,miligramos,20,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1098,Grupo Nº 10: Hematología,ENOXAPARINA,4242,4242,1000042420102,010,000,4242,01,02,NO,Sustantiva,ENOXAPARINA SOLUCION INYECTABLE CADA JERINGA CONTIENE: ENOXAPARINA SODICA 20 MG ENVASE CON 2 JERINGAS CON DISPOSITIVO DE SEGURIDAD DE 0.2 ML.,ENV,2,JGA,20,miligramos,40,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1099,Grupo Nº 10: Hematología,EPTACOG ALFA (FACTOR DE COAGULACIÓN VII ALFA RECOMBINANTE),4245,4245,1000042450000,010,000,4245,00,00,NO,"Entrega hospitalaria,Uso Hospitalario, Hematología,Uso Hospitalario, Hematología,Uso Hospitalario, Hematología,Entrega hospitalaria,Entrega hospitalaria",EPTACOG ALFA (FACTOR DE COAGULACION VII ALFA RECOMBINANTE). SOLUCION INYECTABLE. CADA FRASCO AMPULA CON LIOFILIZADO. CONTIENE: FACTOR DE COAGULACION VII ALFA RECOMBINANTE 120 000 UI (2.4 MG) O 2 MG (100 KUI). ENVASE CON UN,ENV,1,F.A,120000,UI,120000,UI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1100,Grupo Nº 10: Hematología,EPTACOG ALFA (FACTOR DE COAGULACIÓN VII ALFA RECOMBINANTE),4245,4245,1000042450102,010,000,4245,01,02,NO,"Entrega hospitalaria,Uso Hospitalario, Hematología,Uso Hospitalario, Hematología,Uso Hospitalario, Hematología,Entrega hospitalaria,Entrega hospitalaria",EPTACOG ALFA (FACTOR DE COAGULACION VII ALFA RECOMBINANTE). SOLUCION INYECTABLE CADA FRASCO AMPULA CON LIOFILIZADO CONTIENE: FACTOR DE COAGULACION VII ALFA RECOMBINANTE 120 000 UI (2.4 MG) O 2 MG (100 KUI). ENVASE CON UN FRASCO AMPULA,ENV,1,ENV,120000,UI,120000,UI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1101,Grupo Nº 10: Hematología,EPTACOG ALFA (FACTOR DE COAGULACIÓN VII ALFA RECOMBINANTE),4245,4245,1000042450200,010,000,4245,02,00,SI,"Entrega hospitalaria,Uso Hospitalario, Hematología,Uso Hospitalario, Hematología,Uso Hospitalario, Hematología,Entrega hospitalaria,Entrega hospitalaria",EPTACOG ALFA (FACTOR DE COAGULACION VII ALFA RECOMBINANTE). SOLUCION INYECTABLE. CADA FRASCO AMPULA CON LIOFILIZADO CONTIENE: FACTOR DE COAGULACION VII ALFA RECOMBINANTE 120 000 UI (2.4 MG) O 2 MG (100 KUI). ENVASE CON UN,ENV,1,ENV,120000,UI,120000,UI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1104,Grupo Nº 10: Hematología,ABCIXIMAB,4247,4247,1000042470000,010,000,4247,00,00,SI,"Entrega hospitalaria,Uso Hospitalario, Hematología",ABCIXIMAB SOLUCION INYECTABLE ABCIXIMAB 10 MG ENVASE CON UN FRASCO AMPULA (10 MG/5ML).,ENV,1,F.A,10,miligramos,10,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1105,Grupo Nº 10: Hematología,ABCIXIMAB,4247,4247,1000042470002,010,000,4247,00,02,NO,"Entrega hospitalaria,Uso Hospitalario, Hematología",ABCIXIMAB SOLUCION INYECTABLE CADA FRASCO AMPULA CONTIENE ABCIXIMAB 10 MG ENVASE CON UN FRASCO AMPULA (10 MG/5ML).,ENV,1,F.A,10,miligramos,10,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1106,Grupo Nº 10: Hematología,CONCENTRADO DE PROTEÍNAS HUMANAS COAGULABLES,4248,4248,1000042480000,010,000,4248,00,00,SI,Sin programa definido,CONCENTRADO DE PROTEINAS HUMANAS COAGULABLES SOLUCION CADA FRASCO AMPULA I CONTIENE: CONCENTRADO DE PROTEINAS HUMANAS COAGULABLES 80 A 120 MG CADA FRASCO AMPULA II CONTIENE: TROMBINA HUMANA 1800 A 2200 UI CLORURO DE CALCIO 11.2 A,ENV,1,JGO,80,miligramos,80,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1108,Grupo Nº 10: Hematología,EPTACOG ALFA (FACTOR DE COAGULACIÓN VII ALFA RECOMBINANTE),4250,4250,1000042500000,010,000,4250,00,00,NO,"Entrega hospitalaria,Uso Hospitalario, Hematología,Uso Hospitalario, Hematología,Uso Hospitalario, Hematología,Entrega hospitalaria,Entrega hospitalaria",EPTACOG ALFA (FACTOR DE COAGULACION VII ALFA RECOMBINANTE). SOLUCION INYECTABLE. CADA FRASCO AMPULA CON LIOFILIZADO CONTIENE: FACTOR DE COAGULACION VII ALFA RECOMBINANTE 240 000 UI (4.8 MG) O 5 MG (250 KUI). ENVASE CON UN,ENV,1,F.A,240000,UI,240000,UI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1109,Grupo Nº 10: Hematología,EPTACOG ALFA (FACTOR DE COAGULACIÓN VII ALFA RECOMBINANTE),4250,4250,1000042500102,010,000,4250,01,02,NO,"Entrega hospitalaria,Uso Hospitalario, Hematología,Uso Hospitalario, Hematología,Uso Hospitalario, Hematología,Entrega hospitalaria,Entrega hospitalaria",EPTACOG ALFA (FACTOR DE COAGULACION VII ALFA RECOMBINANTE). SOLUCION INYECTABLE CADA FRASCO AMPULA CON LIOFILIZADO CONTIENE: FACTOR DE COAGULACION VII ALFA RECOMBINANTE 240 000 UI (4.8 MG) O 5 MG (250 KUI). ENVASE CON UN FRASCO AMPULA,ENV,1,ENV,240000,UI,240000,UI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1110,Grupo Nº 10: Hematología,EPTACOG ALFA (FACTOR DE COAGULACIÓN VII ALFA RECOMBINANTE),4250,4250,1000042500200,010,000,4250,02,00,SI,"Entrega hospitalaria,Uso Hospitalario, Hematología,Uso Hospitalario, Hematología,Uso Hospitalario, Hematología,Entrega hospitalaria,Entrega hospitalaria",EPTACOG ALFA (FACTOR DE COAGULACION VII ALFA RECOMBINANTE). SOLUCION INYECTABLE. CADA FRASCO AMPULA CON LIOFILIZADO CONTIENE: FACTOR DE COAGULACION VII ALFA RECOMBINANTE 240 000 UI (4.8 MG) O 5 MG (250 KUI). ENVASE CON UN,ENV,1,ENV,240000,UI,240000,UI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1134,Grupo Nº 10: Hematología,CONCENTRADO DE PROTEÍNAS HUMANAS COAGULABLES,4279,4279,1000042790000,010,000,4279,00,00,SI,Sin programa definido,CONCENTRADO DE PROTEINAS HUMANAS COAGULABLES SOLUCION CADA FRASCO AMPULA I CONTIENE: CONCENTRADO DE PROTEINAS HUMANAS COAGULABLES 200 A 300 MG CADA FRASCO AMPULA II CONTIENE: TROMBINA HUMANA 4500 A 5500 UI CLORURO DE CALCIO 28,ENV,1,JGO,300,miligramos,300,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1139,Grupo Nº 10: Hematología,CONCENTRADO DE PROTEÍNAS HUMANAS COAGULABLES,4284,4284,1000042840000,010,000,4284,00,00,SI,,CONCENTRADO DE PROTEINAS HUMANAS COAGULABLES. SOLUCION CADA ML DE SOLUCION RECONSTITUIDA CONTIENE: FIBRINOGENO 70-110 MG PLASMAFIBRONECTINA 2-9 MG FACTOR XIII 10-50 UI PLASMINOGENO 0-120 MICROGRAMOS APROTININA 3000 UIK TROMBINA 4 UI,EQP,1,EQP,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1140,Grupo Nº 10: Hematología,CONCENTRADO DE PROTEÍNAS HUMANAS COAGULABLES,4288,4288,1000042880000,010,000,4288,00,00,SI,Entrega hospitalaria,CONCENTRADO DE PROTEINAS HUMANAS COAGULABLES SOLUCION CADA FRASCO AMPULA 1 CONTIENE: LIOFILIZADO TOTAL DE FIBRINOGENO CONCENTRADO 345-698 MG FIBRINOGENO (FRACCION DE PROTEINA DE PLASMA HUMANO) 195-345 MG FACTOR XIII 120-240 U CADA,ENV,1,ENV,345,miligramos,345,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1328,Grupo Nº 10: Hematología,FACTOR IX,5238,5238,1000052380000,010,000,5238,00,00,SI,"Entrega hospitalaria,Uso Hospitalario, Hematología,Entrega hospitalaria",FACTOR IX SOLUCION INYECTABLE CADA FRASCO AMPULA CON LIOFILIZADO CONTIENE: FACTOR IX 400 A 600 UI ENVASE CON UN FRASCO AMPULA Y DILUYENTE.,ENV,500,UND,500,UI,500,UI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1329,Grupo Nº 10: Hematología,FACTOR IX,5238,5238,1000052380006,010,000,5238,00,06,NO,"Entrega hospitalaria,Uso Hospitalario, Hematología,Entrega hospitalaria",FACTOR IX SOLUCION INYECTABLE CADA FRASCO AMPULA CON LIOFILIZADO CONTIENE:  FACTOR IX 400 A 600 UI ENVASE CON UN FRASCO AMPULA Y DILUYENTE.,ENV,600,UND,600,UI,600,UI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1336,Grupo Nº 10: Hematología,INTERFERÓN,5245,5245,1000052450002,010,000,5245,00,02,NO,Sustantiva -- presentación emisión en 5,"INTERFERON. SOLUCION INYECTABLE. CADA FRASCO AMPULA O JERINGA CONTIENE: INTERFERON ALFA 2A 4.5 O 9 MILLONES UI. ENVASE CON UN FRASCO AMPULA O JERINGA CON UNA AGUJA. O CADA FRASCO AMPULA CONTIENE: INTERFERON ALFA 2B 5, 18 O 25",ENV,1,ENV,9000000,UI,9000000,UI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1337,Grupo Nº 10: Hematología,INTERFERÓN,5245,5245,1000052450100,010,000,5245,01,00,SI,Sustantiva -- presentación emisión en 5,"INTERFERON ALFA 2B SOLUCION INYECTABLE CADA FRASCO AMPULA O JERINGA CONTIENE: INTERFERON ALFA 2A, 4.5 O 9 MILLONES UI. CADA FRASCO AMPULA CONTIENE: INTERFERON ALFA 2B 5, 18 O 25 MILLONES UI ENVASE CON UN FRASCO AMPULA CON O",U.I,1,MLL,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1338,Grupo Nº 10: Hematología,APROTININA,5246,5246,1000052460000,010,000,5246,00,00,SI,"Sustantiva,Uso Hospitalario, Hematología",APROTININA SOLUCION INYECTABLE CADA ML CONTIENE: APROTININA 10 000 UIK ENVASE  CON FRASCO AMPULA CON 50 ML (500 000 UIK).,ENV,1,F.A,50,mililitros,50,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1343,Grupo Nº 10: Hematología,FACTOR VIII RECOMBINANTE,5252,5252,1000052520000,010,000,5252,00,00,SI,"Entrega hospitalaria,Uso Hospitalario, Hematología","FACTOR VIII RECOMBINANTE SOLUCION INYECTABLE CADA FRASCO AMPULA CON LIOFILIZADO  CONTIENE: FACTOR VIII RECOMBINANTE 250 UI ENVASE CON UN FRASCO AMPULA CON  LIOFILIZADO, UN FRASCO AMPULA CON 10 ML DE DILUYENTE O JERINGA CON 2.5 ML DE",ENV,1,ENV,250,UI,250,UI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1344,Grupo Nº 10: Hematología,FACTOR VIII RECOMBINANTE,5253,5253,1000052530000,010,000,5253,00,00,SI,"Entrega hospitalaria,Uso Hospitalario, Hematología","FACTOR VIII RECOMBINANTE SOLUCION INYECTABLE CADA FRASCO AMPULA CON LIOFILIZADO  CONTIENE: FACTOR VIII RECOMBINANTE 500 UI ENVASE CON UN FRASCO AMPULA CON  LIOFILIZADO, UN FRASCO AMPULA CON 10 ML DE DILUYENTE O JERINGA CON 2.5 ML DE",ENV,1,ENV,500,UI,500,UI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
418,Grupo Nº 11: Intoxicaciones,PENICILAMINA,2202,2202,1000022020000,010,000,2202,00,00,SI,Sustantiva,PENICILAMINA CADA TABLETA CONTIENE: PENICILAMINA 300 MG ENVASE CON 50 TABLETAS.,ENV,50,TAB,300,miligramos,15000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
427,Grupo Nº 11: Intoxicaciones,"METILTIONINO, CLORURO DE (Azul de metileno)",2231,2231,1000022310000,010,000,2231,00,00,SI,Sustantiva,METILTIONINO CLORURO DE (AZUL DE METILENO) SOLUCION INYECTABLE CADA AMPOLLETA  CONTIENE: CLORURO DE METILTIONINO TRIHIDRATADO 100 MG ENVASE CON UNA 1  AMPOLLETA CON 10 ML.,ENV,1,AMP,100,miligramos,100,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
428,Grupo Nº 11: Intoxicaciones,CARBÓN ACTIVADO,2242,2242,1000022420000,010,000,2242,00,00,SI,Entrega hospitalaria,CARBON ACTIVADO POLVO CADA ENVASE CONTIENE: CARBON ACTIVADO 1 KG ENVASE CON UN  KG. (PARA USO EN SERES HUMANOS).,ENV,1,KG.,1000,gramos,1000,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
604,Grupo Nº 11: Intoxicaciones,NALOXONA,302,0302,4000003020000,040,000,0302,00,00,SI,"Entrega hospitalaria,Entrega hospitalaria",NALOXONA. SOLUCION INYECTABLE CADA AMPOLLETA CONTIENE: CLORHIDRATO DE NALOXONA 0.4 MG. AMPOLLETA DE 1 ML.,ENV,10,AMP,0.4,miligramos,4,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
605,Grupo Nº 11: Intoxicaciones,NALOXONA,302,0302,4000003020002,040,000,0302,00,02,NO,"Entrega hospitalaria,Entrega hospitalaria",NALOXONA. SOLUCION INYECTABLE. CADA AMPOLLETA CONTIENE: CLORHIDRATO DE NALOXONA 0.4 MG. ENVASE CON 10 AMPOLLETAS CON 1 ML.,ENV,10,AMP,0.4,miligramos,4,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
656,Grupo Nº 11: Intoxicaciones,FLUMAZENIL,4054,4054,4000040540000,040,000,4054,00,00,SI,Sustantiva,FLUMAZENIL SOLUCION INYECTABLE CADA AMPOLLETA CONTIENE: FLUMAZENIL 0.5 MG  ENVASE CON UNA AMPOLLETA CON 5 ML (0.1 MG/ML).,ENV,1,AMP,0.5,miligramos,0.5,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
674,Grupo Nº 11: Intoxicaciones,NICOTINA,80,0080,1000000800000,010,000,0080,00,00,SI,Sin programa definido,NICOTINA TABLETA MASTICABLE CADA TABLETA DE GOMA MASTICABLE CONTIENE:COMPLEJO DE RESINA DE NICOTINA AL 20% EQUIVALENTE A 2.0 MG DE NICOTINA. ENVASE CON 30 TABLETAS DE GOMA MASTICABLE,ENV,30,TAB,2,miligramos,60,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
704,Grupo Nº 11: Intoxicaciones,NEOSTIGMINA,291,0291,1000002910000,010,000,0291,00,00,SI,"Sustantiva,Uso Hospitalario, Intoxicaciones",NEOSTIGMINA SOLUCION INYECTABLE CADA AMPOLLETA CONTIENE: METILSULFATO DE NEOSTIGMINA 0.5 MG ENVASE CON 6 AMPOLLETAS CON 1 ML.,ENV,6,AMP,0.5,miligramos,3,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
766,Grupo Nº 11: Intoxicaciones,PROTAMINA,625,0625,1000006250000,010,000,0625,00,00,SI,"Sustantiva,Uso Hospitalario, Intoxicaciones",PROTAMINA SOLUCION INYECTABLE CADA AMPOLLETA DE 5 MILILITROS CONTIENE: SULFATO DE PROTAMINA 71.5 MG ENVASE CON AMPOLLETA CON 5 ML.,ENV,1,AMP,71.5,miligramos,71.5,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1166,Grupo Nº 11: Intoxicaciones,ACETILCISTEÍNA,4326,4326,1000043260000,010,000,4326,00,00,SI,Sustantiva,ACETILCISTEINA SOLUCION AL 20% CADA AMPOLLETA CONTIENE: ACETILCISTEINA 400 MG ENVASE CON 5 AMPOLLETAS CON 2 ML (200 MG/ML).,ENV,5,AMP,400,miligramos,2000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
11,Grupo Nº 12: Nefrología y Urología,ALFA CETOANÁLOGOS DE AMINOÁCIDOS,5304,5304,1000053040000,010,000,5304,00,00,SI,Sustantiva,"ALFA CETOANALOGOS DE AMINOACIDOS GRAGEA, TABLETA RECUBIERTA O TABLETA CADA  GRAGEA, TABLETA RECUBIERTA O TABLETA CONTIENE: ALFA CETOANALOGOS DE  AMINOACIDOS 630 MG ENVASE CON 100 GRAGEAS, TABLETAS RECUBIERTAS O TABLETAS.",ENV,100,T.G,630,miligramos,63000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,FARMACOS_UTILIZADOS_EN_NEFROLOGIA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0
12,Grupo Nº 12: Nefrología y Urología,ÁCIDO MICOFENÓLICO,5306,5306,1000053060000,010,000,5306,00,00,SI,Sustantiva,ACIDO MICOFENOLICO COMPRIMIDO CADA COMPRIMIDO CONTIENE: MICOFENOLATO DE  MOFETILO 500 MG ENVASE CON 50 COMPRIMIDOS,ENV,50,COM,500,miligramos,25000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
13,Grupo Nº 12: Nefrología y Urología,BASILIXIMAB,5308,5308,1000053080002,010,000,5308,00,02,NO,"Entrega hospitalaria,Uso Hospitalario, Nefrología y Urología,Uso Hospitalario, Nefrología y Urología,Entrega hospitalaria",BASILIXIMAB. SOLUCION INYECTABLE. CADA FRASCO AMPULA CON LIOFILIZADO CONTIENE: BASILIXIMAB 20 MG. ENVASE CON 1 FRASCO AMPULA Y 1 AMPOLLETA CON 5 ML DE DILUYENTE.,ENV,1,F.A,20,miligramos,20,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
14,Grupo Nº 12: Nefrología y Urología,BASILIXIMAB,5308,5308,1000053080100,010,000,5308,01,00,SI,"Entrega hospitalaria,Uso Hospitalario, Nefrología y Urología,Uso Hospitalario, Nefrología y Urología,Entrega hospitalaria",BASILIXIMAB SOLUCION INYECTABLE CADA FRASCO AMPULA CON LIOFILIZADO CONTIENE:  BASILIXIMAB 20 MG ENVASE CON 2 FRASCOS AMPULA Y 2 AMPOLLETAS CON 5 ML DE  DILUYENTE.,ENV,2,F.A,20,miligramos,40,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
15,Grupo Nº 12: Nefrología y Urología,TAMSULOSINA,5309,5309,1000053090003,010,000,5309,00,03,NO,"VALES,Sustantiva",TAMSULOSINA. CAPSULA O TABLETA DE LIBERACION PROLONGADA CADA CAPSULA O TABLETA DE LIBERACION PROLONGADA CONTIENE: CLORHIDRATO DE TAMSULOSINA 0.4 MG ENVASE CON 10 CAPSULAS O TABLETAS DE LIBERACION PROLONGADA.,ENV,10,C.T,0.4,miligramos,4,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,BLOQUEADORES_ALFA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
16,Grupo Nº 12: Nefrología y Urología,TAMSULOSINA,5309,5309,1000053090101,010,000,5309,01,01,SI,"VALES,Sustantiva",TAMSULOSINA. CAPSULA O TABLETA DE LIBERACION PROLONGADA CADA CAPSULA O TABLETA DE LIBERACION PROLONGADA CONTIENE: CLORHIDRATO DE TAMSULOSINA 0.4 MG ENVASE CON 20 CAPSULAS O TABLETAS DE LIBERACION PROLONGADA.,ENV,20,C.T,0.4,miligramos,8,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,BLOQUEADORES_ALFA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
17,Grupo Nº 12: Nefrología y Urología,TAMSULOSINA,5309,5309,1000053090202,010,000,5309,02,02,NO,"VALES,Sustantiva",TAMSULOSINA. CAPSULA O TABLETA DE LIBERACION PROLONGADA CADA CAPSULA O TABLETA DE LIBERACION PROLONGADA CONTIENE: CLORHIDRATO DE TAMSULOSINA 0.4 MG ENVASE CON 30 CAPSULAS O TABLETAS DE LIBERACION PROLONGADA.,ENV,30,C.T,0.4,miligramos,12,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,BLOQUEADORES_ALFA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
31,Grupo Nº 12: Nefrología y Urología,ERITROPOYETINA,5332,5332,1000053320000,010,000,5332,00,00,SI,Sustantiva,ERITROPOYETINA SOLUCION INYECTABLE CADA FRASCO AMPULA CON LIOFILIZADO O  SOLUCION CONTIENE: ERITROPOYETINA HUMANA RECOMBINANTE O ERITROPOYETINA HUMANA  RECOMBINANTE ALFA O ERITROPOYETINA BETA 2000 UI ENVASE CON 12 FRASCOS AMPULA 1,ENV,12,F.A,2000,UI,24000,UI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,FARMACOS_UTILIZADOS_EN_NEFROLOGIA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0
32,Grupo Nº 12: Nefrología y Urología,ERITROPOYETINA,5333,5333,1000053330000,010,000,5333,00,00,SI,Sustantiva,ERITROPOYETINA SOLUCION INYECTABLE CADA FRASCO AMPULA CON LIOFILIZADO O SOLUCION CONTIENE: ERITROPOYETINA HUMANA RECOMBINANTE O ERITROPOYETINA HUMANA RECOMBINANTE ALFA O ERITROPOYETINA BETA 4000 UI ENVASE CON 6 FRASCOS AMPULA,ENV,6,F.A,4000,UI,24000,UI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
33,Grupo Nº 12: Nefrología y Urología,ERITROPOYETINA,5333,5333,1000053330002,010,000,5333,00,02,NO,Sustantiva,ERITROPOYETINA. SOLUCION INYECTABLE. CADA FRASCO AMPULA CON LIOFILIZADO O SOLUCION CONTIENE: ERITROPOYETINA HUMANA RECOMBINANTE O ERITROPOYETINA HUMANA RECOMBINANTE ALFA O ERITROPOYETINA BETA 4000 UI. ENVASE CON 6 FRASCOS AMPULA,ENV,6,F.A,4000,UI,24000,UI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
34,Grupo Nº 12: Nefrología y Urología,ERITROPOYETINA,5333,5333,1000053330100,010,000,5333,01,00,NO,Sustantiva,ERITROPOYETINA. SOLUCION INYECTABLE. CADA FRASCO AMPULA CON LIOFILIZADO O SOLUCION CONTIENE: ERITROPOYETINA HUMANA RECOMBINANTE O ERITROPOYETINA HUMANA RECOMBINANTE ALFA O ERITROPOYETINA BETA 4000 UI. ENVASE CON 1 JERINGA,ENV,1,JGA,4000,UI,4000,UI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
35,Grupo Nº 12: Nefrología y Urología,ERITROPOYETINA,5333,5333,1000053330200,010,000,5333,02,00,NO,Sustantiva,ERITROPOYETINA. SOLUCION INYECTABLE. CADA FRASCO AMPULA CON LIOFILIZADO O SOLUCION CONTIENE: ERITROPOYETINA HUMANA RECOMBINANTE O ERITROPOYETINA HUMANA RECOMBINANTE ALFA O ERITROPOYETINA BETA 4000 UI. ENVASE CON 6 JERINGAS,ENV,6,JGA,4000,UI,24000,UI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
36,Grupo Nº 12: Nefrología y Urología,ERITROPOYETINA,5339,5339,1000053390002,010,000,5339,00,02,NO,"Entrega hospitalaria,Entrega hospitalaria",ERITROPOYETINA. SOLUCION INYECTABLE. CADA FRASCO AMPULA CON LIOFILIZADO O SOLUCION CONTIENE: ERITROPOYETINA BETA O ERITROPOYETINA HUMANA RECOMBINANTE 50 000 UI ENVASE CON 1 FRASCO AMPULA Y 1 AMPOLLETA CON DILUYENTE.,ENV,1,JGO,50000,UI,50000,UI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
37,Grupo Nº 12: Nefrología y Urología,ERITROPOYETINA,5339,5339,1000053390100,010,000,5339,01,00,SI,"Entrega hospitalaria,Entrega hospitalaria",ERITROPOYETINA. SOLUCION INYECTABLE. CADA FRASCO AMPULA CON LIOFILIZADO O SOLUCION CONTIENE: ERITROPOYETINA BETA O ERITROPOYETINA HUMANA RECOMBINANTE 50 000 UI ENVASE CON UN FRASCO AMPULA CON 10 ML DE SOLUCION.,ENV,1,FCO,50000,UI,50000,UI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
263,Grupo Nº 12: Nefrología y Urología,SEVELÁMERO,6084,6084,1000060840000,010,000,6084,00,00,SI,,SEVELAMERO. TABLETA. CADA TABLETA CONTIENE: CARBONATO DE SEVELAMERO 800 MG. ENVASE CON 180 TABLETAS.,ENV,180,TAB,800,miligramos,144000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
432,Grupo Nº 12: Nefrología y Urología,HIDROCLOROTIAZIDA,2301,2301,1000023010000,010,000,2301,00,00,SI,"VALES,Consumo en demanda",HIDROCLOROTIAZIDA TABLETA CADA TABLETA CONTIENE: HIDROCLOROTIAZIDA 25 MG ENVASE  CON 20 TABLETAS.,ENV,20,TAB,25,miligramos,500,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,ANTIHIPERTENSIVOS,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
433,Grupo Nº 12: Nefrología y Urología,ACETAZOLAMIDA,2302,2302,1000023020000,010,000,2302,00,00,SI,Sustantiva,ACETAZOLAMIDA TABLETA CADA TABLETA CONTIENE: ACETAZOLAMIDA 250 MG ENVASE CON 20  TABLETAS.,ENV,20,TAB,250,miligramos,5000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
434,Grupo Nº 12: Nefrología y Urología,ESPIRONOLACTONA,2304,2304,1000023040002,010,000,2304,00,02,NO,"VALES,Sustantiva",ESPIRONOLACTONA. TABLETA. CADA TABLETA CONTIENE: ESPIRO NOLACTONA 25 MG. ENVASE CON 20 TABLETAS.,ENV,20,TAB,25,miligramos,500,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,ANTIHIPERTENSIVOS,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
435,Grupo Nº 12: Nefrología y Urología,ESPIRONOLACTONA,2304,2304,1000023040100,010,000,2304,01,00,SI,"VALES,Sustantiva",ESPIRONOLACTONA TABLETA CADA TABLETA CONTIENE: ESPIRONOLACTONA 25 MG ENVASE CON  30 TABLETAS.,ENV,30,TAB,25,miligramos,750,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,ANTIHIPERTENSIVOS,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
436,Grupo Nº 12: Nefrología y Urología,MANITOL,2306,2306,1000023060000,010,000,2306,00,00,SI,"Sustantiva,Uso Hospitalario, Nefrología y Urología",MANITOL SOLUCION INYECTABLE AL 20% CADA ENVASE CONTIENE: MANITOL 50 G ENVASE  CON 250 ML.,ENV,250,ML.,50,gramos,50,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
437,Grupo Nº 12: Nefrología y Urología,FUROSEMIDA,2307,2307,1000023070000,010,000,2307,00,00,SI,"VALES,Consumo en demanda",FUROSEMIDA TABLETA CADA TABLETA CONTIENE: FUROSEMIDA 40 MG ENVASE CON 20  TABLETAS.,ENV,20,TAB,40,miligramos,800,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,ANTIHIPERTENSIVOS,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
438,Grupo Nº 12: Nefrología y Urología,FUROSEMIDA,2308,2308,1000023080000,010,000,2308,00,00,SI,Sustantiva,FUROSEMIDA SOLUCION INYECTABLE CADA AMPOLLETA CONTIENE: FUROSEMIDA 20 MG ENVASE  CON 5 AMPOLLETAS DE 2 ML.,ENV,5,AMP,20,miligramos,100,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
439,Grupo Nº 12: Nefrología y Urología,FENAZOPIRIDINA,2331,2331,1000023310000,010,000,2331,00,00,SI,"VALES,Sustantiva",FENAZOPIRIDINA TABLETA CADA TABLETA CONTIENE: CLORHIDRATO DE FENAZOPIRIDINA 100  MG ENVASE CON 20 TABLETAS.,ENV,20,TAB,100,miligramos,2000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,ANALGESICOS_URINARIOS,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
441,Grupo Nº 12: Nefrología y Urología,SOLUCIÓN PARA DIÁLISIS PERITONEAL BAJA EN MAGNESIO,2350,2350,1000023500001,010,000,2350,00,01,SI,"Sustantiva,Uso Hospitalario, Nefrología y Urología,Uso Hospitalario, Nefrología y Urología",SOLUCION PARA DIALISIS PERITONEAL BAJA EN MAGNESIO. SOLUCION PARA DIALISIS PERITONEAL AL 1.5%. CADA 100 ML CONTIENEN: GLUCOSA MONOHIDRATADA: 1.5 G. CLORURO DE SODIO 538 MG. CLORURO DE CALCIO DIHIDRATADO 25.7 MG. CLORURO DE,ENV,1,ENV,2.0637,gramos,2.0637,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
442,Grupo Nº 12: Nefrología y Urología,SOLUCIÓN PARA DIÁLISIS PERITONEAL BAJA EN MAGNESIO CON SISTEMA DE DOBLE BOLSA,2352,2352,1000023520001,010,000,2352,00,01,SI,Sustantiva,SOLUCION PARA DIALISIS PERITONEAL BAJA EN MAGNESIO CON SISTEMA DE DOBLE BOLSA. SOLUCION PARA DIALISIS PERITONEAL AL 2.5%. CADA 100 ML CONTIENEN: GLUCOSA MONOHIDRATADA 2.5 G. CLORURO DE SODIO 538 MG. CLORURO DE CALCIO DIHIDRATADO,ENV,1,JGO,3.038,gramos,3.038,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
443,Grupo Nº 12: Nefrología y Urología,SOLUCIÓN PARA DIÁLISIS PERITONEAL BAJA EN MAGNESIO,2353,2353,1000023530001,010,000,2353,00,01,SI,"Sustantiva,Uso Hospitalario, Nefrología y Urología,Uso Hospitalario, Nefrología y Urología",SOLUCION PARA DIALISIS PERITONEAL BAJA EN MAGNESIO. SOLUCION PARA DIALISIS PERITONEAL AL 2.5%. CADA 100 ML CONTIENEN: GLUCOSA MONOHIDRATADA 2.5 G. CLORURO DE SODIO 538 MG. CLORURO DE CALCIO DIHIDRATADO 25.7 MG. CLORURO DE MAGNESIO,ENV,1,ENV,3.0637,gramos,3.0637,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
444,Grupo Nº 12: Nefrología y Urología,SOLUCIÓN PARA DIÁLISIS PERITONEAL BAJA EN MAGNESIO CON SISTEMA DE DOBLE BOLSA,2354,2354,1000023540001,010,000,2354,00,01,SI,Sustantiva,SOLUCION PARA DIALISIS PERITONEAL BAJA EN MAGNESIO CON SISTEMA DE DOBLE BOLSA. SOLUCION PARA DIALISIS PERITONEAL AL 4.25%. CADA 100 ML CONTIENEN: GLUCOSA MONOHIDRATADA 4.25 G. CLORURO DE SODIO 538 MG. CLORURO DE CALCIO DIHIDRATADO,ENV,1,JGO,4.788,gramos,4.788,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
445,Grupo Nº 12: Nefrología y Urología,SOLUCIÓN PARA DIÁLISIS PERITONEAL BAJA EN MAGNESIO,2355,2355,1000023550001,010,000,2355,00,01,SI,"Sin programa definido,Uso Hospitalario, Nefrología y Urología,Uso Hospitalario, Nefrología y Urología",SOLUCION PARA DIALISIS PERITONEAL BAJA EN MAGNESIO. SOLUCION PARA DIALISIS PERITONEAL AL 4.25%. CADA 100 ML CONTIENEN: GLUCOSA MONOHIDRATADA 4.25 G. CLORURO DE SODIO 538 MG. CLORURO DE CALCIO DIHIDRATADO 25.7 MG. CLORURO DE,ENV,1,ENV,4.8137,gramos,4.8137,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
446,Grupo Nº 12: Nefrología y Urología,SOLUCIÓN PARA DIÁLISIS PERITONEAL BAJA EN MAGNESIO CON SISTEMA DE DOBLE BOLSA,2356,2356,1000023560001,010,000,2356,00,01,SI,Sustantiva,SOLUCION PARA DIALISIS PERITONEAL BAJA EN MAGNESIO CON SISTEMA DE DOBLE BOLSA. SOLUCION PARA DIALISIS PERITONEAL AL 1.5%. CADA 100 ML CONTIENEN: GLUCOSA MONOHIDRATADA 1.5 G. CLORURO DE SODIO 538 MG. CLORURO DE CALCIO DIHIDRATADO,ENV,1,JGO,2.038,gramos,2.038,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
447,Grupo Nº 12: Nefrología y Urología,SOLUCIÓN PARA DIÁLISIS PERITONEAL CON ICODEXTRINA,2363,2363,1000023630000,010,000,2363,00,00,SI,"Sin programa definido,Uso Hospitalario, Nefrología y Urología",SOLUCION PARA DIALISIS PERITONEAL CON ICODEXTRINA SOLUCION CADA 100 ML  CONTIENEN: ICODEXTRINA 7.5000 G CLORURO DE SODIO 0.5400 G LACTATO DE SODIO  0.4500 G CLORURO DE CALCIO DIHIDRATADO 0.0257 G CLORURO DE MAGNESIO,ENV,1,ENV,8.5157,gramos,8.5157,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
449,Grupo Nº 12: Nefrología y Urología,SISTEMA INTEGRAL PARA LA APLICACIÓN DE DIÁLISIS PERITONEAL CONTINUA AMBULATORIA,2365,2365,1000023650000,010,000,2365,00,00,SI,Sin programa definido,SISTEMA INTEGRAL PARA LA APLICACION DE DIALISIS PERITONEAL CONTINUA AMBULATORIA  LAS UNIDADES MEDICAS SELECCIONARAN DE ACUERDO A SUS NECESIDADES: SOLUCION PARA  DIALISIS PERITONEAL BAJA EN MAGNESIO SOLUCION PARA DIALISIS PERITONEAL AL 1.5%,JGO,1,JGO,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
450,Grupo Nº 12: Nefrología y Urología,SISTEMA INTEGRAL PARA LA APLICACIÓN DE DIÁLISIS PERITONEAL AUTOMATIZADA,2366,2366,1000023660000,010,000,2366,00,00,SI,Sin programa definido,"SISTEMA INTEGRAL PARA LA APLICACION DE DIALISIS PERITONEAL AUTOMATIZADA LAS  UNIDADES MEDICAS SELECCIONARAN DE ACUERDO A SUS NECESIDADES, ASEGURANDO SU  COMPATIBILIDAD CON LA MARCA Y MODELO DEL EQUIPO: SOLUCION PARA DIALISIS",JGO,1,JGO,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
741,Grupo Nº 12: Nefrología y Urología,CLORTALIDONA,561,0561,1000005610000,010,000,0561,00,00,SI,"VALES,Sustantiva",CLORTALIDONA TABLETA CADA TABLETA CONTIENE: CLORTALIDONA 50 MG ENVASE CON 20 TABLETAS.,ENV,20,TAB,50,miligramos,1000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,ANTIHIPERTENSIVOS,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1087,Grupo Nº 12: Nefrología y Urología,INMUNOGLOBULINA ANTILINFOCITOS T HUMANOS,4231,4231,1000042310000,010,000,4231,00,00,SI,"Entrega hospitalaria,Uso Hospitalario, Nefrología y Urología",INMUNOGLOBULINA ANTILINFOCITOS T HUMANOS SOLUCION INYECTABLE CADA FRASCO AMPULA CONTIENE: INMUNOGLOBULINA ANTILINFOCITOS T HUMANOS OBTENIDA DE CONEJO 25 MG ENVASE CON FRASCO AMPULA CON POLVO LIOFILIZADO.,ENV,1,F.A,25,miligramos,25,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1089,Grupo Nº 12: Nefrología y Urología,INMUNOGLOBULINA ANTILINFOCITOS T HUMANOS,4234,4234,1000042340000,010,000,4234,00,00,SI,"Sustantiva,Uso Hospitalario, Nefrología y Urología",INMUNOGLOBULINA ANTILINFOCITOS T HUMANOS SOLUCION INYECTABLE CADA ML CONTIENE: GLOBULINA ANTILINFOCITO HUMANO 50 MG ENVASE CON 10 FRASCOS AMPULA CON 10 ML.,ENV,10,F.A,50,miligramos,500,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1090,Grupo Nº 12: Nefrología y Urología,CICLOSPORINA,4236,4236,1000042360000,010,000,4236,00,00,SI,"Sustantiva,Uso Hospitalario, Nefrología y Urología",CICLOSPORINA SOLUCION INYECTABLE CADA AMPOLLETA CONTIENE: CICLOSPORINA 50 MG ENVASE CON 10 AMPOLLETAS CON UN ML.,ENV,10,AMP,50,miligramos,500,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1145,Grupo Nº 12: Nefrología y Urología,CICLOSPORINA,4294,4294,1000042940000,010,000,4294,00,00,SI,Sustantiva,CICLOSPORINA EMULSION ORAL CADA ML CONTIENE: CICLOSPORINA MODIFICADA O CICLOSPORINA EN MICROEMULSION 100 MG ENVASE CON 50 ML Y PIPETA DOSIFICADORA.,ENV,1,JGO,100,miligramos,100,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1146,Grupo Nº 12: Nefrología y Urología,CICLOSPORINA,4298,4298,1000042980000,010,000,4298,00,00,SI,Sustantiva,CICLOSPORINA CAPSULA DE GELATINA BLANDA CADA CAPSULA CONTIENE: CICLOSPORINA MODIFICADA O CICLOSPORINA EN MICROEMULSION 100 MG ENVASE CON 50 CAPSULAS,ENV,50,CAP,100,miligramos,5000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1150,Grupo Nº 12: Nefrología y Urología,TOLTERODINA,4304,4304,1000043040000,010,000,4304,00,00,SI,"VALES,Sustantiva",TOLTERODINA TABLETA CADA TABLETA CONTIENE: L TARTRATO DE TOLTERODINA 2 MG ENVASE CON 14 TABLETAS.,ENV,14,TAB,2,miligramos,28,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,ANTIMUSCARINICOS,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1151,Grupo Nº 12: Nefrología y Urología,TOLTERODINA,4304,4304,1000043040102,010,000,4304,01,02,NO,"VALES,Sustantiva",TOLTERODINA. TABLETA. CADA TABLETA CONTIENE: L TARTRATO DE TOLTERODINA 2 MG. ENVASE CON 28 TABLETAS.,ENV,28,TAB,2,miligramos,56,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,ANTIMUSCARINICOS,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1152,Grupo Nº 12: Nefrología y Urología,OXIBUTININA,4305,4305,1000043050000,010,000,4305,00,00,SI,Sustantiva,OXIBUTININA TABLETA CADA TABLETA CONTIENE: CLORURO DE OXIBUTININA 5 MG ENVASE CON 30 TABLETAS.,ENV,30,TAB,5,miligramos,150,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1153,Grupo Nº 12: Nefrología y Urología,OXIBUTININA,4305,4305,1000043050102,010,000,4305,01,02,NO,Sustantiva,OXIBUTININA. TABLETA. CADA TABLETA CONTIENE: CLORURO DE OXIBUTININA 5 MG. ENVASE CON 50 TABLETAS.,ENV,50,TAB,5,miligramos,250,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1154,Grupo Nº 12: Nefrología y Urología,CICLOSPORINA,4306,4306,1000043060000,010,000,4306,00,00,SI,Sustantiva,CICLOSPORINA CAPSULA DE GELATINA BLANDA CADA CAPSULA CONTIENE: CICLOSPORINA MODIFICADA O CICLOSPORINA EN MICROEMULSION 25 MG ENVASE CON 50 CAPSULAS.,ENV,50,CAP,25,miligramos,1250,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1156,Grupo Nº 12: Nefrología y Urología,SILDENAFIL,4308,4308,1000043080002,010,000,4308,00,02,NO,"VALES,Sustantiva",SILDENAFIL. TABLETA. CADA TABLETA CONTIENE: CITRATO DE SILDENAFIL EQUIVALENTE A SILDENAFIL 50 MG. ENVASE CON 1 TABLETA.,ENV,1,TAB,50,miligramos,50,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,DISFUNCION_ERECTIL,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1157,Grupo Nº 12: Nefrología y Urología,SILDENAFIL,4308,4308,1000043080100,010,000,4308,01,00,SI,"VALES,Sustantiva",SILDENAFIL TABLETA CADA TABLETA CONTIENE: CITRATO DE SILDENAFIL EQUIVALENTE A SILDENAFIL 50 MG ENVASE CON 4 TABLETAS.,ENV,4,TAB,50,miligramos,200,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,DISFUNCION_ERECTIL,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1158,Grupo Nº 12: Nefrología y Urología,SILDENAFIL,4308,4308,1000043080200,010,000,4308,02,00,NO,"VALES,Sustantiva",SILDENAFIL. CADA LAMINILLA CONTIENE: CITRATO DE SILDENAFIL EQUIVALENTE A SILDENAFIL 50 MG ENVASE CON 1 LAMINILLA.,ENV,1,LMI,50,miligramos,50,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,DISFUNCION_ERECTIL,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1159,Grupo Nº 12: Nefrología y Urología,SILDENAFIL,4309,4309,1000043090000,010,000,4309,00,00,NO,"VALES,Sustantiva",SILDENAFIL. TABLETA. CADA TABLETA CONTIENE: CITRATO DE SILDENAFIL EQUIVALENTE A SILDENAFIL 100 MG. ENVASE CON 1 TABLETA.,ENV,1,TAB,100,miligramos,100,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1160,Grupo Nº 12: Nefrología y Urología,SILDENAFIL,4309,4309,1000043090100,010,000,4309,01,00,SI,"VALES,Sustantiva",SILDENAFIL TABLETA CADA TABLETA CONTIENE: CITRATO DE SILDENAFIL EQUIVALENTE A SILDENAFIL 100 MG ENVASE CON 4 TABLETAS.,ENV,4,TAB,100,miligramos,400,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1161,Grupo Nº 12: Nefrología y Urología,VARDENAFIL,4311,4311,1000043110000,010,000,4311,00,00,NO,Sustantiva,VARDENAFIL. TABLETA. CADA TABLETA CONTIENE: CLORHIDRATO DE VARDENAFIL TRIHIDRATADO EQUIVALENTE A 20 MG DE VARDENAFIL. ENVASE CON 1 TABLETA.,ENV,1,TAB,20,miligramos,20,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1162,Grupo Nº 12: Nefrología y Urología,VARDENAFIL,4311,4311,1000043110100,010,000,4311,01,00,SI,Sustantiva,VARDENAFIL TABLETA CADA TABLETA CONTIENE: CLORHIDRATO DE VARDENAFIL TRIHIDRATADO EQUIVALENTE A 20 MG DE VARDENAFIL. ENVASE CON 4 TABLETA.,ENV,4,TAB,20,miligramos,80,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1262,Grupo Nº 12: Nefrología y Urología,TACROLIMUS,5082,5082,1000050820000,010,000,5082,00,00,NO,"Entrega hospitalaria,Entrega hospitalaria",TACROLIMUS. CAPSULA. CADA CAPSULA CONTIENE: TACROLIMUS MONOHIDRATADO EQUIVALENTE A 5 MG DE TACROLIMUS. ENVASE CON 50 CAPSULAS.,ENV,50,CAP,5,miligramos,250,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1263,Grupo Nº 12: Nefrología y Urología,TACROLIMUS,5082,5082,1000050820100,010,000,5082,01,00,SI,"Entrega hospitalaria,Entrega hospitalaria",TACROLIMUS CAPSULA CADA CAPSULA CONTIENE: TACROLIMUS MONOHIDRATADO EQUIVALENTE A 5 MG DE TACROLIMUS ENVASE CON 100 CAPSULAS.,ENV,100,CAP,5,miligramos,500,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1264,Grupo Nº 12: Nefrología y Urología,TACROLIMUS,5083,5083,1000050830000,010,000,5083,00,00,SI,"Sin programa definido,Uso Hospitalario, Nefrología y Urología,Uso Hospitalario, Nefrología y Urología",TACROLIMUS SOLUCION INYECTABLE CADA AMPOLLETA CONTIENE: TACROLIMUS 5 MG ENVASE CON 5 AMPOLLETAS.,ENV,5,AMP,5,miligramos,25,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1265,Grupo Nº 12: Nefrología y Urología,TACROLIMUS,5083,5083,1000050830101,010,000,5083,01,01,NO,"Sin programa definido,Uso Hospitalario, Nefrología y Urología,Uso Hospitalario, Nefrología y Urología",TACROLIMUS. SOLUCION INYECTABLE. CADA AMPOLLETA CONTIENE: TACROLIMUS 5 MG. ENVASE CON 10 AMPOLLETAS.,ENV,10,AMP,5,miligramos,50,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1266,Grupo Nº 12: Nefrología y Urología,TACROLIMUS,5084,5084,1000050840000,010,000,5084,00,00,SI,Sustantiva,TACROLIMUS CAPSULA CADA CAPSULA CONTIENE: TACROLIMUS MONOHIDRATADO EQUIVALENTE  A 1 MG DE TACROLIMUS ENVASE CON 50 CAPSULAS.,ENV,50,CAP,1,miligramos,50,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1267,Grupo Nº 12: Nefrología y Urología,TACROLIMUS,5084,5084,1000050840100,010,000,5084,01,00,NO,Sustantiva,TACROLIMUS. CAPSULA. CADA CAPSULA CONTIENE: TACROLIMUS MONOHIDRATADO EQUIVALENTE A 1 MG DE TACROLIMUS. ENVASE CON 100 CAPSULAS.,ENV,100,CAP,1,miligramos,100,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1268,Grupo Nº 12: Nefrología y Urología,DACLIZUMAB,5085,5085,1000050850000,010,000,5085,00,00,SI,"Sustantiva,Uso Hospitalario, Nefrología y Urología,Uso Hospitalario, Nefrología y Urología",DACLIZUMAB SOLUCION INYECTABLE CADA FRASCO AMPULA CONTIENE: DACLIZUMAB 25 MG  ENVASE CON 1 FRASCO AMPULA CON 5 ML.,ENV,1,F.A,25,miligramos,25,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1269,Grupo Nº 12: Nefrología y Urología,DACLIZUMAB,5085,5085,1000050850100,010,000,5085,01,00,NO,"Sustantiva,Uso Hospitalario, Nefrología y Urología,Uso Hospitalario, Nefrología y Urología",DACLIZUMAB. SOLUCION INYECTABLE. CADA FRASCO AMPULA CONTIENE: DACLIZUMAB 25 MG. ENVASE CON 3 FRASCOS AMPULA CON 5 ML.,ENV,3,F.A,25,miligramos,75,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1270,Grupo Nº 12: Nefrología y Urología,SIROLIMUS,5086,5086,1000050860000,010,000,5086,00,00,SI,Sustantiva,SIROLIMUS. SOLUCION ORAL. CADA ML CONTIENE: SIROLIMUS 1 MG. ENVASE CON 60 ML.,ENV,1,ENV,1,miligramos,1,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1271,Grupo Nº 12: Nefrología y Urología,SIROLIMUS,5086,5086,1000050860002,010,000,5086,00,02,NO,Sustantiva,SIROLIMUS. SOLUCION. CADA ML CONTIENE: SIROLIMUS 1 MG. ENVASE CON 60 ML.,ENV,60,ML.,1,miligramos,1,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1272,Grupo Nº 12: Nefrología y Urología,SIROLIMUS,5087,5087,1000050870002,010,000,5087,00,02,SI,Sustantiva,SIROLIMUS. GRAGEA O TABLETA. CADA GRAGEA O TABLETA CONTIENE: SIROLIMUS 1 MG. ENVASE CON 60 GRAGEAS O TABLETAS.,ENV,60,T.G,1,miligramos,60,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1330,Grupo Nº 12: Nefrología y Urología,ANTICUERPOS MONOCLONALES CD,5239,5239,1000052390000,010,000,5239,00,00,SI,"Sin programa definido,Uso Hospitalario, Nefrología y Urología",ANTICUERPOS MONOCLONALES CD3 SOLUCION INYECTABLE CADA AMPOLLETA O FRASCO AMPULA  CONTIENE: ANTICUERPOS MONOCLONALES CD3 5 MG ENVASE CON 5 AMPOLLETAS O FRASCOS  AMPULA.,ENV,5,AFA,5,miligramos,25,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
29,Grupo Nº 13: Neumología,ALFA-DORNASA,5330,5330,1000053300000,010,000,5330,00,00,SI,Entrega hospitalaria,ALFA DORNASA SOLUCION PARA INHALACION CADA AMPOLLETA CONTIENE: ALFA-DORNASA 2.5  MG ENVASE CON 6 AMPOLLETAS DE 2.5 ML.,ENV,6,AMP,2.5,miligramos,15,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
30,Grupo Nº 13: Neumología,BERACTANT,5331,5331,1000053310000,010,000,5331,00,00,SI,"Entrega hospitalaria,Uso Hospitalario, Neumología",BERACTANT SUSPENSION INYECTABLE CADA ML CONTIENE: BERACTANT (FOSFOLIPIDOS DE  PULMON DE ORIGEN BOVINO) 25 MG ENVASE CON FRASCO AMPULA DE 8 ML Y CANULA  ENDOTRAQUEAL.,ENV,1,ENV,25,miligramos,25,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
220,Grupo Nº 13: Neumología,SILDENAFIL,5845,5845,1000058450000,010,000,5845,00,00,SI,Entrega hospitalaria,SILDENAFIL. TABLETA. CADA TABLETA CONTIENE: CITRATO DE SILDENAFIL EQUIVALENTE A 20 MG DE SILDENAFIL. ENVASE CON 90 TABLETAS.,ENV,90,TAB,20,miligramos,1800,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
247,Grupo Nº 13: Neumología,INDACATEROL / GLICOPIRRONIO,6021,6021,1000060210000,010,000,6021,00,00,SI,Sin programa definido,INDACATEROL/GLICOPIRRONIO. CAPSULA. CADA CAPSULA CONTIENE: MALEATO DE INDACATEROL EQUIVALENTE A 110 MICROGRAMOS DE INDACATEROL BROMURO DE GLICOPIRRONIO EQUIVALENTE A 50 MICROGRAMOS DE GLICOPIRRONIO. ENVASE CON 30,ENV,30,CAP,50,microgramos,1500,microgramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
401,Grupo Nº 13: Neumología,IPRATROPIO,2162,2162,1000021620000,010,000,2162,00,00,SI,"VALES,Sustantiva -- Eficiencia terapeutica E - 0%",IPRATROPIO SUSPENSION EN AEROSOL CADA G CONTIENE: BROMURO DE IPRATROPIO 0.286 MG (20 MICROGRAMO POR NEBULIZACION) ENVASE CON 15 ML (21.0 G) COMO AEROSOL.,ENV,1,ENV,0.286,miligramos,0.286,miligramos,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,BRONCODILATADORES_Y_EXPECTORANTES,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
402,Grupo Nº 13: Neumología,IPRATROPIO,2162,2162,1000021620102,010,000,2162,01,02,NO,"VALES,Sustantiva -- Eficiencia terapeutica E - 0%",IPRATROPIO. SUSPENSION EN AEROSOL. CADA G CONTIENE: BROMURO DE IPRATROPIO 0.374 MG (20 MICROGRAMOS POR NEBULIZACION). ENVASE CON 10 ML (11.22 G) COMO AEROSOL.,ENV,1,ENV,0.374,miligramos,0.374,miligramos,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,BRONCODILATADORES_Y_EXPECTORANTES,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
408,Grupo Nº 13: Neumología,IPRATROPIO,2187,2187,1000021870000,010,000,2187,00,00,SI,Sustantiva,IPRATROPIO SOLUCION CADA 100 ML CONTIENEN: BROMURO DE IPRATROPIO MONOHIDRATADO  EQUIVALENTE A 25 MG DE BROMURO DE IPRATROPIO. ENVASE CON FRASCO AMPULA CON 20  ML.,ENV,1,F.A,25,miligramos,25,miligramos,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
409,Grupo Nº 13: Neumología,IPRATROPIO-SALBUTAMOL,2188,2188,1000021880000,010,000,2188,00,00,SI,Sustantiva,IPRATROPIO -SALBUTAMOL SOLUCION CADA AMPOLLETA CONTIENE: BROMURO DE IPRATROPIO  MONOHIDRATADO EQUIVALENTE A 0.500 MG DE BROMURO DE IPRATROPIO. SULFATO DE  SALBUTAMOL EQUIVALENTE A 2.500 MG DE SALBUTAMOL. ENVASE CON 10 AMPOLLETAS DE,ENV,10,AMP,3,miligramos,30,miligramos,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
412,Grupo Nº 13: Neumología,IPRATROPIO-SALBUTAMOL,2190,2190,1000021900003,010,000,2190,00,03,NO,"VALES,Sustantiva",IPRATROPIO-SALBUTAMOL. SUSPENSION EN AEROSOL. CADA G CONTIENE: BROMURO DE  IPRATROPIO MONOHIDRATADO EQUIVALENTE A 0.286 MG DE IPRATROPIO. SULFATO DE  SALBUTAMOL EQUIVALENTE A 1.423 MG DE SALBUTAMOL. ENVASE CON UN FRASCO,ENV,1,ENV,1.709,miligramos,1.709,miligramos,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,BRONCODILATADORES_Y_EXPECTORANTES,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
413,Grupo Nº 13: Neumología,IPRATROPIO-SALBUTAMOL,2190,2190,1000021900100,010,000,2190,01,00,SI,"VALES,Sustantiva",IPRATROPIO -SALBUTAMOL SOLUCION PARA INHALACION. CADA DISPARO PROPORCIONA: BROMURO DE IPRATROPIO MONOHIDRATADO EQUIVALENTE A 20 MICROGRAMOS DE BROMURO DE IPRATROPIO. SULFATO DE SALBUTAMOL EQUIVALENTE A 100 MICROGRAMOS DE SALBUTAMOL.,ENV,1,ENV,120,gramos,120,gramos,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,BRONCODILATADORES_Y_EXPECTORANTES,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
430,Grupo Nº 13: Neumología,"TIOTROPIO, BROMURO DE",2262,2262,1000022620000,010,000,2262,00,00,SI,"VALES,Sustantiva -- Eficiencia terapeutica D - 40%","TIOTROPIO, BROMURO DE CAPSULA CADA CAPSULA CONTIENE: BROMURO DE TIOTROPIO  MONOHIDRATADO EQUIVALENTE A 18 MICROGRAMOS DE TIOTROPIO. ENVASE CON 30  CAPSULAS Y DISPOSITIVO INHALADOR.",ENV,30,CAP,18,microgramos,540,microgramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,BRONCODILATADORES_Y_EXPECTORANTES,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
431,Grupo Nº 13: Neumología,"TIOTROPIO, BROMURO DE",2263,2263,1000022630000,010,000,2263,00,00,SI,"VALES,Sustantiva -- Eficiencia terapeutica D - 45%","TIOTROPIO, BROMURO DE CAPSULA CADA CAPSULA CONTIENE: BROMURO DE TIOTROPIO MONOHIDRATADO EQUIVALENTE A 18 MICROGRAMOS DE TIOTROPIO. ENVASE CON 30 CAPSULAS (REPUESTO).",ENV,30,CAP,18,microgramos,540,microgramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,BRONCODILATADORES_Y_EXPECTORANTES,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
462,Grupo Nº 13: Neumología,DEXTROMETORFANO,2431,2431,1000024310000,010,000,2431,00,00,SI,"VALES,Sustantiva",DEXTROMETORFANO JARABE CADA 100 ML CONTIENEN: BROMHIDRATO DE DEXTROMETORFANO  300 MG ENVASE CON 60 ML Y DOSIFICADOR (15 MG/5 ML).,ENV,60,ML.,300,miligramos,300,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,ANTITUSIVOS,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
463,Grupo Nº 13: Neumología,BENZONATATO,2433,2433,1000024330000,010,000,2433,00,00,SI,"VALES,Sustantiva",BENZONATATO PERLA O CAPSULA CADA PERLA O CAPSULA CONTIENE: BENZONATATO 100 MG  ENVASE CON 20 PERLAS O CAPSULAS.,ENV,20,P.C,100,miligramos,2000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,ANTITUSIVOS,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
464,Grupo Nº 13: Neumología,BENZONATATO,2435,2435,1000024350000,010,000,2435,00,00,SI,"VALES,Sustantiva",BENZONATATO SUPOSITORIO CADA SUPOSITORIO CONTIENE: BENZONATATO 50 MG ENVASE CON  6 SUPOSITORIOS.,ENV,6,SUP,50,miligramos,300,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
465,Grupo Nº 13: Neumología,AMBROXOL,2462,2462,1000024620000,010,000,2462,00,00,SI,"VALES,Sustantiva",AMBROXOL COMPRIMIDO CADA COMPRIMIDO CONTIENE: CLORHIDRATO DE AMBROXOL 30 MG  ENVASE CON 20 COMPRIMIDOS.,ENV,20,COM,30,miligramos,600,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,BRONCODILATADORES_Y_EXPECTORANTES,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
466,Grupo Nº 13: Neumología,AMBROXOL,2463,2463,1000024630000,010,000,2463,00,00,SI,"VALES,Consumo en demanda",AMBROXOL SOLUCION CADA 100 ML CONTIENEN: CLORHIDRATO DE AMBROXOL 300 MG ENVASE  CON 120 ML Y DOSIFICADOR,ENV,120,ML.,300,miligramos,300,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,BRONCODILATADORES_Y_EXPECTORANTES,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
470,Grupo Nº 13: Neumología,"BECLOMETASONA, DIPROPIONATO DE",2508,2508,1000025080003,010,000,2508,00,03,SI,"VALES,Sustantiva","BECLOMETASONA, DIPROPIONATO DE SUSPENSION EN AEROSOL CADA INHALACION CONTIENE: DIPROPIONATO DE BECLOMETASONA 250 MICROGRAMOS. ENVASE CON DISPOSITIVO INHALADOR PARA 200 DOSIS.",ENV,1,DIS,250,microgramos,250,microgramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,BRONCODILATADORES_Y_EXPECTORANTES,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
675,Grupo Nº 13: Neumología,NICOTINA,82,0082,1000000820000,010,000,0082,00,00,SI,Sustantiva,NICOTINA PARCHE CADA PARCHE DE 7 CM2 CONTIENE: NICOTINA 36 MG ENVASES CON 7 PARCHES.,ENV,7,PCH,36,miligramos,252,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
676,Grupo Nº 13: Neumología,NICOTINA,83,0083,1000000830000,010,000,0083,00,00,SI,Sustantiva,NICOTINA PARCHE CADA PARCHE DE 15 CM2 CONTIENE: NICOTINA 78 MG ENVASE CON 7 PARCHES.,ENV,7,PCH,78,miligramos,546,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
677,Grupo Nº 13: Neumología,NICOTINA,84,0084,1000000840000,010,000,0084,00,00,SI,Sustantiva,NICOTINA PARCHE CADA PARCHE DE 22 CM2 CONTIENE: NICOTINA 114 MG ENVASE CON 7 PARCHES.,ENV,7,PCH,114,miligramos,798,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
709,Grupo Nº 13: Neumología,AMINOFILINA,426,0426,1000004260000,010,000,0426,00,00,SI,"Sustantiva,Uso Hospitalario, Neumología",AMINOFILINA SOLUCION INYECTABLE CADA AMPOLLETA CONTIENE: AMINOFILINA 250 MG ENVASE CON 5 AMPOLLETAS DE 10 ML.,ENV,5,AMP,250,miligramos,1250,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
710,Grupo Nº 13: Neumología,SALBUTAMOL,429,0429,1000004290000,010,000,0429,00,00,SI,"VALES,Sustantiva",SALBUTAMOL SUSPENSION EN AEROSOL CADA INHALADOR CONTIENE: SALBUTAMOL 20 MG O SULFATO DE SALBUTAMOL EQUIVALENTE A 20 MG DE SALBUTAMOL ENVASE CON INHALADOR CON 200 DOSIS DE 100 MICROGRAMOS.,ENV,1,ENV,20,miligramos,20,miligramos,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,BRONCODILATADORES_Y_EXPECTORANTES,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
711,Grupo Nº 13: Neumología,SALBUTAMOL,431,0431,1000004310000,010,000,0431,00,00,SI,"VALES,Sustantiva",SALBUTAMOL JARABE CADA 5 ML CONTIENEN: SULFATO DE SALBUTAMOL EQUIVALENTE A 2 MG DE SALBUTAMOL ENVASE CON 60 ML.,ENV,60,ML.,2,miligramos,2,miligramos,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
712,Grupo Nº 13: Neumología,TERBUTALINA,432,0432,1000004320000,010,000,0432,00,00,SI,Sustantiva,TERBUTALINA SOLUCION INYECTABLE CADA ML CONTIENE: SULFATO DE TERBUTALINA 0.25 MG ENVASE CON 3 AMPOLLETAS.,ENV,3,AMP,0.25,miligramos,0.75,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
713,Grupo Nº 13: Neumología,TERBUTALINA,433,0433,1000004330000,010,000,0433,00,00,SI,Sustantiva,TERBUTALINA TABLETA CADA TABLETA CONTIENE: SULFATO DE TERBUTALINA 5 MG ENVASE CON 20 TABLETAS.,ENV,20,TAB,5,miligramos,100,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
714,Grupo Nº 13: Neumología,TEOFILINA,437,0437,1000004370000,010,000,0437,00,00,SI,"VALES,Sustantiva","TEOFILINA COMPRIMIDO O TABLETA O CAPSULA DE LIBERACION PROLONGADA: CADA COMPRIMIDO, TABLETA O CAPSULA CONTIENE TEOFILINA ANHIDRA 100 MG. ENVASE CON 20 COMPRIMIDOS TABLETAS O CAPSULAS DE LIBERACION PROLONGADA",ENV,20,TAB,100,miligramos,2000,miligramos,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,BRONCODILATADORES_Y_EXPECTORANTES,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
715,Grupo Nº 13: Neumología,SALBUTAMOL,439,0439,1000004390000,010,000,0439,00,00,SI,Sustantiva,SALBUTAMOL SOLUCION PARA NEBULIZADOR CADA 100 ML CONTIENEN: SULFATO DE SALBUTAMOL 0.5 G ENVASE CON 10 ML.,ENV,10,ML.,0.5,gramos,0.5,gramos,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
716,Grupo Nº 13: Neumología,FLUTICASONA,440,0440,1000004400002,010,000,0440,00,02,SI,"VALES,Sustantiva -- Eficiencia terapeutica Q - 40%",FLUTICASONA SUSPENSION EN AEROSOL CADA DOSIS CONTIENE: PROPIONATO DE FLUTICASONA 50 MICROGRAMOS. ENVASE CON UN FRASCO PRESURIZADO PARA 60 DOSIS.,ENV,1,FCO,50,microgramos,50,microgramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,BRONCODILATADORES_Y_EXPECTORANTES,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
717,Grupo Nº 13: Neumología,SALMETEROL,441,0441,1000004410000,010,000,0441,00,00,SI,"VALES,Sustantiva",SALMETEROL SUSPENSION EN AEROSOL CADA GRAMO CONTIENE: XINAFOATO DE SALMETEROL EQUIVALENTE A 0.330 MG DE SALMETEROL ENVASE CON INHALADOR CON 12 G PARA 120 DOSIS DE 25 MICROGRAMOS.,ENV,120,DSS,0.33,microgramos,39.6,microgramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
718,Grupo Nº 13: Neumología,"SALMETEROL, FLUTICASONA",442,0442,1000004420000,010,000,0442,00,00,SI,"VALES,Sustantiva",SALMETEROL -FLUTICASONA POLVO CADA DOSIS CONTIENE XINAFOATO DE SALMETEROL EQUIVALENTE A 50 MICROGRAMOS DE SALMETEROL PROPIONATO DE FLUTICASONA 100 MICROGRAMOS ENVASE CON DISPOSITIVO INHALADOR PARA 60 DOSIS.,ENV,1,ENV,150,microgramos,150,microgramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,BRONCODILATADORES_Y_EXPECTORANTES,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
719,Grupo Nº 13: Neumología,BUDESONIDA-FORMOTEROL,445,0445,1000004450000,010,000,0445,00,00,SI,"VALES,Sustantiva",BUDESONIDA -FORMOTEROL POLVO CADA GRAMO CONTIENE: BUDESONIDA 90 MG FUMARATO DE FORMOTEROL DIHIDRATADO 5 MG ENVASE CON FRASCO INHALADOR DOSIFICADOR CON 60 DOSIS CON 80 MG /4.5 MG CADA UNA.,ENV,1,ENV,95,miligramos,95,miligramos,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
720,Grupo Nº 13: Neumología,BUDESONIDA-FORMOTEROL,445,0445,1000004450002,010,000,0445,00,02,NO,"VALES,Sustantiva",BUDESONIDA-FORMOTEROL. POLVO. CADA GRAMO CONTIENE: BUDESONIDA 90 MG. FUMARATO DE FORMOTEROL DIHIDRATADO 5 MG. ENVASE CON FRASCO INHALADOR DOSIFICADOR CON 60 DOSIS CON 80 MICROGRAMOS / 4.5 MICROGRAMOS CADA UNA.,ENV,1,ENV,95,miligramos,95,miligramos,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
721,Grupo Nº 13: Neumología,BUDESONIDA-FORMOTEROL,446,0446,1000004460000,010,000,0446,00,00,SI,"VALES,Sustantiva",BUDESONIDA -FORMOTEROL POLVO CADA GRAMO CONTIENE: BUDESONIDA 180 MG FUMARATO DE FORMOTEROL DIHIDRATADO 5 MG ENVASE CON FRASCO INHALADOR DOSIFICADOR CON 60 DOSIS CON 160 MICROGRAMOS /4.5MICROGRAMOS CADA UNA,ENV,1,ENV,185,miligramos,185,miligramos,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
722,Grupo Nº 13: Neumología,"SALMETEROL, FLUTICASONA",447,0447,1000004470000,010,000,0447,00,00,SI,Sustantiva,"SALMETEROL, FLUTICASONA. POLVO CADA DOSIS CONTIENE: XINAFOATO DE SALMETEROL  EQUIVALENTE A 50 MICROGRAMOS DE SALMETEROL PROPIONATO DE FLUTICASONA 500  MICROGRAMOS. ENVASE CON DISPOSITIVO INHALADOR PARA 60 DOSIS.",ENV,1,DIS,50,microgramos,50,microgramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
723,Grupo Nº 13: Neumología,FLUTICASONA,450,0450,1000004500000,010,000,0450,00,00,SI,Sustantiva -- Eficiencia terapeutica Q - 60%,FLUTICASONA. SUSPENSION EN AEROSOL CADA DOSIS CONTIENE: PROPIONATO DE  FLUTICASONA 50 MICROGRAMOS. ENVASE CON UN FRASCO PRESURIZADO PARA 120 DOSIS.,ENV,1,FCO,50,microgramos,50,microgramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
730,Grupo Nº 13: Neumología,"BECLOMETASONA, DIPROPIONATO DE",477,0477,1000004770003,010,000,0477,00,03,SI,"VALES,Sustantiva","BECLOMETASONA, DIPROPIONATO DE SUSPENSION EN AEROSOL CADA INHALACION CONTIENE: DIPROPIONATO DE BECLOMETASONA 50 MICROGRAMOS. ENVASE CON DISPOSITIVO INHALADOR PARA 200 DOSIS.",ENV,1,DIS,50,microgramos,50,microgramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,BRONCODILATADORES_Y_EXPECTORANTES,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1167,Grupo Nº 13: Neumología,MONTELUKAST,4329,4329,1000043290000,010,000,4329,00,00,SI,"VALES,Sustantiva",MONTELUKAST COMPRIMIDO MASTICABLE CADA COMPRIMIDO CONTIENE: MONTELUKAST SODICO EQUIVALENTE A 5 MG DE MONTELUKAST ENVASE CON 30 COMPRIMIDOS.,ENV,30,COM,5,miligramos,150,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1168,Grupo Nº 13: Neumología,MONTELUKAST,4330,4330,1000043300000,010,000,4330,00,00,SI,"VALES,Sustantiva -- Eficiencia terapeutica F - 100%",MONTELUKAST COMPRIMIDO RECUBIERTO CADA COMPRIMIDO CONTIENE: MONTELUKAST SODICO EQUIVALENTE A 10 MG DE MONTELUKAST ENVASE CON 30 COMPRIMIDOS.,ENV,30,COM,10,miligramos,300,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,ANTIALERGICOS,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1169,Grupo Nº 13: Neumología,ZAFIRLUKAST,4331,4331,1000043310000,010,000,4331,00,00,SI,Sustantiva -- Eficiencia terapeutica G - 0%,ZAFIRLUKAST TABLETA CADA TABLETA CONTIENE: ZAFIRLUKAST 20 MG ENVASE CON 28 TABLETAS.,ENV,28,TAB,20,miligramos,560,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1170,Grupo Nº 13: Neumología,ZAFIRLUKAST,4331,4331,1000043310100,010,000,4331,01,00,NO,Sustantiva -- Eficiencia terapeutica G - 0%,ZAFIRLUKAST TABLETA CADA TABLETA CONTIENE: ZAFIRLUKAST 20 MG. ENVASE CON 30  TABLETAS.,ENV,30,TAB,20,miligramos,600,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1171,Grupo Nº 13: Neumología,BUDESONIDA,4332,4332,1000043320000,010,000,4332,00,00,SI,Sustantiva,BUDESONIDA SUSPENSION PARA NEBULIZAR CADA ENVASE CONTIENE: BUDESONIDA (MICRONIZADA) 0.250 MG ENVASE CON 5 ENVASES CON 2 ML.,ENV,5,ENV,0.25,miligramos,1.25,miligramos,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1172,Grupo Nº 13: Neumología,BUDESONIDA,4332,4332,1000043320100,010,000,4332,01,00,NO,Sustantiva,BUDESONIDA. SUSPENSION PARA NEBULIZAR. CADA ENVASE CONTIENE: BUDESONIDA (MICRONIZADA) 0.250 MG. ENVASE CON 20 ENVASES CON 2 ML.,ENV,20,ENV,0.25,miligramos,5,miligramos,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1173,Grupo Nº 13: Neumología,BUDESONIDA,4333,4333,1000043330000,010,000,4333,00,00,SI,Sustantiva,BUDESONIDA SUSPENSION PARA NEBULIZAR CADA ENVASE CONTIENE: BUDESONIDA (MICRONIZADA) 0.500 MG ENVASE CON 5 ENVASES CON 2 ML.,ENV,5,ENV,0.5,miligramos,2.5,miligramos,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1174,Grupo Nº 13: Neumología,BUDESONIDA,4333,4333,1000043330100,010,000,4333,01,00,NO,Sustantiva,BUDESONIDA. SUSPENSION PARA NEBULIZAR CADA ENVASE CONTIENE: BUDESONIDA (MICRONIZADA) 0.500 MG. ENVASE CON 20 ENVASES CON 2 ML.,ENV,20,ENV,0.5,miligramos,10,miligramos,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1175,Grupo Nº 13: Neumología,BUDESONIDA,4334,4334,1000043340000,010,000,4334,00,00,SI,"VALES,Sustantiva",BUDESONIDA POLVO CADA DOSIS CONTIENE: BUDESONIDA (MICRONIZADA) 100 MICROGRAMOS  ENVASE CON 200 DOSIS Y DISPOSITIVO INHALADOR.,ENV,1,JGO,100,microgramos,100,microgramos,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1177,Grupo Nº 13: Neumología,OMALIZUMAB,4340,4340,1000043400000,010,000,4340,00,00,SI,Catálogo II -- TORRE DE CONTROL,OMALIZUMAB SOLUCION INYECTABLE CADA FRASCO AMPULA CONTIENE: OMALIZUMAB 202.5 MG ENVASE CON UN FRASCO AMPULA Y AMPOLLETA CON 2 ML DE DILUYENTE.,ENV,1,AFA,202.5,miligramos,202.5,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1261,Grupo Nº 13: Neumología,TEOFILINA,5075,5075,1000050750000,010,000,5075,00,00,SI,Sustantiva,TEOFILINA ELIXIR CADA 100 ML CONTIENEN: TEOFILINA ANHIDRA 533 MG ENVASE CON 450  ML Y DOSIFICADOR.,ENV,450,ML.,533,miligramos,533,miligramos,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
43,Grupo Nº 14: Neurología,FLUNARIZINA,5353,5353,1000053530002,010,000,5353,00,02,SI,"VALES,Sustantiva",FLUNARIZINA CAPSULA O TABLETA CADA CAPSULA O TABLETA CONTIENE: FLUNARIZINA 5 MG ENVASE CON 20 CAPSULAS O TABLETAS.,ENV,20,C.T,5,miligramos,100,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,FARMACOS_UTILIZADOS_EN_NEUROLOGIA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0
44,Grupo Nº 14: Neurología,NIMODIPINO,5354,5354,1000053540000,010,000,5354,00,00,SI,"Sustantiva,Uso Hospitalario, Neurología",NIMODIPINO SOLUCION INYECTABLE CADA FRASCO AMPULA CONTIENE: NIMODIPINO 10 MG  ENVASE CON 1 FRASCO AMPULA CON 50 ML CON O SIN EQUIPO PERFUSOR DE POLIETILENO.,ENV,1,ENV,10,miligramos,10,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
45,Grupo Nº 14: Neurología,VIGABATRINA,5355,5355,1000053550000,010,000,5355,00,00,SI,Sustantiva,VIGABATRINA COMPRIMIDO CADA COMPRIMIDO CONTIENE: VIGABATRINA 500 MG ENVASE CON  60 COMPRIMIDOS.,CJA,60,COM,500,miligramos,30000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
46,Grupo Nº 14: Neurología,LAMOTRIGINA,5356,5356,1000053560000,010,000,5356,00,00,SI,"VALES,Sustantiva",LAMOTRIGINA TABLETA CADA TABLETA CONTIENE: LAMOTRIGINA 100 MG ENVASE CON 28  TABLETAS.,ENV,28,TAB,100,miligramos,2800,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
47,Grupo Nº 14: Neurología,LAMOTRIGINA,5358,5358,1000053580000,010,000,5358,00,00,SI,"VALES,Sustantiva",LAMOTRIGINA TABLETA CADA TABLETA CONTIENE: LAMOTRIGINA 25 MG ENVASE CON 28  TABLETAS.,ENV,28,TAB,25,miligramos,700,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
48,Grupo Nº 14: Neurología,VALPROATO DE MAGNESIO,5359,5359,1000053590000,010,000,5359,00,00,SI,"VALES,Sustantiva",VALPROATO DE MAGNESIO TABLETA DE LIBERACION PROLONGADA CADA TABLETA CONTIENE:  VALPROATO DE MAGNESIO 600 MG ENVASE CON 30 TABLETAS.,ENV,30,TAB,600,miligramos,18000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
49,Grupo Nº 14: Neurología,TOPIRAMATO,5363,5363,1000053630000,010,000,5363,00,00,SI,"VALES,Sustantiva",TOPIRAMATO TABLETA CADA TABLETA CONTIENE: TOPIRAMATO 100 MG ENVASE CON 60  TABLETAS.,ENV,60,TAB,100,miligramos,6000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,FARMACOS_UTILIZADOS_EN_NEUROLOGIA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0
50,Grupo Nº 14: Neurología,TOPIRAMATO,5363,5363,1000053630100,010,000,5363,01,00,NO,"VALES,Sustantiva",TOPIRAMATO. TABLETA. CADA TABLETA CONTIENE: TOPIRAMATO 100 MG. ENVASE CON 100 TABLETAS.,ENV,100,TAB,100,miligramos,10000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,FARMACOS_UTILIZADOS_EN_NEUROLOGIA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0
51,Grupo Nº 14: Neurología,TOPIRAMATO,5365,5365,1000053650000,010,000,5365,00,00,SI,"VALES,Sustantiva",TOPIRAMATO TABLETA CADA TABLETA CONTIENE: TOPIRAMATO 25 MG ENVASE CON 60 TABLETAS.,ENV,60,TAB,25,miligramos,1500,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
52,Grupo Nº 14: Neurología,TOPIRAMATO,5365,5365,1000053650100,010,000,5365,01,00,NO,"VALES,Sustantiva",TOPIRAMATO. TABLETA. CADA TABLETA CONTIENE: TOPIRAMATO 25 MG. ENVASE CON 100 TABLETAS.,ENV,100,TAB,25,miligramos,2500,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
167,Grupo Nº 14: Neurología,VALPROATO SEMISÓDICO,5488,5488,1000054880000,010,000,5488,00,00,SI,"VALES,Sustantiva",VALPROATO SEMISODICO COMPRIMIDO CON CAPA ENTERICA CADA COMPRIMIDO CONTIENE:  VALPROATO SEMISODICO EQUIVALENTE A 250 MG DE ACIDO VALPROICO. ENVASE CON 30  COMPRIMIDOS.,ENV,30,COM,250,miligramos,7500,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
202,Grupo Nº 14: Neurología,TOXINA BOTULÍNICA TIPO A,5666,5666,1000056660000,010,000,5666,00,00,SI,,TOXINA BOTULINICA TIPO A. SOLUCION INYECTABLE. CADA FRASCO AMPULA CON POLVO CONTIENE: TOXINA ONABOTULINICA A 100 U* *COMPLEJO PURIFICADO DE NEUROTOXINA (900 KD) 100 U DE TOXINA ONABOTULINICA A CONTIENEN 4.8 NG DE COMPLEJO,ENV,1,F.A,100,U,100,U,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
218,Grupo Nº 14: Neurología,FINGOLIMOD,5815,5815,1000058150000,010,000,5815,00,00,SI,Catálogo II -- TORRE DE CONTROL,FINGOLIMOD. CAPSULA CADA CAPSULA CONTIENE: CLORHIDRATO DE FINGOLIMOD 0.56 MG EQUIVALENTE A 0.50 MG DE FINGOLIMOD.,ENV,28,CAP,0.56,miligramos,15.68,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
227,Grupo Nº 14: Neurología,ALMOTRIPTAN,5900,5900,1000059000001,010,000,5900,00,01,SI,Sustantiva -- Eficiencia terapeutica O - 68%,"ALMOTRIPTAN. COMPRIMIDOS. CADA COMPRIMIDO CONTIENE: ALMOTRIPTAN D, L MALATO ACIDO EQUIVALENTE A 12.5 MG DE ALMOTRIPTAN. ENVASE CON 2 COMPRIMIDOS.",ENV,2,COM,12.5,miligramos,25,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
253,Grupo Nº 14: Neurología,ACETATO DE GLATIRAMER,6036,6036,1000060360000,010,000,6036,00,00,SI,Catálogo II -- TORRE DE CONTROL,ACETATO DE GLATIRAMER. SOLUCION INYECTABLE. CADA JERINGA PRELLENADA CONTIENE: ACETATO DE GLATIRAMER 40 MG. ENVASE CON 12 JERINGAS PRELLENADAS CON 1 ML (40 MG/ML).,ENV,12,JGA,40,miligramos,480,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
255,Grupo Nº 14: Neurología,DIMETILFUMARATO,6048,6048,1000060480000,010,000,6048,00,00,SI,Catálogo II -- TORRE DE CONTROL,DIMETILFUMARATO. CAPSULA DE LIBERACION RETARDADA. CADA CAPSULA DE LIBERACION RETARDADA CONTIENE: DIMETILFUMARATO 240 MG. ENVASE CON 56 CAPSULAS,ENV,56,CAP,240,miligramos,13440,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
482,Grupo Nº 14: Neurología,PRIMIDONA,2606,2606,1000026060000,010,000,2606,00,00,SI,"VALES,Sustantiva",PRIMIDONA TABLETA CADA TABLETA CONTIENE: PRIMIDONA 250 MG ENVASE CON 50  TABLETAS.,ENV,50,TAB,250,miligramos,12500,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
483,Grupo Nº 14: Neurología,FENITOÍNA,2611,2611,1000026110000,010,000,2611,00,00,SI,Sustantiva,FENITOINA SUSPENSION ORAL CADA 5 ML CONTIENEN: FENITOINA 37.5 MG ENVASE CON 120 ML Y VASITO DOSIFICADOR DE 5 ML.,ENV,120,ML.,37.5,miligramos,37.5,miligramos,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
484,Grupo Nº 14: Neurología,LEVETIRACETAM,2617,2617,1000026170000,010,000,2617,00,00,SI,"VALES,Sustantiva",LEVETIRACETAM TABLETA CADA TABLETA CONTIENE: LEVETIRACETAM 500 MG ENVASE CON 60  TABLETAS.,ENV,60,TAB,500,miligramos,30000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
485,Grupo Nº 14: Neurología,LEVETIRACETAM,2618,2618,1000026180000,010,000,2618,00,00,SI,"VALES,Sustantiva",LEVETIRACETAM TABLETA CADA TABLETA CONTIENE: LEVETIRACETAM 1 000 MG ENVASE CON  30 TABLETAS.,ENV,30,TAB,1000,miligramos,30000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
486,Grupo Nº 14: Neurología,VALPROATO DE MAGNESIO,2622,2622,1000026220004,010,000,2622,00,04,SI,"VALES,Sustantiva",VALPROATO DE MAGNESIO TABLETA CON CUBIERTA O CAPA ENTERICA O TABLETA DE LIBERACION RETARDADA CADA TABLETA CONTIENE: VALPROATO DE MAGNESIO 200 MG EQUIVALENTE A 185.6 MG DE ACIDO VALPROICO O VALPROATO DE MAGNESIO 200 MG.,ENV,40,TAB,200,miligramos,8000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,FARMACOS_UTILIZADOS_EN_NEUROLOGIA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0
487,Grupo Nº 14: Neurología,VALPROATO DE MAGNESIO,2623,2623,1000026230000,010,000,2623,00,00,SI,"VALES,Sustantiva",VALPROATO DE MAGNESIO SOLUCION CADA ML CONTIENE: VALPROATO DE MAGNESIO  EQUIVALENTE A 186 MG DE ACIDO VALPROICO. ENVASE CON 40 ML.,ENV,1,ENV,186,miligramos,186,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
488,Grupo Nº 14: Neurología,FENITOÍNA,2624,2624,1000026240000,010,000,2624,00,00,SI,"Sustantiva,Uso Hospitalario, Neurología",FENITOINA SOLUCION INYECTABLE CADA AMPOLLETA CONTIENE: FENITOINA SODICA 250 MG  ENVASE CON UNA AMPOLLETA (250 MG/5 ML).,ENV,1,AMP,250,miligramos,250,miligramos,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
489,Grupo Nº 14: Neurología,OXCARBAZEPINA,2627,2627,1000026270000,010,000,2627,00,00,SI,"Sustantiva,VALES",OXCARBAZEPINA GRAGEA O TABLETA CADA GRAGEA O TABLETA CONTIENE OXCARBAZEPINA 600  MG ENVASE CON 20 GRAGEAS O TABLETAS.,ENV,20,T.G,600,miligramos,12000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,BENZODIAZEPINAS,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
490,Grupo Nº 14: Neurología,OXCARBAZEPINA,2628,2628,1000026280000,010,000,2628,00,00,SI,"Sustantiva,VALES",OXCARBAZEPINA SUSPENSION ORAL CADA 100 ML CONTIENEN: OXCARBAZEPINA 6 G ENVASE  CON 100 ML.,ENV,1,ENV,6,gramos,6,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
491,Grupo Nº 14: Neurología,PRAMIPEXOL,2649,2649,1000026490000,010,000,2649,00,00,SI,"Sustantiva,VALES",PRAMIPEXOL TABLETA CADA TABLETA CONTIENE DICLORHIDRATO DE PRAMIPEXOL  MONOHIDRATADO 0.5 MG ENVASE CON 30 TABLETAS.,ENV,30,TAB,0.5,miligramos,15,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,FARMACOS_UTILIZADOS_EN_NEUROLOGIA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0
492,Grupo Nº 14: Neurología,PRAMIPEXOL,2650,2650,1000026500000,010,000,2650,00,00,SI,"Sustantiva,VALES",PRAMIPEXOL TABLETA CADA TABLETA CONTIENE DICLORHIDRATO DE PRAMIPEXOL  MONOHIDRATADO 1.0 MG ENVASE CON 30 TABLETAS.,ENV,30,TAB,1,miligramos,30,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
493,Grupo Nº 14: Neurología,PIRIDOSTIGMINA,2662,2662,1000026620000,010,000,2662,00,00,SI,Sustantiva,PIRIDOSTIGMINA GRAGEA O TABLETA CADA GRAGEA O TABLETA CONTIENE: BROMURO DE  PIRIDOSTIGMINA 60 MG ENVASE CON 20 GRAGEAS.,ENV,20,T.G,60,miligramos,1200,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
597,Grupo Nº 14: Neurología,DIAZEPAM,202,0202,4000002020000,040,000,0202,00,00,SI,Sustantiva,DIAZEPAM SOLUCION INYECTABLE CADA AMPOLLETA CONTIENE: DIAZEPAM 10 MG ENVASE CON  50 AMPOLLETAS DE 2 ML.,ENV,50,AMP,10,miligramos,500,miligramos,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,BENZODIAZEPINAS,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
621,Grupo Nº 14: Neurología,FENOBARBITAL,2601,2601,4000026010000,040,000,2601,00,00,SI,"VALES,Sustantiva",FENOBARBITAL TABLETA CADA TABLETA CONTIENE: FENOBARBITAL 100 MG ENVASE CON 20  TABLETAS.,ENV,20,TAB,100,miligramos,2000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
622,Grupo Nº 14: Neurología,CARBAMAZEPINA,2608,2608,4000026080000,040,000,2608,00,00,SI,"VALES,Sustantiva",CARBAMAZEPINA. TABLETAS. CADA TABLETA CONTIENE: CARBAMAZEPINA 200 MG. ENVASE CON 20 TABLETAS,ENV,20,TAB,200,miligramos,4000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,BENZODIAZEPINAS,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
623,Grupo Nº 14: Neurología,CARBAMAZEPINA,2609,2609,4000026090000,040,000,2609,00,00,SI,Sustantiva,"CARBAMAZEPINA, SUSPENSION ORAL, CADA 5 ML CONTIENEN: CARBAMAZEPINA 100 MG  ENVASE CON 120 ML Y DOSIFICADOR DE 5 ML.",ENV,120,ML.,100,miligramos,100,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
624,Grupo Nº 14: Neurología,CLONAZEPAM,2612,2612,4000026120000,040,000,2612,00,00,SI,"VALES,Sustantiva",CLONAZEPAM TABLETA CADA TABLETA CONTIENE: CLONAZEPAM 2 MG ENVASE CON 30 TABLETAS.,ENV,30,TAB,2,miligramos,60,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,BENZODIAZEPINAS,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
625,Grupo Nº 14: Neurología,CLONAZEPAM,2613,2613,4000026130000,040,000,2613,00,00,SI,"VALES,Sustantiva",CLONAZEPAM SOLUCION CADA ML CONTIENE: CLONAZEPAM 2.5 MG ENVASE CON 10 ML Y  GOTERO INTEGRAL.,FCO,10,ML.,2.5,miligramos,2.5,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
626,Grupo Nº 14: Neurología,FENOBARBITAL,2619,2619,4000026190000,040,000,2619,00,00,SI,Sustantiva,FENOBARBITAL ELIXIR CADA 5 ML CONTIENEN: FENOBARBITAL 20 MG ENVASE CON 60 ML Y  VASITO DOSIFICADOR DE 5 ML.,ENV,1,ENV,20,miligramos,20,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
627,Grupo Nº 14: Neurología,TRIHEXIFENIDILO,2651,2651,4000026510000,040,000,2651,00,00,SI,"VALES,Sustantiva",TRIHEXIFENIDILO TABLETA CADA TABLETA CONTIENE: CLORHIDRATO DE TRIHEXIFENIDILO 5  MG ENVASE CON 50 TABLETAS.,ENV,50,TAB,5,miligramos,250,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
628,Grupo Nº 14: Neurología,BIPERIDENO,2652,2652,4000026520000,040,000,2652,00,00,SI,"VALES,Sustantiva",BIPERIDENO TABLETA CADA TABLETA CONTIENE: CLORHIDRATO DE BIPERIDENO 2 MG ENVASE  CON 50 TABLETAS.,ENV,50,TAB,2,miligramos,100,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,FARMACOS_UTILIZADOS_EN_NEUROLOGIA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0
629,Grupo Nº 14: Neurología,BIPERIDENO,2653,2653,4000026530000,040,000,2653,00,00,SI,Sustantiva,BIPERIDENO SOLUCION INYECTABLE CADA AMPOLLETA CONTIENE: LACTATO DE BIPERIDENO 5  MG ENVASE CON 5 AMPOLLETAS DE 1 ML.,ENV,5,AMP,5,miligramos,25,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
630,Grupo Nº 14: Neurología,LEVODOPA Y CARBIDOPA,2654,2654,4000026540000,040,000,2654,00,00,SI,"VALES,Sustantiva",LEVODOPA Y CARBIDOPA TABLETA CADA TABLETA CONTIENE: LEVODOPA 250 MG CARBIDOPA 25 MG ENVASE CON 100 TABLETAS.,ENV,100,TAB,275,miligramos,27500,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,FARMACOS_UTILIZADOS_EN_NEUROLOGIA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0
631,Grupo Nº 14: Neurología,ERGOTAMINA Y CAFEÍNA,2673,2673,4000026730000,040,000,2673,00,00,SI,Sustantiva,"ERGOTAMINA Y CAFEINA COMPRIMIDO, GRAGEA O TABLETA CADA COMPRIMIDO, GRAGEA O  TABLETA CONTIENE: TARTRATO DE ERGOTAMINA 1 MG CAFEINA 100 MG ENVASE CON 20  COMPRIMIDOS, GRAGEAS O TABLETAS.",ENV,20,CGT,100,miligramos,2000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,FARMACOS_UTILIZADOS_EN_NEUROLOGIA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0
635,Grupo Nº 14: Neurología,DIAZEPAM,3215,3215,4000032150000,040,000,3215,00,00,SI,"VALES,Sustantiva",DIAZEPAM TABLETA CADA TABLETA CONTIENE: DIAZEPAM 10 MG ENVASE CON 20 TABLETAS.,ENV,20,TAB,10,miligramos,200,miligramos,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
669,Grupo Nº 14: Neurología,METILFENIDATO,5351,5351,4000053510000,040,000,5351,00,00,SI,Sustantiva,METILFENIDATO COMPRIMIDO CADA COMPRIMIDO CONTIENE: CLORHIDRATO DE METILFENIDATO  10 MG ENVASE CON 30 COMPRIMIDOS.,ENV,30,COM,10,miligramos,300,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
736,Grupo Nº 14: Neurología,FENITOÍNA,525,0525,1000005250000,010,000,0525,00,00,SI,"VALES,Sustantiva",FENITOINA TABLETA O CAPSULA CADA TABLETA O CAPSULA CONTIENE: FENITOINA SODICA 100 MG ENVASE CON 50 TABLETAS O CAPSULAS.,ENV,50,C.T,100,miligramos,5000,miligramos,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,FARMACOS_UTILIZADOS_EN_NEUROLOGIA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0
1178,Grupo Nº 14: Neurología,TOXINA BOTULÍNICA TIPO A,4352,4352,1000043520000,010,000,4352,00,00,SI,Entrega hospitalaria,TOXINA BOTULINICA TIPO A. SOLUCION INYECTABLE CADA FRASCO AMPULA CON POLVO CONTIENE: TOXINA BOTULINICA TIPO A 12.5 NG (500 U).,ENV,1,F.A,500,U,500,U,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1179,Grupo Nº 14: Neurología,PREGABALINA,4356,4356,1000043560000,010,000,4356,00,00,NO,"VALES,Sustantiva -- Eficiencia terapeutica P - 25%",PREGABALINA. CAPSULA. CADA CAPSULA CONTIENE: PREGABALINA 75 MG. ENVASE CON 14 CAPSULAS.,FCO,14,CAP,75,miligramos,1050,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,ANTINEURITICOS,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1180,Grupo Nº 14: Neurología,PREGABALINA,4356,4356,1000043560100,010,000,4356,01,00,SI,"VALES,Sustantiva -- Eficiencia terapeutica P - 25%",PREGABALINA CAPSULA CADA CAPSULA CONTIENE: PREGABALINA 75 MG ENVASE CON 28 CAPSULAS,ENV,28,CAP,75,miligramos,2100,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,ANTINEURITICOS,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1181,Grupo Nº 14: Neurología,PREGABALINA,4358,4358,1000043580000,010,000,4358,00,00,NO,"VALES,Sustantiva -- Eficiencia terapeutica P - 25%",PREGABALINA. CAPSULA. CADA CAPSULA CONTIENE: PREGABALINA 150 MG. ENVASE CON 14 CAPSULAS.,ENV,14,CAP,150,miligramos,2100,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,ANTINEURITICOS,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1182,Grupo Nº 14: Neurología,PREGABALINA,4358,4358,1000043580100,010,000,4358,01,00,SI,"VALES,Sustantiva -- Eficiencia terapeutica P - 25%",PREGABALINA CAPSULA CADA CAPSULA CONTIENE: PREGABALINA 150 MG ENVASE CON 28 CAPSULAS.,ENV,28,CAP,150,miligramos,4200,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,ANTINEURITICOS,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1183,Grupo Nº 14: Neurología,GABAPENTINA,4359,4359,1000043590000,010,000,4359,00,00,SI,"VALES,Consumo en demanda",GABAPENTINA CAPSULA CADA CAPSULA CONTIENE: GABAPENTINA 300 MG ENVASE CON 15 CAPSULAS.,ENV,15,CAP,300,miligramos,4500,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,ANTINEURITICOS,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1184,Grupo Nº 14: Neurología,ZOLMITRIPTANO,4361,4361,1000043610000,010,000,4361,00,00,SI,"VALES,Sustantiva -- Eficiencia terapeutica Q - 68%",ZOLMITRIPTANO. TABLETAS DISPERSABLES. CADA TABLETA DISPERSABLE CONTIENE: ZOLMITRIPTANO 2.5 MG. ENVASE CON 2 TABLETAS DISPERSABLES.,ENV,2,TAB,2.5,miligramos,5,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1185,Grupo Nº 14: Neurología,ZOLMITRIPTANO,4361,4361,1000043610100,010,000,4361,01,00,NO,"VALES,Sustantiva -- Eficiencia terapeutica Q - 68%",ZOLMITRIPTANO. TABLETA DISPERSABLE. CADA TABLETA DISPERSABLE CONTIENE: ZOLMITRIPTANO 2.5 MG. ENVASE CON 3 TABLETAS DISPERSABLES.,ENV,3,TAB,2.5,miligramos,7.5,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1186,Grupo Nº 14: Neurología,TOXINA BOTULÍNICA TIPO A,4362,4362,1000043620000,010,000,4362,00,00,SI,Entrega hospitalaria,TOXINA BOTULINICA TIPO A SOLUCION INYECTABLE CADA FRASCO AMPULA CON POLVO CONTIENE: TOXINA BOTULINICA TIPO A 100 U ENVASE CON UN FRASCO AMPULA.,ENV,1,F.A,100,U,100,U,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1187,Grupo Nº 14: Neurología,ACETATO DE GLATIRAMER,4363,4363,1000043630000,010,000,4363,00,00,SI,Catálogo II -- TORRE DE CONTROL,ACETATO DE GLATIRAMER SOLUCION INYECTABLE CADA JERINGA PRELLENADA CONTIENE:  ACETATO DE GLATIRAMER 20 MG ENVASE CON 28 JERINGAS PRELLENADAS (20 MG/ML CADA  UNA).,ENV,28,JGA,20,miligramos,560,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1188,Grupo Nº 14: Neurología,ELETRIPTÁN,4366,4366,1000043660000,010,000,4366,00,00,SI,Sustantiva -- Eficiencia terapeutica Q - 1%,ELETRIPTAN TABLETA CADA TABLETA CONTIENE: BROMHIDRATO DE ELETRIPTAN EQUIVALENTE A 40 MG DE ELETRIPTAN ENVASE CON DOS TABLETAS.,ENV,2,TAB,40,miligramos,80,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1189,Grupo Nº 14: Neurología,ELETRIPTÁN,4367,4367,1000043670000,010,000,4367,00,00,SI,Sustantiva -- Eficiencia terapeutica Q - 1%,ELETRIPTAN TABLETA CADA TABLETA CONTIENE: BROMHIDRATO DE ELETRIPTAN EQUIVALENTE A 80 MG DE ELETRIPTAN ENVASE CON DOS TABLETAS.,ENV,2,TAB,80,miligramos,160,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1324,Grupo Nº 14: Neurología,INTERFERÓN (BETA),5237,5237,1000052370002,010,000,5237,00,02,NO,Sustantiva,INTERFERON (BETA). SOLUCION INYECTABLE. CADA FRASCO AMPULA CONTIENE: INTERFERON BETA 1A 44 MICROGRAMOS (12 MILLONES UI). ENVASE CON FRASCO AMPULA CON LIOFILIZADO Y AMPOLLETA CON 2 ML DE DILUYENTE.,ENV,1,F.A,12000000,UI,12000000,UI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1325,Grupo Nº 14: Neurología,INTERFERÓN (BETA),5237,5237,1000052370102,010,000,5237,01,02,NO,Sustantiva,INTERFERON (BETA). SOLUCION INYECTABLE. CADA JERINGA PRELLENADA CONTIENE: INTERFERON BETA 1 A 44 MICROGRAMOS (12 MILLONES UI). ENVASE CON 12 JERINGAS PRELLENADAS CON 0.5 ML CON AUTOINYECTOR NO ESTERIL DE INYECCION AUTOMATICA.,ENV,12,JGA,12000000,UI,144000000,UI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1326,Grupo Nº 14: Neurología,INTERFERÓN (BETA),5237,5237,1000052370200,010,000,5237,02,00,SI,Sustantiva,"INTERFERON (BETA) SOLUCION INYECTABLE, CADA FRASCO AMPULA O JERINGA PRELLENADA CONTIENE: INTERFERON BETA 1A 44 MICROGRAMOS (12 MILLONES UI) ENVASE CON JERINGA PRELLENADA CON 0.5 ML.",ENV,1,JGA,12000000,UI,12000000,UI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1327,Grupo Nº 14: Neurología,INTERFERÓN (BETA),5237,5237,1000052370300,010,000,5237,03,00,NO,Sustantiva,"INTERFERON (BETA) SOLUCION INYECTABLE, CADA FRASCO AMPULA O JERINGA PRELLENADA O CARTUCHO PRELLENADO CONTIENE: INTERFERON BETA 1A 44 MICROGRAMOS (12 MILLONES UI) ENVASE CON CARTUCHO PRELLENADO DE 1.5 ML (3 DOSIS DE 44 MICROGRAMOS/0.5",ENV,1,CHO,12000000,UI,12000000,UI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1339,Grupo Nº 14: Neurología,INTERFERÓN (BETA),5250,5250,1000052500000,010,000,5250,00,00,NO,Catálogo II -- TORRE DE CONTROL,INTERFERON (BETA) SOLUCION INYECTABLE EL FRASCO AMPULA CON LIOFILIZADO CONTIENE: INTERFERON BETA 1B RECOMBINANTE HUMANO 8 MILLONES UI O INTERFERON BETA 1B 8 MILLONES UI ENVASE CON UN FRASCO AMPULA CON LIOFILIZADO Y UN FRASCO,ENV,1,F.A,8000000,UI,8000000,UI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1340,Grupo Nº 14: Neurología,INTERFERÓN (BETA),5250,5250,1000052500100,010,000,5250,01,00,SI,Catálogo II -- TORRE DE CONTROL,INTERFERON (BETA) SOLUCION INYECTABLE EL FRASCO AMPULA CON LIOFILIZADO CONTIENE: INTERFERON BETA 1B RECOMBINANTE HUMANO 8 MILLONES UI O INTERFERON BETA 1B 8 MILLONES UI. ENVASE CON 15 FRASCOS AMPULA CON LIOFILIZADO Y 15,ENV,15,AFA,8000000,UI,120000000,UI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1341,Grupo Nº 14: Neurología,INTERFERÓN (BETA),5250,5250,1000052500200,010,000,5250,02,00,NO,Catálogo II -- TORRE DE CONTROL,INTERFERON (BETA). SOLUCION INYECTABLE. EL FRASCO AMPULA CON LIOFILIZADO  CONTIENE: INTERFERON BETA 1B RECOMBINANTE HUMANO 8 MILLONES UI O INTERFERON  BETA 1B 8 MILLONES UI. ENVASE CON 1 FRASCO AMPULA CON LIOFILIZADO Y 1 JERINGA,ENV,1,FAJ,8000000,UI,8000000,UI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1342,Grupo Nº 14: Neurología,INTERFERÓN (BETA),5251,5251,1000052510000,010,000,5251,00,00,SI,Sustantiva,INTERFERON (BETA) SOLUCION INYECTABLE CADA FRASCO AMPULA CON LIOFILIZADO O CADA JERINGA PRELLENADA CONTIENE: INTERFERON BETA 1 A 6 MILLONES UI (30 MICROGRAMOS) ENVASE CON UN FRASCO AMPULA CON DISPOSITIVO MEDICO Y UNA JERINGA,ENV,1,JGO,30,microgramos,30,microgramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1347,Grupo Nº 14: Neurología,NATALIZUMAB,5257,5257,1000052570000,010,000,5257,00,00,SI,"Catálogo II -- TORRE DE CONTROL,Uso Hospitalario, Neurología",NATALIZUMAB. SOLUCION INYECTABLE CADA FRASCO AMPULA CONTIENE: NATALIZUMAB 300  MG. ENVASE CON FRASCO AMPULA CON 300 MG.,ENV,1,F.A,300,miligramos,300,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
407,Grupo Nº 15: Oftalmología,CIPROFLOXACINO,2174,2174,1000021740000,010,000,2174,00,00,SI,"VALES,Sustantiva",CIPROFLOXACINO SOLUCION OFTALMICA CADA 1 ML CONTIENE: CLORHIDRATO DE  CIPROFLOXACINO MONOHIDRATADO EQUIVALENTE A 3.0 MG DE CIPROFLOXACINO. ENVASE  CON GOTERO INTEGRAL CON 5 ML.,ENV,1,ENV,3,miligramos,3,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
410,Grupo Nº 15: Oftalmología,TOBRAMICINA,2189,2189,1000021890002,010,000,2189,00,02,NO,Sustantiva,"TOBRAMICINA, SOLUCION OFTALMICA. CADA ML. CONTIENE: SULFATO DE TOBRAMICINA EQUIVALENTE A 3.0 MG DE TOBRAMICINA O TOBRAMICINA 3.0 MG. ENVASE CON GOTERO INTEGRAL CON 5 ML.",ENV,1,ENV,3,miligramos,3,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
411,Grupo Nº 15: Oftalmología,TOBRAMICINA,2189,2189,1000021890100,010,000,2189,01,00,SI,Sustantiva,TOBRAMICINA SOLUCION OFTALMICA CADA ML CONTIENE: SULFATO DE TOBRAMICINA  EQUIVALENTE A 3.0 MG O TOBRAMICINA 3.0 MG ENVASE CON GOTERO INTEGRAL CON15 ML.,ENV,1,ENV,3,miligramos,3,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
513,Grupo Nº 15: Oftalmología,ZINC Y FENILEFRINA,2801,2801,1000028010000,010,000,2801,00,00,SI,"Sustantiva,VALES",ZINC Y FENILEFRINA SOLUCION OFTALMICA CADA ML CONTIENE: SULFATO DE ZINC  HEPTAHIDRATADO 2.5 MG CLORHIDRATO DE FENILEFRINA 1.2 MG ENVASE CON GOTERO  INTEGRAL CON 15 ML.,ENV,15,ML.,3.7,miligramos,3.7,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
514,Grupo Nº 15: Oftalmología,NAFAZOLINA,2804,2804,1000028040000,010,000,2804,00,00,SI,"Sustantiva,VALES",NAFAZOLINA SOLUCION OFTALMICA CADA ML CONTIENE: CLORHIDRATO DE NAFAZOLINA 1 MG  ENVASE CON GOTERO INTEGRAL CON 15 ML.,FCO,15,ML.,1,miligramos,1,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,FARMACOS_OCULARES,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0
515,Grupo Nº 15: Oftalmología,CROMOGLICATO DE SODIO,2806,2806,1000028060000,010,000,2806,00,00,SI,"Sustantiva,VALES",CROMOGLICATO DE SODIO SOLUCION OFTALMICA CADA ML CONTIENE: CROMOGLICATO DE  SODIO 40 MG ENVASE CON GOTERO INTEGRAL CON 5 ML.,FCO,5,ML.,40,miligramos,40,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,BRONCODILATADORES_Y_EXPECTORANTES,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
516,Grupo Nº 15: Oftalmología,HIPROMELOSA,2814,2814,1000028140000,010,000,2814,00,00,SI,"Sustantiva,VALES",HIPROMELOSA SOLUCION OFTALMICA AL 0.5% CADA ML CONTIENE: HIPROMELOSA 5 MG ENVASE CON GOTERO INTEGRAL CON 15 ML.,FCO,15,ML.,5,miligramos,5,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,FARMACOS_OCULARES,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0
517,Grupo Nº 15: Oftalmología,CLORANFENICOL,2821,2821,1000028210000,010,000,2821,00,00,SI,Sustantiva,CLORANFENICOL SOLUCION OFTALMICA CADA ML CONTIENE: CLORANFENICOL LEVOGIRO 5 MG  ENVASE CON GOTERO INTEGRAL CON 15 ML.,ENV,15,ML.,5,miligramos,5,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,ANTIBIOTICOS,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
518,Grupo Nº 15: Oftalmología,CLORANFENICOL,2822,2822,1000028220000,010,000,2822,00,00,SI,"Sustantiva,VALES","CLORANFENICOL UNGÜENTO OFTALMICO CADA G CONTIENE: CLORANFENICOL LEVOGIRO 5 MG,  ENVASE CON 5 G.",ENV,1,TBO,5,miligramos,5,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
519,Grupo Nº 15: Oftalmología,"NEOMICINA, POLIMIXINA B Y GRAMICIDINA",2823,2823,1000028230000,010,000,2823,00,00,SI,"Sustantiva,VALES","NEOMICINA, POLIMIXINA B Y GRAMICIDINA SOLUCION OFTALMICA CADA ML CONTIENE:  SULFATO DE NEOMICINA EQUIVALENTE A 1.75 MG DE NEOMICINA. SULFATO DE POLIMIXINA  B EQUIVALENTE A 5 000 U DE POLIMIXINA B. GRAMICIDINA 25 MICROGRAMOS ENVASE CON",ENV,15,ML.,1.75,miligramos,1.75,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,FARMACOS_OCULARES,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0
520,Grupo Nº 15: Oftalmología,"NEOMICINA, POLIMIXINA B Y BACITRACINA",2824,2824,1000028240000,010,000,2824,00,00,SI,"Sustantiva,VALES","NEOMICINA, POLIMIXINA B Y BACITRACINA UNGÜENTO OFTALMICO CADA GRAMO CONTIENE:  SULFATO DE NEOMICINA EQUIVALENTE A 3.5 MG, DE NEOMICINA. SULFATO DE POLIMIXINA  B, EQUIVALENTE A 5 000 U, DE POLIMIXINA B, BACITRACINA 400 U, ENVASE CON 3.5",ENV,1,TBO,3.5,miligramos,3.5,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
521,Grupo Nº 15: Oftalmología,GENTAMICINA,2828,2828,1000028280000,010,000,2828,00,00,SI,"Sustantiva,VALES","GENTAMICINA SOLUCION OFTALMICA CADA ML CONTIENE: SULFATO DE GENTAMICINA  EQUIVALENTE A 3 MG, DE GENTAMICINA. ENVASE CON GOTERO INTEGRAL CON 5 ML.",ENV,5,ML.,3,miligramos,3,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
522,Grupo Nº 15: Oftalmología,SULFACETAMIDA,2829,2829,1000028290000,010,000,2829,00,00,SI,"Sustantiva,VALES",SULFACETAMIDA SOLUCION OFTALMICA CADA ML CONTIENE: SULFACETAMIDA SODICA 0.1 G  ENVASE CON GOTERO INTEGRAL CON 15 ML.,FCO,15,ML.,0.1,gramos,0.1,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
523,Grupo Nº 15: Oftalmología,ACICLOVIR,2830,2830,1000028300000,010,000,2830,00,00,SI,"Sustantiva,VALES",ACICLOVIR UNGÜENTO OFTALMICO CADA 100 GRAMOS CONTIENEN ACICLOVIR 3 G ENVASE CON  4.5 G.,TBO,1,TBO,3,gramos,3,gramos,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,ANTIBIOTICOS,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
524,Grupo Nº 15: Oftalmología,PREDNISOLONA,2841,2841,1000028410000,010,000,2841,00,00,SI,"Sustantiva,VALES",PREDNISOLONA SOLUCION OFTALMICA CADA ML CONTIENE: FOSFATO SODICO DE  PREDNISOLONA EQUIVALENTE A 5 MG DE FOSFATO DE PREDNISOLONA ENVASE CON GOTERO  INTEGRAL CON 5 ML.,ENV,5,ML.,5,miligramos,25,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,FARMACOS_OCULARES,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0
525,Grupo Nº 15: Oftalmología,PILOCARPINA,2851,2851,1000028510000,010,000,2851,00,00,SI,Sustantiva,PILOCARPINA SOLUCION OFTALMICA AL 2% CADA ML CONTIENE: CLORHIDRATO DE  PILOCARPINA 20 MG ENVASE CON GOTERO INTEGRAL CON 15 ML.,ENV,15,ML.,20,miligramos,20,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
526,Grupo Nº 15: Oftalmología,PILOCARPINA,2852,2852,1000028520000,010,000,2852,00,00,SI,Sustantiva,"PILOCARPINA SOLUCION OFTALMICA AL 4% CADA ML CONTIENE: CLORHIDRATO DE  PILOCARPINA 40 MG, ENVASE CON GOTERO INTEGRAL CON 15 ML.",ENV,15,ML.,40,miligramos,40,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
527,Grupo Nº 15: Oftalmología,TIMOLOL,2858,2858,1000028580000,010,000,2858,00,00,SI,"Sustantiva,VALES","TIMOLOL SOLUCION OFTALMICA CADA ML CONTIENE: MALEATO DE TIMOLOL, EQUIVALENTE A  5 MG, DE TIMOLOL. ENVASE CON GOTERO INTEGRAL CON 5 ML.",ENV,5,ML.,5,miligramos,25,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,FARMACOS_OCULARES,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0
528,Grupo Nº 15: Oftalmología,FENILEFRINA,2871,2871,1000028710000,010,000,2871,00,00,SI,Sustantiva,FENILEFRINA SOLUCION OFTALMICA CADA ML CONTIENE: CLORHIDRATO DE FENILEFRINA 100  MG ENVASE CON GOTERO INTEGRAL CON 15 ML.,FCO,15,ML.,100,miligramos,100,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
529,Grupo Nº 15: Oftalmología,ATROPINA,2872,2872,1000028720000,010,000,2872,00,00,SI,"Sustantiva,VALES",ATROPINA SOLUCION OFTALMICA CADA ML CONTIENE: SULFATO DE ATROPINA 10 MG ENVASE  CON GOTERO INTEGRAL CON 15 ML.,FCO,15,ML.,10,miligramos,10,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
530,Grupo Nº 15: Oftalmología,HIPROMELOSA,2893,2893,1000028930000,010,000,2893,00,00,SI,"Sustantiva,VALES",HIPROMELOSA SOLUCION OFTALMICA AL 2% CADA ML CONTIENE: HIPROMELOSA 20 MG ENVASE  CON GOTERO INTEGRAL CON 15 ML.,ENV,15,ML.,20,miligramos,20,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
531,Grupo Nº 15: Oftalmología,CLORURO DE SODIO,2899,2899,1000028990000,010,000,2899,00,00,SI,Sustantiva,CLORURO DE SODIO POMADA O SOLUCION OFTALMICA CADA GRAMO O ML CONTIENE:CLORURO  DE SODIO 50 MG ENVASE CON 7 G O CON GOTERO INTEGRAL CON 10 ML.,ENV,1,ENV,50,miligramos,50,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
532,Grupo Nº 15: Oftalmología,"ACETILCOLINA, CLORURO DE",2900,2900,1000029000003,010,000,2900,00,03,SI,Sustantiva,ACETILCOLINA CLORURO DE SOLUCION OFTALMICA CADA FRASCO AMPULA CON LIOFILIZADO CONTIENE: CLORURO DE ACETILCOLINA 20 MG. ENVASE CON UN FRASCO AMPULA CON LIOFILIZADO Y AMPOLLETA CON 2 ML DE DILUYENTE.,ENV,1,F.A,20,miligramos,20,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
632,Grupo Nº 15: Oftalmología,CICLOPENTOLATO,2877,2877,4000028770000,040,000,2877,00,00,SI,"VALES,Sustantiva",CICLOPENTOLATO SOLUCION OFTALMICA CADA ML CONTIENE: CLORHIDRATO DE  CICLOPENTOLATO 10 MG ENVASE CON GOTERO INTEGRAL CON 3 ML.,ENV,1,ENV,10,miligramos,10,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1203,Grupo Nº 15: Oftalmología,TETRACAÍNA,4407,4407,1000044070000,010,000,4407,00,00,SI,Sustantiva,TETRACAINA SOLUCION OFTALMICA CADA ML CONTIENE: CLORHIDRATO DE TETRACAINA 5.0  MG ENVASE CON GOTERO INTEGRAL CON 10 ML.,ENV,1,FCO,5,miligramos,5,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1204,Grupo Nº 15: Oftalmología,DICLOFENACO,4408,4408,1000044080000,010,000,4408,00,00,SI,Sustantiva,DICLOFENACO SOLUCION OFTALMICA CADA ML CONTIENE: DICLOFENACO SODICO 1.0 MG  ENVASE CON GOTERO INTEGRAL CON 5 ML.,ENV,1,F.G,1,miligramos,1,miligramos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1205,Grupo Nº 15: Oftalmología,DICLOFENACO,4408,4408,1000044080100,010,000,4408,01,00,NO,Sustantiva,DICLOFENACO. SOLUCION OFTALMICA. CADA ML CONTIENE: DICLOFENACO SODICO 1.0 MG. ENVASE CON GOTERO INTEGRAL CON 15 ML.,ENV,1,F.G,1,miligramos,1,miligramos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1206,Grupo Nº 15: Oftalmología,TROPICAMIDA,4409,4409,1000044090000,010,000,4409,00,00,SI,Sustantiva,TROPICAMIDA SOLUCION OFTALMICA CADA 100 ML CONTIENEN: TROPICAMIDA 1 G ENVASE  CON GOTERO INTEGRAL CON 5 ML.,ENV,1,ENV,1,gramos,1,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1207,Grupo Nº 15: Oftalmología,TROPICAMIDA,4409,4409,1000044090100,010,000,4409,01,00,NO,Sustantiva,TROPICAMIDA. SOLUCION OFTALMICA. CADA 100 ML CONTIENEN: TROPICAMIDA 1 G. ENVASE CON GOTERO INTEGRAL CON 15 ML.,ENV,1,F.G,1,gramos,1,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1208,Grupo Nº 15: Oftalmología,DORZOLAMIDA,4410,4410,1000044100000,010,000,4410,00,00,SI,"VALES,Sustantiva",DORZOLAMIDA SOLUCION OFTALMICA CADA ML CONTIENE: CLORHIDRATO DE DORZOLAMIDA  EQUIVALENTE A 20 MG DE DORZOLAMIDA ENVASE CON GOTERO INTEGRAL CON 5 ML.,ENV,1,F.G,20,miligramos,20,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1209,Grupo Nº 15: Oftalmología,LATANOPROST,4411,4411,1000044110000,010,000,4411,00,00,SI,"VALES,Sustantiva",LATANOPROST SOLUCION OFTALMICA CADA ML CONTIENE: LATANOPROST 50 MICROGRAMOS  ENVASE CON UN FRASCO GOTERO CON 2.5 ML.,ENV,1,F.G,50,microgramos,50,microgramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,FARMACOS_OCULARES,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0
1210,Grupo Nº 15: Oftalmología,LATANOPROST,4411,4411,1000044110100,010,000,4411,01,00,NO,"VALES,Sustantiva",LATANOPROST SOLUCION OFTALMICA CADA ML CONTIENE: LATANOPROST 50 MICROGRAMOS  ENVASE CON UN FRASCO GOTERO CON 3.0 ML.,ENV,1,F.G,50,microgramos,50,microgramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,FARMACOS_OCULARES,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0
1211,Grupo Nº 15: Oftalmología,DORZOLAMIDA Y TIMOLOL,4412,4412,1000044120000,010,000,4412,00,00,SI,"VALES,Sustantiva",DORZOLAMIDA Y TIMOLOL SOLUCION OFTALMICA CADA ML CONTIENE: CLORHIDRATO DE  DORZOLAMIDA EQUIVALENTE A 20 MG DE DORZOLAMIDA MALEATO DE TIMOLOL EQUIVALENTE  A 5 MG DE TIMOLOL ENVASE CON GOTERO INTEGRAL CON 5 ML.,ENV,1,F.G,25,miligramos,25,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,FARMACOS_OCULARES,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0
1212,Grupo Nº 15: Oftalmología,VERTEPORFINA,4415,4415,1000044150000,010,000,4415,00,00,SI,"Entrega hospitalaria,Uso Hospitalario, Oftalmología",VERTEPORFINA SOLUCION INYECTABLE CADA FRASCO AMPULA CON LIOFILIZADO CONTIENE:  VERTEPORFINA 15 MG ENVASE CON UN FRASCO AMPULA.,ENV,1,F.A,15,miligramos,15,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1213,Grupo Nº 15: Oftalmología,CICLOSPORINA,4416,4416,1000044160000,010,000,4416,00,00,SI,Sustantiva,CICLOSPORINA SOLUCION OFTALMICA CADA ML CONTIENE: CICLOSPORINA A 1.0 MG; ENVASE  CON FRASCO GOTERO CON 5 ML.,ENV,1,ENV,1,miligramos,1,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1214,Grupo Nº 15: Oftalmología,TRAVOPROST,4418,4418,1000044180000,010,000,4418,00,00,SI,"VALES,Sustantiva",TRAVOPROST SOLUCION OFTALMICA CADA ML CONTIENE: TRAVOPROST 40 MICROGRAMOS  ENVASE CON UN FRASCO GOTERO CON 2.5 ML.,ENV,1,F.G,40,microgramos,40,microgramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,FARMACOS_OCULARES,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0
99,Grupo Nº 16: Oncología,EXEMESTANO,5418,5418,1000054180000,010,000,5418,00,00,NO,Sustantiva,EXEMESTANO. GRAGEA. CADA GRAGEA CONTIENE: EXEMESTANO 25.0 MG. ENVASE CON 15 GRAGEAS.,ENV,15,GRA,25,miligramos,375,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
100,Grupo Nº 16: Oncología,EXEMESTANO,5418,5418,1000054180100,010,000,5418,01,00,SI,Sustantiva,EXEMESTANO GRAGEA CADA GRAGEA CONTIENE: EXEMESTANO 25.0 MG ENVASE CON 30 GRAGEAS.,ENV,30,GRA,25,miligramos,750,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
101,Grupo Nº 16: Oncología,EXEMESTANO,5418,5418,1000054180200,010,000,5418,02,00,NO,Sustantiva,EXEMESTANO. GRAGEA. CADA GRAGEA CONTIENE: EXEMESTANO 25.0 MG. ENVASE CON 90 GRAGEAS.,ENV,90,GRA,25,miligramos,2250,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
102,Grupo Nº 16: Oncología,TRASTUZUMAB,5422,5422,1000054220000,010,000,5422,00,00,SI,"Catálogo II -- TNF,Uso Hospitalario, Oncología",TRASTUZUMAB SOLUCION INYECTABLE CADA FRASCO AMPULA CON POLVO CONTIENE:  TRASTUZUMAB 150 MG ENVASE CON FRASCO AMPULA.,ENV,1,F.A,150,miligramos,150,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
103,Grupo Nº 16: Oncología,TRASTUZUMAB,5423,5423,1000054230000,010,000,5423,00,00,SI,Catálogo II -- TNF,TRASTUZUMAB SOLUCION INYECTABLE CADA FRASCO AMPULA CON POLVO CONTIENE:  TRASTUZUMAB 440 MG ENVASE CON UN FRASCO AMPULA CON POLVO Y UN FRASCO AMPULA  CON 20 ML DE DILUYENTE.,ENV,1,JGO,440,miligramos,440,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
104,Grupo Nº 16: Oncología,RALTITREXED,5425,5425,1000054250000,010,000,5425,00,00,SI,"Sin programa definido,Uso Hospitalario, Oncología",RALTITREXED SOLUCION INYECTABLE CADA FRASCO AMPULA CON LIOFILIZADO CONTIENE:  RALTITREXED 2 MG ENVASE CON UN FRASCO AMPULA.,ENV,1,F.A,2,miligramos,2,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
105,Grupo Nº 16: Oncología,FLUTAMIDA,5426,5426,1000054260000,010,000,5426,00,00,SI,"VALES,Sustantiva",FLUTAMIDA TABLETA CADA TABLETA CONTIENE: FLUTAMIDA 250 MG ENVASE CON 90 TABLETAS.,ENV,90,TAB,250,miligramos,22500,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
106,Grupo Nº 16: Oncología,TROPISETRÓN,5427,5427,1000054270000,010,000,5427,00,00,SI,"VALES,Sustantiva",TROPISETRON CAPSULA CADA CAPSULA CONTIENE: CLORHIDRATO DE TROPISETRON  EQUIVALENTE A 5 MG DE TROPISETRON. ENVASE CON 5 CAPSULAS.,ENV,5,CAP,5,miligramos,25,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
107,Grupo Nº 16: Oncología,ONDANSETRÓN,5428,5428,1000054280000,010,000,5428,00,00,SI,"Sustantiva,Uso Hospitalario, Oncología",ONDANSETRON SOLUCION INYECTABLE CADA AMPOLLETA O FRASCO AMPULA CONTIENE:  CLORHIDRATO DIHIDRATADO DE ONDANSETRON EQUIVALENTE A 8 MG DE ONDANSETRON  ENVASE CON 3 AMPOLLETAS O FRASCOS AMPULA CON 4 ML.,ENV,3,AFA,8,miligramos,24,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
108,Grupo Nº 16: Oncología,MOLGRAMOSTIM,5429,5429,1000054290000,010,000,5429,00,00,SI,Sustantiva,"MOLGRAMOSTIM, LIOFILIZADO PARA SOLUCION INYECTABLE, 400 MICROGRAMOS, FRASCO AMPULA Y DILUYENTE 1 MILILITRO.",ENV,1,JGO,400,microgramos,400,microgramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
109,Grupo Nº 16: Oncología,MOLGRAMOSTIM,5429,5429,1000054290003,010,000,5429,00,03,NO,Sustantiva,MOLGRAMOSTIM. SOLUCION INYECTABLE. CADA FRASCO AMPULA CON LIOFILIZADO CONTIENE: MOLGRAMOSTIM 400 MICROGRAMOS. ENVASE CON FRASCO AMPULA Y UNA AMPOLLETA CON DILUYENTE DE UN MILILITRO.,ENV,1,JGO,400,microgramos,400,microgramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
110,Grupo Nº 16: Oncología,MEGESTROL,5430,5430,1000054300000,010,000,5430,00,00,SI,Sustantiva,"MEGESTROL TABLETA CADA TABLETA CONTIENE: ACETATO DE MEGESTROL 40 MG, ENVASE CON  100 TABLETAS.",ENV,100,TAB,40,miligramos,4000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
111,Grupo Nº 16: Oncología,LEUPRORELINA,5431,5431,1000054310000,010,000,5431,00,00,SI,Sustantiva -- Eficiencia terapeutica M - 30%,LEUPRORELINA SUSPENSION INYECTABLE CADA FRASCO AMPULA CON MICROESFERAS  LIOFILIZADAS CONTIENE: ACETATO DE LEUPRORELINA 3.75 MG ENVASE CON UN FRASCO  AMPULA Y DILUYENTE CON 2 ML Y EQUIPO PARA SU ADMINISTRACION.,ENV,1,JGO,3.75,miligramos,3.75,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
112,Grupo Nº 16: Oncología,FILGRASTIM,5432,5432,1000054320000,010,000,5432,00,00,SI,Sustantiva,FILGRASTIM SOLUCION INYECTABLE CADA FRASCO AMPULA O JERINGA CONTIENE:  FILGRASTIM 300 MICROGRAMOS ENVASE CON 5 FRASCOS AMPULA O JERINGAS.,ENV,5,FAJ,300,microgramos,1500,microgramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
113,Grupo Nº 16: Oncología,RITUXIMAB,5433,5433,1000054330000,010,000,5433,00,00,NO,"Entrega hospitalaria,Uso Hospitalario, Oncología,Uso Hospitalario, Oncología,Entrega hospitalaria","RITUXIMAB SOLUCION INYECTABLE CADA FRASCO AMPULA CONTIENE RITUXIMAB 100 MG, ENVASE CON 1 FRASCO AMPULA CON 10 ML.",ENV,1,F.A,100,miligramos,100,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
114,Grupo Nº 16: Oncología,RITUXIMAB,5433,5433,1000054330100,010,000,5433,01,00,SI,"Entrega hospitalaria,Uso Hospitalario, Oncología,Uso Hospitalario, Oncología,Entrega hospitalaria",RITUXIMAB SOLUCION INYECTABLE CADA FRASCO AMPULA CONTIENE RITUXIMAB 100 MG ENVASE CON 2 FRASCOS AMPULA CON 10 ML.,ENV,2,F.A,100,miligramos,200,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
115,Grupo Nº 16: Oncología,LEUPRORELINA,5434,5434,1000054340000,010,000,5434,00,00,SI,,"LEUPRORELINA SUSPENSION INYECTABLE EL FRASCO AMPULA CONTIENE: ACETATO DE  LEUPRORELINA 11.25 MG ENVASE CON UN FRASCO AMPULA, AMPOLLETA CON 2 ML DE  DILUYENTE Y EQUIPO PARA ADMINISTRACION.",ENV,1,ENV,1.25,miligramos,1.25,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
116,Grupo Nº 16: Oncología,PACLITAXEL,5435,5435,1000054350000,010,000,5435,00,00,SI,"Sustantiva,Uso Hospitalario, Oncología","SOLUCION INYECTABLE CADA FRASCO AMPULA CONTIENE: PACLITAXEL 300 MG ENVASE CON UN FRASCO AMPULA CON 50 ML, CON EQUIPO PARA VENOCLISIS LIBRE DE POLIVINILCLORURO (PVC) Y FILTRO CON MEMBRANA NO MAYOR DE 0.22 µm MICRAS.",ENV,1,JGO,300,miligramos,300,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
117,Grupo Nº 16: Oncología,PACLITAXEL,5435,5435,1000054350002,010,000,5435,00,02,NO,"Sustantiva,Uso Hospitalario, Oncología","PACLITAXEL. SOLUCION INYECTABLE. CADA FRASCO AMPULA CONTIENE: PACLITAXEL 300 MG. ENVASE CON UN FRASCO AMPULA CON 50 ML, CON EQUIPO PARA VENOCLISIS LIBRE DE POLIVINILCLORURO (PVC) Y FILTRO1 CON MEMBRANA NO MAYOR DE 0.22 MICRAS.",ENV,1,JGO,300,miligramos,300,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
118,Grupo Nº 16: Oncología,TRETINOÍNA,5436,5436,1000054360000,010,000,5436,00,00,SI,Entrega hospitalaria,TRETINOINA CAPSULA CADA CAPSULA CONTIENE: TRETINOINA 10 MG ENVASE CON 100  CAPSULAS.,ENV,100,CAP,10,miligramos,1000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
119,Grupo Nº 16: Oncología,DOCETAXEL,5437,5437,1000054370000,010,000,5437,00,00,SI,"Entrega hospitalaria,Uso Hospitalario, Oncología,Uso Hospitalario, Oncología,Uso Hospitalario, Oncología,Entrega hospitalaria,Entrega hospitalaria",DOCETAXEL SOLUCION INYECTABLE. CADA FRASCO AMPULA CONTIENE: DOCETAXEL ANHIDRO O TRIHIDRATADO EQUIVALENTE A 80 MGDE DOCETA EL ENVASE CON UN FRASCO AMPULA CON 80 MG Y FRASCO AMPULA CON 6 ML DE DILUYENTE.,ENV,1,ENV,80,miligramos,80,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
120,Grupo Nº 16: Oncología,DOCETAXEL,5437,5437,1000054370102,010,000,5437,01,02,NO,"Entrega hospitalaria,Uso Hospitalario, Oncología,Uso Hospitalario, Oncología,Uso Hospitalario, Oncología,Entrega hospitalaria,Entrega hospitalaria",DOCETAXEL SOLUCION INYECTABLE. CADA FRASCO AMPULA CONTIENE: DOCETAXEL ANHIDRO O  TRIHIDRATADO EQUIVALENTE A  80 MG DE DOCETAXEL ENVASE CON FRASCO AMPULA CON  80 MG CON 4 ML.,ENV,1,AFA,80,miligramos,80,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
121,Grupo Nº 16: Oncología,DOCETAXEL,5437,5437,1000054370202,010,000,5437,02,02,NO,"Entrega hospitalaria,Uso Hospitalario, Oncología,Uso Hospitalario, Oncología,Uso Hospitalario, Oncología,Entrega hospitalaria,Entrega hospitalaria",DOCETAXEL. SOLUCION INYECTABLE CADA FRASCO AMPULA CONTIENE: DOCETAXEL ANHIDRO O TRIHIDRATADO EQUIVALENTE A    80 MG DE DOCETAXEL ENVASE CON FRASCO AMPULA CON 80 MG CON 8 ML.,ENV,1,F.A,80,miligramos,80,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
122,Grupo Nº 16: Oncología,GEMCITABINA,5438,5438,1000054380000,010,000,5438,00,00,SI,"Sustantiva,Uso Hospitalario, Oncología",GEMCITABINA SOLUCION INYECTABLE CADA FRASCO AMPULA CONTIENE: CLORHIDRATO DE  GEMCITABINA EQUIVALENTA A 1 G DE GEMCITABINA. ENVASE CON UN FRASCO AMPULA.,ENV,1,ENV,1,gramos,1,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
123,Grupo Nº 16: Oncología,AMIFOSTINA,5439,5439,1000054390000,010,000,5439,00,00,SI,"Entrega hospitalaria,Uso Hospitalario, Oncología",AMIFOSTINA SOLUCION INYECTABLE. CADA FRASCO AMPULA CONTIENE: AMIFOSTINA (BASE  ANHIDRA) 500 MG ENVASE CON UN FRASCO AMPULA.,ENV,10,ML.,500,miligramos,500,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
124,Grupo Nº 16: Oncología,BICALUTAMIDA,5440,5440,1000054400001,010,000,5440,00,01,NO,"VALES,Sustantiva",BICALUTAMIDA. TABLETA. CADA TABLETA CONTIENE: BICALUTAMIDA 50 MG. ENVASE CON 14 TABLETAS.,ENV,14,TAB,50,miligramos,700,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,ANTIANDROGENICOS,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
125,Grupo Nº 16: Oncología,BICALUTAMIDA,5440,5440,1000054400002,010,000,5440,00,02,NO,"VALES,Sustantiva",BICALUTAMIDA. TABLETA. CADA TABLETA CONTIENE BICALUTAMIDA 50 MG. ENVASE CON 14 TABLETAS.,ENV,14,TAB,50,miligramos,700,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,ANTIANDROGENICOS,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
126,Grupo Nº 16: Oncología,BICALUTAMIDA,5440,5440,1000054400100,010,000,5440,01,00,SI,"VALES,Sustantiva",BICALUTAMIDA TABLETA. CADA TABLETA CONTIENE: BICALUTAMIDA 50 MG. ENVASE CON 28 TABLETAS.,ENV,28,TAB,50,miligramos,1400,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,ANTIANDROGENICOS,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
127,Grupo Nº 16: Oncología,IDARUBICINA,5441,5441,1000054410000,010,000,5441,00,00,SI,Sin programa definido,IDARUBICINA CAPSULA CADA CAPSULA CONTIENE: CLORHIDRATO DE IDARUBICINA 25 MG  ENVASE CON UNA CAPSULA.,ENV,1,CAP,25,miligramos,25,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
128,Grupo Nº 16: Oncología,ESTRAMUSTINA,5443,5443,1000054430000,010,000,5443,00,00,SI,Entrega hospitalaria,ESTRAMUSTINA CAPSULA CADA CAPSULA CONTIENE: FOSFATO SODICO DE ESTRAMUSTINA  EQUIVALENTE A 140 MG DE FOSFATO DE ESTRAMUSTINA. ENVASE CON 100 CAPSULAS.,ENV,100,CAP,140,miligramos,14000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
129,Grupo Nº 16: Oncología,IRINOTECAN,5444,5444,1000054440000,010,000,5444,00,00,SI,"Sustantiva,Uso Hospitalario, Oncología",IRINOTECAN SOLUCION INYECTABLE EL FRASCO AMPULA CONTIENE: CLORHIDRATO DE  IRINOTECAN O CLORHIDRATO DE IRINOTECAN TRIHIDRATADO 100 MG ENVASE CON UN  FRASCO AMPULA CON 5 ML.,ENV,1,F.A,100,miligramos,100,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
130,Grupo Nº 16: Oncología,RITUXIMAB,5445,5445,1000054450000,010,000,5445,00,00,SI,"Entrega hospitalaria,Uso Hospitalario, Oncología,Uso Hospitalario, Oncología,Entrega hospitalaria",RITUXIMAB. SOLUCION INYECTABLE. CADA FRASCO AMPULA CONTIENE RITUXIMAB 500 MG. ENVASE CON UN FRASCO AMPULA CON 50 ML.,ENV,1,F.A,500,miligramos,500,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
131,Grupo Nº 16: Oncología,RITUXIMAB,5445,5445,1000054450100,010,000,5445,01,00,NO,"Entrega hospitalaria,Uso Hospitalario, Oncología,Uso Hospitalario, Oncología,Entrega hospitalaria",RITUXIMAB. SOLUCION INYECTABLE. CADA FRASCO AMPULA CONTIENE RITUXIMAB 500 MG. ENVASE CON DOS FRASCOS AMPULA CON 50 ML CADA UNO.,ENV,2,F.A,500,miligramos,1000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
132,Grupo Nº 16: Oncología,MECLORETAMINA,5447,5447,1000054470000,010,000,5447,00,00,SI,"Sin programa definido,Uso Hospitalario, Oncología",MECLORETAMINA SOLUCION INYECTABLE CADA FRASCO AMPULA CONTIENE: CLORHIDRATO DE  MECLORETAMINA 10 MG ENVASE CON 1 FRASCO AMPULA.,ENV,1,F.A,10,miligramos,10,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
133,Grupo Nº 16: Oncología,ANASTROZOL,5449,5449,1000054490000,010,000,5449,00,00,SI,Sustantiva,ANASTROZOL TABLETA CADA TABLETA CONTIENE: ANASTROZOL 1 MG ENVASE CON 28  TABLETAS.,ENV,28,TAB,1,miligramos,28,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,FARMACOS_UTILIZADOS_EN_CANCER_DE_MAMA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0
134,Grupo Nº 16: Oncología,LEUPRORELINA,5450,5450,1000054500002,010,000,5450,00,02,SI,,LEUPRORELINA SUSPENSION INYECTABLE CADA JERINGA PRELLENADA CON POLVO LIOFILIZADO CONTIENE: ACETATO DE LEUPRORELINA 22.5 MG ENVASE CON JERINGA PRELLENADA CON POLVO LIOFILIZADO Y JERINGA PRELLENADA CON 0.5 ML CON SISTEMA,ENV,1,JGO,22.5,miligramos,22.5,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
136,Grupo Nº 16: Oncología,PEMETREXED,5453,5453,1000054530003,010,000,5453,00,03,SI,"Catálogo II -- TORRE DE CONTROL,Uso Hospitalario, Oncología",PEMETREXED SOLUCION INYECTABLE CADA FRASCO AMPULA CON LIOFILIZADO CONTIENE: PEMETREXED DISODICO HEPTAHIDRATADO O PEMETREXED DISODICO EQUIVALENTE A 500 MG DE PEMETREXE. ENVASE CON FRASCO AMPULA.,ENV,1,F.A,500,miligramos,500,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
137,Grupo Nº 16: Oncología,FLUDARABINA,5455,5455,1000054550000,010,000,5455,00,00,SI,,FLUDARABINA COMPRIMIDO CADA COMPRIMIDO CONTIENE: FOSFATO DE FLUDARABINA 10 MG  ENVASE CON 15 COMPRIMIDOS.,ENV,15,COM,10,miligramos,150,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
138,Grupo Nº 16: Oncología,DOCETAXEL,5457,5457,1000054570000,010,000,5457,00,00,NO,"Sustantiva,Uso Hospitalario, Oncología,Uso Hospitalario, Oncología,Uso Hospitalario, Oncología",DOCETAXEL SOLUCION INYECTABLE CADA FRASCO AMPULA CONTIENE: DOCETAXEL ANHIDRO O TRIHIDRATADO EQUIVALENTE A 20 MG DE DOCETAXEL ENVASE CON FRASCO AMPULA CON 20 MG Y FRASCO AMPULA CON 1.5 ML DE DILUYENTE.,ENV,1,ENV,20,miligramos,20,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
139,Grupo Nº 16: Oncología,DOCETAXEL,5457,5457,1000054570102,010,000,5457,01,02,NO,"Sustantiva,Uso Hospitalario, Oncología,Uso Hospitalario, Oncología,Uso Hospitalario, Oncología",DOCETAXEL SOLUCION INYECTABLE. CADA FRASCO AMPULA CONTIENE: DOCETAXEL ANHIDRO O  TRIHIDRATADO EQUIVALENTE A 20 MG DE DOCETAXEL ENVASE CON FRASCO AMPULA CON 20  MG CON 1 ML.,ENV,1,AFA,20,miligramos,20,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
140,Grupo Nº 16: Oncología,DOCETAXEL,5457,5457,1000054570200,010,000,5457,02,00,SI,"Sustantiva,Uso Hospitalario, Oncología,Uso Hospitalario, Oncología,Uso Hospitalario, Oncología",DOCETAXEL. SOLUCION INYECTABLE CADA FRASCO AMPULA CONTIENE: DOCETAXEL ANHIDRO O TRIHIDRATADO EQUIVALENTE A 20 MG DE DOCETAXEL ENVASE CON FRASCO AMPULA CON 20 MG CON 2 ML.,ENV,1,F.A,20,miligramos,20,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
141,Grupo Nº 16: Oncología,OXALIPLATINO,5458,5458,1000054580000,010,000,5458,00,00,SI,"Sustantiva,Uso Hospitalario, Oncología",OXALIPLATINO SOLUCION INYECTABLE CADA FRASCO AMPULA CONTIENE: OXALIPLATINO 50  MG ENVASE CON UN FRASCO AMPULA CON LIOFILIZADO O ENVASE CON UN FRASCO AMPULA  CON 10 ML.,ENV,1,ENV,50,miligramos,50,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
142,Grupo Nº 16: Oncología,OXALIPLATINO,5459,5459,1000054590000,010,000,5459,00,00,SI,"Sustantiva,Uso Hospitalario, Oncología",OXALIPLATINO SOLUCION INYECTABLE CADA FRASCO AMPULA CONTIENE: OXALIPLATINO 100  MG ENVASE CON UN FRASCO AMPULA CON LIOFILIZADO O ENVASE CON UN FRASCO AMPULA  CON 20 ML.,ENV,1,ENV,100,miligramos,100,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
143,Grupo Nº 16: Oncología,CAPECITABINA,5460,5460,1000054600002,010,000,5460,00,02,SI,Sin programa definido,CAPECITABINA. TABLETA. CADA TABLETA CONTIENE: CAPECITABINA 150 MG. ENVASE CON 60 TABLETAS.,ENV,60,TAB,150,miligramos,9000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
144,Grupo Nº 16: Oncología,CAPECITABINA,5461,5461,1000054610000,010,000,5461,00,00,SI,"Entrega hospitalaria,Entrega hospitalaria",CAPECITABINA GRAGEA CADA GRAGEA CONTIENE: CAPECITABINA 500 MG ENVASE CON 120 GRAGEAS.,ENV,120,GRA,500,miligramos,60000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
145,Grupo Nº 16: Oncología,CAPECITABINA,5461,5461,1000054610002,010,000,5461,00,02,NO,"Entrega hospitalaria,Entrega hospitalaria",CAPECITABINA. TABLETA. CADA TABLETA CONTIENE: CAPECITABINA 500 MG. ENVASE CON 120 TABLETAS.,ENV,120,TAB,500,miligramos,60000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
146,Grupo Nº 16: Oncología,TEMOZOLOMIDA,5463,5463,1000054630000,010,000,5463,00,00,SI,Sustantiva,TEMOZOLOMIDA CAPSULA CADA CAPSULA CONTIENE: TEMOZOLOMIDA 100 MG ENVASE CON 5  CAPSULAS.,ENV,5,CAP,100,miligramos,500,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
147,Grupo Nº 16: Oncología,TEMOZOLOMIDA,5463,5463,1000054630100,010,000,5463,01,00,NO,Sustantiva,TEMOZOLOMIDA. CAPSULA. CADA CAPSULA CONTIENE: TEMOZOLOMIDA 100 MG. ENVASE CON 10 CAPSULAS.,ENV,10,CAP,100,miligramos,1000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
148,Grupo Nº 16: Oncología,TEMOZOLOMIDA,5463,5463,1000054630200,010,000,5463,02,00,NO,Sustantiva,TEMOZOLOMIDA. CAPSULA. CADA CAPSULA CONTIENE: TEMOZOLOMIDA 100 MG. ENVASE CON 20 CAPSULAS.,ENV,20,CAP,100,miligramos,2000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
149,Grupo Nº 16: Oncología,TEMOZOLOMIDA,5465,5465,1000054650000,010,000,5465,00,00,SI,Sustantiva,TEMOZOLOMIDA CAPSULA CADA CAPSULA CONTIENE: TEMOZOLOMIDA 20 MG ENVASE CON 5  CAPSULAS.,ENV,5,CAP,20,miligramos,100,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
150,Grupo Nº 16: Oncología,TEMOZOLOMIDA,5465,5465,1000054650100,010,000,5465,01,00,NO,Sustantiva,TEMOZOLOMIDA. CAPSULA. CADA CAPSULA CONTIENE: TEMOZOLOMIDA 20 MG. ENVASE CON 10 CAPSULAS.,ENV,10,CAP,20,miligramos,200,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
151,Grupo Nº 16: Oncología,TEMOZOLOMIDA,5465,5465,1000054650200,010,000,5465,02,00,NO,Sustantiva,TEMOZOLOMIDA. CAPSULA. CADA CAPSULA CONTIENE: TEMOZOLOMIDA 20 MG. ENVASE CON 20 CAPSULAS.,ENV,20,CAP,20,miligramos,400,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
152,Grupo Nº 16: Oncología,CULTIVO BCG,5466,5466,1000054660000,010,000,5466,00,00,SI,"Sustantiva,Uso Hospitalario, Oncología","CULTIVO BCG, SUSPENSION. CADA FRASCO CON LIOFILIZADO CONTIENE: MYCOBACTERIUM BOVIS (BCG) CEPA DANESA 1331 30 MG. ENVASE CON 4 FRASCOS AMPULA.",ENV,4,F.A,30,miligramos,120,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
153,Grupo Nº 16: Oncología,ÁCIDO ZOLEDRÓNICO,5468,5468,1000054680000,010,000,5468,00,00,SI,"Sustantiva,Uso Hospitalario, Oncología",ACIDO ZOLEDRONICO SOLUCION INYECTABLE CADA FRASCO AMPULA CON 5 ML CONTIENE:  ACIDO ZOLEDRONICO MONOHIDRATADO EQUIVALENTE A 4.0 MG DE ACIDO ZOLEDRONICO  ENVASE CON UN FRASCO AMPULA.,ENV,1,ENV,4,miligramos,4,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
154,Grupo Nº 16: Oncología,GEFITINIB,5470,5470,1000054700001,010,000,5470,00,01,SI,,GEFITINIB. TABLETA. CADA TABLETA CONTIENE: GEFITINIB 250 MG.,ENV,30,TAB,250,miligramos,7500,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
155,Grupo Nº 16: Oncología,BEVACIZUMAB,5472,5472,1000054720000,010,000,5472,00,00,SI,"Catálogo II -- TORRE DE CONTROL,Uso Hospitalario, Oncología",BEVACIZUMAB SOLUCION INYECTABLE CADA FRASCO AMPULA CONTIENE: BEVACIZUMAB 100 MG  ENVASE CON FRASCO AMPULA CON 4 ML.,ENV,1,F.A,100,miligramos,100,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
156,Grupo Nº 16: Oncología,BEVACIZUMAB,5473,5473,1000054730000,010,000,5473,00,00,SI,"Catálogo II -- TORRE DE CONTROL,Uso Hospitalario, Oncología",BEVACIZUMAB SOLUCION INYECTABLE CADA FRASCO AMPULA CONTIENE: BEVACIZUMAB 400 MG  ENVASE CON FRASCO AMPULA CON 16 ML.,ENV,1,F.A,400,miligramos,400,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
157,Grupo Nº 16: Oncología,CETUXIMAB,5475,5475,1000054750000,010,000,5475,00,00,NO,"Catálogo II -- TORRE DE CONTROL,Uso Hospitalario, Oncología,Uso Hospitalario, Oncología",CETUXIMAB. SOLUCION INYECTABLE. CADA FRASCO AMPULA CONTIENE: CETUXIMAB 100 MG. ENVASE CON FRASCO AMPULA CON 50 ML (2 MG/ML).,ENV,1,F.A,100,miligramos,100,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
158,Grupo Nº 16: Oncología,CETUXIMAB,5475,5475,1000054750100,010,000,5475,01,00,SI,"Catálogo II -- TORRE DE CONTROL,Uso Hospitalario, Oncología,Uso Hospitalario, Oncología",CETUXIMAB SOLUCION INYECTABLE CADA FRASCO AMPULA CONTIENE: CETUXIMAB 100 MG ENVASE CON FRASCO AMPULA CON 20 ML (5 MG/ML).,ENV,1,FCO,100,miligramos,100,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
159,Grupo Nº 16: Oncología,SORAFENIB,5480,5480,1000054800000,010,000,5480,00,00,SI,Catálogo II -- TORRE DE CONTROL,"SORAFENIB COMPRIMIDO CADA COMPRIMIDO CONTIENE: TOSILATO DE SORAFENIB  EQUIVALENTE A 200 MG, DE SORAFENIB ENVASE CON 112 COMPRIMIDOS.",ENV,112,COM,200,miligramos,22400,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
161,Grupo Nº 16: Oncología,SUNITINIB,5482,5482,1000054820000,010,000,5482,00,00,SI,Catálogo II -- TORRE DE CONTROL,SUNITINIB CAPSULA CADA CAPSULA CONTIENE: MALATO DE SUNITINIB EQUIVALENTE A 12.5  MG DE SUNITINIB ENVASE CON 28 CAPSULAS.,ENV,28,CAP,12.5,miligramos,350,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
170,Grupo Nº 16: Oncología,LEVAMISOL,5502,5502,1000055020000,010,000,5502,00,00,SI,Sustantiva,LEVAMISOL TABLETA CADA TABLETA CONTIENE: CLORHIDRATO DE LEVAMISOL EQUIVALENTE A  50 MG DE LEVAMISOL. ENVASE CON 2 TABLETAS.,ENV,2,TAB,50,miligramos,100,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
174,Grupo Nº 16: Oncología,LETROZOL,5541,5541,1000055410000,010,000,5541,00,00,SI,Sustantiva,LETROZOL GRAGEA O TABLETA CADA GRAGEA O TABLETA CONTIENE: LETROZOL 2.5 MG  ENVASE CON 30 GRAGEAS O TABLETAS.,ENV,30,T.G,2.5,miligramos,75,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
201,Grupo Nº 16: Oncología,PAZOPANIB,5654,5654,1000056540000,010,000,5654,00,00,SI,Catálogo II -- TORRE DE CONTROL,PAZOPANIB. TABLETA CADA TABLETA CONTIENE: CLORHIDRATO DE PAZOPANIB EQUIVALENTE A 200 MG DE PAZOPANIB.,ENV,30,TAB,200,miligramos,6000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
232,Grupo Nº 16: Oncología,DEGARELIX,5970,5970,1000059700000,010,000,5970,00,00,NO,Sin programa definido,"DEGARELIX SOLUCION INYECTABLE CADA FRASCO AMPULA CON LIOFILIZADO CONTIENE: DEGARELIX 120 MG. ENVASE CON DOS FRASCOS AMPULA CON LIOFILIZADO Y DOS FRASCOS AMPULA CON 6 ML DILUYENTE CADA UNO, 2 JERINGAS, 2 AGUJAS PARA RECONSTITUCION Y",ENV,1,ENV,120,miligramos,120,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
233,Grupo Nº 16: Oncología,DEGARELIX,5970,5970,1000059700101,010,000,5970,01,01,SI,Sin programa definido,"DEGARELIX. SOLUCION INYECTABLE CADA FRASCO AMPULA CON LIOFILIZADO CONTIENE: DEGARELIX 120 MG. ENVASE CON DOS FRASCOS AMPULA CON LIOFILIZADO, 2 JERINGAS PRELLENADAS CON 3 ML DE DILUYENTE, 2 ADAPTADORES, 2 EMBOLOS, Y 2 AGUJAS",ENV,1,ENV,120,miligramos,120,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
234,Grupo Nº 16: Oncología,DEGARELIX,5971,5971,1000059710000,010,000,5971,00,00,NO,Sin programa definido,"DEGARELIX SOLUCION INYECTABLE CADA FRASCO AMPULA CON LIOFILIZADO CONTIENE: DEGARELIX 80 MG. ENVASE CON UN FRASCO AMPULA CON LIOFILIZADO Y UN FRASCO AMPULA CON 6 ML DILUYENTE, 1 JERINGA, 1 AGUJA PARA RECONSTITUCION Y 1 AGUJA PARA",ENV,1,ENV,80,miligramos,80,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
235,Grupo Nº 16: Oncología,DEGARELIX,5971,5971,1000059710101,010,000,5971,01,01,SI,Sin programa definido,"DEGARELIX. SOLUCION INYECTABLE CADA FRASCO AMPULA CON LIOFILIZADO CONTIENE: DEGARELIX 80 MG. ENVASE CON UN FRASCO AMPULA CON LIOFILIZADO, UNA JERINGA PRELLENADA CON 4.2 ML DE DILUYENTE, 1 ADAPTADOR DE FRASCO AMPULA, 1 EMBOLO, Y",ENV,1,ENV,80,miligramos,80,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
236,Grupo Nº 16: Oncología,LEUPRORELINA,5972,5972,1000059720000,010,000,5972,00,00,SI,,LEUPRORELINA. SUSPENSION INYECTABLE. CADA JERINGA PRELLENADA CON POLVO LIOFILIZADO CONTIENE: ACETATO DE LEUPRORELINA 45 MG. ENVASE CON JERINGA PRELLENADA CON POLVO LIOFILIZADO Y JERINGA PRELLENADA CON 0.5 ML DE DILUYENTE.,ENV,1,JGA,45,miligramos,45,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
248,Grupo Nº 16: Oncología,FOSAPREPITANT,6023,6023,1000060230000,010,000,6023,00,00,SI,"Sin programa definido,Uso Hospitalario, Oncología,Uso Hospitalario, Oncología",FOSAPREPITANT SOLUCION INYECTABLE CADA FRASCO AMPULA CON LIOFILIZADO CONTIENE: FOSAPREPITANT DE DIMEGLUMINA EQUIVALENTE A 150 MG DE FOSAPREPITANT. ENVASE CON UN FRASCO AMPULA.,ENV,1,F.A,150,miligramos,150,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
249,Grupo Nº 16: Oncología,FOSAPREPITANT,6023,6023,1000060230100,010,000,6023,01,00,NO,"Sin programa definido,Uso Hospitalario, Oncología,Uso Hospitalario, Oncología",FOSAPREPITANT SOLUCION INYECTABLE CADA FRASCO AMPULA CON LIOFILIZADO CONTIENE: FOSAPREPITANT DE DIMEGLUMINA EQUIVALENTE A 150 MG DE FOSAPREPITANT. ENVASE CON 10 FRASCOS AMPULA.,ENV,10,F.A,150,miligramos,1500,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
269,Grupo Nº 16: Oncología,PEMBROLIZUMAB,6153,6153,1000061530001,010,000,6153,00,01,SI,,PEMBROLIZUMAB. SOLUCION INYECTABLE. CADA FRASCO AMPULA CONTIENE: PEMBROLIZUMAB 100 MG. ENVASE CON UN FRASCO AMPULA CON 4 ML DE SOLUCION (100 MG/4 ML).,ENV,1,F.A,100,miligramos,100,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
414,Grupo Nº 16: Oncología,ÁCIDO FOLÍNICO,2192,2192,1000021920000,010,000,2192,00,00,SI,Sustantiva,ACIDO FOLINICO SOLUCION INYECTABLE CADA FRASCO AMPULA O AMPOLLETA CONTIENE:  FOLINATO CALCICO EQUIVALENTE A 50 MG DE ACIDO FOLINICO. ENVASE CON UN FRASCO  AMPULA O AMPOLLETA CON 4 ML.,ENV,1,AFA,50,miligramos,50,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
415,Grupo Nº 16: Oncología,ONDANSETRÓN,2195,2195,1000021950000,010,000,2195,00,00,SI,Sustantiva,ONDANSETRON CADA TABLETA CONTIENE: CLORHIDRATO DIHIDRATADO DE ONDANSETRON  EQUIVALENTE A 8 MG DE ONDANSETRON ENVASE CON 10 TABLETAS.,ENV,10,TAB,8,miligramos,80,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
533,Grupo Nº 16: Oncología,DACARBAZINA,3003,3003,1000030030000,010,000,3003,00,00,SI,"Sustantiva,Uso Hospitalario, Oncología",DACARBAZINA SOLUCION INYECTABLE CADA FRASCO AMPULA CON POLVO CONTIENE:  DACARBAZINA 200 MG ENVASE CON UN FRASCO AMPULA.,ENV,1,F.A,200,miligramos,200,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
534,Grupo Nº 16: Oncología,FLUOROURACILO,3012,3012,1000030120000,010,000,3012,00,00,SI,"Sustantiva,Uso Hospitalario, Oncología",FLUOROURACILO SOLUCION INYECTABLE CADA AMPOLLETA O FRASCO AMPULA CONTIENE:  FLUOROURACILO 250 MG ENVASE CON 10 AMPOLLETAS O FRASCOS AMPULA CON 10 ML.,ENV,10,AFA,250,miligramos,2500,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
535,Grupo Nº 16: Oncología,MITOMICINA,3022,3022,1000030220000,010,000,3022,00,00,SI,"Sustantiva,Uso Hospitalario, Oncología",MITOMICINA SOLUCION INYECTABLECADA FRASCO AMPULA CON POLVO CONTIENE: MITOMICINA  5 MG ENVASE CON UN FRASCO AMPULA.,ENV,1,F.A,5,miligramos,5,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
538,Grupo Nº 16: Oncología,CISPLATINO,3046,3046,1000030460000,010,000,3046,00,00,SI,"Sustantiva,Uso Hospitalario, Oncología",CISPLATINO SOLUCION INYECTABLE EL FRASCO AMPULA CON LIOFILIZADO O SOLUCION  CONTIENE: CISPLATINO 10 MG ENVASE CON UN FRASCO AMPULA.,ENV,1,F.A,10,miligramos,10,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
539,Grupo Nº 16: Oncología,TAMOXIFENO,3047,3047,1000030470000,010,000,3047,00,00,SI,"Sustantiva,VALES",TAMOXIFENO TABLETA CADA TABLETA CONTIENE: CITRATO DE TAMOXIFENO EQUIVALENTE A  20 MG DE TAMOXIFENO ENVASE CON 14 TABLETAS.,ENV,14,TAB,20,miligramos,280,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
540,Grupo Nº 16: Oncología,GOSERELINA,3048,3048,1000030480000,010,000,3048,00,00,SI,,GOSERELINA IMPLANTE DE LIBERACION PROLONGADA CADA IMPLANTE CONTIENE: ACETATO DE  GOSERELINA EQUIVALENTE A 3.6 MG DE GOSERELINA BASE. ENVASE CON IMPLANTE  CILINDRICO ESTERIL EN UNA JERINGA LISTA PARA SU APLICACION.,ENV,1,ENV,3.6,miligramos,3.6,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
541,Grupo Nº 16: Oncología,GOSERELINA,3049,3049,1000030490000,010,000,3049,00,00,SI,,GOSERELINA IMPLANTE DE LIBERACION PROLONGADA CADA IMPLANTE CONTIENE: ACETATO DE  GOSERELINA EQUIVALENTE A 10.8 MG DE GOSERELINA. ENVASE CON UNA JERINGA QUE  CONTIENE UN IMPLANTE CILINDRICO ESTERIL.,ENV,1,JGA,10.8,miligramos,10.8,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
542,Grupo Nº 16: Oncología,BCG INMUNOTERAPÉUTICO,3050,3050,1000030500000,010,000,3050,00,00,SI,"Sustantiva,Uso Hospitalario, Oncología","BCG INMUNOTERAPEUTICO. SUSPENSION. CADA FRASCO AMPULA CON LIOFILIZADO CONTIENE: BACILO DE CALMETTE-GUERIN 81.00 MG, EQUIVALENTE A 1.8 X 100000000 - 19.2 X 100000000 UFC (UNIDADES FORMADORAS DE COLONIAS). ENVASE CON UN FRASCO AMPULA",ENV,1,ENV,81,miligramos,81,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
543,Grupo Nº 16: Oncología,BCG INMUNOTERAPÉUTICO,3050,3050,1000030500002,010,000,3050,00,02,NO,"Sustantiva,Uso Hospitalario, Oncología","BCG INMUNOTERAPEUTICO. SUSPENSION. CADA FRASCO AMPULA CON LIOFILIZADO CONTIENE: BACILO DE CALMETTE-GUERIN 81.00 MG, EQUIVALENTE A 1.8 X 108 - 19.2 X 108 UFC (UNIDADES FORMADORAS DE COLONIAS). ENVASE CON UN FRASCO AMPULA CON LIOFILIZADO",ENV,1,ENV,81,miligramos,81,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
544,Grupo Nº 16: Oncología,LEUPRORELINA,3055,3055,1000030550000,010,000,3055,00,00,NO,"Sustantiva -- Eficiencia terapeutica M - 60%,VALES",LEUPRORELINA SOLUCION INYECTABLE CADA JERINGA PRELLENADA CON POLVO LIOFILIZADO CONTIENE: ACETATO DE LEUPRORELINA 7.5 MG ENVASE CON JERINGA PRELLENADA CON POLVO LIOFILIZADO Y JERINGA PRELLENADA CON 0.3 ML CON SISTEMA DE LIBERACION.,ENV,1,ENV,7.5,miligramos,7.5,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
545,Grupo Nº 16: Oncología,LEUPRORELINA,3055,3055,1000030550002,010,000,3055,00,02,NO,"Sustantiva -- Eficiencia terapeutica M - 60%,VALES",LEUPRORELINA SUSPENSION INYECTABLE CADA JERINGA PRELLENADA CON POLVO LIOFILIZADO CONTIENE: ACETATO DE LEUPRORELINA 7.5 MG ENVASE CON JERINGA PRELLENADA CON POLVO LIOFILIZADO Y JERINGA PRELLENADA CON 0.3 ML CON SISTEMA DE,ENV,1,ENV,7.5,miligramos,7.5,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
546,Grupo Nº 16: Oncología,LEUPRORELINA,3055,3055,1000030550003,010,000,3055,00,03,SI,"Sustantiva -- Eficiencia terapeutica M - 60%,VALES",LEUPRORELINA SUSPENSION INYECTABLE CADA JERINGA PRELLENADA CON POLVO LIOFILIZADO O CADA FRASCO AMPULA CON MICROESFERAS LIOFILIZADAS CONTIENE: ACETATO DE LEUPRORELINA 7.5 MG ENVASE CON JERINGA PRELLENADA CON POLVO,ENV,1,ENV,7.5,miligramos,7.5,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
547,Grupo Nº 16: Oncología,LEUPRORELINA,3055,3055,1000030550100,010,000,3055,01,00,NO,"Sustantiva -- Eficiencia terapeutica M - 60%,VALES",LEUPRORELINA. SUSPENSION INYECTABLE CADA JERINGA PRELLENADA CON POLVO LIOFILIZADO O CADA FRASCO AMPULA CON MICROESFERAS LIOFILIZADAS CONTIENE: ACETATO DE LEUPRORELINA 7.5 MG. ENVASE CON FRASCO AMPULA CON MICROESFERAS,ENV,1,ENV,7.5,miligramos,7.5,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
548,Grupo Nº 16: Oncología,LEUPRORELINA,3055,3055,1000030550103,010,000,3055,01,03,NO,"Sustantiva -- Eficiencia terapeutica M - 60%,VALES","LEUPRORELINA. SUSPENSION INYECTABLE. CADA FRASCO AMPULA CON MICROESFERAS LIOFILIZADAS CONTIENE: ACETATO DE LEUPRORELINA 7.5 MG. ENVASE CON FRASCO AMPULA CON MICROESFERAS LIOFILIZADAS, UN FRASCO AMPULA CON 2 ML DE DILUYENTE Y JERINGA",ENV,1,ENV,7.5,miligramos,7.5,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
611,Grupo Nº 16: Oncología,METENOLONA,1710,1710,4000017100000,040,000,1710,00,00,SI,Sustantiva,METENOLONA SOLUCION INYECTABLE CADA AMPOLLETA CONTIENE: ENANTATO DE METENOLONA 50 MG ENVASE CON AMPOLLETA CON 1 ML.,ENV,1,AMP,50,miligramos,50,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
880,Grupo Nº 16: Oncología,ÁCIDO FOLÍNICO,1707,1707,1000017070000,010,000,1707,00,00,SI,Sustantiva,ACIDO FOLINICO SOLUCION INYECTABLE CADA AMPOLLETA O FRASCO AMPULA CONTIENE: FOLINATO CALCICO EQUIVALENTE A 3 MG DE ACIDO FOLINICO. ENVASE CON 6 AMPOLLETAS O FRASCOS AMPULA CON UN ML,ENV,6,AFA,3,miligramos,18,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
888,Grupo Nº 16: Oncología,CICLOFOSFAMIDA,1751,1751,1000017510000,010,000,1751,00,00,NO,Sustantiva,CICLOFOSFAMIDA GRAGEA CADA GRAGEA CONTIENE: CICLOFOSFAMIDA MONOHIDRATADA EQUIVALENTE A 50 MG DE CICLOFOSFAMIDA. ENVASE CON 30 GRAGEAS.,ENV,30,GRA,50,miligramos,1500,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
889,Grupo Nº 16: Oncología,CICLOFOSFAMIDA,1751,1751,1000017510100,010,000,1751,01,00,SI,Sustantiva,CICLOFOSFAMIDA GRAGEA CADA GRAGEA CONTIENE: CICLOFOSFAMIDA MONOHIDRATADA EQUIVALENTE A 50 MG DE CICLOFOSFAMIDA ENVASE CON 50 GRAGEAS.,ENV,50,GRA,50,miligramos,2500,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
890,Grupo Nº 16: Oncología,CICLOFOSFAMIDA,1752,1752,1000017520000,010,000,1752,00,00,SI,"Sustantiva,Uso Hospitalario, Oncología",CICLOFOSFAMIDA SOLUCION INYECTABLE CADA FRASCO AMPULA CON LIOFILIZADO CONTIENE: CICLOFOSFAMIDA MONOHIDRATADA EQUIVALENTE A 200 MG DE CICLOFOSFAMIDA. ENVASE CON 5 FRASCOS AMPULA.,ENV,5,F.A,200,miligramos,1000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
891,Grupo Nº 16: Oncología,CICLOFOSFAMIDA,1753,1753,1000017530000,010,000,1753,00,00,SI,"Sustantiva,Uso Hospitalario, Oncología",CICLOFOSFAMIDA SOLUCION INYECTABLE. CADA FRASCO AMPULA CON LIOFILIZADO CONTIENE: CICLOFOSFAMIDA MONOHIDRATADA EQUIVALENTE A 500 MG DE CICLOFOSFAMIDA. ENVASE CON 2 FRASCOS AMPULA.,ENV,2,F.A,500,miligramos,1000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
892,Grupo Nº 16: Oncología,CLORAMBUCILO,1754,1754,1000017540000,010,000,1754,00,00,SI,Sustantiva,CLORAMBUCILO TABLETA CADA TABLETA CONTIENE: CLORAMBUCILO 2 MG ENVASE CON 25 TABLETAS.,ENV,25,TAB,2,miligramos,50,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
893,Grupo Nº 16: Oncología,BUSULFÁN,1755,1755,1000017550000,010,000,1755,00,00,SI,Sustantiva,BUSULFAN TABLETA CADA TABLETA CONTIENE: BUSULFAN 2 MG ENVASE CON 25 TABLETAS.,ENV,25,TAB,2,miligramos,50,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
894,Grupo Nº 16: Oncología,MELFALÁN,1756,1756,1000017560000,010,000,1756,00,00,SI,Sustantiva,MELFALAN TABLETA CADA TABLETA CONTIENE: MELFALAN 2 MG ENVASE CON 25 TABLETAS.,ENV,25,TAB,2,miligramos,50,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
895,Grupo Nº 16: Oncología,CARMUSTINA,1758,1758,1000017580000,010,000,1758,00,00,SI,"Sustantiva,Uso Hospitalario, Oncología",CARMUSTINA SOLUCION INYECTABLE. CADA FRASCO AMPULA CON LIOFILIZADO CONTIENE: CARMUSTINA 100 MG ENVASE CON UN FRASCO AMPULA Y DILUYENTE ESTERIL (ETANOL ABSOLUTO) 3 ML.,ENV,1,ENV,100,miligramos,100,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
896,Grupo Nº 16: Oncología,METOTREXATO,1759,1759,1000017590000,010,000,1759,00,00,SI,"VALES,Sustantiva","METOTREXATO TABLETA CADA TABLETA CONTIENE: METOTREXATO SODICO, EQUIVALENTE A 2.5 MG, DE METOTREXATO ENVASE CON 50 TABLETAS.",ENV,50,TAB,2.5,miligramos,125,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,FARMACOS_MODIFICADORES_DE_LA_ENFERMEDAD,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0
897,Grupo Nº 16: Oncología,METOTREXATO,1760,1760,1000017600000,010,000,1760,00,00,SI,Sustantiva,METOTREXATO SOLUCION INYECTABLE CADA FRASCO AMPULA CON LIOFILIZADO CONTIENE: METOTREXATO SODICO EQUIVALENTE A 50 MG DE METOTREXATO ENVASE CON UN FRASCO AMPULA.,ENV,1,F.A,50,miligramos,50,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
898,Grupo Nº 16: Oncología,MERCAPTOPURINA,1761,1761,1000017610000,010,000,1761,00,00,NO,Sustantiva,"MERCAPTOPURINA TABLETA CADA TABLETA CONTIENE: MERCAPTOPURINA 50 MG, ENVASE CON 20 TABLETAS.",ENV,20,TAB,50,miligramos,1000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
899,Grupo Nº 16: Oncología,MERCAPTOPURINA,1761,1761,1000017610100,010,000,1761,01,00,SI,Sustantiva,MERCAPTOPURINA. TABLETA. CADA TABLETA CONTIENE: MERCAPTOPURINA 50 MG. ENVASE CON 25 TABLETAS.,ENV,25,TAB,50,miligramos,1250,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
900,Grupo Nº 16: Oncología,DOXORUBICINA,1766,1766,1000017660000,010,000,1766,00,00,SI,"Entrega hospitalaria,Uso Hospitalario, Oncología",DOXORUBICINA SUSPENSION INYECTABLE CADA FRASCO AMPULA CONTIENE: CLORHIDRATO DE DOXORUBICINA LIPOSOMAL PEGILADA EQUIVALENTE A 20 MG DE DOXORUBICINA (2 MG/ML) ENVASE CON UN FRASCO AMPULA CON 10 ML (2 MG/ML).,ENV,1,F.A,20,miligramos,20,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
901,Grupo Nº 16: Oncología,BLEOMICINA,1767,1767,1000017670000,010,000,1767,00,00,SI,Sustantiva,BLEOMICINA SOLUCION INYECTABLE CADA AMPOLLETA O FRASCO AMPULA CON LIOFILIZADO CONTIENE: SULFATO DE BLEOMICINA EQUIVALENTE A 15 UI DE BLEOMICINA. ENVASE CON UNA AMPOLLETA O UN FRASCO AMPULA Y DILUYENTE DE 5 ML.,ENV,1,JGO,15,UI,15,UI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
902,Grupo Nº 16: Oncología,VINCRISTINA,1768,1768,1000017680000,010,000,1768,00,00,SI,"Sustantiva,Uso Hospitalario, Oncología",VINCRISTINA SOLUCION INYECTABLE CADA FRASCO AMPULA CON LIOFILIZADO CONTIENE: SULFATO DE VINCRISTINA 1 MG ENVASE CON FRASCO AMPULA Y UNA AMPOLLETA CON 10 ML DE DILUYENTE.,ENV,1,JGO,1,miligramos,1,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
903,Grupo Nº 16: Oncología,VINBLASTINA,1770,1770,1000017700000,010,000,1770,00,00,SI,"Sustantiva,Uso Hospitalario, Oncología",VINBLASTINA SOLUCION INYECTABLE. CADA FRASCO AMPULA CON LIOFILIZADO CONTIENE: SULFATO DE VINBLASTINA 10 MG ENVASE CON UN FRASCO AMPULA Y AMPOLLETA CON 10 ML DE DILUYENTE.,ENV,1,F.A,10,miligramos,10,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
904,Grupo Nº 16: Oncología,PROCARBAZINA,1771,1771,1000017710000,010,000,1771,00,00,SI,Sin programa definido,PROCARBAZINA CAPSULA O COMPRIMIDO CADA CAPSULA O COMPRIMIDO CONTIENE: CLORHIDRATO DE PROCARBAZINAEQUIVALENTE A 50 MG DE PROCARBAZINA. ENVASE CON 50 CAPSULAS O COMPRIMIDOS.,ENV,50,C.C,50,miligramos,2500,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
905,Grupo Nº 16: Oncología,EPIRUBICINA,1773,1773,1000017730000,010,000,1773,00,00,SI,"Sustantiva,Uso Hospitalario, Oncología",EPIRUBICINA SOLUCION INYECTABLE CADA ENVASE CONTIENE: CLORHIDRATO DE EPIRUBICINA 10 MG ENVASE CON UN FRASCO AMPULA CON LIOFILIZADO O ENVASE CON UN FRASCO AMPULA CON 5 ML DE SOLUCION (10 MG/5 ML).,ENV,1,FAJ,10,miligramos,10,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
906,Grupo Nº 16: Oncología,EPIRUBICINA,1774,1774,1000017740000,010,000,1774,00,00,SI,"Sustantiva,Uso Hospitalario, Oncología",EPIRUBICINA SOLUCION INYECTABLE CADA ENVASE CONTIENE: CLORHIDRATO DE EPIRUBICINA 50 MG ENVASE CON UN FRASCO AMPULA CON LIOFILIZADO O ENVASE CON UN FRASCO AMPULA CON 25 ML DE SOLUCION (50 MG/25 ML).,ENV,1,FAJ,50,miligramos,50,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
907,Grupo Nº 16: Oncología,CITARABINA,1775,1775,1000017750000,010,000,1775,00,00,SI,"Sustantiva,Uso Hospitalario, Oncología",SOLUCION INYECTABLE CADA FRASCO AMPULA O FRASCO AMPULA CON LIOFILIZADO CONTIENE: CITARABINA 500 MG ENVASE CON UN FRASCO AMPULA O CON UN FRASCO AMPULA CON LIOFILIZADO.,ENV,1,ENV,500,miligramos,500,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
908,Grupo Nº 16: Oncología,CITARABINA,1775,1775,1000017750002,010,000,1775,00,02,NO,"Sustantiva,Uso Hospitalario, Oncología",CITARABINA. SOLUCION INYECTABLE. CADA FRASCO AMPULA O FRASCO AMPULA CON LIOFILIZADO CONTIENE: CITARABINA 500 MG. ENVASE CON UN FRASCO AMPULA O CON UN FRASCO AMPULA CON LIOFILIZADO.,ENV,1,ENV,500,miligramos,500,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
909,Grupo Nº 16: Oncología,METOTREXATO,1776,1776,1000017760000,010,000,1776,00,00,SI,Sustantiva,METOTREXATO SOLUCION INYECTABLE CADA FRASCO AMPULA CON LIOFILIZADO CONTIENE: METOTREXATO SODICO EQUIVALENTE A 500 MG DE METOTREXATO ENVASE CON UN FRASCO AMPULA.,ENV,1,F.A,500,miligramos,500,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1081,Grupo Nº 16: Oncología,IMATINIB,4225,4225,1000042250000,010,000,4225,00,00,SI,Catálogo II -- TORRE DE CONTROL,IMATINIB COMPRIMIDO RECUBIERTO CADA COMPRIMIDO RECUBIERTO CONTIENE: MESILATO DE IMATINIB 100 MG ENVASE CON 60 COMPRIMIDOS RECUBIERTOS.,ENV,60,COM,100,miligramos,6000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1082,Grupo Nº 16: Oncología,HIDROXICARBAMIDA,4226,4226,1000042260000,010,000,4226,00,00,SI,Sustantiva,HIDROXICARBAMIDA CAPSULA CADA CAPSULA CONTIENE: HIDROXICARBAMIDA 500 MG ENVASE CON 100 CAPSULAS.,ENV,100,CAP,500,miligramos,50000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1083,Grupo Nº 16: Oncología,DAUNORUBICINA,4228,4228,1000042280000,010,000,4228,00,00,SI,"Sustantiva,Uso Hospitalario, Oncología",DAUNORUBICINA SOLUCION INYECTABLE CADA FRASCO AMPULA CON LIOFILIZADO CONTIENE: CLORHIDRATO DE DAUNORUBICINA EQUIVALENTE A 20 MG DE DAUNORUBICINA. ENVASE CON UN FRASCO AMPULA.,ENV,1,F.A,20,miligramos,20,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1084,Grupo Nº 16: Oncología,L-ASPARAGINASA,4229,4229,1000042290000,010,000,4229,00,00,SI,Sustantiva,"L-ASPARGINASA SOLUCION INYECTABLE. CADA FRASCO AMPULA CON POLVO CONTIENE: L- ASPARAGINASA 10,000 UI ENVASE CON 1 FRASCO AMPULA.",ENV,1,F.A,10000,UI,10000,UI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1085,Grupo Nº 16: Oncología,L-ASPARAGINASA,4229,4229,1000042290102,010,000,4229,01,02,NO,Sustantiva,"L-ASPARGINASA. SOLUCION INYECTABLE. CADA FRASCO AMPULA CON POLVO CONTIENE: L- ASPARAGINASA 10,000 UI. ENVASE CON 5 FRASCOS AMPULA.",ENV,5,F.A,10000,UI,50000,UI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1086,Grupo Nº 16: Oncología,ETOPÓSIDO,4230,4230,1000042300000,010,000,4230,00,00,SI,"Sustantiva,Uso Hospitalario, Oncología",ETOPOSIDO SOLUCION INYECTABLE CADA AMPOLLETA O FRASCO AMPULA CONTIENE: ETOPOSIDO 100 MG ENVASE CON 10 AMPOLLETAS O FRASCOS AMPULA DE 5 ML.,ENV,10,AFA,100,miligramos,1000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1088,Grupo Nº 16: Oncología,MITOXANTRONA,4233,4233,1000042330000,010,000,4233,00,00,SI,"Sustantiva,Uso Hospitalario, Oncología",MITOXANTRONA SOLUCION INYECTABLE CADA FRASCO AMPULA CONTIENE: CLORHIDRATO DE MITOXANTRONA EQUIVALENTE A 20 MG. DE MITOXANTRONA BASE ENVASE CON UN FRASCO AMPULA CON 10 ML.,ENV,1,F.A,20,miligramos,20,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1149,Grupo Nº 16: Oncología,FINASTERIDA,4302,4302,1000043020000,010,000,4302,00,00,SI,"VALES,Sustantiva",FINASTERIDA GRAGEA O TABLETA RECUBIERTA CADA GRAGEA O TABLETA RECUBIERTA CONTIENE: FINASTERIDA 5 MG ENVASE CON 30 GRAGEAS O TABLETAS RECUBIERTAS.,ENV,30,GRA,5,miligramos,150,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,BLOQUEADORES_ALFA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1163,Grupo Nº 16: Oncología,NILOTINIB,4322,4322,1000043220000,010,000,4322,00,00,NO,Catálogo II -- TORRE DE CONTROL,NILOTINIB CAPSULA CADA CAPSULA CONTIENE: CLORHIDRATO DE NILOTINIB EQUIVALENTE A 200 MG DE NILOTINIB ENVASE CON 112 CAPSULAS.,ENV,112,CAP,200,miligramos,22400,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1164,Grupo Nº 16: Oncología,NILOTINIB,4322,4322,1000043220100,010,000,4322,01,00,SI,Catálogo II -- TORRE DE CONTROL,NILOTINIB. CAPSULA. CADA CAPSULA CONTIENE: CLORHIDRATO DE NILOTINIB EQUIVALENTE A 200 MG DE NILOTINIB. ENVASE CON 120 CAPSULAS.,ENV,120,CAP,200,miligramos,24000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1165,Grupo Nº 16: Oncología,DASATINIB,4323,4323,1000043230000,010,000,4323,00,00,SI,Catálogo II -- TORRE DE CONTROL,DASATINIB TABLETA CADA TABLETA CONTIENE: DASATINIB 50 MG ENVASE CON 60 TABLETAS.,ENV,60,TAB,50,miligramos,3000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1215,Grupo Nº 16: Oncología,LOMUSTINA,4428,4428,1000044280000,010,000,4428,00,00,SI,Sin programa definido,LOMUSTINA CAPSULA CADA FRASCO CON DOS CAPSULAS CONTIENE: LOMUSTINA: 10 MG  LOMUSTINA 40 MG LOMUSTINA 100 MG ENVASE CON 3 FRASCOS CONTENIENDO 2 CAPSULAS  DE CADA UNA DE LAS CANTIDADES.,ENV,3,FCO,150,miligramos,450,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1216,Grupo Nº 16: Oncología,DACTINOMICINA,4429,4429,1000044290000,010,000,4429,00,00,SI,"Sustantiva,Uso Hospitalario, Oncología",DACTINOMICINA SOLUCION INYECTABLE CADA FRASCO AMPULA CON LIOFILIZADO CONTIENE:  DACTINOMICINA 0.5 MG ENVASE CON UN FRASCO AMPULA.,ENV,1,F.A,0.5,miligramos,0.5,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1217,Grupo Nº 16: Oncología,CARBOPLATINO,4431,4431,1000044310000,010,000,4431,00,00,SI,"Sustantiva,Uso Hospitalario, Oncología",CARBOPLATINO SOLUCION INYECTABLE. CADA FRASCO AMPULA CON LIOFILIZADO CONTIENE:  CARBOPLATINO 150 MG ENVASE CON UN FRASCO AMPULA.,ENV,1,F.A,150,miligramos,150,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1218,Grupo Nº 16: Oncología,IFOSFAMIDA,4432,4432,1000044320000,010,000,4432,00,00,SI,"Sustantiva,Uso Hospitalario, Oncología","IFOSFAMIDA SOLUCION INYECTABLE CADA FRASCO AMPULA CON POLVO O LIOFILIZADO  CONTIENE: IFOSFAMIDA 1 G, ENVASE CON UN FRASCO AMPULA.",ENV,1,F.A,1,gramos,1,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1219,Grupo Nº 16: Oncología,MESNA,4433,4433,1000044330000,010,000,4433,00,00,SI,"Sustantiva,Uso Hospitalario, Oncología",MESNA SOLUCION INYECTABLE CADA AMPOLLETA CONTIENE: MESNA 400 MG ENVASE CON 5  AMPOLLETAS CON 4 ML (100 MG/ML).,ENV,5,AMP,400,miligramos,2000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1220,Grupo Nº 16: Oncología,IDARUBICINA,4434,4434,1000044340000,010,000,4434,00,00,SI,"Sustantiva,Uso Hospitalario, Oncología",IDARUBICINA SOLUCION INYECTABLE CADA FRASCO AMPULA CONTIENE: CLORHIDRATO DE  IDARUBICINA 5 MG ENVASE CON FRASCO AMPULA CON LIOFILIZADO O FRASCO AMPULA CON  5 ML (1 MG/ML).,ENV,1,F.A,5,miligramos,5,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1221,Grupo Nº 16: Oncología,VINORELBINA,4435,4435,1000044350000,010,000,4435,00,00,SI,"Sustantiva,Uso Hospitalario, Oncología",VINORELBINA SOLUCION INYECTABLE CADA FRASCO AMPULA CONTIENE: DITARTRATO DE  VINORELBINA EQUIVALENTE A 10 MG DE VINORELBINA ENVASE CON UN FRASCO AMPULA CON  1 ML.,ENV,1,F.A,10,miligramos,10,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1222,Grupo Nº 16: Oncología,PALONOSETRÓN,4437,4437,1000044370000,010,000,4437,00,00,SI,"Sustantiva,Uso Hospitalario, Oncología",PALONOSETRON SOLUCION INYECTABLE CADA FRASCO AMPULA CONTIENE: CLORHIDRATO DE PALONOSETRON EQUIVALENTE A 0.25 MG DE PALONOSETRON ENVASE CON UN FRASCO AMPULA CON 5 ML.,F.A,5,ML.,0.25,miligramos,0.25,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1223,Grupo Nº 16: Oncología,GRANISETRÓN,4439,4439,1000044390000,010,000,4439,00,00,SI,Sustantiva,GRANISETRON GRAGEA O TABLETA CADA GRAGEA O TABLETA CONTIENE: CLORHIDRATO DE  GRANISETRON EQUIVALENTE A 1 MG DE GRANISETRON. ENVASE CON 2 GRAGEAS O  TABLETAS.,ENV,2,T.G,1,miligramos,2,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1224,Grupo Nº 16: Oncología,GRANISETRÓN,4441,4441,1000044410000,010,000,4441,00,00,SI,"Sustantiva,Uso Hospitalario, Oncología",GRANISETRON SOLUCION INYECTABLE CADA AMPOLLETA CONTIENE: CLORHIDRATO DE GRANISETRONEQUIVALENTE A 3 MG DE GRANISETRON. ENVASE CON 3 ML.,ENV,1,ENV,3,miligramos,3,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1225,Grupo Nº 16: Oncología,APREPITANT,4442,4442,1000044420000,010,000,4442,00,00,SI,Sustantiva,APREPITANT CAPSULA CADA CAPSULA CONTIENE: 125 MG DE APREPITANT CADA CAPSULA  CONTIENE: 80 MG DE APREPITANT ENVASE CON UNA CAPSULA DE 125 MG Y 2 CAPSULAS DE  80 MG.,ENV,3,CAP,80,miligramos,240,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1226,Grupo Nº 16: Oncología,DEXRAZOXANO,4444,4444,1000044440000,010,000,4444,00,00,SI,"Entrega hospitalaria,Uso Hospitalario, Oncología",DEXRAZOXANO SOLUCION INYECTABLE EL FRASCO AMPULA CONTIENE: CLORHIDRATO DE  DEXRAZOXANOEQUIVALENTE A 500 MG DE DEXRAZOXANO. ENVASE CON UN FRASCO AMPULA.,ENV,1,F.A,500,miligramos,500,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1227,Grupo Nº 16: Oncología,VINORELBINA,4445,4445,1000044450000,010,000,4445,00,00,SI,Sustantiva,VINORELBINA CAPSULA CADA CAPSULA CONTIENE: BITARTRATO DE VINORELBINA  EQUIVALENTE A 20.00 MG DE VINORELBINA ENVASE CON UNA CAPSULA.,ENV,1,CAP,20,miligramos,20,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1228,Grupo Nº 16: Oncología,VINORELBINA,4446,4446,1000044460000,010,000,4446,00,00,SI,Entrega hospitalaria,VINORELBINA CAPSULA CADA CAPSULA CONTIENE: BITARTRATO DE VINORELBINA  EQUIVALENTE A 30.00 MG DE VINORELBINA ENVASE CON UNA CAPSULA.,ENV,1,CAP,30,miligramos,30,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1229,Grupo Nº 16: Oncología,BORTEZOMIB,4448,4448,1000044480000,010,000,4448,00,00,SI,"Catálogo II -- TORRE DE CONTROL,Uso Hospitalario, Oncología",BORTEZOMIB SOLUCION INYECTABLE CADA FRASCO AMPULA CON LIOFILIZADO CONTIENE:  BORTEZOMIB 3.5 MG ENVASE CON UN FRASCO AMPULA.,ENV,1,F.A,3.5,miligramos,3.5,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1323,Grupo Nº 16: Oncología,ÁCIDO FOLÍNICO,5233,5233,1000052330000,010,000,5233,00,00,SI,Sustantiva,ACIDO FOLINICO TABLETA CADA TABLETA CONTIENE: FOLINATO CALCICO EQUIVALENTE A 15  MG DE ACIDO FOLINICO ENVASE CON 12 TABLETAS.,ENV,12,TAB,15,miligramos,180,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
135,Grupo Nº 17: Otorrinolaringología,CINARIZINA,5451,5451,1000054510000,010,000,5451,00,00,SI,"VALES,Sustantiva","CINARIZINA TABLETA CADA TABLETA CONTIENE: CINARIZINA 75 MG, ENVASE CON 60  TABLETAS.",ENV,60,TAB,75,miligramos,4500,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,ANTIVERTIGINOSOS,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
416,Grupo Nº 17: Otorrinolaringología,OXIMETAZOLINA,2198,2198,1000021980000,010,000,2198,00,00,SI,Sustantiva,OXIMETAZOLINA SOLUCION NASAL CADA 100 ML CONTIENEN: CLORHIDRATO DE  OXIMETAZOLINA 50 MG ENVASE CON GOTERO INTEGRAL CON 20 ML.,ENV,1,ENV,50,miligramos,50,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
417,Grupo Nº 17: Otorrinolaringología,OXIMETAZOLINA,2199,2199,1000021990000,010,000,2199,00,00,SI,Sustantiva,OXIMETAZOLINA SOLUCION NASAL CADA 100 ML CONTIENEN CLORHIDRATO DE OXIMETAZOLINA  25 MG ENVASE CON GOTERO INTEGRAL CON 20 ML.,ENV,1,ENV,25,miligramos,25,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
467,Grupo Nº 17: Otorrinolaringología,CLORFENAMINA COMPUESTA,2471,2471,1000024710000,010,000,2471,00,00,SI,"VALES,Sustantiva","CLORFENAMINA COMPUESTA TABLETA CADA TABLETA CONTIENE PARACETAMOL 500 MG,  CAFEINA 25 MG, CLORHIDRATO DE FENILEFRINA 5 MG, MALEATO DE CLORFENAMINA 4 MG,  ENVASE CON 10 TABLETAS.",ENV,10,TAB,534,miligramos,5340,miligramos,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,ANTIALERGICOS,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
549,Grupo Nº 17: Otorrinolaringología,FENILEFRINA,3102,3102,1000031020000,010,000,3102,00,00,SI,"Sustantiva,VALES","FENILEFRINA SOLUCION NASAL CADA ML CONTIENE: CLORHIDRATO DE FENILEFRINA 2.5 MG,  ENVASE CON GOTERO INTEGRAL CON 15 ML.",FCO,15,ML.,2.5,miligramos,2.5,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
550,Grupo Nº 17: Otorrinolaringología,DIFENIDOL,3111,3111,1000031110000,010,000,3111,00,00,SI,"Sustantiva,VALES",DIFENIDOL TABLETA CADA TABLETA CONTIENE: CLORHIDRATO DE DIFENIDOL EQUIVALENTE A  25 MG DE DIFENIDOL ENVASE CON 30 TABLETAS.,ENV,30,TAB,25,miligramos,750,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,ANTIVERTIGINOSOS,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
551,Grupo Nº 17: Otorrinolaringología,DIFENIDOL,3112,3112,1000031120000,010,000,3112,00,00,SI,Sustantiva,DIFENIDOL SOLUCION INYECTABLE CADA AMPOLLETA CONTIENE: CLORHIDRATO DE DIFENIDOL  EQUIVALENTE A 40 MG DE DIFENIDOL ENVASE CON 2 AMPOLLETAS DE 2 ML.,ENV,2,AMP,40,miligramos,80,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
552,Grupo Nº 17: Otorrinolaringología,"NEOMICINA, POLIMIXINA B, FLUOCINOLONA Y LIDOCAÍNA",3132,3132,1000031320000,010,000,3132,00,00,SI,"Sustantiva,VALES","NEOMICINA, POLIMIXINA B, FLUOCINOLONA Y LIDOCAINA SOLUCION OTICA CADA 100 ML  CONTIENEN: ACETONIDO DE FLUOCINOLONA 0.025 G SULFATO DE POLIMIXINA B  EQUIVALENTE A 1 000 000 U DE POLIMIXINA B, SULFATO DE NEOMICINA EQUIVALENTE A",ENV,5,ML.,0.025,gramos,0.025,gramos,0,0,0,0,1,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,ANTIBIOTICOS,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1176,Grupo Nº 17: Otorrinolaringología,BUDESONIDA,4337,4337,1000043370000,010,000,4337,00,00,SI,"VALES,Sustantiva -- Eficiencia terapeutica F - 4%",BUDESONIDA SUSPENSION PARA INHALACION CADA ML CONTIENE BUDESONIDA 1.280 MG ENVASE CON FRASCO PULVERIZADOR CON 6 ML (120 DOSIS DE 64 MICROGRAMOS CADA UNA),ENV,1,ENV,1.28,microgramos,1.28,microgramos,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
423,Grupo Nº 18: Planificación Familiar,LEVONORGESTREL,2208,2208,1000022080000,010,000,2208,00,00,SI,Programa de Planificación Familiar,LEVONORGESTREL POLVO EL DISPOSITIVO CON POLVO CONTIENE: LEVONORGESTREL  (MICRONIZADO) 52 MG ENVASE CON UN DISPOSITIVO.,ENV,1,ENV,52,miligramos,52,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
424,Grupo Nº 18: Planificación Familiar,LEVONORGESTREL,2210,2210,1000022100000,010,000,2210,00,00,SI,"VALES,Programa de Planificación Familiar,Sustantiva",LEVONORGESTREL COMPRIMIDO O TABLETA CADA COMPRIMIDO O TABLETA CONTIENE:  LEVONORGESTREL 0.750 MG ENVASE CON 2 COMPRIMIDOS O TABLETAS.,ENV,2,T.C,0.75,miligramos,1.5,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
939,Grupo Nº 18: Planificación Familiar,LEVONORGESTREL Y ETINILESTRADIOL,3504,3504,1000035040000,010,000,3504,00,00,SI,"Sustantiva,Programa de Planificación Familiar,VALES","LEVONORGESTREL Y ETINILESTRADIOL GRAGEA CADA GRAGEA CONTIENE: LEVONORGESTREL  0.15 MG, ETINILESTRADIOL 0.03 MG, ENVASE CON 21 GRAGEAS.",ENV,21,GRA,0.18,miligramos,3.78,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
940,Grupo Nº 18: Planificación Familiar,DESOGESTREL Y ETINILESTRADIOL,3505,3505,1000035050000,010,000,3505,00,00,SI,"Sustantiva,Programa de Planificación Familiar,VALES","DESOGESTREL Y ETINILESTRADIOL TABLETA CADA TABLETA CONTIENE: DESOGESTREL 0.15  MG ETINILESTRADIOL 0.03 MG, ENVASE CON 21 TABLETAS.",CJA,21,TAB,0.18,miligramos,3.78,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
941,Grupo Nº 18: Planificación Familiar,MEDROXIPROGESTERONA Y CIPIONATO DE ESTRADIOL,3509,3509,1000035090000,010,000,3509,00,00,SI,"Sustantiva,Programa de Planificación Familiar,VALES","MEDROXIPROGESTERONA Y CIPIONATO DE ESTRADIOL SUSPENSION INYECTABLE CADA  AMPOLLETA O JERINGA CONTIENE: ACETATO DE MEDROXIPROGESTERONA 25 MG, CIPIONATO  DE ESTRADIOL 5 MG ENVASE CON UNA AMPOLLETA O JERINGA PRELLENADA DE 0.5 ML.",ENV,1,AMP,30,miligramos,30,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
942,Grupo Nº 18: Planificación Familiar,ETONOGESTREL,3510,3510,1000035100000,010,000,3510,00,00,SI,"Sustantiva,Programa de Planificación Familiar","ETONOGESTREL IMPLANTE EL IMPLANTE CONTIENE: ETONOGESTREL 68.0 MG, ENVASE CON UN  IMPLANTE Y APLICADOR.",ENV,1,JGO,68,miligramos,68,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
943,Grupo Nº 18: Planificación Familiar,NORELGESTROMINA-ETINILESTRADIOL,3511,3511,1000035110000,010,000,3511,00,00,SI,"Sustantiva,Programa de Planificación Familiar,VALES",NORELGESTROMINA Y ETINILESTRADIOL PARCHE CADA PARCHE CONTIENE: NORELGESTROMINA  6.00 MG ETINILESTRADIOL 0.60 MG ENVASE CON 3 PARCHES.,ENV,3,PCH,6.6,miligramos,19.8,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
944,Grupo Nº 18: Planificación Familiar,NORETISTERONA Y ESTRADIOL,3515,3515,1000035150000,010,000,3515,00,00,SI,"Sustantiva,Programa de Planificación Familiar,VALES",NORETISTERONA Y ESTRADIOL SOLUCION INYECTABLE CADA AMPOLLETA O JERINGA  CONTIENE:ENANTATO DE NORETISTERONA 50 MG VALERATO DE ESTRADIOL 5 MG ENVASE CON  UNA AMPOLLETA O JERINGA CON UN ML.,ENV,1,AMP,55,miligramos,55,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1069,Grupo Nº 18: Planificación Familiar,NORETISTERONA Y ESTRADIOL,4207,4207,1000042070000,010,000,4207,00,00,SI,Sustantiva,PROGESTERONA GEL CADA APLICADOR CONTIENE: PROGESTERONA 90 MG ENVASE CON 6 APLICADORES.,ENV,6,PZA,90,miligramos,540,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1070,Grupo Nº 18: Planificación Familiar,CETRORELIX,4210,4210,1000042100000,010,000,4210,00,00,SI,Sin programa definido,CETRORELIX SOLUCION INYECTABLE EL FRASCO AMPULA CON LIOFILIZADO CONTIENE: ACETATO DE CETRORELIX EQUIVALENTE A 0.25 MGDE CETRORELIX. ENVASE CON UN FRASCO AMPULA Y JERINGA DE 1 ML CON DILUYENTE.,ENV,1,JGO,0.25,miligramos,0.25,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1071,Grupo Nº 18: Planificación Familiar,CETRORELIX,4211,4211,1000042110000,010,000,4211,00,00,SI,Sin programa definido,CETRORELIX SOLUCION INYECTABLE EL FRASCO AMPULA CON LIOFILIZADO CONTIENE: ACETATO DE CETRORELIX EQUIVALENTE A 3.0 MG DE CETRORELIX. ENVASE CON UN FRASCO AMPULA Y JERINGA DE 3 ML CON DILUYENTE.,ENV,1,JGO,3,miligramos,3,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
160,Grupo Nº 19: Psiquiatría,PAROXETINA,5481,5481,1000054810000,010,000,5481,00,00,SI,"VALES,Sustantiva",PAROXETINA TABLETA CADA TABLETA CONTIENE: CLORHIDRATO DE PAROXETINA EQUIVALENTE  A 20 MG DE PAROXETINA. ENVASE CON 10 TABLETAS.,ENV,10,TAB,20,miligramos,200,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,ANTIDEPRESIVOS,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
162,Grupo Nº 19: Psiquiatría,ZUCLOPENTIXOL,5483,5483,1000054830000,010,000,5483,00,00,SI,Sustantiva,ZUCLOPENTIXOL SOLUCION INYECTABLE CADA AMPOLLETA CONTIENE: DECANOATO DE  ZUCLOPENTIXOL 200 MG ENVASE CON UNA AMPOLLETA.,ENV,1,AMP,200,miligramos,200,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
163,Grupo Nº 19: Psiquiatría,OLANZAPINA,5486,5486,1000054860000,010,000,5486,00,00,SI,"VALES,Sustantiva -- Eficiencia terapeutica L - 45%",OLANZAPINA TABLETA CADA TABLETA CONTIENE: OLANZAPINA 10 MG ENVASE CON 14 TABLETAS.,ENV,14,TAB,10,miligramos,140,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,BENZODIAZEPINAS,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
164,Grupo Nº 19: Psiquiatría,OLANZAPINA,5486,5486,1000054860100,010,000,5486,01,00,NO,"VALES,Sustantiva -- Eficiencia terapeutica L - 45%",OLANZAPINA. TABLETA. CADA TABLETA CONTIENE: OLANZAPINA 10 MG. ENVASE CON 28 TABLETAS.,ENV,28,TAB,10,miligramos,280,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,BENZODIAZEPINAS,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
165,Grupo Nº 19: Psiquiatría,CITALOPRAM,5487,5487,1000054870000,010,000,5487,00,00,SI,"VALES,Sustantiva",CITALOPRAM TABLETA CADA TABLETA CONTIENE: BROMHIDRATO DE CITALOPRAM EQUIVALENTE  A 20 MG DE CITALOPRAM. ENVASE CON 14 TABLETAS.,ENV,14,TAB,20,miligramos,280,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,ANTIDEPRESIVOS,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
166,Grupo Nº 19: Psiquiatría,CITALOPRAM,5487,5487,1000054870100,010,000,5487,01,00,NO,"VALES,Sustantiva",CITALOPRAM. TABLETA. CADA TABLETA CONTIENE: BROMHIDRATO DE CITALOPRAM EQUIVALENTE A 20 MG DE CITALOPRAM. ENVASE CON 28 TABLETAS.,ENV,28,TAB,20,miligramos,560,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,ANTIDEPRESIVOS,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
168,Grupo Nº 19: Psiquiatría,QUETIAPINA,5489,5489,1000054890000,010,000,5489,00,00,SI,Sustantiva -- Eficiencia terapeutica L - 6%,QUETIAPINA TABLETA CADA TABLETA CONTIENE: FUMARATO DE QUETIAPINA EQUIVALENTE A  100 MG DE QUETIAPINA ENVASE CON 60 TABLETAS.,ENV,60,TAB,100,miligramos,6000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,FARMACOS_UTILIZADOS_EN_PSIQUIATRIA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0
556,Grupo Nº 19: Psiquiatría,FLUPENTIXOL,3261,3261,1000032610000,010,000,3261,00,00,SI,Sustantiva,FLUPENTIXOL SOLUCION INYECTABLE CADA AMPOLLETA CONTIENE: DECANOATO DE  FLUPENTIXOL 20 MG ENVASE CON UNA AMPOLLETA DE 1 ML.,ENV,1,F.A,20,miligramos,20,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
559,Grupo Nº 19: Psiquiatría,FLUPENTIXOL,3263,3263,1000032630000,010,000,3263,00,00,SI,Sustantiva,FLUPENTIXOL GRAGEA CADA GRAGEA CONTIENE: DICLORHIDRATO DE FLUPENTIXOL EQUIVALENTE A 5 MG DE FLUPENTIXOL ENVASE CON 20 GRAGEAS.,ENV,20,GRA,5,miligramos,100,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
560,Grupo Nº 19: Psiquiatría,FLUPENTIXOL,3263,3263,1000032630100,010,000,3263,01,00,NO,Sustantiva,FLUPENTIXOL. GRAGEA. CADA GRAGEA CONTIENE: DICLORHIDRATO DE FLUPENTIXOL EQUIVALENTE A 5 MG DE FLUPENTIXOL. ENVASE CON 30 GRAGEAS.,ENV,30,GRA,5,miligramos,150,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
561,Grupo Nº 19: Psiquiatría,FLUPENTIXOL,3263,3263,1000032630200,010,000,3263,02,00,NO,Sustantiva,FLUPENTIXOL. GRAGEA. CADA GRAGEA CONTIENE: DICLORHIDRATO DE FLUPENTIXOL EQUIVALENTE A 5 MG DE FLUPENTIXOL. ENVASE CON 50 GRAGEAS.,ENV,50,GRA,5,miligramos,250,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
562,Grupo Nº 19: Psiquiatría,ZIPRASIDONA,3264,3264,1000032640000,010,000,3264,00,00,SI,Sustantiva -- Eficiencia terapeutica M - 0%,ZIPRASIDONA CAPSULA CADA CAPSULA CONTIENE: CLORHIDRATO DE ZIPRASIDONA  EQUIVALENTE A 40 MG DE ZIPRASIDONA. ENVASE CON 28 CAPSULAS.,ENV,28,CAP,40,miligramos,1120,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
563,Grupo Nº 19: Psiquiatría,ZIPRASIDONA,3265,3265,1000032650000,010,000,3265,00,00,SI,Sustantiva,ZIPRASIDONA CAPSULA CADA CAPSULA CONTIENE: CLORHIDRATO DE ZIPRASIDONA  EQUIVALENTE A 80 MG DE ZIPRASIDONA. ENVASE CON 28 CAPSULAS.,ENV,28,CAP,80,miligramos,2240,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
620,Grupo Nº 19: Psiquiatría,ALPRAZOLAM,2499,2499,4000024990000,040,000,2499,00,00,SI,"VALES,Sustantiva",ALPRAZOLAM TABLETA CADA TABLETA CONTIENE: ALPRAZOLAM 2.0 MG ENVASE CON 30  TABLETAS.,ENV,30,TAB,2,miligramos,60,miligramos,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,BENZODIAZEPINAS,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
633,Grupo Nº 19: Psiquiatría,LEVOMEPROMAZINA,3204,3204,4000032040000,040,000,3204,00,00,SI,Sustantiva,LEVOMEPROMAZINA TABLETA CADA TABLETA CONTIENE: MALEATO DE LEVOMEPROMAZINA EQUIVALENTE A 25 MG DE LEVOMEPROMAZINA ENVASE CON 20 TABLETAS.,ENV,20,TAB,25,miligramos,500,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,BENZODIAZEPINAS,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
634,Grupo Nº 19: Psiquiatría,TRIAZOLAM,3206,3206,4000032060000,040,000,3206,00,00,SI,"VALES,Sustantiva",TRIAZOLAM TABLETA CADA TABLETA CONTIENE: TRIAZOLAM 0.125 MG ENVASE CON 20  TABLETAS.,ENV,20,TAB,0.125,miligramos,2.5,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,BENZODIAZEPINAS,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
636,Grupo Nº 19: Psiquiatría,TRIFLUOPERAZINA,3241,3241,4000032410000,040,000,3241,00,00,SI,"VALES,Sustantiva",TRIFLUOPERAZINA GRAGEA O TABLETA CADA GRAGEA O TABLETA CONTIENE: CLORHIDRATO DE  TRIFLUOPERAZINA EQUIVALENTE A 5 MG DE TRIFLUOPERAZINA ENVASE CON 20 GRAGEAS O  TABLETAS.,ENV,20,GRA,5,miligramos,100,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
637,Grupo Nº 19: Psiquiatría,TRIFLUOPERAZINA,3241,3241,4000032410100,040,000,3241,01,00,NO,"VALES,Sustantiva",TRIFLUOPERAZINA. GRAGEA O TABLETA. CADA GRAGEA O TABLETA CONTIENE: CLORHIDRATO DE TRIFLUOPERAZINA EQUIVALENTE A 5 MG DE TRIFLUOPERAZINA. ENVASE CON 30 GRAGEAS O TABLETAS.,ENV,30,T.G,5,miligramos,150,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
639,Grupo Nº 19: Psiquiatría,HALOPERIDOL,3251,3251,4000032510000,040,000,3251,00,00,SI,"VALES,Sustantiva",HALOPERIDOL TABLETA CADA TABLETA CONTIENE: HALOPERIDOL 5 MG ENVASE CON 20 TABLETAS.,ENV,20,TAB,5,miligramos,100,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
640,Grupo Nº 19: Psiquiatría,HALOPERIDOL,3253,3253,4000032530000,040,000,3253,00,00,SI,Sustantiva,HALOPERIDOL SOLUCION INYECTABLE CADA AMPOLLETA CONTIENE: HALOPERIDOL 5 MG  ENVASE CON 6 AMPOLLETAS (5 MG/ ML).,ENV,6,AMP,5,miligramos,30,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
641,Grupo Nº 19: Psiquiatría,LITIO,3255,3255,4000032550000,040,000,3255,00,00,SI,"VALES,Sustantiva",LITIO TABLETA CADA TABLETA CONTIENE: CARBONATO DE LITIO 300 MG ENVASE CON 50  TABLETAS.,ENV,50,TAB,300,miligramos,15000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
642,Grupo Nº 19: Psiquiatría,RISPERIDONA,3258,3258,4000032580000,040,000,3258,00,00,SI,"VALES,Sustantiva -- Eficiencia terapeutica L - 48%",RISPERIDONA TABLETA CADA TABLETA CONTIENE: RISPERIDONA 2 MG ENVASE CON 40  TABLETAS.,ENV,40,TAB,2,miligramos,80,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,BENZODIAZEPINAS,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
643,Grupo Nº 19: Psiquiatría,CLOZAPINA,3259,3259,4000032590000,040,000,3259,00,00,SI,"VALES,Sustantiva -- Eficiencia terapeutica M - 1%",CLOZAPINA COMPRIMIDO CADA COMPRIMIDO CONTIENE: CLOZAPINA 100 MG ENVASE CON 30 COMPRIMIDOS.,ENV,30,COM,100,miligramos,3000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
644,Grupo Nº 19: Psiquiatría,CLOZAPINA,3259,3259,4000032590100,040,000,3259,01,00,NO,"VALES,Sustantiva -- Eficiencia terapeutica M - 1%",CLOZAPINA. COMPRIMIDO. CADA COMPRIMIDO CONTIENE: CLOZAPINA 100 MG. ENVASE CON 50 COMPRIMIDOS.,ENV,50,COM,100,miligramos,5000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
645,Grupo Nº 19: Psiquiatría,RISPERIDONA,3262,3262,4000032620000,040,000,3262,00,00,SI,Sustantiva,RISPERIDONA SOLUCION ORAL CADA MILILITRO CONTIENE: RISPERIDONA 1 MG ENVASE CON 60 ML Y GOTERO DOSIFICADOR.,ENV,1,ENV,1,miligramos,1,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
646,Grupo Nº 19: Psiquiatría,IMIPRAMINA,3302,3302,4000033020000,040,000,3302,00,00,SI,"VALES,Sustantiva",IMIPRAMINA GRAGEA O TABLETA CADA GRAGEA O TABLETA CONTIENE: CLORHIDRATO DE  IMIPRAMINA 25 MG ENVASE CON 20 GRAGEAS O TABLETAS.,ENV,20,T.G,25,miligramos,500,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,ANTIDEPRESIVOS,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
647,Grupo Nº 19: Psiquiatría,AMITRIPTILINA,3305,3305,4000033050000,040,000,3305,00,00,SI,"VALES,Sustantiva",AMITRIPTILINA TABLETA CADA TABLETA CONTIENE: CLORHIDRATO DE AMITRIPTILINA 25 MG  ENVASE CON 20 TABLETAS.,ENV,20,TAB,25,miligramos,500,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
659,Grupo Nº 19: Psiquiatría,HALOPERIDOL,4477,4477,4000044770000,040,000,4477,00,00,SI,Sustantiva,HALOPERIDOL SOLUCION ORAL CADA ML CONTIENE: HALOPERIDOL 2 MG ENVASE CON GOTERO INTEGRAL CON 15 ML.,FCO,15,ML.,2,miligramos,2,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
660,Grupo Nº 19: Psiquiatría,HALOPERIDOL,4477,4477,4000044770003,040,000,4477,00,03,NO,Sustantiva,HALOPERIDOL. SOLUCION ORAL. CADA ML CONTIENE: HALOPERIDOL 2 MG. ENVASE CON GOTERO INTEGRAL CON 15 ML.,ENV,15,ML.,2,miligramos,2,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
661,Grupo Nº 19: Psiquiatría,HALOPERIDOL,4477,4477,4000044770102,040,000,4477,01,02,NO,Sustantiva,HALOPERIDOL. SOLUCION ORAL. CADA ML CONTIENE: HALOPERIDOL 2 MG. ENVASE CON GOTERO INTEGRAL CON 30 ML.,ENV,30,ML.,2,miligramos,2,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
662,Grupo Nº 19: Psiquiatría,FLUNITRAZEPAM,4478,4478,4000044780000,040,000,4478,00,00,SI,,FLUNITRAZEPAM COMPRIMIDO CADA COMPRIMIDO CONTIENE: FLUNITRAZEPAM 1 MG ENVASE  CON 30 COMPRIMIDOS.,ENV,30,COM,1,miligramos,30,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
663,Grupo Nº 19: Psiquiatría,HALOPERIDOL,4481,4481,4000044810000,040,000,4481,00,00,SI,Sustantiva,HALOPERIDOL SOLUCION INYECTABLE CADA AMPOLLETA CONTIENE: DECANOATO DE HALOPERIDOL EQUIVALENTE A 50 MG DE HALOPERIDOL ENVASE CON 1 AMPOLLETA CON 1 ML,ENV,1,AMP,50,miligramos,50,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
664,Grupo Nº 19: Psiquiatría,HALOPERIDOL,4481,4481,4000044810100,040,000,4481,01,00,NO,Sustantiva,HALOPERIDOL. SOLUCION INYECTABLE. CADA AMPOLLETA CONTIENE: DECANOATO DE HALOPERIDOL EQUIVALENTE A 50 MG DE HALOPERIDOL. ENVASE CON 5 AMPOLLETAS CON 1 ML.,ENV,5,AMP,50,miligramos,250,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
665,Grupo Nº 19: Psiquiatría,BROMAZEPAM,4482,4482,4000044820000,040,000,4482,00,00,SI,"VALES,Sustantiva",BROMAZEPAM COMPRIMIDO CADA COMPRIMIDO CONTIENE: BROMAZEPAM 3 MG ENVASE CON 30  COMPRIMIDOS.,ENV,30,COM,3,miligramos,90,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,BENZODIAZEPINAS,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
666,Grupo Nº 19: Psiquiatría,SERTRALINA,4484,4484,4000044840000,040,000,4484,00,00,SI,"VALES,Sustantiva",SERTRALINA CAPSULA O TABLETA CADA CAPSULA O TABLETA CONTIENE: CLORHIDRATO DE SERTRALINA EQUIVALENTE A 50 MG DE SERTRALINA. ENVASE CON 14 CAPSULAS O TABLETAS.,ENV,14,C.T,50,miligramos,700,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,ANTIDEPRESIVOS,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
667,Grupo Nº 19: Psiquiatría,ANFEBUTAMONA O BUPROPIÓN,4486,4486,4000044860002,040,000,4486,00,02,NO,"VALES,Sustantiva",ANFEBUTAMONA O BUPROPION. TABLETA O GRAGEA DE LIBERACION PROLONGADA. CADA TABLETA O GRAGEA DE LIBERACION PROLONGADA CONTIENE: ANFEBUTAMONA O BUPROPION 150 MG. ENVASE CON 15 TABLETAS O GRAGEAS DE LIBERACION PROLONGADA.,ENV,15,T.G,150,miligramos,2250,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
668,Grupo Nº 19: Psiquiatría,ANFEBUTAMONA O BUPROPIÓN,4486,4486,4000044860102,040,000,4486,01,02,SI,"VALES,Sustantiva",ANFEBUTAMONA O BUPROPION. TABLETA O GRAGEA DE LIBERACION PROLONGADA. CADA TABLETA O GRAGEA DE LIBERACION PROLONGADA CONTIENE: ANFEBUTAMONA O BUPROPION 150 MG. ENVASE CON 30 TABLETAS O GRAGEAS DE LIBERACION PROLONGADA.,ENV,30,T.G,150,miligramos,4500,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
671,Grupo Nº 19: Psiquiatría,LORAZEPAM,5478,5478,4000054780000,040,000,5478,00,00,SI,"VALES,Sustantiva",LORAZEPAM TABLETA CADA TABLETA CONTIENE: LORAZEPAM 1 MG ENVASE CON 40 TABLETAS,ENV,40,TAB,1,miligramos,40,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,BENZODIAZEPINAS,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1231,Grupo Nº 19: Psiquiatría,FLUOXETINA,4483,4483,1000044830000,010,000,4483,00,00,SI,"VALES,Sustantiva",FLUOXETINA CAPSULA O TABLETA CADA CAPSULA O TABLETA CONTIENE: CLORHIDRATO DE FLUOXETINA EQUIVALENTE A 20 MG DE FLUOXETINA. ENVASE CON 14 CAPSULAS O TABLETAS.,ENV,14,C.T,20,miligramos,280,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,ANTIDEPRESIVOS,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1232,Grupo Nº 19: Psiquiatría,FLUOXETINA,4483,4483,1000044830100,010,000,4483,01,00,NO,"VALES,Sustantiva",FLUOXETINA. CAPSULA O TABLETA. CADA CAPSULA O TABLETA CONTIENE: CLORHIDRATO DE FLUOXETINA EQUIVALENTE A 20 MG DE FLUOXETINA. ENVASE CON 28 CAPSULAS O TABLETAS.,ENV,28,CAP,20,miligramos,560,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,ANTIDEPRESIVOS,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1233,Grupo Nº 19: Psiquiatría,REBOXETINA,4487,4487,1000044870000,010,000,4487,00,00,SI,Sustantiva,REBOXETINA TABLETA CADA TABLETA CONTIENE METANSULFONATO DE REBOXETINA  EQUIVALENTE A 4 MG DE REBOXETINA ENVASE CON 60 TABLETAS.,ENV,60,TAB,4,miligramos,240,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1234,Grupo Nº 19: Psiquiatría,VENLAFAXINA,4488,4488,1000044880000,010,000,4488,00,00,SI,"VALES,Sustantiva",VENLAFAXINA CAPSULA O GRAGEA DE LIBERACION PROLONGADA CADA CAPSULA O GRAGEA DE  LIBERACION PROLONGADA CONTIENE: CLORHIDRATO DE VENLAFAXINA EQUIVALENTE A 75 MG  DE VENLAFAXINA. ENVASE CON 10 CAPSULAS O GRAGEAS DE LIBERACION PROLONGADA.,ENV,10,G.C,75,miligramos,750,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,ANTIDEPRESIVOS,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1235,Grupo Nº 19: Psiquiatría,OLANZAPINA,4489,4489,1000044890000,010,000,4489,00,00,SI,Sustantiva,OLANZAPINA SOLUCION INYECTABLE CADA FRASCO AMPULA CON LIOFILIZADO CONTIENE:  OLANZAPINA 10 MG ENVASE CON UN FRASCO AMPULA.,ENV,1,F.A,10,miligramos,10,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
598,Grupo Nº 2: Anestesia,FLUNITRAZEPAM,206,0206,4000002060000,040,000,0206,00,00,SI,Nueva inclusión,FLUNITRAZEPAM SOLUCION INYECTABLE. CADA AMPOLLETA CONTIENE: FLUNITRAZEPAN 2 MG. ENVASE CON 3 AMPOLLETAS Y 3 AMPOLLETAS CON DILUYENTE.,ENV,3,JGO,2,miligramos,6,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
599,Grupo Nº 2: Anestesia,FLUNITRAZEPAM,206,0206,4000002060100,040,000,0206,01,00,NO,Nueva inclusión,FLUNITRAZEPAM. SOLUCION INYECTABLE. CADA AMPOLLETA CONTIENE: FLUNITRAZEPAN 2 MG. ENVASE CON 5 AMPOLLETAS Y 5 AMPOLLETAS CON DILUYENTE.,ENV,5,JGO,2,miligramos,10,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
600,Grupo Nº 2: Anestesia,TIOPENTAL SÓDICO,221,0221,4000002210000,040,000,0221,00,00,SI,Sustantiva,TIOPENTAL SODICO SOLUCION INYECTABLE CADA FRASCO AMPULA CON POLVO CONTIENE:  TIOPENTAL SODICO 0.5 G ENVASE CON FRASCO AMPULA Y DILUYENTE CON 20 ML.,ENV,1,JGO,0.5,gramos,0.5,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
601,Grupo Nº 2: Anestesia,KETAMINA,226,0226,4000002260000,040,000,0226,00,00,SI,Sustantiva,KETAMINA SOLUCION INYECTABLE CADA FRASCO AMPULA CONTIENE: CLORHIDRATO DE  KETAMINA EQUIVALENTE A 500 MG DE KETAMINA ENVASE CON UN FRASCO AMPULA DE 10  ML.,ENV,1,F.A,500,miligramos,500,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
602,Grupo Nº 2: Anestesia,FENTANILO,242,0242,4000002420000,040,000,0242,00,00,SI,"Cofepris - Sin CPM_V,Uso Hospitalario, Anestesia",FENTANILO SOLUCION INYECTABLE CADA AMPOLLETA O FRASCO AMPULA CONTIENE: CITRATO  DE FENTANILO EQUIVALENTE A 0.5 MG DE FENTANILO. ENVASE CON 6 AMPOLLETAS O  FRASCOS AMPULA CON 10 ML.,ENV,6,AFA,0.5,miligramos,3,miligramos,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
603,Grupo Nº 2: Anestesia,ETOMIDATO,243,0243,4000002430000,040,000,0243,00,00,SI,Sustantiva,ETOMIDATO SOLUCION INYECTABLE CADA AMPOLLETA CONTIENE: ETOMIDATO 20 MG ENVASE  CON 5 AMPOLLETAS CON 10 ML.,ENV,5,AMP,20,miligramos,100,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
657,Grupo Nº 2: Anestesia,MIDAZOLAM,4057,4057,4000040570000,040,000,4057,00,00,SI,Sustantiva,MIDAZOLAM SOLUCION INYECTABLE CADA AMPOLLETA CONTIENE: CLORHIDRATO DE MIDAZOLAM  EQUIVALENTE A 15 MG DE MIDAZOLAM O MIDAZOLAM 15 MG ENVASE CON 5 AMPOLLETAS CON  3 ML.,ENV,5,AMP,15,miligramos,75,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
685,Grupo Nº 2: Anestesia,ATROPINA,204,0204,1000002040000,010,000,0204,00,00,SI,Sustantiva,ATROPINA SOLUCION INYECTABLE CADA AMPOLLETA CONTIENE: SULFATO DE ATROPINA 1 MG ENVASE CON 50 AMPOLLETAS CON 1 ML.,ENV,50,AMP,1,miligramos,50,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
686,Grupo Nº 2: Anestesia,ISOFLURANO,232,0232,1000002320002,010,000,0232,00,02,SI,"Sustantiva --Vaporizadores ZONA,Uso Hospitalario, Anestesia",ISOFLURANO. LIQUIDO O SOLUCION. CADA ENVASE CONTIENE: ISOFLURANO 100 ML.,ENV,100,ML.,100,mililitros,100,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
687,Grupo Nº 2: Anestesia,SEVOFLURANO,233,0233,1000002330000,010,000,0233,00,00,SI,"Sustantiva --Vaporizadores ZONA,Uso Hospitalario, Anestesia","SEVOFLURANO, LIQUIDO, CADA ENVASE CONTIENE: SEVOFLURANO 250 ML. ENVASE CON 250 MILILITROS DE LIQUIDO.",ENV,1,ENV,250,mililitros,250,mililitros,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
688,Grupo Nº 2: Anestesia,SEVOFLURANO,233,0233,1000002330002,010,000,0233,00,02,NO,"Sustantiva --Vaporizadores ZONA,Uso Hospitalario, Anestesia",SEVOFLURANO. LIQUIDO O SOLUCION. CADA ENVASE CONTIENE: SEVOFLURANO 250 ML. ENVASE CON 250 ML DE LIQUIDO O SOLUCION.,ENV,250,ML.,250,mililitros,250,mililitros,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
689,Grupo Nº 2: Anestesia,DESFLURANO,234,0234,1000002340000,010,000,0234,00,00,SI,"Entrega hospitalaria,Uso Hospitalario, Anestesia",DESFLURANO LIQUIDO CADA ENVASE CONTIENE: DESFLURANO 240 ML ENVASE CON 240 ML.,ENV,1,ENV,240,mililitros,240,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
690,Grupo Nº 2: Anestesia,PROPOFOL,246,0246,1000002460000,010,000,0246,00,00,SI,"Sustantiva,Uso Hospitalario, Anestesia",PROPOFOL EMULSION INYECTABLE CADA AMPOLLETA O FRASCO AMPULA CONTIENE: PROPOFOL 200 MG EN EMULSION CON EDETATO DISODICO (DIHIDRATADO). ENVASE CON 5 AMPOLLETAS O FRASCOS AMPULA DE 20 ML.,ENV,5,AFA,200,miligramos,1000,miligramos,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
694,Grupo Nº 2: Anestesia,VECURONIO,254,0254,1000002540000,010,000,0254,00,00,SI,"Sustantiva,Uso Hospitalario, Anestesia",VECURONIO SOLUCION INYECTABLE CADA FRASCO AMPULA CON LIOFILIZADO CONTIENE: BROMURO DE VECURONIO 4 MG ENVASE CON 50 FRASCOS AMPULA Y 50 AMPOLLETAS CON 1 ML DE DILUYENTE (4 MG/ML),ENV,50,JGO,4,miligramos,200,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
696,Grupo Nº 2: Anestesia,LIDOCAÍNA,262,0262,1000002620000,010,000,0262,00,00,SI,"Sustantiva,Uso Hospitalario, Anestesia",LIDOCAINA SOLUCION INYECTABLE AL 2% CLORHIDRATO DE LIDOCAINA 1 G ENVASE CON 5 FRASCOS AMPULA CON 50 ML.,ENV,5,F.A,1,gramos,5,gramos,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
697,Grupo Nº 2: Anestesia,LIDOCAÍNA,262,0262,1000002620004,010,000,0262,00,04,NO,"Sustantiva,Uso Hospitalario, Anestesia",LIDOCAINA SOLUCION INYECTABLE AL 2% CADA FRASCO AMPULA CONTIENE: CLORHIDRATO DE LIDOCAINA 1 G. ENVASE CON 5 FRASCOS AMPULA CON 50 ML.,ENV,5,F.A,1,gramos,5,gramos,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
698,Grupo Nº 2: Anestesia,LIDOCAÍNA,264,0264,1000002640000,010,000,0264,00,00,SI,"Sustantiva,Uso Hospitalario, Anestesia",LIDOCAINA SOLUCION AL 10% CADA 100 ML CONTIENE: LIDOCAINA 10.0 G ENVASE CON 115 ML CON ATOMIZADOR MANUAL.,ENV,1,ENV,10,gramos,10,gramos,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
699,Grupo Nº 2: Anestesia,"LIDOCAÍNA, EPINEFRINA",265,0265,1000002650000,010,000,0265,00,00,SI,"Sustantiva,Uso Hospitalario, Anestesia","LIDOCAINA, EPINEFRINA SOLUCION INYECTABLE AL 2% CADA FRASCO AMPULA CONTIENE: CLORHIDRATO DE LIDOCAINA 1 G EPINEFRINA (1:200000) 0.25 MG. ENVASE CON 5 FRASCOS AMPULA CON 50 ML.",ENV,5,F.A,0.25,miligramos,1.25,miligramos,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
700,Grupo Nº 2: Anestesia,"LIDOCAÍNA, EPINEFRINA",267,0267,1000002670000,010,000,0267,00,00,SI,"Sustantiva,Uso Hospitalario, Anestesia","LIDOCAINA, EPINEFRINA SOLUCION INYECTABLE AL 2% CADA CARTUCHO DENTAL CONTIENE: CLORHIDRATO DE LIDOCAINA 36 MG EPINEFRINA (1:100000) 0.018 MG ENVASE CON 50 CARTUCHOS DENTALES CON 1.8 ML.",ENV,50,CHO,36,miligramos,1800,miligramos,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
701,Grupo Nº 2: Anestesia,ROPIVACAINA,269,0269,1000002690000,010,000,0269,00,00,SI,"Sustantiva,Uso Hospitalario, Anestesia",ROPIVACAINA SOLUCION INYECTABLE CADA AMPOLLETA CONTIENE: CLORHIDRATO DE ROPIVACAINA MONOHIDRATADA EQUIVALENTE A 40 MG DE CLORHIDRATO DE ROPIVACAINA. ENVASE CON 5 AMPOLLETAS CON 20 ML.,ENV,5,AMP,40,miligramos,200,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
702,Grupo Nº 2: Anestesia,ROPIVACAINA,270,0270,1000002700000,010,000,0270,00,00,SI,"Sustantiva,Uso Hospitalario, Anestesia",ROPIVACAINA SOLUCION INYECTABLE CADA AMPOLLETA CONTIENE: CLORHIDRATO DE ROPIVACAINA MONOHIDRATADA EQUIVALENTE A 150 MG DE CLORHIDRATO DE ROPIVACAINA. ENVASE CON 5 AMPOLLETAS CON 20 ML.,ENV,5,AMP,150,miligramos,750,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
703,Grupo Nº 2: Anestesia,BUPIVACAÍNA,271,0271,1000002710000,010,000,0271,00,00,SI,"Sustantiva,Uso Hospitalario, Anestesia",BUPIVACAINA SOLUCION INYECTABLE CADA ML CONTIENE: CLORHIDRATO DE BUPIVACAINA 5 MG ENVASE CON 30 ML.,ENV,1,ENV,5,miligramos,5,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1001,Grupo Nº 2: Anestesia,BUPIVACAÍNA,4055,4055,1000040550000,010,000,4055,00,00,SI,"Sustantiva,Uso Hospitalario, Anestesia",BUPIVACAINA HIPERBARICA SOLUCION INYECTABLE CADA AMPOLLETA CONTIENE: CLORHIDRATO DE BUPIVACAINA 15 MG DEXTROSA ANHIDRA O GLUCOSA ANHIDRA 240 MG O GLUCOSA MONOHIDRATADA EQUIVALENTE A 240 MG DE GLUCOSA ANHIDRA. ENVASE CON 5,ENV,5,AMP,240,miligramos,1200,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1002,Grupo Nº 2: Anestesia,BUPIVACAÍNA,4055,4055,1000040550002,010,000,4055,00,02,NO,"Sustantiva,Uso Hospitalario, Anestesia",BUPIVACAINA. SOLUCION INYECTABLE. CADA AMPOLLETA CONTIENE: CLORHIDRATO DE BUPIVACAINA 15 MG. DEXTROSA ANHIDRA O GLUCOSA ANHIDRA 240 MG. GLUCOSA MONOHIDRATADA EQUIVALENTE A 240 MG DE GLUCOSA ANHIDRA. ENVASE CON 5 AMPOLLETAS,ENV,5,AMP,240,miligramos,1200,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1003,Grupo Nº 2: Anestesia,"PRILOCAÍNA, FELIPRESINA",4058,4058,1000040580003,010,000,4058,00,03,NO,"Sustantiva,Uso Hospitalario, Anestesia,Uso Hospitalario, Anestesia","PRILOCAÍNA, FELIPRESINA. SOLUCION INYECTABLE. CADA CARTUCHO DENTAL CONTIENE: CLORHIDRATO DE PRILOCAÍNA 54 MG FELIPRESINA 0.054 UI. ENVASE CON 1 CARTUCHO CON 1.8 ML.",ENV,1,CHO,54,miligramos,54,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1004,Grupo Nº 2: Anestesia,"PRILOCAÍNA, FELIPRESINA",4058,4058,1000040580100,010,000,4058,01,00,SI,"Sustantiva,Uso Hospitalario, Anestesia,Uso Hospitalario, Anestesia",SOLUCION INYECTABLE CADA CARTUCHO DENTAL CONTIENE: CLORHIDRATO DE PRILOCAINA 54 MG FELIPRESINA 0.054 UI ENVASE CON 50 CARTUCHO CON 1.8 ML.,ENV,50,CHO,54,miligramos,2700,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1005,Grupo Nº 2: Anestesia,"ROCURONIO, BROMURO DE",4059,4059,1000040590000,010,000,4059,00,00,SI,"Sustantiva,Uso Hospitalario, Anestesia","ROCURONIO, BROMURO DE SOLUCION INYECTABLE CADA AMPOLLETA O FRASCO AMPULA  CONTIENE: BROMURO DE ROCURONIO 50 MG ENVASE CON 12 AMPOLLETAS O FRASCOS AMPULA  DE 5 ML.",ENV,12,AMP,50,miligramos,600,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1006,Grupo Nº 2: Anestesia,"CISATRACURIO, BESILATO DE",4061,4061,1000040610000,010,000,4061,00,00,SI,"Sustantiva,Uso Hospitalario, Anestesia","CISATRACURIO, BESILATO DE SOLUCION INYECTABLE CADA ML CONTIENE: BESILATO DE  CISATRACURIO EQUIVALENTE A 2 MG DE CISATRACURIO ENVASE CON 1 AMPOLLETA CON 5  ML.",ENV,1,AMP,2,miligramos,2,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
169,Grupo Nº 20: Reumatología y Traumatología,DICLOFENACO,5501,5501,1000055010000,010,000,5501,00,00,SI,"Sustantiva,Programa de Planificación Familiar",DICLOFENACO SOLUCION INYECTABLE CADA AMPOLLETA CONTIENE: DICLOFENACO SODICO 75  MG ENVASE CON 2 AMPOLLETAS CON 3 ML.,ENV,2,AMP,75,miligramos,150,miligramos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
171,Grupo Nº 20: Reumatología y Traumatología,SULINDACO,5503,5503,1000055030000,010,000,5503,00,00,SI,"VALES,Consumo en demanda","SULINDACO TABLETA O GRAGEA CADA TABLETA O GRAGEA CONTIENE: SULINDACO 200 MG,  ENVASE CON 20 TABLETAS O GRAGEAS.",ENV,20,TAB,200,miligramos,4000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,ANTIINFLAMATORIOS_NO_ESTEROIDEOS,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
172,Grupo Nº 20: Reumatología y Traumatología,CELECOXIB,5505,5505,1000055050000,010,000,5505,00,00,SI,"VALES,Sustantiva",CELECOXIB CAPSULA CADA CAPSULA CONTIENE: CELECOXIB 100 MG ENVASE CON 20  CAPSULAS.,ENV,20,CAP,100,miligramos,2000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,ANTIINFLAMATORIOS_NO_ESTEROIDEOS,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
173,Grupo Nº 20: Reumatología y Traumatología,CELECOXIB,5506,5506,1000055060000,010,000,5506,00,00,SI,"VALES,Sustantiva",CELECOXIB CAPSULA CADA CAPSULA CONTIENE: CELECOXIB 200 MG ENVASE CON 10  CAPSULAS.,ENV,10,CAP,200,miligramos,2000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
217,Grupo Nº 20: Reumatología y Traumatología,CERTOLIZUMAB PEGOL,5795,5795,1000057950000,010,000,5795,00,00,SI,Catálogo II -- TORRE DE CONTROL,CERTOLIZUMAB PEGOL. SOLUCION INYECTABLE. CADA JERINGA PRELLENADA CONTIENE: CERTOLIZUMAB PEGOL 200 MG. ENVASE CON 2 JERINGAS PRELLENADAS CON 1 ML.,ENV,2,JGA,200,miligramos,400,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
219,Grupo Nº 20: Reumatología y Traumatología,ABATACEPT,5820,5820,1000058200000,010,000,5820,00,00,SI,Catálogo II -- TORRE DE CONTROL,ABATACEPT. SOLUCION INYECTABLE. CADA JERINGA PRELLENADA CONTIENE: ABATACEPT 125 MG. ENVASE CON 4 JERINGAS PRELLENADAS CON 1 ML. CADA UNA (125 MG/ML).,ENV,4,JGA,125,miligramos,500,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
231,Grupo Nº 20: Reumatología y Traumatología,GOLIMUMAB,5950,5950,1000059500000,010,000,5950,00,00,SI,,GOLIMUMAB. SOLUCION INYECTABLE. CADA PLUMA PRECARGADA CONTIENE: GOLIMUMAB 50 MG. ENVASE CON UNA PLUMA PRECARGADA CON 0.5 ML.,ENV,1,PLU,50,miligramos,50,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
246,Grupo Nº 20: Reumatología y Traumatología,HIALURONATO DE SODIO,6019,6019,1000060190000,010,000,6019,00,00,SI,"Sin programa definido,Uso Hospitalario, Reumatología y Traumatología",HIALURONATO DE SODIO. SOLUCION INYECTABLE CADA JERINGA PRELLENADA CONTIENE: HIALURONATO DE SODIO 25 MG. ENVASE CON UNA JERINGA PRELLENADA CON 2.5 ML.,ENV,1,JGA,25,miligramos,25,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
270,Grupo Nº 20: Reumatología y Traumatología,GOLIMUMAB,6154,6154,1000061540000,010,000,6154,00,00,SI,,GOLIMUMAB. SOLUCION INYECTABLE. CADA PLUMA PRECARGADA CONTIENE: GOLIMUMAB 100 MG. ENVASE CON UNA PLUMA PRECARGADA CON 1 ML.,ENV,1,PLU,100,miligramos,100,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
564,Grupo Nº 20: Reumatología y Traumatología,NAPROXENO,3407,3407,1000034070000,010,000,3407,00,00,SI,"VALES,Programa de Planificación Familiar,Consumo en demanda",NAPROXENO TABLETA CADA TABLETA CONTIENE: NAPROXENO 250 MG ENVASE CON 30  TABLETAS.,ENV,30,TAB,250,miligramos,7500,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,ANTIINFLAMATORIOS_NO_ESTEROIDEOS,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
565,Grupo Nº 20: Reumatología y Traumatología,COLCHICINA,3409,3409,1000034090000,010,000,3409,00,00,SI,"VALES,Sustantiva",COLCHICINA TABLETA CADA TABLETA CONTIENE: COLCHICINA 1 MG ENVASE CON 30  TABLETAS.,ENV,30,TAB,1,miligramos,30,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,ANTIURICOSURICOS,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
568,Grupo Nº 20: Reumatología y Traumatología,INDOMETACINA,3413,3413,1000034130000,010,000,3413,00,00,SI,"VALES,Sustantiva",INDOMETACINA CAPSULA CADA CAPSULA CONTIENE: INDOMETACINA 25 MG ENVASE CON 30  CAPSULAS.,ENV,30,CAP,25,miligramos,750,miligramos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
569,Grupo Nº 20: Reumatología y Traumatología,PIROXICAM,3415,3415,1000034150000,010,000,3415,00,00,SI,"VALES,Sustantiva",PIROXICAM CAPSULA O TABLETA CADA CAPSULA O TABLETA CONTIENE: PIROXICAM 20 MG  ENVASE CON 20 CAPSULAS O TABLETAS.,ENV,20,C.T,20,miligramos,400,miligramos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,ANTIINFLAMATORIOS_NO_ESTEROIDEOS,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
570,Grupo Nº 20: Reumatología y Traumatología,DICLOFENACO,3417,3417,1000034170000,010,000,3417,00,00,SI,"VALES,Programa de Planificación Familiar,Consumo en demanda",DICLOFENACO CAPSULA O GRAGEA DE LIBERACION PROLONGADA CADA GRAGEA CONTIENE:  DICLOFENACO SODICO 100 MG ENVASE CON 20 CAPSULAS O GRAGEAS.,ENV,20,G.C,100,miligramos,2000,miligramos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,ANTIINFLAMATORIOS_NO_ESTEROIDEOS,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
571,Grupo Nº 20: Reumatología y Traumatología,MELOXICAM,3421,3421,1000034210000,010,000,3421,00,00,SI,Sustantiva,MELOXICAM SUSPENSION ORAL CADA 100 ML CONTIENEN: MELOXICAM 0.150 G ENVASE CON  40 ML Y PIPETA DOSIFICADORA DE 5 ML.,ENV,1,ENV,0.15,gramos,0.15,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
932,Grupo Nº 20: Reumatología y Traumatología,MELOXICAM,3423,3423,1000034230000,010,000,3423,00,00,SI,"Sustantiva,VALES",MELOXICAM TABLETA CADA TABLETA CONTIENE: MELOXICAM 15 MG. ENVASE CON 10  TABLETAS.,ENV,10,TAB,15,miligramos,150,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
935,Grupo Nº 20: Reumatología y Traumatología,ORFENADRINA,3443,3443,1000034430000,010,000,3443,00,00,SI,Sustantiva,ORFENADRINA SOLUCION INYECTABLE CADA AMPOLLETA CONTIENE: CITRATO DE ORFENADRINA  60 MG. ENVASE CON 6 AMPOLLETAS DE 2 ML.,ENV,6,AMP,60,miligramos,360,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,ANTIINFLAMATORIOS_NO_ESTEROIDEOS,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
936,Grupo Nº 20: Reumatología y Traumatología,METOCARBAMOL,3444,3444,1000034440000,010,000,3444,00,00,SI,Sustantiva,METOCARBAMOL TABLETA CADA TABLETA CONTIENE: METOCARBAMOL 400 MG ENVASE CON 30  TABLETAS.,ENV,30,TAB,400,miligramos,12000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
937,Grupo Nº 20: Reumatología y Traumatología,ALOPURINOL,3451,3451,1000034510000,010,000,3451,00,00,SI,"Sustantiva,VALES",ALOPURINOL TABLETA CADA TABLETA CONTIENE: ALOPURINOL 300 MG ENVASE CON 20  TABLETAS.,ENV,20,TAB,300,miligramos,6000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,ANTIURICOSURICOS,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
938,Grupo Nº 20: Reumatología y Traumatología,AZATIOPRINA,3461,3461,1000034610000,010,000,3461,00,00,SI,"Sustantiva,VALES",AZATIOPRINA TABLETA CADA TABLETA CONTIENE: AZATIOPRINA 50 MG ENVASE CON 50  TABLETAS.,ENV,50,TAB,50,miligramos,2500,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,FARMACOS_MODIFICADORES_DE_LA_ENFERMEDAD,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0
990,Grupo Nº 20: Reumatología y Traumatología,COLÁGENA-POLIVINILPIRROLIDONA,3999,3999,1000039990000,010,000,3999,00,00,SI,"Sustantiva,Uso Hospitalario, Reumatología y Traumatología,Uso Hospitalario, Reumatología y Traumatología",COLAGENA-POLIVINILPIRROLIDONA SOLUCION INYECTABLECADA MILILITRO CONTIENE: COLAGENA- POLIVINILPIRROLIDONA 141.3 MILIEQUIVALENTE A 8.33 MG DE COLAGENA ENVASE CON 1.5 ML.,ENV,1,ENV,8.33,miligramos,8.33,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
991,Grupo Nº 20: Reumatología y Traumatología,COLÁGENA-POLIVINILPIRROLIDONA,3999,3999,1000039990100,010,000,3999,01,00,NO,"Sustantiva,Uso Hospitalario, Reumatología y Traumatología,Uso Hospitalario, Reumatología y Traumatología",COLAGENA-POLIVINILPIRROLIDONA. SOLUCION INYECTABLE. CADA MILILITRO CONTIENE: COLAGENA- POLIVINILPIRROLIDONA 141.3 MILIEQUIVALENTE A 8.33 MG DE COLAGENA. ENVASE CON 4 ML.,ENV,4,ML.,8.33,miligramos,8.33,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1239,Grupo Nº 20: Reumatología y Traumatología,INFLIXIMAB,4508,4508,1000045080000,010,000,4508,00,00,SI,"Catálogo II -- TNF,Uso Hospitalario, Reumatología y Traumatología",INFLIXIMAB SOLUCION INYECTABLE EL FRASCO AMPULA CON LIOFILIZADO CONTIENE:  INFLIXIMAB 100 MG ENVASE CON UN FRASCO AMPULA CON LIOFILIZADO E INSTRUCTIVO.,ENV,1,JGO,100,miligramos,100,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1240,Grupo Nº 20: Reumatología y Traumatología,ETANERCEPT,4510,4510,1000045100000,010,000,4510,00,00,SI,Catálogo II -- TNF,"ETANERCEPT. SOLUCION INYECTABLE. CADA FRASCO AMPULA CONTIENE: ETANERCEPT 25 MG. ENVASE CON 4 FRASCOS AMPULA, 4 JERINGAS CON 1 ML DE DILUYENTE Y 8 ALMOHADILLAS.",ENV,1,JGO,25,miligramos,25,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1241,Grupo Nº 20: Reumatología y Traumatología,ETANERCEPT,4510,4510,1000045100100,010,000,4510,01,00,NO,Catálogo II -- TNF,ETANERCEPT. SOLUCION INYECTABLE. CADA FRASCO AMPULA CONTIENE: ETANERCEPT 25 MG. ENVASE CON 4 JERINGAS PRELLENADAS CON 0.5 ML.,ENV,4,JGA,25,miligramos,100,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1242,Grupo Nº 20: Reumatología y Traumatología,ETANERCEPT,4511,4511,1000045110000,010,000,4511,00,00,SI,Catálogo II -- TNF,"ETANERCEPT. SOLUCION INYECTABLE. CADA ENVASE CONTIENE: ETANERCEPT 50 MG. ENVASE CON 2 FRASCOS AMPULA, 2 JERINGAS CON 1 ML DE DILUYENTE.",ENV,2,JGO,50,miligramos,100,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1243,Grupo Nº 20: Reumatología y Traumatología,ETANERCEPT,4511,4511,1000045110100,010,000,4511,01,00,NO,Catálogo II -- TNF,"ETANERCEPT. SOLUCION INYECTABLE, CADA ENVASE CONTIENE: ETANERCEPT 50 MG, ENVASE  CON 2 JERINGAS PRELLENADAS CON 1 ML.",ENV,2,JGA,50,miligramos,100,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1244,Grupo Nº 20: Reumatología y Traumatología,ETANERCEPT,4511,4511,1000045110200,010,000,4511,02,00,NO,Catálogo II -- TNF,ETANERCEPT SOLUCION INYECTABLE CADA ENVASE CONTIENE: ETANERCEPT 50 MG. ENVASE CON 2 PLUMAS PRELLENADAS CON 1 ML.,ENV,2,PLU,50,miligramos,100,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1245,Grupo Nº 20: Reumatología y Traumatología,ADALIMUMAB,4512,4512,1000045120002,010,000,4512,00,02,NO,Catálogo II -- TNF,ADALIMUMAB. SOLUCION INYECTABLE. CADA JERINGA PRELLENADA CONTIENE: ADALIMUMAB 40 MG. ENVASE CON UNA JERINGA PRELLENADA.,ENV,1,JGA,40,miligramos,40,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1246,Grupo Nº 20: Reumatología y Traumatología,ADALIMUMAB,4512,4512,1000045120101,010,000,4512,01,01,NO,Catálogo II -- TNF,ADALIMUMAB. SOLUCION INYECTABLE. CADA FRASCO AMPULA CONTIENE: ADALIMUMAB 40 MG. ENVASE CON UN FRASCO AMPULA Y JERINGA.,ENV,1,FAJ,40,miligramos,40,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1247,Grupo Nº 20: Reumatología y Traumatología,ADALIMUMAB,4512,4512,1000045120201,010,000,4512,02,01,NO,Catálogo II -- TNF,ADALIMUMAB. SOLUCION INYECTABLE. CADA JERINGA PRELLENADA EN AUTOINYECTOR CON 0.8 ML CONTIENE: ADALIMUMAB 40 MG. ENVASE CON UNA JERINGA PRELLENADA EN AUTOINYECTOR.,ENV,1,JGA,40,miligramos,40,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1248,Grupo Nº 20: Reumatología y Traumatología,ADALIMUMAB,4512,4512,1000045120300,010,000,4512,03,00,SI,Catálogo II -- TNF,ADALIMUMAB. SOLUCION INYECTABLE. CADA JERINGA PRELLENADA EN AUTOINYECTOR CON 0.4 ML CONTIENE: ADALIMUMAB 40 MG. ENVASE CON UNA JERINGA PRELLENADA EN AUTOINYECTOR.,ENV,1,JGA,40,miligramos,40,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1249,Grupo Nº 20: Reumatología y Traumatología,TOCILIZUMAB,4513,4513,1000045130000,010,000,4513,00,00,SI,"Catálogo II -- TORRE DE CONTROL,Uso Hospitalario, Reumatología y Traumatología","TOCILIZUMAB, SOLUCION INYECTABLE, CADA FRASCO AMPULA CONTIENE: TOCILIZUMAB 80 MG ENVASE CON FRASCO AMPULA CON 4 ML.",PZA,1,ENV,80,miligramos,80,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1250,Grupo Nº 20: Reumatología y Traumatología,LEFLUNOMIDA,4514,4514,1000045140000,010,000,4514,00,00,SI,Sustantiva,LEFLUNOMIDA COMPRIMIDO CADA COMPRIMIDO CONTIENE: LEFLUNOMIDA 20 MG ENVASE CON  30 COMPRIMIDOS.,ENV,30,COM,20,miligramos,600,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,FARMACOS_MODIFICADORES_DE_LA_ENFERMEDAD,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1251,Grupo Nº 20: Reumatología y Traumatología,LEFLUNOMIDA,4515,4515,1000045150000,010,000,4515,00,00,SI,Sustantiva,LEFLUNOMIDA COMPRIMIDO CADA COMPRIMIDO CONTIENE: LEFLUNOMIDA 100 MG ENVASE CON  3 COMPRIMIDOS.,ENV,3,COM,100,miligramos,300,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1252,Grupo Nº 20: Reumatología y Traumatología,TOCILIZUMAB,4516,4516,1000045160000,010,000,4516,00,00,SI,"Catálogo II -- TORRE DE CONTROL,Uso Hospitalario, Reumatología y Traumatología","TOCILIZUMAB, SOLUCION INYECTABLE CADA FRASCO AMPULA CONTIENE: TOCILIZUMAB 200  MG. ENVASE CON FRASCO AMPULA CON 10 ML.",ENV,1,ENV,200,miligramos,200,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
63,Grupo Nº 21: Soluciones Electrolíticas y Sustitutos del Plasma,CLORURO DE SODIO,5386,5386,1000053860000,010,000,5386,00,00,SI,"Sustantiva,Uso Hospitalario, Soluciones Electrolíticas y Sustitutos del Plasma",CLORURO DE SODIO SOLUCION INYECTABLE AL 17.7% CADA ML CONTIENE: CLORURO DE  SODIO 0.177 G ENVASE CON CIEN AMPOLLETAS DE 10 ML.,ENV,100,AMP,0.177,gramos,17.7,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
735,Grupo Nº 21: Soluciones Electrolíticas y Sustitutos del Plasma,CLORURO DE POTASIO,524,0524,1000005240000,010,000,0524,00,00,SI,"Sustantiva,Uso Hospitalario, Soluciones Electrolíticas y Sustitutos del Plasma","CLORURO DE POTASIO SOLUCION INYECTABLE CADA AMPOLLETA CONTIENE: CLORURO DE POTASIO 1.49 G. (20 MILIEQUIVALENTES DE POTASIO, 20 MILIEQUIVALENTES DE CLORO) ENVASE CON 50 AMPOLLETAS CON 10 ML.",ENV,50,AMP,1.49,gramos,74.5,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
945,Grupo Nº 21: Soluciones Electrolíticas y Sustitutos del Plasma,GLUCOSA,3601,3601,1000036010000,010,000,3601,00,00,SI,"Sustantiva -- macro soluciones,Uso Hospitalario, Soluciones Electrolíticas y Sustitutos del Plasma",GLUCOSA SOLUCION INYECTABLE AL 5 % CADA 100 ML CONTIENE: GLUCOSA ANHIDRA O GLUCOSA 5 G O GLUCOSA MONOHIDRATADA EQUIVALENTE A 5.0 G DE GLUCOSA ENVASE CON 250 ML. CONTIENE: GLUCOSA 12.5 G.,ENV,250,ML.,5,gramos,5,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
946,Grupo Nº 21: Soluciones Electrolíticas y Sustitutos del Plasma,GLUCOSA,3603,3603,1000036030000,010,000,3603,00,00,SI,"Sustantiva -- macro soluciones,Uso Hospitalario, Soluciones Electrolíticas y Sustitutos del Plasma",GLUCOSA SOLUCION INYECTABLE AL 5% CADA 100 ML CONTIENEN: GLUCOSA ANHIDRA O GLUCOSA 5 G O GLUCOSA MONOHIDRATADA EQUIVALENTE A 5.0 G DE GLUCOSA ENVASE CON 1 000 ML. CONTIENE: GLUCOSA 50.0 G.,ENV,1000,ML.,5,gramos,5,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
947,Grupo Nº 21: Soluciones Electrolíticas y Sustitutos del Plasma,GLUCOSA,3604,3604,1000036040000,010,000,3604,00,00,SI,"Sustantiva -- macro soluciones,Uso Hospitalario, Soluciones Electrolíticas y Sustitutos del Plasma",GLUCOSA SOLUCION INYECTABLE AL 10% CADA 100 ML CONTIENEN: GLUCOSA ANHIDRA O GLUCOSA 10 G O GLUCOSA MONOHIDRATADA EQUIVALENTE A 10.0 G DE GLUCOSA ENVASE CON 500 ML. CONTIENE: GLUCOSA 50.0 G,ENV,500,ML.,10,gramos,10,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
948,Grupo Nº 21: Soluciones Electrolíticas y Sustitutos del Plasma,GLUCOSA,3605,3605,1000036050000,010,000,3605,00,00,SI,"Sustantiva -- macro soluciones,Uso Hospitalario, Soluciones Electrolíticas y Sustitutos del Plasma",GLUCOSA SOLUCION INYECTABLE AL 10% CADA 100 ML CONTIENEN: GLUCOSA ANHIDRA O  GLUCOSA 10 G O GLUCOSA MONOHIDRATADA EQUIVALENTE A 10.0 G DE GLUCOSA ENVASE  CON 1 000 ML. CONTIENE: GLUCOSA 100.0 G.,ENV,1000,ML.,10,gramos,10,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
949,Grupo Nº 21: Soluciones Electrolíticas y Sustitutos del Plasma,GLUCOSA,3606,3606,1000036060000,010,000,3606,00,00,SI,"Sustantiva -- macro soluciones,Uso Hospitalario, Soluciones Electrolíticas y Sustitutos del Plasma",GLUCOSA SOLUCION INYECTABLE AL 50 % CADA 100 ML CONTIENEN: GLUCOSA ANHIDRA O  GLUCOSA 50 G AGUA INYECTABLE 100 ML O GLUCOSA MONOHIDRATADA EQUIVALENTE A 50 G  DE GLUCOSA ENVASE CON 250 ML. CONTIENE: GLUCOSA 125 G.,ENV,250,ML.,50,gramos,50,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
950,Grupo Nº 21: Soluciones Electrolíticas y Sustitutos del Plasma,GLUCOSA,3607,3607,1000036070000,010,000,3607,00,00,SI,"Sustantiva -- macro soluciones,Uso Hospitalario, Soluciones Electrolíticas y Sustitutos del Plasma",GLUCOSA SOLUCION INYECTABLE AL 50% CADA 100 ML CONTIENEN: GLUCOSA ANHIDRA O  GLUCOSA 50 G O GLUCOSA MONOHIDRATADA EQUIVALENTE A 50.0 G DE GLUCOSA ENVASE  CON 50 ML. CONTIENE: GLUCOSA 25.0 G.,ENV,1,ENV,50,gramos,50,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
951,Grupo Nº 21: Soluciones Electrolíticas y Sustitutos del Plasma,CLORURO DE SODIO,3608,3608,1000036080000,010,000,3608,00,00,SI,"Sustantiva -- macro soluciones,Uso Hospitalario, Soluciones Electrolíticas y Sustitutos del Plasma",CLORURO DE SODIO SOLUCION INYECTABLE AL 0.9% CADA 100 ML CONTIENEN: CLORURO DE  SODIO 0.9 G AGUA INYECTABLE 100 ML ENVASE CON 250 ML. CONTIENE: SODIO 38.5  MILIEQUIVALENTES CLORURO 38.5 MILIEQUIVALENTES.,ENV,250,ML.,0.9,gramos,0.9,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
952,Grupo Nº 21: Soluciones Electrolíticas y Sustitutos del Plasma,CLORURO DE SODIO,3609,3609,1000036090000,010,000,3609,00,00,SI,"Sustantiva -- macro soluciones,Uso Hospitalario, Soluciones Electrolíticas y Sustitutos del Plasma",CLORURO DE SODIO SOLUCION INYECTABLE AL 0.9% CADA 100 ML CONTIENEN: CLORURO DE  SODIO 0.9 G AGUA INYECTABLE 100 ML ENVASE CON 500 ML. CONTIENE: SODIO 77  MILIEQUIVALENTES. CLORURO 77 MILIEQUIVALENTES.,ENV,500,ML.,0.9,gramos,0.9,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
953,Grupo Nº 21: Soluciones Electrolíticas y Sustitutos del Plasma,CLORURO DE SODIO,3610,3610,1000036100000,010,000,3610,00,00,SI,Sustantiva -- macro soluciones,CLORURO DE SODIO SOLUCION INYECTABLE AL 0.9% CADA 100 ML CONTIENEN: CLORURO DE  SODIO 0.9 G AGUA INYECTABLE 100 ML ENVASE CON 1 000 ML. CONTIENE: SODIO 154  MILIEQUIVALENTES CLORURO 154 MILIEQUIVALENTES.,ENV,1000,ML.,0.9,gramos,0.9,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
954,Grupo Nº 21: Soluciones Electrolíticas y Sustitutos del Plasma,CLORURO DE SODIO Y GLUCOSA,3611,3611,1000036110000,010,000,3611,00,00,SI,"Sustantiva -- macro soluciones,Uso Hospitalario, Soluciones Electrolíticas y Sustitutos del Plasma",CLORURO DE SODIO Y GLUCOSA SOLUCION INYECTABLE CADA 100 ML CONTIENEN: CLORURO  DE SODIO 0.9 G GLUCOSA ANHIDRA O GLUCOSA 5.0 G O GLUCOSA MONOHIDRATADA  EQUIVALENTE A 5.0 G DE GLUCOSA ENVASE CON 250 ML. CONTIENE: SODIO 38.5,ENV,250,ML.,5.9,gramos,5.9,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
955,Grupo Nº 21: Soluciones Electrolíticas y Sustitutos del Plasma,CLORURO DE SODIO Y GLUCOSA,3612,3612,1000036120000,010,000,3612,00,00,SI,"Sustantiva -- macro soluciones,Uso Hospitalario, Soluciones Electrolíticas y Sustitutos del Plasma",CLORURO DE SODIO Y GLUCOSA SOLUCION INYECTABLE CADA 100 ML CONTIENEN: CLORURO  DE SODIO 0.9 G GLUCOSA ANHIDRA O GLUCOSA 5.0 G O GLUCOSA MONOHIDRATADA  EQUIVALENTE A 5.0 G DE GLUCOSA ENVASE CON 500 ML. CONTIENE: SODIO 77 MEQ,ENV,500,ML.,5.9,gramos,5.9,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
956,Grupo Nº 21: Soluciones Electrolíticas y Sustitutos del Plasma,CLORURO DE SODIO Y GLUCOSA,3613,3613,1000036130000,010,000,3613,00,00,SI,"Sustantiva -- macro soluciones,Uso Hospitalario, Soluciones Electrolíticas y Sustitutos del Plasma",CLORURO DE SODIO Y GLUCOSA SOLUCION INYECTABLE CADA 100 ML CONTIENEN: CLORURO  DE SODIO 0.9 G GLUCOSA ANHIDRA O GLUCOSA 5.0 G O GLUCOSA MONOHIDRATADA  EQUIVALENTE A 5.0 G DE GLUCOSA. ENVASE CON 1 000 ML. CONTIENE: SODIO 154.0 MEQ,ENV,1000,ML.,5.9,gramos,5.9,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
957,Grupo Nº 21: Soluciones Electrolíticas y Sustitutos del Plasma,SOLUCIÓN HARTMANN,3614,3614,1000036140000,010,000,3614,00,00,SI,"Sustantiva -- macro soluciones,Uso Hospitalario, Soluciones Electrolíticas y Sustitutos del Plasma",SOLUCION HARTMANN. SOLUCION INYECTABLE. CADA 100 ML CONTIENEN: CLORURO DE SODIO  0.600 G CLORURO DE POTASIO 0.030 G CLORURO DE CALCIO DIHIDRATADO 0.020 G  LACTATO DE SODIO 0.310 G. ENVASE CON 250 ML. MILIEQUIVALENTES POR LITRO: SODIO,ENV,250,ML.,0.36,gramos,0.36,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
958,Grupo Nº 21: Soluciones Electrolíticas y Sustitutos del Plasma,SOLUCIÓN HARTMANN,3615,3615,1000036150000,010,000,3615,00,00,SI,"Sustantiva -- macro soluciones,Uso Hospitalario, Soluciones Electrolíticas y Sustitutos del Plasma",SOLUCION HARTMANN. SOLUCION INYECTABLE. CADA 100 ML CONTIENEN: CLORURO DE SODIO  0.600 G CLORURO DE POTASIO 0.030 G CLORURO DE CALCIO DIHIDRATADO 0.020 G  LACTATO DE SODIO 0.310 G. ENVASE CON 500 ML. MILIEQUIVALENTES POR LITRO: SODIO,ENV,500,ML.,0.36,gramos,0.36,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
959,Grupo Nº 21: Soluciones Electrolíticas y Sustitutos del Plasma,SOLUCIÓN HARTMANN,3616,3616,1000036160000,010,000,3616,00,00,SI,"Sustantiva -- macro soluciones,Uso Hospitalario, Soluciones Electrolíticas y Sustitutos del Plasma",SOLUCION HARTMANN. SOLUCION INYECTABLE. CADA 100 ML CONTIENEN: CLORURO DE SODIO  0.600 G CLORURO DE POTASIO 0.030 G CLORURO DE CALCIO DIHIDRATADO 0.020 G  LACTATO DE SODIO 0.310 G. ENVASE CON 1000 ML. MILIEQUIVALENTES POR LITRO:,ENV,1000,ML.,0.36,gramos,0.36,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
960,Grupo Nº 21: Soluciones Electrolíticas y Sustitutos del Plasma,FOSFATO DE POTASIO,3617,3617,1000036170000,010,000,3617,00,00,SI,"Sustantiva -- macro soluciones,Uso Hospitalario, Soluciones Electrolíticas y Sustitutos del Plasma",FOSFATO DE POTASIO SOLUCION INYECTABLE CADA AMPOLLETA CONTIENE: FOSFATO DE  POTASIO DIBASICO 1.550 G FOSFATO DE POTASIO MONOBASICO 0.300 G (POTASIO 20  MILIEQUIVALENTE) (FOSFATO 20 MEQ) ENVASE CON 50 AMPOLLETAS CON 10 ML.,ENV,50,AMP,1.85,gramos,92.5,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
961,Grupo Nº 21: Soluciones Electrolíticas y Sustitutos del Plasma,BICARBONATO DE SODIO,3618,3618,1000036180000,010,000,3618,00,00,SI,"Sustantiva -- macro soluciones,Uso Hospitalario, Soluciones Electrolíticas y Sustitutos del Plasma",BICARBONATO DE SODIO SOLUCION INYECTABLE AL 7.5% CADA FRASCO AMPULA CONTIENE:  BICARBONATO DE SODIO 3.75 G ENVASE CON FRASCO AMPULA DE 50 ML. EL ENVASE CON  50 ML CONTIENE: BICARBONATO DE SODIO 44.5 MILIEQUIVALENTE.,ENV,1,F.A,3.75,gramos,3.75,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
962,Grupo Nº 21: Soluciones Electrolíticas y Sustitutos del Plasma,BICARBONATO DE SODIO,3619,3619,1000036190000,010,000,3619,00,00,SI,"Sustantiva -- macro soluciones,Uso Hospitalario, Soluciones Electrolíticas y Sustitutos del Plasma",BICARBONATO DE SODIO SOLUCION INYECTABLE AL 7.5% CADA AMPOLLETA CONTIENE:  BICARBONATO DE SODIO 0.75 G ENVASE CON 50 AMPOLLETAS DE 10 ML. CADA AMPOLLETA  CON 10 ML CONTIENE: BICARBONATO DE SODIO 8.9 MILIEQUIVALENTE.,ENV,50,AMP,3.75,gramos,187.5,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
963,Grupo Nº 21: Soluciones Electrolíticas y Sustitutos del Plasma,GLUCONATO DE CALCIO,3620,3620,1000036200000,010,000,3620,00,00,SI,"Sustantiva -- macro soluciones,Uso Hospitalario, Soluciones Electrolíticas y Sustitutos del Plasma,Uso Hospitalario, Soluciones Electrolíticas y Sustitutos del Plasma",GLUCONATO DE CALCIO SOLUCION INYECTABLE CADA AMPOLLETA CONTIENE: GLUCONATO DE  CALCIO 1 G EQUIVALENTE A 0.093 G DE CALCIO IONIZABLE. ENVASE CON 50 AMPOLLETAS  DE 10 ML.,ENV,50,AMP,1,gramos,50,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
964,Grupo Nº 21: Soluciones Electrolíticas y Sustitutos del Plasma,GLUCONATO DE CALCIO,3620,3620,1000036200100,010,000,3620,01,00,NO,"Sustantiva -- macro soluciones,Uso Hospitalario, Soluciones Electrolíticas y Sustitutos del Plasma,Uso Hospitalario, Soluciones Electrolíticas y Sustitutos del Plasma",GLUCONATO DE CALCIO. SOLUCION INYECTABLE. CADA AMPOLLETA CONTIENE: GLUCONATO DE CALCIO 1 G EQUIVALENTE A 0.093 G DE CALCIO IONIZABLE. ENVASE CON 100 AMPOLLETAS DE 10 ML.,ENV,100,AMP,1,gramos,100,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
965,Grupo Nº 21: Soluciones Electrolíticas y Sustitutos del Plasma,ELECTROLITOS ORALES,3623,3623,1000036230000,010,000,3623,00,00,SI,"Sustantiva -- Meta médica,VALES",ELECTROLITOS ORALES SOLUCION CADA SOBRE CON POLVO CONTIENE: GLUCOSA 20.0 G  CLORURO DE POTASIO 1.5 G CLORURO DE SODIO 3.5 G CITRATO TRISODICO DIHIDRATADO  2.9 G ENVASE CON 27.9 G.,ENV,1,PZA,27.9,gramos,27.9,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,ELECTROLITOS_ORALES,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
966,Grupo Nº 21: Soluciones Electrolíticas y Sustitutos del Plasma,GLUCOSA,3624,3624,1000036240000,010,000,3624,00,00,SI,"Sustantiva -- macro soluciones,Uso Hospitalario, Soluciones Electrolíticas y Sustitutos del Plasma",GLUCOSA SOLUCION INYECTABLE AL 5% CADA 100 ML CONTIENEN: GLUCOSA ANHIDRA O  GLUCOSA 5 G O GLUCOSA MONOHIDRATADA EQUIVALENTE A 5.0 G DE GLUCOSA. ENVASE CON  50 ML. CONTIENE: GLUCOSA 2.5 G.,ENV,50,ML.,5,gramos,5,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
967,Grupo Nº 21: Soluciones Electrolíticas y Sustitutos del Plasma,GLUCOSA,3625,3625,1000036250000,010,000,3625,00,00,SI,"Sustantiva -- macro soluciones,Uso Hospitalario, Soluciones Electrolíticas y Sustitutos del Plasma",GLUCOSA SOLUCION INYECTABLE AL 5% CADA 100 ML CONTIENEN: GLUCOSA ANHIDRA O  GLUCOSA 5 G O GLUCOSA MONOHIDRATADA EQUIVALENTE A 5.0 G DE GLUCOSA. ENVASE CON  100 ML. CONTIENE: GLUCOSA 5.0 G.,ENV,1,ENV,5,gramos,5,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
968,Grupo Nº 21: Soluciones Electrolíticas y Sustitutos del Plasma,CLORURO DE SODIO,3626,3626,1000036260000,010,000,3626,00,00,SI,"Sustantiva -- macro soluciones,Uso Hospitalario, Soluciones Electrolíticas y Sustitutos del Plasma",CLORURO DE SODIO SOLUCION INYECTABLE AL 0.9% CADA 100 ML CONTIENEN: CLORURO DE  SODIO 0.9 G AGUA INYECTABLE 100 ML ENVASE CON 50 ML.,ENV,50,ML.,0.9,gramos,0.9,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
969,Grupo Nº 21: Soluciones Electrolíticas y Sustitutos del Plasma,CLORURO DE SODIO,3627,3627,1000036270000,010,000,3627,00,00,SI,"Sustantiva -- macro soluciones,Uso Hospitalario, Soluciones Electrolíticas y Sustitutos del Plasma",CLORURO DE SODIO SOLUCION INYECTABLE AL 0.9% CADA 100 ML CONTIENEN: CLORURO DE  SODIO 0.9 G AGUA INYECTABLE 100 ML ENVASE CON 100 ML.,ENV,1,ENV,0.9,gramos,0.9,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
970,Grupo Nº 21: Soluciones Electrolíticas y Sustitutos del Plasma,MAGNESIO SULFATO DE,3629,3629,1000036290000,010,000,3629,00,00,SI,"Sustantiva -- macro soluciones,Uso Hospitalario, Soluciones Electrolíticas y Sustitutos del Plasma",MAGNESIO SULFATO DE SOLUCION INYECTABLE CADA AMPOLLETA CONTIENE: SULFATO DE  MAGNESIO 1G (MAGNESIO 8.1 MILIEQUIVALENTE SULFATO 8.1 MILIEQUIVALENTE) ENVASE  CON 100 AMPOLLETAS DE 10 ML CON 1 G (100 MG/1 ML).,ENV,100,AMP,1,gramos,100,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
971,Grupo Nº 21: Soluciones Electrolíticas y Sustitutos del Plasma,GLUCOSA,3630,3630,1000036300000,010,000,3630,00,00,SI,"Sustantiva -- macro soluciones,Uso Hospitalario, Soluciones Electrolíticas y Sustitutos del Plasma",GLUCOSA SOLUCION INYECTABLE AL 5 % CADA 100 ML CONTIENE: GLUCOSA ANHIDRA  OGLUCOSA 5 G O GLUCOSA MONOHIDRATADA EQUIVALENTE A 5.0 G DE GLUCOSA. ENVASE  CON 500 ML. CONTIENE: GLUCOSA 25.0 G.,ENV,500,ML.,5,gramos,5,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
972,Grupo Nº 21: Soluciones Electrolíticas y Sustitutos del Plasma,GLUCOSA,3631,3631,1000036310000,010,000,3631,00,00,SI,"Sustantiva -- macro soluciones,Uso Hospitalario, Soluciones Electrolíticas y Sustitutos del Plasma",GLUCOSA SOLUCION INYECTABLE AL 5% CADA 100 ML CONTIENEN: GLUCOSA ANHIDRA O  GLUCOSA 5 G O GLUCOSA MONOHIDRATADA EQUIVALENTE A 5 G DE GLUCOSA ENVASE CON  BOLSA DE 50 ML Y ADAPTADOR PARA VIAL.,ENV,1,ENV,5,gramos,5,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
973,Grupo Nº 21: Soluciones Electrolíticas y Sustitutos del Plasma,GLUCOSA,3632,3632,1000036320000,010,000,3632,00,00,SI,"Sustantiva -- macro soluciones,Uso Hospitalario, Soluciones Electrolíticas y Sustitutos del Plasma",GLUCOSA SOLUCION INYECTABLE AL 5% CADA 100 ML CONTIENEN: GLUCOSA ANHIDRA O  GLUCOSA 5 G O GLUCOSA MONOHIDRATADA EQUIVALENTE A 5 G DE GLUCOSA ENVASE CON  BOLSA DE 100 ML Y ADAPTADOR PARA VIAL.,ENV,1,ENV,5,gramos,5,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
974,Grupo Nº 21: Soluciones Electrolíticas y Sustitutos del Plasma,CLORURO DE SODIO,3633,3633,1000036330000,010,000,3633,00,00,SI,"Sustantiva -- macro soluciones,Uso Hospitalario, Soluciones Electrolíticas y Sustitutos del Plasma",CLORURO DE SODIO AL 0.9% SOLUCION INYECTABLE CADA 100 ML CONTIENEN: CLORURO DE SODIO 900 MG AGUA INYECTABLE 100 ML ENVASE CON BOLSA DE 50 ML Y ADAPTADOR PARA VIAL.,ENV,1,ENV,900,miligramos,900,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
975,Grupo Nº 21: Soluciones Electrolíticas y Sustitutos del Plasma,CLORURO DE SODIO,3633,3633,1000036330002,010,000,3633,00,02,NO,"Sustantiva -- macro soluciones,Uso Hospitalario, Soluciones Electrolíticas y Sustitutos del Plasma",CLORURO DE SODIO SOLUCION INYECTABLE CADA 100 ML CONTIENEN: CLORURO DE SODIO 900 MG AGUA INYECTABLE 100 ML ENVASE CON BOLSA DE 50 ML Y ADAPTADOR PARA VIAL.,ENV,1,ENV,900,miligramos,900,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
976,Grupo Nº 21: Soluciones Electrolíticas y Sustitutos del Plasma,CLORURO DE SODIO,3634,3634,1000036340000,010,000,3634,00,00,SI,"Sustantiva -- macro soluciones,Uso Hospitalario, Soluciones Electrolíticas y Sustitutos del Plasma",CLORURO DE SODIO AL 0.9% SOLUCION INYECTABLE CADA 100 ML CONTIENEN: CLORURO DE SODIO 900 MG AGUA INYECTABLE 100 ML ENVASE CON BOLSA DE 100 ML Y ADAPTADOR PARA VIAL.,ENV,1,ENV,900,miligramos,900,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
977,Grupo Nº 21: Soluciones Electrolíticas y Sustitutos del Plasma,CLORURO DE SODIO,3634,3634,1000036340002,010,000,3634,00,02,NO,"Sustantiva -- macro soluciones,Uso Hospitalario, Soluciones Electrolíticas y Sustitutos del Plasma",CLORURO DE SODIO SOLUCION INYECTABLE CADA 100 ML CONTIENEN: CLORURO DE SODIO 900 MG AGUA INYECTABLE 100 ML ENVASE CON BOLSA DE 100 ML Y ADAPTADOR PARA VIAL.,ENV,1,ENV,900,miligramos,900,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
978,Grupo Nº 21: Soluciones Electrolíticas y Sustitutos del Plasma,POLIGELINA,3661,3661,1000036610000,010,000,3661,00,00,SI,"Sustantiva -- macro soluciones,Uso Hospitalario, Soluciones Electrolíticas y Sustitutos del Plasma",POLIGELINA SOLUCION INYECTABLE CADA 100 ML CONTIENEN: POLIGELINA 3.5 G ENVASE  CON 500 ML CON O SIN EQUIPO PARA SU ADMINISTRACION.,ENV,500,ML.,3.5,gramos,3.5,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
979,Grupo Nº 21: Soluciones Electrolíticas y Sustitutos del Plasma,SEROALBÚMINA HUMANA O ALBÚMINA HUMANA,3662,3662,1000036620000,010,000,3662,00,00,SI,"Sustantiva -- macro soluciones,Uso Hospitalario, Soluciones Electrolíticas y Sustitutos del Plasma","SEROALBUMINA HUMANA O ALBUMINA HUMANA. SOLUCION INYECTABLE, CADA ENVASE  CONTIENE: SEROALBUMINA HUMANA O ALBUMINA HUMANA 12.5 G. ENVASE CON 50 ML",ENV,1,F.A,12.5,gramos,12.5,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
980,Grupo Nº 21: Soluciones Electrolíticas y Sustitutos del Plasma,ALMIDÓN,3663,3663,1000036630000,010,000,3663,00,00,NO,"Sustantiva -- macro soluciones,Uso Hospitalario, Soluciones Electrolíticas y Sustitutos del Plasma,Uso Hospitalario, Soluciones Electrolíticas y Sustitutos del Plasma",ALMIDON. SOLUCIÓN INYECTABLE AL 10%. CADA 100 ML CONTIENEN: POLI (0-2 HIDROXIETIL) ALMIDÓN O PENTALMIDÓN O HIDROXIETIL ALMIDON (200/0.5) 10 G ENVASE CON 250 ML.,ENV,250,ML.,10,gramos,10,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
981,Grupo Nº 21: Soluciones Electrolíticas y Sustitutos del Plasma,ALMIDÓN,3663,3663,1000036630100,010,000,3663,01,00,SI,"Sustantiva -- macro soluciones,Uso Hospitalario, Soluciones Electrolíticas y Sustitutos del Plasma,Uso Hospitalario, Soluciones Electrolíticas y Sustitutos del Plasma",ALMIDON SOLUCIÓN INYECTABLE AL 10%. CADA 100 ML CONTIENEN: POLI (0-2  HIDROXIETIL) ALMIDÓN O PENTALMIDÓN O HIDROXIETIL ALMIDON (200/0.5) 10 G ENVASE  CON 500 ML.,ENV,500,ML.,10,gramos,10,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
982,Grupo Nº 21: Soluciones Electrolíticas y Sustitutos del Plasma,POLIGELINA,3664,3664,1000036640000,010,000,3664,00,00,SI,"Sustantiva -- macro soluciones,Uso Hospitalario, Soluciones Electrolíticas y Sustitutos del Plasma",POLIMERIZADO DE GELATINA SOLUCION INYECTABLE CADA 100 ML CONTIENEN: POLIMERIZADO DE GELATINA SUCCINILADA DEGRADADA 4.0 G ENVASE CON 500 ML,ENV,1,ENV,40,gramos,40,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
983,Grupo Nº 21: Soluciones Electrolíticas y Sustitutos del Plasma,POLIGELINA,3664,3664,1000036640002,010,000,3664,00,02,NO,"Sustantiva -- macro soluciones,Uso Hospitalario, Soluciones Electrolíticas y Sustitutos del Plasma",POLIGELINA SOLUCION INYECTABLE CADA 100 ML CONTIENEN: POLIMERIZADO DE GELATINA SUCCINILADA DEGRADADA 4.0 G. ENVASE CON 500 ML.,ENV,500,ML.,500,mililitros,500,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
984,Grupo Nº 21: Soluciones Electrolíticas y Sustitutos del Plasma,ALMIDÓN,3666,3666,1000036660000,010,000,3666,00,00,NO,"Sustantiva -- macro soluciones,Uso Hospitalario, Soluciones Electrolíticas y Sustitutos del Plasma,Uso Hospitalario, Soluciones Electrolíticas y Sustitutos del Plasma","ALMIDÓN. SOLUCIÓN INYECTABLE AL 6%. CADA 100 ML CONTIENEN: POLI-(O-2 HIDROXIETIL)-ALMIDÓN (130,000 DALTONS) O HIDROXIETIL ALMIDÓN (130/0.4) 6 G. ENVASE CON 250 ML.",ENV,250,ML.,250,mililitros,250,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
985,Grupo Nº 21: Soluciones Electrolíticas y Sustitutos del Plasma,ALMIDÓN,3666,3666,1000036660100,010,000,3666,01,00,SI,"Sustantiva -- macro soluciones,Uso Hospitalario, Soluciones Electrolíticas y Sustitutos del Plasma,Uso Hospitalario, Soluciones Electrolíticas y Sustitutos del Plasma","ALMIDON SOLUCIÓN INYECTABLE AL 6 % CADA 100 ML CONTIENEN: POLI-(O-2  HIDROXIETIL)-ALMIDÓN (130,000 DALTONS) O HIDROXIETIL ALMIDON (130/0.4) 6 G  ENVASE CON 500 ML.",ENV,500,ML.,6,gramos,6,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
986,Grupo Nº 21: Soluciones Electrolíticas y Sustitutos del Plasma,CLORURO DE SODIO,3671,3671,1000036710000,010,000,3671,00,00,SI,"Sustantiva -- macro soluciones,Uso Hospitalario, Soluciones Electrolíticas y Sustitutos del Plasma",CLORURO DE SODIO SOLUCION INYECTABLE 0.9% CADA AMPOLLETA DE 10 ML CONTIENE:  CLORURO DE SODIO 0.09 G (SODIO 1.54 MEQ) (CLORURO 1.54 MEQ) ENVASE CON 100  AMPOLLETAS DE 10 ML.,ENV,100,AMP,0.09,gramos,9,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
987,Grupo Nº 21: Soluciones Electrolíticas y Sustitutos del Plasma,AGUA INYECTABLE,3673,3673,1000036730000,010,000,3673,00,00,SI,"Sustantiva,Uso Hospitalario, Soluciones Electrolíticas y Sustitutos del Plasma",AGUA INYECTABLE SOLUCION INYECTABLE CADA AMPOLLETA CONTIENE: AGUA INYECTABLE 5  ML ENVASE CON 100 AMPOLLETAS CON 5 ML.,ENV,100,AMP,5,mililitros,500,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
988,Grupo Nº 21: Soluciones Electrolíticas y Sustitutos del Plasma,AGUA INYECTABLE,3674,3674,1000036740000,010,000,3674,00,00,SI,"Sustantiva,Uso Hospitalario, Soluciones Electrolíticas y Sustitutos del Plasma",AGUA INYECTABLE SOLUCION INYECTABLE CADA AMPOLLETA CONTIENE: AGUA INYECTABLE 10  ML ENVASE CON 100 AMPOLLETAS CON 10 ML.,ENV,100,AMP,10,mililitros,1000,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
989,Grupo Nº 21: Soluciones Electrolíticas y Sustitutos del Plasma,AGUA INYECTABLE,3675,3675,1000036750000,010,000,3675,00,00,SI,"Sustantiva -- macro soluciones,Uso Hospitalario, Soluciones Electrolíticas y Sustitutos del Plasma",AGUA INYECTABLE SOLUCION INYECTABLE CADA ENVASE CONTIENE: AGUA INYECTABLE 500  ML ENVASE CON 500 ML.,ENV,500,ML.,500,mililitros,500,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1253,Grupo Nº 21: Soluciones Electrolíticas y Sustitutos del Plasma,SEROALBÚMINA HUMANA O ALBÚMINA HUMANA,4552,4552,1000045520000,010,000,4552,00,00,SI,"Sustantiva,Uso Hospitalario, Soluciones Electrolíticas y Sustitutos del Plasma",SEROALBUMINA HUMANA O ALBUMINA HUMANA. SOLUCION INYECTABLE. CADA ENVASE CONTIENE: SEROALBUMINA HUMANA O ALBUMINA HUMANA 10 G. ENVASE CON 50 ML.,ENV,1,ENV,10,gramos,10,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
272,"Grupo Nº 22: Vacunas, Toxoides, Inmunoglobulinas, Antitoxinas",VACUNA ANTINEUMOCÓCCICA,145,0145,2000001450001,020,000,0145,00,01,NO,,"VACUNA ANTINEUMOCOCCICA. SUSPENSION INYECTABLE. CADA DOSIS DE 0.5 MILILITROS CONTIENEN: SACARIDOS DEL ANTIGENO CAPSULAR DEL STREPTOCOCCUS PNEUMONIAE, SEROTIPOS 4, 2 MICROGRAMOS; 9V, 2 MICROGRAMOS; 14, 2 MICROGRAMOS; 18C, 2",ENV,1,F.A,0.5,mililitros,0.5,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
273,"Grupo Nº 22: Vacunas, Toxoides, Inmunoglobulinas, Antitoxinas",VACUNA ANTINEUMOCÓCCICA,145,0145,2000001450101,020,000,0145,01,01,NO,,"VACUNA ANTINEUMOCOCCICA. SUSPENSION INYECTABLE. CADA DOSIS DE 0.5 ML CONTIENEN: SACARIDOS DEL ANTIGENO CAPSULAR DEL STREPTOCOCCUS PNEUMONIAE, SEROTIPOS 4 2 MICROGRAMOS 9V 2 MICROGRAMOS 14 2 MICROGRAMOS 18C 2 MICROGRAMOS 19F 2",DSS,1,DSS,0.5,mililitros,0.5,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
274,"Grupo Nº 22: Vacunas, Toxoides, Inmunoglobulinas, Antitoxinas",VACUNA ANTINEUMOCÓCCICA,146,0146,2000001460000,020,000,0146,00,00,SI,,"VACUNA ANTINEUMOCOCCICA SOLUCION INYECTABLE CADA DOSIS DE 0.5 ML CONTIENE: POLIOSIDOS PURIFICADOS DEL STREPTOCOCCUS PNEUMONIAE SEROTIPOS 1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14,15B, 17F, 18C, 19A, 19F, 20, 22F, 23F Y",JGO,1,JGO,0.5,mililitros,0.5,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
275,"Grupo Nº 22: Vacunas, Toxoides, Inmunoglobulinas, Antitoxinas",VACUNA ANTINEUMOCÓCCICA,146,0146,2000001460100,020,000,0146,01,00,NO,,"VACUNA ANTINEUMOCOCCICA SOLUCION INYECTABLE CADA DOSIS DE 0.5 ML CONTIENE:  POLIOSIDOS PURIFICADOS DEL STREPTOCOCCUS PNEUMONIAE SEROTIPOS 1, 2, 3, 4, 5,  6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14,15B, 17F, 18C, 19A, 19F, 20, 22F, 23F Y",JGO,1,JGO,0.5,mililitros,0.5,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
276,"Grupo Nº 22: Vacunas, Toxoides, Inmunoglobulinas, Antitoxinas",VACUNA ANTINEUMOCÓCCICA,146,0146,2000001460200,020,000,0146,02,00,NO,,"VACUNA ANTINEUMOCOCCICA SOLUCION INYECTABLE CADA DOSIS DE 0.5 ML CONTIENE: POLIOSIDOS PURIFICADOS DEL STREPTOCOCCUS PNEUMONIAE SEROTIPOS 1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14,15B, 17F, 18C, 19A, 19F, 20, 22F, 23F Y",JGO,1,JGO,0.5,mililitros,0.5,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
277,"Grupo Nº 22: Vacunas, Toxoides, Inmunoglobulinas, Antitoxinas",VACUNA ANTINEUMOCÓCCICA CONJUGADA CON PROTEÍNA D DE HAEMOPHILUS INFLUENZAE NO TIPIFICABLE (NHTi),147,0147,2000001470002,020,000,0147,00,02,NO,,"VACUNA ANTINEUMOCOCCICA CONJUGADA CON PROTEINA D DE HAEMOPHILUS INFLUENZAE NO TIPIFICABLE (NHTI). SUSPENSION INYECTABLE. CADA DOSIS DE 0.5 ML CONTIENE: POLISACARIDOS DE STREPTOCOCCUS PNEUMONIAE SEROTIPOS 1, 5, 6B, 7F, 9V, 14, 23F",ENV,10,JGA,0.5,mililitros,5,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
278,"Grupo Nº 22: Vacunas, Toxoides, Inmunoglobulinas, Antitoxinas",VACUNA ANTINEUMOCÓCCICA CONJUGADA CON PROTEÍNA D DE HAEMOPHILUS INFLUENZAE NO TIPIFICABLE (NHTi),147,0147,2000001470101,020,000,0147,01,01,SI,,"VACUNA ANTINEUMOCOCCICA CONJUGADA CON PROTEINA D DE HAEMOPHILUS INFLUENZAE NO TIPIFICABLE (NHTI). SUSPENSION INYECTABLE. CADA DOSIS DE 0.5 ML CONTIENE: POLISACARIDOS DE STREPTOCOCCUS PNEUMONIAE SEROTIPOS 1, 5, 6B, 7F, 9V, 14, 23F",ENV,10,F.A,0.5,mililitros,5,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
279,"Grupo Nº 22: Vacunas, Toxoides, Inmunoglobulinas, Antitoxinas",VACUNA ANTINEUMOCÓCCICA CONJUGADA CON PROTEÍNA D DE HAEMOPHILUS INFLUENZAE NO TIPIFICABLE (NHTi),147,0147,2000001470201,020,000,0147,02,01,NO,,"VACUNA ANTINEUMOCOCCICA CONJUGADA CON PROTEINA D DE HAEMOPHILUS INFLUENZAE NO TIPIFICABLE (NHTI). SUSPENSION INYECTABLE. CADA DOSIS DE 0.5 ML CONTIENE: POLISACARIDOS DE STREPTOCOCCUS PNEUMONIAE SEROTIPOS 1, 5, 6B, 7F, 9V, 14, 23F",ENV,100,F.A,0.5,mililitros,50,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
280,"Grupo Nº 22: Vacunas, Toxoides, Inmunoglobulinas, Antitoxinas",VACUNA ANTINEUMOCÓCCICA CONJUGADA CON PROTEÍNA D DE HAEMOPHILUS INFLUENZAE NO TIPIFICABLE (NHTi),147,0147,2000001470301,020,000,0147,03,01,NO,,"VACUNA ANTINEUMOCOCCICA CONJUGADA CON PROTEINA D DE HAEMOPHILUS INFLUENZAE NO TIPIFICABLE (NHTI). SUSPENSION INYECTABLE. CADA DOSIS DE 0.5 ML CONTIENE: POLISACARIDOS DE STREPTOCOCCUS PNEUMONIAE SEROTIPOS 1, 5, 6B, 7F, 9V, 14, 23F",ENV,1,JGA,0.5,mililitros,0.5,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
281,"Grupo Nº 22: Vacunas, Toxoides, Inmunoglobulinas, Antitoxinas",VACUNA ANTINEUMOCÓCCICA CONJUGADA CON PROTEÍNA D DE HAEMOPHILUS INFLUENZAE NO TIPIFICABLE (NHTi),147,0147,2000001470400,020,000,0147,04,00,NO,,"VACUNA ANTINEUMOCOCCICA CONJUGADA CON PROTEINA D DE HAEMOPHILUS INFLUENZAE NO TIPIFICABLE (NHTI). SUSPENSION INYECTABLE. CADA DOSIS DE 0.5 ML CONTIENE: POLISACARIDOS DE STREPTOCOCCUS PNEUMONIAE SEROTIPOS 1, 5, 6B, 7F, 9V, 14, 23F",ENV,1,F.A,0.5,mililitros,0.5,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
282,"Grupo Nº 22: Vacunas, Toxoides, Inmunoglobulinas, Antitoxinas",VACUNA CONJUGADA NEUMOCÓCICA -VALENTE,148,0148,2000001480001,020,000,0148,00,01,NO,,VACUNA CONJUGADA NEUMOCOCICA 13-VALENTE. SUSPENSION INYECTABLE. CADA DOSIS DE 0.5 ML CONTIENE: SACARIDOS DE STREPTOCOCCUS PNEUMONIAE DE LOS SEROTIPOS 1 2.2 MICROGRAMOS. 3 2.2 MICROGRAMOS. 4 2.2 MICROGRAMOS. 5 2.2 MICROGRAMOS. 6A 2.2,ENV,1,JGA,0.5,mililitros,0.5,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
283,"Grupo Nº 22: Vacunas, Toxoides, Inmunoglobulinas, Antitoxinas",VACUNA CONJUGADA NEUMOCÓCICA -VALENTE,148,0148,2000001480101,020,000,0148,01,01,SI,,VACUNA CONJUGADA NEUMOCOCICA 13-VALENTE. SUSPENSION INYECTABLE. CADA DOSIS DE 0.5 ML CONTIENE: SACARIDOS DE STREPTOCOCCUS PNEUMONIAE DE LOS SEROTIPOS 1 2.2 MICROGRAMOS 3 2.2 MICROGRAMOS 4 2.2 MICROGRAMOS 5 2.2 MICROGRAMOS 6A 2.2,ENV,10,JGA,0.5,mililitros,5,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
284,"Grupo Nº 22: Vacunas, Toxoides, Inmunoglobulinas, Antitoxinas",VACUNA CONTRA ROTAVIRUS,150,0150,2000001500000,020,000,0150,00,00,SI,,VACUNA CONTRA ROTAVIRUS. SUSPENSION ORAL. CADA DOSIS DE 1.5 ML. CONTIENE:  ROTAVIRUS VIVO ATENUADO HUMANO CEPA RIX4414 NO MENOS DE 10 A LA SEIS DICC50.  ENVASE CON JERINGA PRELLENADA CON 1.5 ML.,ENV,1,JGA,1.5,mililitros,1.5,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
285,"Grupo Nº 22: Vacunas, Toxoides, Inmunoglobulinas, Antitoxinas",VACUNA CONTRA ROTAVIRUS,150,0150,2000001500100,020,000,0150,01,00,NO,,VACUNA CONTRA ROTAVIRUS. SUSPENSION ORAL. CADA DOSIS DE 1.5 ML. CONTIENE:  ROTAVIRUS VIVO ATENUADO HUMANO CEPA RIX4414 NO MENOS DE 10 A LA SEIS DICC50.  ENVASE CON TUBO DE PLASTICO CON 1.5 ML.,ENV,1,TBO,1.5,mililitros,1.5,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
286,"Grupo Nº 22: Vacunas, Toxoides, Inmunoglobulinas, Antitoxinas",VACUNA CONTRA ROTAVIRUS,150,0150,2000001500200,020,000,0150,02,00,NO,,VACUNA CONTRA ROTAVIRUS. SUSPENSION ORAL. CADA DOSIS DE 1.5 ML. CONTIENE:  ROTAVIRUS VIVO ATENUADO HUMANO CEPA RIX4414 NO MENOS DE 10 A LA SEIS DICC50.  ENVASE CON 10 JERINGAS PRELLENADAS CON 1.5 ML.,ENV,10,JGA,1.5,mililitros,15,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
287,"Grupo Nº 22: Vacunas, Toxoides, Inmunoglobulinas, Antitoxinas",VACUNA CONTRA ROTAVIRUS,150,0150,2000001500300,020,000,0150,03,00,NO,,VACUNA CONTRA ROTAVIRUS. SUSPENSION ORAL. CADA DOSIS DE 1.5 ML. CONTIENE:  ROTAVIRUS VIVO ATENUADO HUMANO CEPA RIX4414 NO MENOS DE 10 A LA SEIS DICC50.  ENVASE CON 10 TUBOS DE PLASTICO CON 1.5 ML.,ENV,10,TBO,1.5,mililitros,15,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
288,"Grupo Nº 22: Vacunas, Toxoides, Inmunoglobulinas, Antitoxinas",VACUNA CONTRA ROTAVIRUS,150,0150,2000001500400,020,000,0150,04,00,NO,,VACUNA CONTRA ROTAVIRUS. SUSPENSION ORAL. CADA DOSIS DE 1.5 ML. CONTIENE:  ROTAVIRUS VIVO ATENUADO HUMANO CEPA RIX4414 NO MENOS DE 10 A LA SEIS DICC50.  ENVASE CON 50 JERINGAS PRELLENADAS CON 1.5 ML.,ENV,50,JGA,1.5,mililitros,75,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
289,"Grupo Nº 22: Vacunas, Toxoides, Inmunoglobulinas, Antitoxinas",VACUNA CONTRA ROTAVIRUS,150,0150,2000001500500,020,000,0150,05,00,NO,,VACUNA CONTRA ROTAVIRUS. SUSPENSION ORAL. CADA DOSIS DE 1.5 ML. CONTIENE:  ROTAVIRUS VIVO ATENUADO HUMANO CEPA RIX4414 NO MENOS DE 10 A LA SEIS DICC50.  ENVASE CON 50 TUBOS DE PLASTICO CON 1.5 ML.,ENV,50,TBO,1.5,mililitros,75,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
290,"Grupo Nº 22: Vacunas, Toxoides, Inmunoglobulinas, Antitoxinas",VACUNA PENTAVALENTE CONTRA ROTAVIRUS,151,0151,2000001510001,020,000,0151,00,01,SI,,"VACUNA PENTAVALENTE CONTRA ROTAVIRUS. SUSPENSION. CADA DOSIS DE 2 ML CONTIENE: SEROTIPO REORDENADO G1 2.21 X 106 UI, SEROTIPO REORDENADO G2 2.84 X 106 UI, SEROTIPO REORDENADO G3 2.22 X 106 UI, SEROTIPO REORDENADO G4 2.04 X 106 UI,",ENV,1,ENV,2,mililitros,2,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
291,"Grupo Nº 22: Vacunas, Toxoides, Inmunoglobulinas, Antitoxinas",VACUNA PENTAVALENTE CONTRA ROTAVIRUS,152,0152,2000001520000,020,000,0152,00,00,SI,,"VACUNA PENTAVALENTE CONTRA ROTAVIRUS. SUSPENSION. CADA DOSIS DE 2 ML CONTIENE:  SEROTIPO REORDENADO G1 2.21 X 106 UI, SEROTIPO REORDENADO G2 2.84 X 106 UI,  SEROTIPO REORDENADO G3 2.22 X 106 UI, SEROTIPO REORDENADO G4 2.04 X 106 UI,",ENV,10,TBO,2,mililitros,20,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
292,"Grupo Nº 22: Vacunas, Toxoides, Inmunoglobulinas, Antitoxinas",VACUNA RECOMBINANTE CONTRA LA HEPATITIS B,2511,2511,2000025110000,020,000,2511,00,00,SI,,VACUNA RECOMBINANTE CONTRA HEPATITIS B SUSPENSION INYECTABLE CADA DOSIS DE 1 ML  CONTIENE: AGSHB 20 MICROGRAMOS ENVASE CON UN FRASCO AMPULA O JERINGA  PRELLENADA CON 1 ML.,ENV,1,DSS,1,mililitros,1,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
293,"Grupo Nº 22: Vacunas, Toxoides, Inmunoglobulinas, Antitoxinas","VACUNA ACELULAR ANTIPERTUSSIS, CON TOXOIDES DIFTÉRICO Y TETÁNICO ADSORBIDOS, CON VACUNA ANTIPOLIOMIELÍTICA INACTIVADA Y CON VACUNA CONJUGADA DE HAEMOPHILUS INFLUENZAE TIPO B",2522,2522,2000025220000,020,000,2522,00,00,NO,,"VACUNA ACELULAR ANTIPERTUSSIS, CON TOXOIDES DIFTERICO Y TETANICO ADSORBIDOS, CON VACUNA ANTIPOLIOMIELITICA INACTIVADA Y CON VACUNA CONJUGADA DE HAEMOPHILUS INFLUENZAE TIPO B. SUSPENSION INYECTABLE. CADA DOSIS DE 0.5 ML DE VACUNA",DSS,1,DSS,0.5,mililitros,0.5,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
294,"Grupo Nº 22: Vacunas, Toxoides, Inmunoglobulinas, Antitoxinas","VACUNA ACELULAR ANTIPERTUSSIS, CON TOXOIDES DIFTÉRICO Y TETÁNICO ADSORBIDOS, CON VACUNA ANTIPOLIOMIELÍTICA INACTIVADA Y CON VACUNA CONJUGADA DE HAEMOPHILUS INFLUENZAE TIPO B",2522,2522,2000025220100,020,000,2522,01,00,SI,,"VACUNA ACELULAR ANTIPERTUSSIS, CON TOXOIDES DIFTERICO Y TETANICO ADSORBIDOS, CON VACUNA ANTIPOLIOMIELITICA INACTIVADA Y CON VACUNA CONJUGADA DE HAEMOPHILUS INFLUENZAE TIPO B. SUSPENSION INYECTABLE. CADA DOSIS DE 0.5 ML DE VACUNA",ENV,20,DSS,0.5,mililitros,10,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
295,"Grupo Nº 22: Vacunas, Toxoides, Inmunoglobulinas, Antitoxinas","VACUNA ACELULAR ANTIPERTUSSIS, CON TOXOIDES DIFTÉRICO Y TETÁNICO ADSORBIDOS, CON VACUNA ANTIPOLIOMIELÍTICA INACTIVADA Y CON VACUNA CONJUGADA DE HAEMOPHILUS INFLUENZAE TIPO B",2522,2522,2000025220101,020,000,2522,01,01,NO,,"VACUNA ACELULAR ANTIPERTUSSIS, CON TOXOIDES DIFTERICO Y TETANICO ADSORBIDOS, CON VACUNA ANTIPOLIOMIELITICA INACTIVADA Y CON VACUNA CONJUGADA DE HAEMOPHILUS INFLUENZAE TIPO B. SUSPENSION INYECTABLE. CADA DOSIS DE 0.5 ML DE VACUNA",DSS,1,DSS,0.5,mililitros,0.5,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
296,"Grupo Nº 22: Vacunas, Toxoides, Inmunoglobulinas, Antitoxinas",VACUNA RECOMBINANTE CONTRA LA HEPATITIS B,2526,2526,2000025260000,020,000,2526,00,00,SI,,VACUNA RECOMBINANTE CONTRA HEPATITIS B SUSPENSION INYECTABLE CADA DOSIS DE 1 ML CONTIENE: AGSHB 20 MICROGRAMOS ENVASE CON UN FRASCO AMPULA CON 10 ML (10 DOSIS).,F.A,10,DSS,1,mililitros,10,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
297,"Grupo Nº 22: Vacunas, Toxoides, Inmunoglobulinas, Antitoxinas",VACUNA RECOMBINANTE CONTRA LA HEPATITIS B,2527,2527,2000025270002,020,000,2527,00,02,SI,,VACUNA RECOMBINANTE CONTRA LA HEPATITIS B. SUSPENSION INYECTABLE. CADA DOSIS DE 0.5 ML CONTIENE: ANTIGENO DE SUPERFICIE DEL VIRUS DE LA HEPATITIS B PURIFICADO DNA RECOMBINANTE 10 MICROGRAMOS. ENVASE CON JERINGA PRELLENADA CON 0.5 ML O,ENV,1,ENV,0.5,mililitros,0.5,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
298,"Grupo Nº 22: Vacunas, Toxoides, Inmunoglobulinas, Antitoxinas",INMUNOGLOBULINA ANTIHEPATITIS B,2528,2528,2000025280002,020,000,2528,00,02,NO,,"INMUNOGLOBULINA ANTIHEPATITIS B. SOLUCION INYECTABLE. CADA ML CONTIENE: PROTEINAS HUMANAS 100-170 MG. ANTICUERPOS PARA EL ANTIGENO DE LA HEPATITIS B, MINIMO 200 UI. ENVASE CON 1 AMPOLLETA DE 1 ML.",ENV,1,AMP,1,mililitros,1,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
299,"Grupo Nº 22: Vacunas, Toxoides, Inmunoglobulinas, Antitoxinas",INMUNOGLOBULINA ANTIHEPATITIS B,2528,2528,2000025280100,020,000,2528,01,00,SI,,"INMUNOGLOBULINA ANTIHEPATITIS B SOLUCION INYECTABLE. CADA ML CONTIENE:  PROTEINAS HUMANAS 100-170 MG ANTICUERPOS PARA EL ANTIGENO DE LA HEPATITIS B,  MINIMO 200 UI. ENVASE CON 1 AMPOLLETA DE 5 ML.",ENV,1,ENV,5,mililitros,5,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
300,"Grupo Nº 22: Vacunas, Toxoides, Inmunoglobulinas, Antitoxinas",VACUNA RECOMBINANTE CONTRA LA HEPATITIS B,2529,2529,2000025290002,020,000,2529,00,02,SI,,"VACUNA RECOMBINANTE CONTRA LA HEPATITIS B. SUSPENSION INYECTABLE. CADA DOSIS DE 0.5 ML CONTIENE: ANTIGENO DE SUPERFICIE DEL VIRUS DE LA HEPATITIS B PURIFICADO DNA RECOMBINANTE 5 MICROGRAMOS. ENVASE CON 1 FRASCO AMPULA CON DOSIS DE 0.5 ML,",ENV,1,F.A,0.5,mililitros,0.5,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
301,"Grupo Nº 22: Vacunas, Toxoides, Inmunoglobulinas, Antitoxinas",VACUNA RECOMBINANTE CONTRA LA HEPATITIS B,2529,2529,2000025290102,020,000,2529,01,02,NO,,VACUNA RECOMBINANTE CONTRA LA HEPATITIS B. SUSPENSION INYECTABLE. CADA DOSIS DE 0.5 ML CONTIENE: ANTIGENO DE SUPERFICIE DEL VIRUS DE LA HEPATITIS B PURIFICADO DNA RECOMBINANTE 5 MICROGRAMOS. ENVASE CON 10 FRASCOS AMPULA CON DOSIS DE 0.5,ENV,10,F.A,0.5,mililitros,5,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
302,"Grupo Nº 22: Vacunas, Toxoides, Inmunoglobulinas, Antitoxinas",VACUNA DOBLE VIRAL (SR) CONTRA SARAMPIÓN Y RUBÉOLA,3800,3800,2000038000000,020,000,3800,00,00,SI,,VACUNA DOBLE VIRAL (SR) CONTRA SARAMPION Y RUBEOLA SUSPENSION INYECTABLE CADA DOSIS DE 0.5 ML DE VACUNA RECONSTITUIDA CONTIENE: VIRUS ATENUADOS DEL SARAMPION CEPA EDMONSTON- ZAGREB (CULTIVADOS EN CELULAS DIPLOIDES HUMANAS) O,ENV,10,DSS,0.5,mililitros,5,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
303,"Grupo Nº 22: Vacunas, Toxoides, Inmunoglobulinas, Antitoxinas",VACUNA DOBLE VIRAL (SR) CONTRA SARAMPIÓN Y RUBÉOLA,3800,3800,2000038000002,020,000,3800,00,02,NO,,VACUNA DOBLE VIRAL (SR) CONTRA SARAMPION Y RUBEOLA SUSPENSION INYECTABLE CADA DOSIS DE 0.5 ML DE VACUNA RECONSTITUIDA CONTIENE: VIRUS ATENUADOS DEL SARAMPION CEPA EDMONSTON- ZAGREB (CULTIVADOS EN CELULAS DIPLOIDES HUMANAS) O CEPA ENDERS,ENV,10,DSS,0.5,mililitros,5,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
304,"Grupo Nº 22: Vacunas, Toxoides, Inmunoglobulinas, Antitoxinas",VACUNA BCG,3801,3801,2000038010000,020,000,3801,00,00,NO,,VACUNA BCG SUSPENSION INYECTABLE CADA DOSIS DE 0.1 ML DE LA SUSPENSION RECONSTITUIDA DE BACILOS ATENUADOS CONTIENE LA CEPA: FRANCESA 1173P2 200 000- 500 000 UFC O DANESA 1331 200 000-300 000 UFC O GLAXO* 1077 800 000-3 200 000,ENV,5,DSS,0.1,mililitros,0.5,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
305,"Grupo Nº 22: Vacunas, Toxoides, Inmunoglobulinas, Antitoxinas",VACUNA BCG,3801,3801,2000038010100,020,000,3801,01,00,SI,,VACUNA BCG SUSPENSION INYECTABLE CADA DOSIS DE 0.1 ML DE LA SUSPENSION RECONSTITUIDA DE BACILOS ATENUADOS CONTIENE LA CEPA: FRANCESA 1173P2 200 000- 500 000 UFC O DANESA 1331 200 000-300 000 UFC O GLAXO* 1077 800 000-3 200 000,ENV,10,DSS,0.1,mililitros,1,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
306,"Grupo Nº 22: Vacunas, Toxoides, Inmunoglobulinas, Antitoxinas",VACUNA BCG,3801,3801,2000038010103,020,000,3801,01,03,NO,,VACUNA BCG SUSPENSION INYECTABLE CADA DOSIS DE 0.1 ML DE LA SUSPENSION RECONSTITUIDA DE BACILOS ATENUADOS CONTIENE LA CEPA: FRANCESA 1173P2 200 000- 500 000 UFC O DANESA 1331 200 000-300 000 UFC O GLAXO* 1077 800 000-3 200 000,ENV,10,DSS,0.1,mililitros,1,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
307,"Grupo Nº 22: Vacunas, Toxoides, Inmunoglobulinas, Antitoxinas",VACUNA ANTIPOLIOMIELÍTICA BIVALENTE ORAL,3802,3802,2000038020003,020,000,3802,00,03,SI,,VACUNA ANTIPOLIOMIELITICA BIVALENTE ORAL. SUSPENSION DE VIRUS ATENUADOS CADA DOSIS DE 0.1 ML (DOS GOTAS) CONTIENE AL MENOS LOS POLIOVIRUS ATENUADOS: TIPO 1 NO MENOS DE 1 000 000 DICC 50. TIPO 3 NO MENOS DE 600 000 DICC 50. ENVASE,ENV,20,DSS,0.1,mililitros,2,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
308,"Grupo Nº 22: Vacunas, Toxoides, Inmunoglobulinas, Antitoxinas",VACUNA ANTIPOLIOMIELÍTICA BIVALENTE ORAL,3802,3802,2000038020105,020,000,3802,01,05,NO,,VACUNA ANTIPOLIOMIELITICA BIVALENTE ORAL. SUSPENSION DE VIRUS ATENUADOS. CADA DOSIS DE 0.1 ML (DOS GOTAS) CONTIENE AL MENOS LOS POLIOVIRUS ATENUADOS: TIPO I 1 000 000 DICC 50. TIPO III 600 000 DICC 50. TUBO DE PLASTICO DEPRESIBLE CON 25,TBO,25,DSS,0.1,mililitros,2.5,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
310,"Grupo Nº 22: Vacunas, Toxoides, Inmunoglobulinas, Antitoxinas",VACUNA ANTIPERTUSSIS CON TOXOIDES DIFTÉRICO Y TETÁNICO (DPT),3805,3805,2000038050000,020,000,3805,00,00,SI,,VACUNA ANTIPERTUSSIS CON TOXOIDES DIFTERICO Y TETANICO (DPT). SUSPENSION INYECTABLE. CADA DOSIS DE 0.5 ML CONTIENE: BORDETELLA PERTUSSIS NO MAS DE 16 UO. TOXOIDE DIFTERICO NO MAS DE 30 LF. TOXOIDE TETANICO NO MAS DE 25 LF. O,ENV,10,DSS,0.5,mililitros,5,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
311,"Grupo Nº 22: Vacunas, Toxoides, Inmunoglobulinas, Antitoxinas",VACUNA ANTIPERTUSSIS CON TOXOIDES DIFTÉRICO Y TETÁNICO (DPT),3805,3805,2000038050003,020,000,3805,00,03,NO,,VACUNA ANTIPERTUSSIS CON TOXOIDES DIFTERICO Y TETANICO (DPT). SUSPENSION INYECTABLE. * CADA DOSIS DE 0.5 ML CONTIENE: BORDETELLA PERTUSSIS NO MAS DE 16 UO. TOXOIDE DIFTERICO NO MAS DE 30 LF. TOXOIDE TETANICO NO MAS DE 25 LF. O **,ENV,10,DSS,0.5,mililitros,5,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
312,"Grupo Nº 22: Vacunas, Toxoides, Inmunoglobulinas, Antitoxinas",VACUNA ANTITIFOÍDICA INACTIVADA,3806,3806,2000038060000,020,000,3806,00,00,SI,,"VACUNA ANTITIFOIDICA INACTIVADA SUSPENSION INYECTABLE CADA ML CONTIENE: VACUNA  ANTITIFOIDICA CON 500 A 1 000 MILLONES DE CELULAS DE SALMONELLA TYPHI, MUERTAS  POR CALOR Y FENOL. ENVASE CON FRASCO AMPULA DE 5 ML. (10 DOSIS DE 0.5 ML).",F.A,10,DSS,5,mililitros,50,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
313,"Grupo Nº 22: Vacunas, Toxoides, Inmunoglobulinas, Antitoxinas","VACUNA DE REFUERZO CONTRA DIFTERIA, TÉTANOS Y TOSFERINA ACELULAR (Tdpa)",3808,3808,2000038080002,020,000,3808,00,02,SI,,"VACUNA DE REFUERZO CONTRA DIFTERIA, TETANOS Y TOSFERINA ACELULAR (TDPA). SUSPENSION INYECTABLE. CADA DOSIS DE 0.5 ML CONTIENE: TOXOIDE DIFTERICO NO MENOS DE 2 UI (2 O 2.5 LF) TOXOIDE TETANICO NO MENOS DE 20 UI (5 LF) TOXOIDE",ENV,1,JGA,0.5,mililitros,0.5,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
314,"Grupo Nº 22: Vacunas, Toxoides, Inmunoglobulinas, Antitoxinas","VACUNA DE REFUERZO CONTRA DIFTERIA, TÉTANOS Y TOSFERINA ACELULAR (Tdpa)",3808,3808,2000038080102,020,000,3808,01,02,NO,,"VACUNA DE REFUERZO CONTRA DIFTERIA, TETANOS Y TOSFERINA ACELULAR (TDPA). SUSPENSION INYECTABLE. CADA DOSIS DE 0.5 ML CONTIENE: TOXOIDE DIFTERICO NO MENOS DE 2 UI (2 O 2.5 LF) TOXOIDE TETANICO NO MENOS DE 20 UI (5 LF) TOXOIDE",ENV,10,JGA,0.5,mililitros,5,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
315,"Grupo Nº 22: Vacunas, Toxoides, Inmunoglobulinas, Antitoxinas","VACUNA DE REFUERZO CONTRA DIFTERIA, TÉTANOS Y TOSFERINA ACELULAR (Tdpa)",3808,3808,2000038080202,020,000,3808,02,02,NO,,"VACUNA DE REFUERZO CONTRA DIFTERIA, TETANOS Y TOSFERINA ACELULAR (TDPA). SUSPENSION INYECTABLE. CADA DOSIS DE 0.5 ML CONTIENE: TOXOIDE DIFTERICO NO MENOS DE 2 UI (2 O 2.5 LF) TOXOIDE TETANICO NO MENOS DE 20 UI (5 LF) TOXOIDE",ENV,1,F.A,0.5,mililitros,0.5,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
316,"Grupo Nº 22: Vacunas, Toxoides, Inmunoglobulinas, Antitoxinas","VACUNA DE REFUERZO CONTRA DIFTERIA, TÉTANOS Y TOSFERINA ACELULAR (Tdpa)",3808,3808,2000038080302,020,000,3808,03,02,NO,,"VACUNA DE REFUERZO CONTRA DIFTERIA, TETANOS Y TOSFERINA ACELULAR (TDPA). SUSPENSION INYECTABLE. CADA DOSIS DE 0.5 ML CONTIENE: TOXOIDE DIFTERICO NO MENOS DE 2 UI (2 O 2.5 LF) TOXOIDE TETANICO NO MENOS DE 20 UI (5 LF) TOXOIDE",ENV,5,DSS,0.5,mililitros,2.5,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
317,"Grupo Nº 22: Vacunas, Toxoides, Inmunoglobulinas, Antitoxinas","VACUNA DE REFUERZO CONTRA DIFTERIA, TÉTANOS Y TOSFERINA ACELULAR (Tdpa)",3808,3808,2000038080402,020,000,3808,04,02,NO,,"VACUNA DE REFUERZO CONTRA DIFTERIA, TETANOS Y TOSFERINA ACELULAR (TDPA). SUSPENSION INYECTABLE CADA DOSIS DE 0.5 ML CONTIENE: TOXOIDE DIFTERICO NO MENOS DE 2 UI (2 O 2.5 LF) TOXOIDE TETANICO NO MENOS DE 20 UI (5LF)TOXOIDE PERTUSSIS",ENV,10,F.A,0.5,mililitros,5,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
318,"Grupo Nº 22: Vacunas, Toxoides, Inmunoglobulinas, Antitoxinas",TOXOIDES TETÁNICO Y DIFTÉRICO(Td),3810,3810,2000038100000,020,000,3810,00,00,SI,,TOXOIDES TETANICO Y DIFTERICO (TD) SUSPENSION INYECTABLE POR FORMULACION DE PROCESO CADA DOSIS DE 0.5 ML CONTIENE: TOXOIDE DIFTERICO NO MAS DE 5 LF TOXOIDE TETANICO NO MAS DE 25 LF POR POTENCIA DE PRODUCTO TERMINADO CADA DOSIS,ENV,10,DSS,0.5,mililitros,5,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
319,"Grupo Nº 22: Vacunas, Toxoides, Inmunoglobulinas, Antitoxinas",TOXOIDES TETÁNICO Y DIFTÉRICO(Td),3810,3810,2000038100100,020,000,3810,01,00,NO,,TOXOIDES TETANICO Y DIFTERICO (TD) SUSPENSION INYECTABLE POR FORMULACION DE PROCESO CADA DOSIS DE 0.5 ML CONTIENE: TOXOIDE DIFTERICO NO MAS DE 5 LF TOXOIDE TETANICO NO MAS DE 25 LF O POR POTENCIA DE PRODUCTO TERMINADO CADA,ENV,10,JGA,0.5,mililitros,5,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
320,"Grupo Nº 22: Vacunas, Toxoides, Inmunoglobulinas, Antitoxinas",VACUNA ANTIRRÁBICA,3817,3817,2000038170002,020,000,3817,00,02,NO,,VACUNA ANTIRRABICA SOLUCION INYECTABLE CADA DOSIS DE 1 ML DE VACUNA RECONSTITUIDA CONTIENE: LIOFILIZADO DE VIRUS DE LA RABIA INACTIVADO (CEPA FLURY LEP- C25) CON POTENCIA >= 2.5 UI CULTIVADOS EN CELULAS EMBRIONARIAS DE POLLO.,JGO,1,DSS,1,mililitros,1,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
321,"Grupo Nº 22: Vacunas, Toxoides, Inmunoglobulinas, Antitoxinas",VACUNA ANTIRRÁBICA,3817,3817,2000038170102,020,000,3817,01,02,SI,,"VACUNA ANTIRRABICA SUSPENSION INYECTABLE CADA DOSIS DE 0.5 ML DE VACUNA RECONSTITUIDA CONTIENE: LIOFILIZADO DE VIRUS INACTIVADOS DE LA RABIA (CEPA WISTAR PM/WI 38-1503-3M) CON POTENCIA >= 2.5 UI, CULTIVADO EN CELULAS VERO.",JGO,1,DSS,0.5,mililitros,0.5,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
322,"Grupo Nº 22: Vacunas, Toxoides, Inmunoglobulinas, Antitoxinas",VACUNA ANTIRRÁBICA,3818,3818,2000038180000,020,000,3818,00,00,SI,,"VACUNA ANTIRRABICA SOLUCION INYECTABLE CADA FRASCO AMPULA CON LIOFILIZADO CONTIENE: PREPARADO EN CELULAS DIPLOIDES HUMANAS CEPA WISTAR PM/W1- 38-1503- 3M, CON POTENCIA IGUAL O MAYOR A 2.5 UI. ENVASE CON UN FRASCO AMPULA Y JERINGA",JGO,1,DSS,2.5,UI,2.5,UI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
323,"Grupo Nº 22: Vacunas, Toxoides, Inmunoglobulinas, Antitoxinas",VACUNA ATENUADA CONTRA VARICELA,3819,3819,2000038190000,020,000,3819,00,00,SI,,"VACUNA ATENUADA CONTRA VARICELA SOLUCION INYECTABLE CADA FRASCO AMPULA CON  LIOFILIZADO CONTIENE: VIRUS VIVOS ATENUADOS CULTIVADOS EN CELULAS DIPLOIDES  MRC-5, DERIVADAS DE LA CEPA OKA ORIGINAL. NO MENOS DE 1000 UFP ENVASE CON UN",ENV,1,ENV,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
324,"Grupo Nº 22: Vacunas, Toxoides, Inmunoglobulinas, Antitoxinas","VACUNA TRIPLE VIRAL (SRP) CONTRA SARAMPIÓN, RUBÉOLA Y PAROTIDITIS",3820,3820,2000038200000,020,000,3820,00,00,SI,,"VACUNA TRIPLE VIRAL (SRP) CONTRA SARAMPION, RUBEOLA Y PAROTIDITIS. SOLUCION  INYECTABLE. CADA DOSIS DE 0.5 ML DE VACUNA RECONSTITUIDA CONTIENE: VIRUS  ATENUADOS DE SARAMPION DE LAS CEPAS EDMONSTON- ZAGREB (CULTIVADOS EN CELULAS",ENV,1,ENV,0.5,mililitros,0.5,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
325,"Grupo Nº 22: Vacunas, Toxoides, Inmunoglobulinas, Antitoxinas",VACUNA ANTIINFLUENZA,3822,3822,2000038220002,020,000,3822,00,02,NO,,VACUNA ANTIINFLUENZA. SUSPENSION INYECTABLE. CADA DOSIS DE 0.5 ML CONTIENE: FRACCIONES ANTIGENICAS PURIFICADAS DE VIRUS DE INFLUENZA INACTIVADOS CORRESPONDIENTES A LAS CEPAS AUTORIZADAS POR LA ORGANIZACION MUNDIAL DE LA,ENV,1,DSS,0.5,mililitros,0.5,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
326,"Grupo Nº 22: Vacunas, Toxoides, Inmunoglobulinas, Antitoxinas",VACUNA ANTIINFLUENZA,3822,3822,2000038220103,020,000,3822,01,03,NO,,VACUNA ANTIINFLUENZA. SUSPENSION INYECTABLE. CADA DOSIS DE 0.5 ML CONTIENE: FRACCIONES ANTIGENICAS PURIFICADAS DE VIRUS DE INFLUENZA INACTIVADOS CORRESPONDIENTES A LAS CEPAS AUTORIZADAS POR LA ORGANIZACION MUNDIAL DE LA,ENV,10,DSS,0.5,mililitros,5,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
327,"Grupo Nº 22: Vacunas, Toxoides, Inmunoglobulinas, Antitoxinas",VACUNA ANTIINFLUENZA,3822,3822,2000038220202,020,000,3822,02,02,SI,,VACUNA ANTIINFLUENZA. SUSPENSION INYECTABLE. CADA DOSIS DE 0.5 ML CONTIENE: FRACCIONES ANTIGENICAS PURIFICADAS DE VIRUS DE INFLUENZA INACTIVADOS CORRESPONDIENTES A LAS CEPAS AUTORIZADAS POR LA ORGANIZACION MUNDIAL DE LA,ENV,10,FCO,0.5,mililitros,5,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
328,"Grupo Nº 22: Vacunas, Toxoides, Inmunoglobulinas, Antitoxinas",VACUNA CONTRA LA HEPATITIS A,3825,3825,2000038250002,020,000,3825,00,02,NO,,"VACUNA CONTRA LA HEPATITIS A. SOLUCION INYECTABLE. LA DOSIS DE 0.5 ML CONTIENE: ANTIGENO DEL VIRUS DE HEPATITIS A. (CEPA RG-SB), AL MENOS 500 U RIA. ENVASE CON UNA AMPOLLETA CON UNA DOSIS (0.5 ML).",ENV,1,AMP,0.5,mililitros,0.5,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
329,"Grupo Nº 22: Vacunas, Toxoides, Inmunoglobulinas, Antitoxinas",VACUNA CONTRA LA HEPATITIS A,3825,3825,2000038250100,020,000,3825,01,00,SI,,"VACUNA CONTRA LA HEPATITIS A. SUSPENSION INYECTABLE CADA DOSIS DE 0.5 ML CONTIENE: ANTIGENO VIRAL HEPATITIS A CEPA HM175, 720 U ELISA (PEDIATRICA). ENVASE CON JERINGA PRELLENADA CON UNA DOSIS DE 0.5 ML.",ENV,1,JGA,0.5,mililitros,0.5,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
330,"Grupo Nº 22: Vacunas, Toxoides, Inmunoglobulinas, Antitoxinas",VACUNA CONTRA LA HEPATITIS A,3825,3825,2000038250200,020,000,3825,02,00,NO,,"VACUNA CONTRA LA HEPATITIS A. SUSPENSION INYECTABLE. CADA DOSIS DE 0.5 ML CONTIENE: VIRUS DE HEPATITIS A INACTIVADOS (CEPA GBM CULTIVADA SOBRE CELULAS DIPLOIDES HUMANAS MRC-5), NO MENOS DE 80 U ANTIGENICAS (PEDIATRICO). ENVASE CON",ENV,1,JGA,0.5,mililitros,0.5,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
331,"Grupo Nº 22: Vacunas, Toxoides, Inmunoglobulinas, Antitoxinas",VACUNA CONTRA LA HEPATITIS A,3825,3825,2000038250300,020,000,3825,03,00,NO,,"VACUNA CONTRA LA HEPATITIS A. SUSPENSION INYECTABLE. CADA DOSIS DE 0.5 ML CONTIENE: VIRUS DE HEPATITIS A INACTIVADOS (CEPA GBM CULTIVADA SOBRE CELULAS DIPLOIDES HUMANAS MRC-5), NO MENOS DE 80 U ANTIGENICAS (PEDIATRICO). ENVASE CON",ENV,10,DSS,0.5,mililitros,5,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
332,"Grupo Nº 22: Vacunas, Toxoides, Inmunoglobulinas, Antitoxinas",VACUNA CONTRA LA HEPATITIS A,3825,3825,2000038250400,020,000,3825,04,00,NO,,"VACUNA CONTRA LA HEPATITIS A. SOLUCION INYECTABLE. LA DOSIS DE 0.5 ML CONTIENE: ANTIGENO DEL VIRUS DE HEPATITIS A (CEPA RG-SB), AL MENOS 500 U RIA. ENVASE CON UNA AMPOLLETA CON UNA DOSIS (0.5 ML).",ENV,1,AMP,0.5,mililitros,0.5,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
333,"Grupo Nº 22: Vacunas, Toxoides, Inmunoglobulinas, Antitoxinas",VACUNA CONTRA LA HEPATITIS A,3825,3825,2000038250500,020,000,3825,05,00,NO,,"VACUNA CONTRA LA HEPATITIS A. SUSPENSION INYECTABLE. CADA DOSIS DE 1.0 ML CONTIENE: ANTIGENO VIRAL HEPATITIS A CEPA HM175, 1440 U ELISA (ADULTO). ENVASE CON JERINGA PRELLENADA CON UNA DOSIS DE 1.0 ML.",ENV,1,JGA,0.5,mililitros,0.5,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
334,"Grupo Nº 22: Vacunas, Toxoides, Inmunoglobulinas, Antitoxinas",VACUNA CONTRA LA HEPATITIS A,3825,3825,2000038250600,020,000,3825,06,00,NO,,"VACUNA CONTRA LA HEPATITIS A. SUSPENSION INYECTABLE. CADA DOSIS DE 0.5 ML CONTIENE: VIRUS DE HEPATITIS A INACTIVADOS (CEPA GBM CULTIVADA SOBRE CELULAS DIPLOIDES HUMANAS MRC-5), NO MENOS DE 160 U ANTIGENICAS (ADULTO). ENVASE CON",ENV,1,JGA,0.5,mililitros,0.5,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
335,"Grupo Nº 22: Vacunas, Toxoides, Inmunoglobulinas, Antitoxinas",VACUNA CONTRA LA HEPATITIS A,3825,3825,2000038250700,020,000,3825,07,00,NO,,"VACUNA CONTRA LA HEPATITIS A. SUSPENSION INYECTABLE. CADA DOSIS DE 0.5 ML CONTIENE: VIRUS DE HEPATITIS A INACTIVADOS (CEPA GBM CULTIVADA SOBRE CELULAS DIPLOIDES HUMANAS MRC-5), NO MENOS DE 160 U ANTIGENICAS (ADULTO). ENVASE CON UN",ENV,10,DSS,0.5,mililitros,5,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
336,"Grupo Nº 22: Vacunas, Toxoides, Inmunoglobulinas, Antitoxinas",VACUNA CONTRA LA HEPATITIS A,3825,3825,2000038250800,020,000,3825,08,00,NO,,"VACUNA CONTRA LA HEPATITIS A. SUSPENSION INYECTABLE. CADA DOSIS DE 0.5 ML CONTIENE: ANTIGENO VIRAL HEPATITIS A CEPA HM175, 720 U ELISA (PEDIATRICA). ENVASE CON UN FRASCO AMPULA CON UNA DOSIS DE 0.5 ML.",ENV,1,FAJ,0.5,mililitros,0.5,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
337,"Grupo Nº 22: Vacunas, Toxoides, Inmunoglobulinas, Antitoxinas",VACUNA CONTRA LA HEPATITIS A,3825,3825,2000038250900,020,000,3825,09,00,NO,,"VACUNA CONTRA LA HEPATITIS A. SUSPENSION INYECTABLE. CADA DOSIS DE 1.0 ML CONTIENE: ANTIGENO VIRAL HEPATITIS A CEPA HM175, 1440 U ELISA (ADULTO). ENVASE CON UN FRASCO AMPULA CON UNA DOSIS DE 1.0 ML.",ENV,1,FAJ,1,mililitros,1,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
338,"Grupo Nº 22: Vacunas, Toxoides, Inmunoglobulinas, Antitoxinas","VACUNA CONTRA DIFTERIA, TOSFERINA, TÉTANOS, HEPATITIS B, POLIOMIELITIS Y HAEMOPHILUS INFLUENZAE TIPO B",3828,3828,2000038280000,020,000,3828,00,00,SI,,"VACUNA CONTRA DIFTERIA, TOSFERINA, TETANOS, HEPATITIS B, POLIOMIELITIS Y HAEMOPHILUS INFLUENZAE TIPO B SUSPENSION INYECTABLE CADA JERINGA PRELLENADA CON 0.5 ML CONTIENE: ANTIGENO DE SUPERFICIE DEL VIRUS DE HB REC 10 MICROGRAMOS",JGO,1,JGO,0.5,mililitros,0.5,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
339,"Grupo Nº 22: Vacunas, Toxoides, Inmunoglobulinas, Antitoxinas",INMUNOGLOBULINA HUMANA HIPERHINMUNE ANTITETÁNICA,3831,3831,2000038310000,020,000,3831,00,00,SI,,INMUNOGLOBULINA HUMANA HIPERINMUNE ANTITETANICA SOLUCION INYECTABLE CADA FRASCO AMPULA O AMPOLLETA CONTIENE: INMUNOGLOBULINA HUMANA HIPERINMUNE ANTITETANICA 250 UI ENVASE CON UN FRASCO AMPULA 3 ML O UNA AMPOLLETA CON UN ML.,ENV,1,ENV,3,mililitros,3,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
340,"Grupo Nº 22: Vacunas, Toxoides, Inmunoglobulinas, Antitoxinas",INMUNOGLOBULINA HUMANA HIPERHINMUNE ANTITETÁNICA,3831,3831,2000038310100,020,000,3831,01,00,NO,,"INMUNOGLOBULINA HUMANA HIPERINMUNE ANTITETANICA. SOLUCION INYECTABLE. CADA FRASCO AMPULA, AMPOLLETA O JERINGA PRELLENADA CONTIENE: INMUNOGLOBULINA HUMANA HIPERINMUNE ANTITETANICA 250 UI. ENVASE CON UNA AMPOLLETA CON 1 ML (250 UI/ML).",ENV,1,AMP,250,UI,250,UI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
341,"Grupo Nº 22: Vacunas, Toxoides, Inmunoglobulinas, Antitoxinas",INMUNOGLOBULINA HUMANA HIPERHINMUNE ANTITETÁNICA,3831,3831,2000038310200,020,000,3831,02,00,NO,,"INMUNOGLOBULINA HUMANA HIPERINMUNE ANTITETANICA. SOLUCION INYECTABLE. CADA FRASCO AMPULA, AMPOLLETA O JERINGA PRELLENADA CONTIENE: INMUNOGLOBULINA HUMANA HIPERINMUNE ANTITETANICA 250 UI. ENVASE CON UNA JERINGA PRELLENADA CON 1 ML",ENV,1,JGA,250,UI,250,UI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
342,"Grupo Nº 22: Vacunas, Toxoides, Inmunoglobulinas, Antitoxinas",INMUNOGLOBULINA HUMANA ANTIRRÁBICA,3833,3833,2000038330002,020,000,3833,00,02,NO,,INMUNOGLOBULINA HUMANA ANTIRRABICA SOLUCION INYECTABLE CADA FRASCO AMPULA CONTIENE: INMUNOGLOBULINA HUMANA ANTIRRABICA 300 UI. ENVASE CON UN FRASCO AMPULA CON 2ML. (150 UI/ ML).,ENV,1,F.A,300,UI,300,UI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
343,"Grupo Nº 22: Vacunas, Toxoides, Inmunoglobulinas, Antitoxinas",INMUNOGLOBULINA HUMANA ANTIRRÁBICA,3833,3833,2000038330100,020,000,3833,01,00,NO,,INMUNOGLOBULINA HUMANA ANTIRRABICA SOLUCION INYECTABLE CADA AMPOLLETA CONTIENE: INMUNOGLOBULINA HUMANA ANTIRRABICA 300 UI.ENVASE CON UNA AMPOLLETA CON 2 ML (150 UI/ ML).,ENV,1,AMP,300,UI,300,UI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
344,"Grupo Nº 22: Vacunas, Toxoides, Inmunoglobulinas, Antitoxinas",INMUNOGLOBULINA HUMANA ANTIRRÁBICA,3833,3833,2000038330200,020,000,3833,02,00,SI,,INMUNOGLOBULINA HUMANA ANTIRRABICA SOLUCION INYECTABLE CADA JERINGA PRELLENADA CONTIENE: INMUNOGLOBULINA HUMANA ANTIRRABICA 300 UI.ENVASE CON UNA JERINGA PRELLENADA CON 2 ML (150 UI/ ML).,ENV,1,JGA,300,UI,300,UI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
347,"Grupo Nº 22: Vacunas, Toxoides, Inmunoglobulinas, Antitoxinas",FABOTERÁPICO,3847,3847,2000038470000,020,000,3847,00,00,SI,,FABOTERAPICO POLIVALENTE ANTIALACRAN. SOLUCION INYECTABLE. CADA FRASCO AMPULA CON LIOFILIZADO CONTIENE: FABOTERAPICO POLIVALENTE ANTIALACRAN MODIFICADO POR DIGESTION ENZIMATICA PARA NEUTRALIZAR 150 DL50 (1.8 MG) DE VENENO DE ALACRAN,ENV,1,ENV,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
348,"Grupo Nº 22: Vacunas, Toxoides, Inmunoglobulinas, Antitoxinas",FABOTERÁPICO,3848,3848,2000038480000,020,000,3848,00,00,SI,,FABOTERAPICO POLIVALENTE ANTIARACNIDO. SOLUCION INYECTABLE. CADA FRASCO AMPULA CON LIOFILIZADO CONTIENE: FABOTERAPICO POLIVALENTE ANTIARACNIDO MODIFICADO POR DIGESTION ENZIMATICA PARA NEUTRALIZAR 6000 DL50 (180 GLANDULAS DE VENENO,ENV,1,ENV,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
349,"Grupo Nº 22: Vacunas, Toxoides, Inmunoglobulinas, Antitoxinas",FABOTERÁPICO,3849,3849,2000038490000,020,000,3849,00,00,SI,,FABOTERAPICO POLIVALENTE ANTIVIPERINO. SOLUCION INYECTABLE. CADA FRASCO AMPULA CON LIOFILIZADO CONTIENE: FABOTERAPICO POLIVALENTE ANTIVIPERINO MODIFICADO POR DIGESTION ENZIMATICA PARA NEUTRALIZAR NO MENOS DE 790 DL50 DE VENENO DE,ENV,1,ENV,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
350,"Grupo Nº 22: Vacunas, Toxoides, Inmunoglobulinas, Antitoxinas",FABOTERÁPICO,3850,3850,2000038500000,020,000,3850,00,00,SI,,FABOTERAPICO POLIVALENTE ANTICORALILLO FABOTERAPICO POLIVALENTE ANTICORALILLO SOLUCION INYECTABLE CADA FRASCO AMPULA CON LIOFILIZADO CONTIENE: FABOTERAPICO POLIVALENTE ANTICORALILLO MODIFICADO POR DIGESTION ENZIMATICA PARA NEUTRALIZAR,ENV,1,ENV,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
351,"Grupo Nº 22: Vacunas, Toxoides, Inmunoglobulinas, Antitoxinas",FABOTERÁPICO,3850,3850,2000038500001,020,000,3850,00,01,NO,,FABOTERAPICO POLIVALENTE ANTICORALILLO. SOLUCION INYECTABLE. CADA FRASCO AMPULA CON LIOFILIZADO CONTIENE: FABOTERAPICO POLIVALENTE ANTICORALILLO MODIFICADO POR DIGESTION ENZIMATICA PARA NEUTRALIZAR 450 DL50 (5 MG) DE VENENO DE MICRURUS SP.,ENV,1,ENV,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
353,"Grupo Nº 22: Vacunas, Toxoides, Inmunoglobulinas, Antitoxinas",VACUNA CONTRA EL VIRUS DEL PAPILOMA HUMANO,4172,4172,2000041720002,020,000,4172,00,02,NO,,VACUNA CONTRA EL VIRUS DEL PAPILOMA HUMANO. SUSPENSION INYECTABLE. CADA DOSIS DE 0.5 ML CONTIENE: PROTEINA L1 TIPO 6 20 MICROGRAMOS PROTEINA L1 TIPO 11 40 MICROGRAMOS PROTEINA L1 TIPO 16 40 MICROGRAMOS PROTEINA L1 TIPO 18 20,ENV,1,FAJ,0.5,mililitros,0.5,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
354,"Grupo Nº 22: Vacunas, Toxoides, Inmunoglobulinas, Antitoxinas",VACUNA CONTRA EL VIRUS DEL PAPILOMA HUMANO,4172,4172,2000041720100,020,000,4172,01,00,SI,,VACUNA CONTRA EL VIRUS DEL PAPILOMA HUMANO SUSPENSION INYECTABLE CADA DOSIS DE  0.5 ML CONTIENE: PROTEINA L1 TIPO 6 20 MICROGRAMOS PROTEINA L1 TIPO 11 40  MICROGRAMOS PROTEINA L1 TIPO 16 40 MICROGRAMOS PROTEINA L1 TIPO 18 20,ENV,10,FAJ,0.5,mililitros,5,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
355,"Grupo Nº 22: Vacunas, Toxoides, Inmunoglobulinas, Antitoxinas",VACUNA CONTRA EL VIRUS DEL PAPILOMA HUMANO,4173,4173,2000041730000,020,000,4173,00,00,NO,,"VACUNA CONTRA EL VIRUS DEL PAPILOMA HUMANO SUSPENSION INYECTABLE CADA DOSIS DE 0.5 ML CONTIENE: PROTEINA L1 TIPO 16, 20 MICROGRAMOS PROTEINA L1 TIPO 18, 20 MICROGRAMOS ENVASE CON 1 FRASCO AMPULA CON 0.5 ML O JERINGA PRELLENADA CON 0.5",ENV,1,FAJ,0.5,mililitros,0.5,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
356,"Grupo Nº 22: Vacunas, Toxoides, Inmunoglobulinas, Antitoxinas",VACUNA CONTRA EL VIRUS DEL PAPILOMA HUMANO,4173,4173,2000041730100,020,000,4173,01,00,SI,,"VACUNA CONTRA EL VIRUS DEL PAPILOMA HUMANO SUSPENSION INYECTABLE CADA DOSIS DE 0.5 ML CONTIENE: PROTEINA L1 TIPO 16, 20 MICROGRAMOS PROTEINA L1 TIPO 18, 20 MICROGRAMOS ENVASE CON 10 FRASCOS AMPULA CON 0.5 ML O JERINGA PRELLENADA CON",ENV,10,FAJ,0.5,mililitros,5,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
357,"Grupo Nº 22: Vacunas, Toxoides, Inmunoglobulinas, Antitoxinas",VACUNA CONTRA EL VIRUS DEL PAPILOMA HUMANO,4173,4173,2000041730200,020,000,4173,02,00,NO,,"VACUNA CONTRA EL VIRUS DEL PAPILOMA HUMANO. SUSPENSION INYECTABLE. CADA DOSIS DE 0.5 ML CONTIENE: PROTEINA L1 TIPO 16,20 MICROGRAMOS PROTEINA L1 TIPO 18, 20 MICROGRAMOS. ENVASE CON 100 FRASCOS AMPULA CON 0.5 ML O JERINGA PRELLENADA CON",ENV,100,FAJ,0.5,mililitros,50,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
358,"Grupo Nº 22: Vacunas, Toxoides, Inmunoglobulinas, Antitoxinas",VACUNA ANTIVARICELA ATENUADA,6056,6056,2000060560000,020,000,6056,00,00,SI,,"VACUNA ANTIVARICELA ATENUADA. SUSPENSION INYECTABLE. CADA FRASCO AMPULA CON LIOFILIZADO CONTIENE: VIRUS VIVOS DE VARICELA ZOSTER ATENUADOS, CEPA OKA/MERCK 1350 UFP (UNIDADES FORMADORAS DE PLACA). ENVASE CON UN FRASCO AMPULA CON",ENV,1,ENV,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
573,"Grupo Nº 22: Vacunas, Toxoides, Inmunoglobulinas, Antitoxinas",VACUNA ANTIVARICELA ATENUADA,6056,6056,2000060560100,020,000,6056,01,00,NO,,"VACUNA ANTIVARICELA ATENUADA. SUSPENSION INYECTABLE. CADA FRASCO AMPULA CON LIOFILIZADO CONTIENE: VIRUS VIVOS DE VARICELA ZOSTER ATENUADOS, CEPA OKA/MERCK 1350 UFP (UNIDADES FORMADORAS DE PLACA). ENVASE CON 10 FRASCOS AMPULA CON",ENV,1,ENV,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
256,Grupo Nº 3: Cardiología,ALPROSTADIL,6051,6051,1000060510000,010,000,6051,00,00,SI,,ALPROSTADIL. SOLUCION INYECTABLE. CADA AMPOLLETA CONTIENE: ALPROSTADIL 500 MICROGRAMOS. ENVASE CON 5 AMPOLLETAS CON 1 ML CADA UNA (500 MICROGRAMOS/ML).,ENV,5,AMP,50,microgramos,250,microgramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
262,Grupo Nº 3: Cardiología,IBUPROFENO,6076,6076,1000060760000,010,000,6076,00,00,SI,"Sustantiva,Uso Hospitalario, Cardiología",IBUPROFENO. SOLUCION INYECTABLE. CADA AMPOLLETA CONTIENE: IBUPROFENO 10 MG. ENVASE CON 4 AMPOLLETAS DE 2 ML (10 MG/2 ML).,ENV,4,AMP,10,miligramos,40,miligramos,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
380,Grupo Nº 3: Cardiología,AMLODIPINO,2111,2111,1000021110000,010,000,2111,00,00,NO,"VALES,Consumo en demanda",AMLODIPINO. TABLETA O CAPSULA. CADA TABLETA O CAPSULA CONTIENE: BESILATO O MALEATO DE AMLODIPINO EQUIVALENTE A 5 MG DE AMLODIPINO. ENVASE CON 10 TABLETAS O CAPSULAS.,ENV,10,C.T,5,miligramos,50,miligramos,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIHIPERTENSIVOS,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
381,Grupo Nº 3: Cardiología,AMLODIPINO,2111,2111,1000021110100,010,000,2111,01,00,SI,"VALES,Consumo en demanda",AMLODIPINO. TABLETA O CAPSULA. CADA TABLETA O CAPSULA CONTIENE: BESILATO O MALEATO DE AMLODIPINO EQUIVALENTE A 5 MG DE AMLODIPINO. ENVASE CON 30 TABLETAS O CAPSULAS.,ENV,30,C.T,5,miligramos,150,miligramos,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIHIPERTENSIVOS,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
382,Grupo Nº 3: Cardiología,DILTIAZEM,2112,2112,1000021120000,010,000,2112,00,00,SI,"VALES,Sustantiva",DILTIAZEM TABLETA O GRAGEA CADA TABLETA CONTIENE: CLORHIDRATO DE DILTIAZEM 30  MG ENVASE CON 30 TABLETAS O GRAGEAS.,ENV,30,T.G,30,miligramos,900,miligramos,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
383,Grupo Nº 3: Cardiología,FELODIPINO,2114,2114,1000021140000,010,000,2114,00,00,SI,"VALES,Sustantiva -- Eficiencia terapeutica A - 5%",FELODIPINO TABLETA DE LIBERACION PROLONGADA CADA TABLETA CONTIENE: FELODIPINO 5  MG ENVASE CON 10 TABLETAS DE LIBERACION PROLONGADA.,ENV,10,TAB,5,miligramos,50,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIHIPERTENSIVOS,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
469,Grupo Nº 3: Cardiología,ENALAPRIL O LISINOPRIL O RAMIPRIL,2501,2501,1000025010000,010,000,2501,00,00,SI,"VALES,Consumo en demanda",ENALAPRIL O LISINOPRIL O RAMIPRIL CAPSULA O TABLETA CADA CAPSULA O TABLETA  CONTIENE: MALEATO DE ENALAPRIL 10 MG O LISINOPRIL 10 MG O RAMIPRIL 10 MG  ENVASE CON 30 CAPSULAS O TABLETAS.,ENV,30,C.T,10,miligramos,300,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIHIPERTENSIVOS,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
476,Grupo Nº 3: Cardiología,LOSARTÁN,2520,2520,1000025200000,010,000,2520,00,00,SI,VALES,LOSARTAN GRAGEA O COMPRIMIDO RECUBIERTO CADA GRAGEA O COMPRIMIDO RECUBIERTO  CONTIENE: LOSARTAN POTASICO 50 MG ENVASE CON 30 GRAGEAS O COMPRIMIDOS  RECUBIERTOS.,ENV,30,C.G,50,miligramos,1500,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIHIPERTENSIVOS,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
480,Grupo Nº 3: Cardiología,CANDESARTÁN CILEXETILO-HIDROCLOROTIAZIDA,2530,2530,1000025300000,010,000,2530,00,00,SI,Sustantiva -- Eficiencia terapeutica B - 0%,CANDESARTAN CILEXETILO -HIDROCLOROTIAZIDA TABLETA CADA TABLETA CONTIENE:  CANDESARTAN CILEXETILO 16.0 MG HIDROCLOROTIAZIDA 12.5 MG ENVASE CON 28  TABLETAS.,ENV,28,TAB,28.5,miligramos,798,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
481,Grupo Nº 3: Cardiología,TELMISARTÁN,2540,2540,1000025400000,010,000,2540,00,00,SI,"VALES,Sustantiva -- Eficiencia terapeutica B - 45%",TELMISARTAN TABLETA CADA TABLETA CONTIENE: TELMISARTAN 40 MG ENVASE CON 30  TABLETAS.,ENV,30,TAB,40,miligramos,1200,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIHIPERTENSIVOS,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
619,Grupo Nº 3: Cardiología,EFEDRINA,2107,2107,4000021070000,040,000,2107,00,00,SI,Entrega hospitalaria,EFEDRINA SOLUCION INYECTABLE CADA AMPOLLETA CONTIENE: SULFATO DE EFEDRINA 50 MG  ENVASE CON 100 AMPOLLETAS CON 2 ML. (25 MG/ML).,ENV,100,AMP,50,miligramos,5000,miligramos,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
695,Grupo Nº 3: Cardiología,LIDOCAÍNA,261,0261,1000002610000,010,000,0261,00,00,SI,"Sustantiva,Uso Hospitalario, Cardiología",LIDOCAINA SOLUCION INYECTABLE AL 1% CADA FRASCO AMPULA CONTIENE: CLORHIDRATO DE LIDOCAINA 500 MG ENVASE CON 5 FRASCOS AMPULA DE 50 ML.,ENV,5,F.A,500,miligramos,2500,miligramos,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
731,Grupo Nº 3: Cardiología,DIGOXINA,502,0502,1000005020000,010,000,0502,00,00,SI,"VALES,Sustantiva",DIGOXINA TABLETA CADA TABLETA CONTIENE: DIGOXINA 0.25 MG ENVASE CON 20 TABLETAS,ENV,20,TAB,0.25,miligramos,5,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,FARMACOS_INSUFICIENCIA_CARDIACA_Y_ANTIANGINOSOS,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
732,Grupo Nº 3: Cardiología,DIGOXINA,503,0503,1000005030000,010,000,0503,00,00,SI,Sustantiva,DIGOXINA ELIXIR CADA ML CONTIENE: DIGOXINA 0.05 MG ENVASE CONTENIENDO 60 ML CON GOTERO CALIBRADO DE 1 ML INTEGRADO O ADJUNTO AL FRASCO Y LE SIRVE DE TAPA.,FCO,60,ML.,0.05,miligramos,0.05,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
733,Grupo Nº 3: Cardiología,DIGOXINA,504,0504,1000005040000,010,000,0504,00,00,SI,"Sustantiva,Uso Hospitalario, Cardiología",DIGOXINA SOLUCION INYECTABLE CADA AMPOLLETA CONTIENE: DIGOXINA 0.5 MG ENVASE CON 6 AMPOLLETAS DE 2 ML.,ENV,6,AMP,0.5,miligramos,3,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
734,Grupo Nº 3: Cardiología,"POTASIO, SALES DE",523,0523,1000005230000,010,000,0523,00,00,SI,Sustantiva,POTASIO SALES DE TABLETA SOLUBLE O EFERVESCENTE CADA TABLETA CONTIENE: BICARBONATO DE POTASIO 766 MG BITARTRATO DE POTASIO 460 MG ACIDO CITRICO 155 MG ENVASE CON 50 TABLETAS SOLUBLES.,ENV,50,TAB,1381,miligramos,69050,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,FARMACOS_INSUFICIENCIA_CARDIACA_Y_ANTIANGINOSOS,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
737,Grupo Nº 3: Cardiología,QUINIDINA,527,0527,1000005270000,010,000,0527,00,00,SI,Sustantiva,QUINIDINA TABLETA CADA TABLETA CONTIENE: SULFATO DE QUINIDINA 200 MG ENVASE CON 20 TABLETAS.,ENV,20,TAB,200,miligramos,4000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
738,Grupo Nº 3: Cardiología,PROPRANOLOL,530,0530,1000005300000,010,000,0530,00,00,SI,Sustantiva,PROPRANOLOL TABLETA CADA TABLETA CONTIENE: CLORHIDRATO DE PROPRANOLOL 40 MG ENVASE CON 30 TABLETAS.,ENV,30,TAB,40,miligramos,1200,miligramos,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIHIPERTENSIVOS,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
739,Grupo Nº 3: Cardiología,PROPAFENONA,537,0537,1000005370000,010,000,0537,00,00,SI,"VALES,Sustantiva",PROPAFENONA TABLETA CADA TABLETA CONTIENE: CLORHIDRATO DE PROPAFENONA 150 MG ENVASE CON 20 TABLETAS.,ENV,20,TAB,150,miligramos,3000,miligramos,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIARRITMICOS,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
740,Grupo Nº 3: Cardiología,PROPRANOLOL,539,0539,1000005390000,010,000,0539,00,00,SI,"VALES,Sustantiva",PROPRANOLOL TABLETA CADA TABLETA CONTIENE: CLORHIDRATO DE PROPRANOLOL 10 MG ENVASE CON 30 TABLETAS.,ENV,30,TAB,10,miligramos,300,miligramos,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
742,Grupo Nº 3: Cardiología,METILDOPA,566,0566,1000005660000,010,000,0566,00,00,SI,"VALES,Sustantiva",METILDOPA TABLETA CADA TABLETA CONTIENE: METILDOPA 250 MG ENVASE CON 30 TABLETAS.,ENV,30,TAB,250,miligramos,7500,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIHIPERTENSIVOS,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
743,Grupo Nº 3: Cardiología,DIAZÓXIDO,568,0568,1000005680000,010,000,0568,00,00,SI,"Sustantiva,Uso Hospitalario, Cardiología",DIAZOXIDO SOLUCION INYECTABLE CADA AMPOLLETA CONTIENE: DIAZOXIDO 300 MG ENVASE CON UNA AMPOLLETA DE 20 ML. (15 MG/ML).,ENV,1,AMP,300,miligramos,300,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
744,Grupo Nº 3: Cardiología,NITROPRUSIATO DE SODIO,569,0569,1000005690000,010,000,0569,00,00,SI,"Entrega hospitalaria,Uso Hospitalario, Cardiología",NITROPRUSIATO DE SODIO SOLUCION INYECTABLE CADA FRASCO AMPULA CON POLVO O SOLUCION CONTIENE: NITROPRUSIATO DE SODIO 50 MG ENVASE CON UN FRASCO AMPULA CON O SIN DILUYENTE.,ENV,1,ENV,50,miligramos,50,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
745,Grupo Nº 3: Cardiología,HIDRALAZINA,570,0570,1000005700000,010,000,0570,00,00,SI,"VALES,Sustantiva",HIDRALAZINA TABLETA CADA TABLETA CONTIENE: CLORHIDRATO DE HIDRALAZINA 10 MG ENVASE CON 20 TABLETAS.,ENV,20,TAB,10,miligramos,200,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIHIPERTENSIVOS,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
746,Grupo Nº 3: Cardiología,METOPROLOL,572,0572,1000005720000,010,000,0572,00,00,SI,"VALES,Consumo en demanda",METOPROLOL TABLETA CADA TABLETA CONTIENE: TARTRATO DE METOPROLOL 100 MG ENVASE CON 20 TABLETAS.,ENV,20,TAB,100,miligramos,2000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIHIPERTENSIVOS,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
747,Grupo Nº 3: Cardiología,PRAZOSINA,573,0573,1000005730000,010,000,0573,00,00,SI,"VALES,Sustantiva",PRAZOSINA CAPSULA O COMPRIMIDO CADA CAPSULA O COMPRIMIDO CONTIENE: CLORHIDRATO DE PRAZOSINA EQUIVALENTE A 1 MG DE PRAZOSINA. ENVASE CON 30 CAPSULAS O COMPRIMIDOS.,ENV,30,C.C,1,miligramos,30,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIHIPERTENSIVOS,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
748,Grupo Nº 3: Cardiología,CAPTOPRIL,574,0574,1000005740000,010,000,0574,00,00,SI,"VALES,Consumo en demanda",CAPTOPRIL TABLETA CADA TABLETA CONTIENE: CAPTOPRIL 25 MG ENVASE CON 30 TABLETAS.,ENV,30,TAB,25,miligramos,750,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIHIPERTENSIVOS,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
749,Grupo Nº 3: Cardiología,TRINITRATO DE GLICERILO,591,0591,1000005910000,010,000,0591,00,00,SI,Sustantiva,TRINITRATO DE GLICERILO CAPSULA O TABLETA MASTICABLE CADA CAPSULA O TABLETA MASTICABLE CONTIENE: TRINITRATO DE GLICEROL 0.8 MG ENVASE CON 24 CAPSULAS O TABLETAS MASTICABLES.,ENV,24,C.T,0.8,miligramos,19.2,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,FARMACOS_INSUFICIENCIA_CARDIACA_Y_ANTIANGINOSOS,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
750,Grupo Nº 3: Cardiología,ISOSORBIDA,592,0592,1000005920000,010,000,0592,00,00,SI,"VALES,Sustantiva",ISOSORBIDA TABLETA SUBLINGUAL CADA TABLETA CONTIENE: DINITRATO DE ISOSORBIDA 5 MG ENVASE CON 20 TABLETAS SUBLINGUALES.,ENV,20,TAB,5,miligramos,100,miligramos,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,FARMACOS_INSUFICIENCIA_CARDIACA_Y_ANTIANGINOSOS,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
751,Grupo Nº 3: Cardiología,ISOSORBIDA,593,0593,1000005930000,010,000,0593,00,00,SI,"VALES,Sustantiva",ISOSORBIDA TABLETA CADA TABLETA CONTIENE: DINITRATO DE ISOSORBIDA 10 MG ENVASE CON 20 TABLETAS.,ENV,20,TAB,10,miligramos,200,miligramos,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
752,Grupo Nº 3: Cardiología,VERAPAMILO,596,0596,1000005960000,010,000,0596,00,00,SI,"VALES,Sustantiva",VERAPAMILO GRAGEA O TABLETA RECUBIERTA CADA GRAGEA O TABLETA RECUBIERTA CONTIENE: CLORHIDRATO DE VERAPAMILO 80 MG ENVASE CON 20 GRAGEAS O TABLETAS RECUBIERTAS.,ENV,20,T.G,80,miligramos,1600,miligramos,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIHIPERTENSIVOS,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
753,Grupo Nº 3: Cardiología,NIFEDIPINO,597,0597,1000005970000,010,000,0597,00,00,SI,"VALES,Sustantiva",NIFEDIPINO CAPSULA DE GELATINA BLANDA CADA CAPSULA CONTIENE: NIFEDIPINO 10 MG ENVASE CON 20 CAPSULAS.,ENV,20,CAP,10,miligramos,200,miligramos,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIHIPERTENSIVOS,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
754,Grupo Nº 3: Cardiología,VERAPAMILO,598,0598,1000005980000,010,000,0598,00,00,SI,"Sustantiva,Uso Hospitalario, Cardiología",VERAPAMILO SOLUCION INYECTABLE CADA AMPOLLETA CONTIENE: CLORHIDRATO DE VERAPAMILO 5 MG ENVASE CON 2 ML (2.5 MG/ ML).,ENV,1,AMP,5,miligramos,5,miligramos,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
755,Grupo Nº 3: Cardiología,NIFEDIPINO,599,0599,1000005990000,010,000,0599,00,00,SI,"VALES,Sustantiva -- Eficiencia terapeutica A - 25%",NIFEDIPINO COMPRIMIDO DE LIBERACION PROLONGADA CADA COMPRIMIDO CONTIENE: NIFEDIPINO 30 MG ENVASE CON 30 COMPRIMIDOS.,ENV,30,COM,30,miligramos,900,miligramos,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
756,Grupo Nº 3: Cardiología,EPINEFRINA,611,0611,1000006110000,010,000,0611,00,00,SI,"Sustantiva,Uso Hospitalario, Cardiología",EPINEFRINA SOLUCION INYECTABLE CADA AMPOLLETA CONTIENE: EPINEFRINA 1 MG (1:1 000) ENVASE CON 50 AMPOLLETAS CON 1 ML.,ENV,50,AMP,1,miligramos,50,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
757,Grupo Nº 3: Cardiología,NOREPINEFRINA,612,0612,1000006120000,010,000,0612,00,00,SI,"Entrega hospitalaria,Uso Hospitalario, Cardiología",NOREPINEFRINA SOLUCION INYECTABLE CADA AMPOLLETA CONTIENE: BITARTRATO DE NOREPINEFRINA EQUIVALENTE A 4 MG DE NOREPINEFRINA. ENVASE CON 50 AMPOLLETAS DE 4 ML.,ENV,50,AMP,4,miligramos,200,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
758,Grupo Nº 3: Cardiología,DOPAMINA,614,0614,1000006140000,010,000,0614,00,00,SI,"Sustantiva,Uso Hospitalario, Cardiología",DOPAMINA SOLUCION INYECTABLE CADA AMPOLLETA CONTIENE: CLORHIDRATO DE DOPAMINA 200 MG ENVASE CON 5 AMPOLLETAS CON 5 ML.,ENV,5,AMP,200,miligramos,1000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
759,Grupo Nº 3: Cardiología,DOBUTAMINA,615,0615,1000006150003,010,000,0615,00,03,SI,"Sustantiva,Uso Hospitalario, Cardiología,Uso Hospitalario, Cardiología",DOBUTAMINA SOLUCION INYECTABLE CADA AMPOLLETA CONTIENE: CLORHIDRATO DE DOBUTAMINA EQUIVALENTE A 250 MG DE DOBUTAMINA. ENVASE CON 5 AMPOLLETAS CON 5 ML CADA UNA.,ENV,5,AMP,250,miligramos,1250,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
760,Grupo Nº 3: Cardiología,DOBUTAMINA,615,0615,1000006150100,010,000,0615,01,00,NO,"Sustantiva,Uso Hospitalario, Cardiología,Uso Hospitalario, Cardiología",DOBUTAMINA. SOLUCION INYECTABLE CADA FRASCO AMPULA CONTIENE: CLORHIDRATO DE DOBUTAMINA EQUIVALENTE A 250 MG DE DOBUTAMINA. ENVASE CON UN FRASCO AMPULA CON 20 ML.,ENV,1,F.A,250,miligramos,250,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
770,Grupo Nº 3: Cardiología,DIPIRIDAMOL,642,0642,1000006420003,010,000,0642,00,03,NO,"Sustantiva,Uso Hospitalario, Cardiología,Uso Hospitalario, Cardiología,Uso Hospitalario, Cardiología,Uso Hospitalario, Cardiología",DIPIRIDAMOL. SOLUCION INYECTABLE. CADA AMPOLLETA CONTIENE: DIPIRIDAMOL 10 MG. ENVASE CON 1 AMPOLLETA CON 2 ML (5 MG/ML).,ENV,1,AMP,10,miligramos,10,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
771,Grupo Nº 3: Cardiología,DIPIRIDAMOL,642,0642,1000006420102,010,000,0642,01,02,NO,"Sustantiva,Uso Hospitalario, Cardiología,Uso Hospitalario, Cardiología,Uso Hospitalario, Cardiología,Uso Hospitalario, Cardiología","DIPIRIDAMOL, SOLUCION INYECTABLE. CADA AMPOLLETA CONTIENE: DIPIRIDAMOL: 10 MG. ENVASE CON 3 AMPOLLETAS DE 2 ML. (5 MG/ML).",ENV,3,AMP,10,miligramos,30,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
772,Grupo Nº 3: Cardiología,DIPIRIDAMOL,642,0642,1000006420200,010,000,0642,02,00,SI,"Sustantiva,Uso Hospitalario, Cardiología,Uso Hospitalario, Cardiología,Uso Hospitalario, Cardiología,Uso Hospitalario, Cardiología",DIPIRIDAMOL SOLUCION INYECTABLE CADA AMPOLLETA CONTIENE: DIPIRIDAMOL 10 MG. ENVASE CON 5 AMPOLLETAS CON 2 ML (5 MG/ML).,ENV,5,AMP,10,miligramos,50,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
773,Grupo Nº 3: Cardiología,DIPIRIDAMOL,642,0642,1000006420302,010,000,0642,03,02,NO,"Sustantiva,Uso Hospitalario, Cardiología,Uso Hospitalario, Cardiología,Uso Hospitalario, Cardiología,Uso Hospitalario, Cardiología",DIPIRIDAMOL. SOLUCION INYECTABLE. CADA AMPOLLETA CONTIENE: DIPIRIDAMOL 10 MG. ENVASE CON 10 AMPOLLETAS CON 2 ML (5 MG/ML).,ENV,10,AMP,10,miligramos,100,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
886,Grupo Nº 3: Cardiología,ESTREPTOQUINASA,1735,1735,1000017350000,010,000,1735,00,00,SI,"Entrega hospitalaria,Uso Hospitalario, Cardiología",ESTREPTOQUINASA SOLUCION INYECTABLE. CADA FRASCO AMPULA CON LIOFILIZADO CONTIENE: ESTREPTOQUINASA NATURAL O ESTREPTOQUINASA RECOMBINANTE 750 000 UI ENVASE CON UN FRASCO AMPULA.,ENV,1,F.A,750000,UI,750000,UI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
887,Grupo Nº 3: Cardiología,ESTREPTOQUINASA,1736,1736,1000017360000,010,000,1736,00,00,SI,"Entrega hospitalaria,Uso Hospitalario, Cardiología","ESTREPTOQUINASA SOLUCION INYECTABLE CADA FRASCO AMPULA CON LIOFILIZADO CONTIENE: ESTREPTOQUINASA 1,500,000 UI ENVASE CON UN FRASCO AMPULA.",ENV,1,F.A,1500000,UI,1500000,UI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1007,Grupo Nº 3: Cardiología,AMIODARONA,4107,4107,1000041070000,010,000,4107,00,00,SI,"Sustantiva,Uso Hospitalario, Cardiología",AMIODARONA SOLUCION INYECTABLE CADA AMPOLLETA CONTIENE: CLORHIDRATO DE  AMIODARONA 150 MG ENVASE CON 6 AMPOLLETAS DE 3 ML.,ENV,6,AMP,150,miligramos,900,miligramos,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIARRITMICOS,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1008,Grupo Nº 3: Cardiología,AMIODARONA,4110,4110,1000041100000,010,000,4110,00,00,SI,"Sustantiva,VALES",AMIODARONA TABLETA CADA TABLETA CONTIENE: CLORHIDRATO DE AMIODARONA 200 MG  ENVASE CON 20 TABLETAS.,ENV,20,TAB,200,miligramos,4000,miligramos,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1009,Grupo Nº 3: Cardiología,TRINITRATO DE GLICERILO,4111,4111,1000041110000,010,000,4111,00,00,SI,"Sustantiva,VALES",TRINITRATO DE GLICERILO PARCHE CADA PARCHE LIBERA: TRINITRATO DE GLICERILO 5  MG/DIA ENVASE CON 7 PARCHES.,ENV,7,PZA,5,miligramos,35,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1012,Grupo Nº 3: Cardiología,TRINITRATO DE GLICERILO,4114,4114,1000041140000,010,000,4114,00,00,SI,"Sustantiva,Uso Hospitalario, Cardiología",TRINITRATO DE GLICERILO SOLUCION INYECTABLE CADA FRASCO AMPULA CONTIENE: TRINITRATO DE GLICERILO 50 MG ENVASE CON UN FRASCO AMPULA DE 10 ML.,ENV,1,F.A,50,miligramos,50,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1013,Grupo Nº 3: Cardiología,PENTOXIFILINA,4117,4117,1000041170000,010,000,4117,00,00,SI,"VALES,Consumo en demanda",PENTOXIFILINA TABLETA O GRAGEA DE LIBERACION PROLONGADA CADA TABLETA O GRAGEA CONTIENE: PENTOXIFILINA 400 MG ENVASE CON 30 TABLETAS O GRAGEAS.,ENV,30,T.G,400,miligramos,12000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,METILXANTINAS,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0
1014,Grupo Nº 3: Cardiología,"ISOSORBIDA, DINITRATO DE",4118,4118,1000041180000,010,000,4118,00,00,SI,"Sustantiva,Uso Hospitalario, Cardiología,Uso Hospitalario, Cardiología",ISOSORBIDA DINITRATO DE SOLUCION INYECTABLE CADA ML CONTIENE: DINITRATO DE ISOSORBIDA 1 MG ENVASE CON 100 ML.,ENV,1,FCO,1,miligramos,1,miligramos,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1015,Grupo Nº 3: Cardiología,"ISOSORBIDA, DINITRATO DE",4118,4118,1000041180002,010,000,4118,00,02,NO,"Sustantiva,Uso Hospitalario, Cardiología,Uso Hospitalario, Cardiología","ISOSORBIDA, DINITRATO DE SOLUCION INYECTABLE. CADA ML CONTIENE: DINITRATO DE ISOSORBIDA 1 MG. ENVASE CON 100 ML (1 MG/1 ML).",ENV,100,ML.,1,miligramos,1,miligramos,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1016,Grupo Nº 3: Cardiología,"ISOSORBIDA, DINITRATO DE",4118,4118,1000041180102,010,000,4118,01,02,NO,"Sustantiva,Uso Hospitalario, Cardiología,Uso Hospitalario, Cardiología","ISOSORBIDA, DINITRATO DE SOLUCION INYECTABLE CADA ML CONTIENE: DINITRATO DE  ISOSORBIDA 1 MG. ENVASE CON 10 AMPOLLETAS CON 10 ML (10 MG/10 ML).",ENV,10,AMP,1,miligramos,10,miligramos,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1017,Grupo Nº 3: Cardiología,"ISOSORBIDA, DINITRATO DE",4120,4120,1000041200000,010,000,4120,00,00,SI,Sustantiva,ISOSORBIDA MONONITRATO DE TABLETA CADA TABLETA CONTIENE: 5-MONONITRATO DE ISOSORBIDA 20 MG ENVASE CON 20 TABLETAS.,ENV,20,TAB,20,miligramos,400,miligramos,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1018,Grupo Nº 3: Cardiología,TIROFIBAN,4123,4123,1000041230000,010,000,4123,00,00,SI,"Entrega hospitalaria,Uso Hospitalario, Cardiología,Uso Hospitalario, Cardiología,Entrega hospitalaria",TIROFIBAN SOLUCION INYECTABLE CADA FRASCO AMPULA CONTIENE: CLORHIDRATO DE TIROFIBAN EQUIVALENTE A 12.5 MG DE TIROFIBAN. ENVASE CON UN FRASCO AMPULA CON 50 ML.,ENV,1,F.A,12.5,miligramos,12.5,miligramos,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1019,Grupo Nº 3: Cardiología,TIROFIBAN,4123,4123,1000041230100,010,000,4123,01,00,NO,"Entrega hospitalaria,Uso Hospitalario, Cardiología,Uso Hospitalario, Cardiología,Entrega hospitalaria",TIROFIBAN. SOLUCION INYECTABLE. CADA BOLSA CONTIENE: CLORHIDRATO DE TIROFIBAN  EQUIVALENTE A 12.5 MG DE TIROFIBAN. ENVASE CON UNA BOLSA CON 250 ML.,ENV,1,BSA,12.5,miligramos,12.5,miligramos,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1067,Grupo Nº 3: Cardiología,HIDRALAZINA,4201,4201,1000042010002,010,000,4201,00,02,SI,"Sustantiva,Uso Hospitalario, Cardiología",HIDRALAZINA SOLUCION INYECTABLE. CADA AMPOLLETA O FRASCO AMPULA CONTIENE: CLORHIDRATO DE HIDRALAZINA 20 MG. ENVASE CON 5 AMPOLLETAS O 5 FRASCOS AMPULA CON 1.0 ML.,ENV,5,AFA,20,miligramos,100,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1102,Grupo Nº 3: Cardiología,CLOPIDOGREL,4246,4246,1000042460000,010,000,4246,00,00,NO,"VALES,Sustantiva",CLOPIDOGREL. GRAGEA O TABLETA. CADA GRAGEA O TABLETA CONTIENE: BISULFATO DE CLOPIDOGREL O BISULFATO DE CLOPIDOGREL (POLIMORFO FORMA 2) EQUIVALENTE A 75 MG DE CLOPIDOGREL. ENVASE CON 14 GRAGEAS O TABLETAS.,CJA,14,T.G,75,miligramos,1050,miligramos,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIAGREGANTES_PLAQUETARIOS,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1103,Grupo Nº 3: Cardiología,CLOPIDOGREL,4246,4246,1000042460100,010,000,4246,01,00,SI,"VALES,Sustantiva",CLOPIDOGREL GRAGEA O TABLETA CADA GRAGEA O TABLETA CONTIENE: BISULFATO DE CLOPIDOGREL O BISULFATO DE CLOPIDOGREL (POLIMORFO FORMA 2) EQUIVALENTE A 75 MG DE CLOPIDOGREL. ENVASE CON 28 GRAGEAS O TABLETAS.,ENV,28,T.G,75,miligramos,2100,miligramos,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIAGREGANTES_PLAQUETARIOS,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1155,Grupo Nº 3: Cardiología,CILOSTAZOL,4307,4307,1000043070000,010,000,4307,00,00,SI,Sustantiva,CILOSTAZOL TABLETA CADA TABLETA CONTIENE: CILOSTAZOL 100 MG ENVASE CON 30 TABLETAS.,ENV,30,TAB,100,miligramos,3000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1273,Grupo Nº 3: Cardiología,LEVOSIMENDAN,5097,5097,1000050970000,010,000,5097,00,00,SI,"Entrega hospitalaria,Uso Hospitalario, Cardiología,Uso Hospitalario, Cardiología,Entrega hospitalaria",LEVOSIMENDAN SOLUCION INYECTABLE CADA ML CONTIENE: LEVOSIMENDAN 2.5 MG ENVASE  CON 1 FRASCO AMPULA CON 5 ML.,ENV,1,F.A,2.5,miligramos,2.5,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1274,Grupo Nº 3: Cardiología,LEVOSIMENDAN,5097,5097,1000050970100,010,000,5097,01,00,NO,"Entrega hospitalaria,Uso Hospitalario, Cardiología,Uso Hospitalario, Cardiología,Entrega hospitalaria",LEVOSIMENDAN SOLUCION INYECTABLE CADA ML CONTIENE: LEVOSIMENDAN 2.5 MG ENVASE  CON 1 FRASCO AMPULA CON 10 ML.,ENV,1,F.A,2.5,miligramos,2.5,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1275,Grupo Nº 3: Cardiología,ADENOSINA,5099,5099,1000050990000,010,000,5099,00,00,SI,"Sustantiva,Uso Hospitalario, Cardiología",ADENOSINA SOLUCION INYECTABLE CADA FRASCO AMPULA CONTIENE: ADENOSINA 6 MG  ENVASE CON 6 FRASCOS AMPULA CON 2 ML.,ENV,6,F.A,6,miligramos,36,miligramos,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1276,Grupo Nº 3: Cardiología,MILRINONA,5100,5100,1000051000000,010,000,5100,00,00,NO,"Entrega hospitalaria,Uso Hospitalario, Cardiología,Uso Hospitalario, Cardiología,Entrega hospitalaria",MILRINONA SOLUCION INYECTABLE CADA FRASCO AMPULA CONTIENE: LACTATO DE MILRINONA EQUIVALENTE A 20 MG DE MILRINONA. ENVASE CON UN FRASCO AMPULA CON 20 ML (1 MG/1 ML).,ENV,1,F.A,20,miligramos,20,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1277,Grupo Nº 3: Cardiología,MILRINONA,5100,5100,1000051000101,010,000,5100,01,01,SI,"Entrega hospitalaria,Uso Hospitalario, Cardiología,Uso Hospitalario, Cardiología,Entrega hospitalaria",MILRINONA. SOLUCION INYECTABLE CADA AMPOLLETA CONTIENE: LACTATO DE MILRINONA EQUIVALENTE A 10 MG DE MILRINONA. ENVASE CON TRES AMPOLLETAS CON 10 ML CADA UNA (1 MG/1 ML).,ENV,3,F.A,10,miligramos,30,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1278,Grupo Nº 3: Cardiología,ESMOLOL,5104,5104,1000051040000,010,000,5104,00,00,SI,"Sustantiva,Uso Hospitalario, Cardiología",ESMOLOL SOLUCION INYECTABLE CADA FRASCO AMPULA CONTIENE: CLORHIDRATO DE ESMOLOL  100 MG ENVASE CON UN FRASCO AMPULA CON 10 ML (10 MG/ ML).,ENV,1,F.A,100,miligramos,100,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1279,Grupo Nº 3: Cardiología,ESMOLOL,5105,5105,1000051050000,010,000,5105,00,00,SI,"Entrega hospitalaria,Uso Hospitalario, Cardiología",ESMOLOL SOLUCION INYECTABLE CADA AMPOLLETA CONTIENE: CLORHIDRATO DE ESMOLOL 2.5  G ENVASE CON 2 AMPOLLETAS CON 10 ML. (250 MG/ ML).,ENV,2,AMP,250,miligramos,500,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1281,Grupo Nº 3: Cardiología,ALTEPLASA,5107,5107,1000051070000,010,000,5107,00,00,SI,"Entrega hospitalaria,Uso Hospitalario, Cardiología",ALTEPLASA SOLUCION INYECTABLE CADA FRASCO AMPULA CON LIOFILIZADO CONTIENE:  ALTEPLASA (ACTIVADOR TISULAR DEL PLASMINOGENO HUMANO) 50 MG ENVASE CON 2  FRASCOS AMPULA CON LIOFILIZADO. 2 FRASCOS AMPULA CON DISOLVENTE Y EQUIPO,ENV,1,JGO,50,miligramos,50,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1282,Grupo Nº 3: Cardiología,VALSARTÁN,5111,5111,1000051110000,010,000,5111,00,00,SI,"VALES,Sustantiva -- Eficiencia terapeutica B - 10%",VALSARTAN COMPRIMIDO CADA COMPRIMIDO CONTIENE 80 MG ENVASE CON 30 COMPRIMIDOS.,ENV,30,COM,80,miligramos,2400,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1283,Grupo Nº 3: Cardiología,TENECTEPLASA,5117,5117,1000051170000,010,000,5117,00,00,SI,"Entrega hospitalaria,Uso Hospitalario, Cardiología","TENECTEPLASA SOLUCION INYECTABLE CADA FRASCO AMPULA CONTIENE: TENECTEPLASA 50  MG (10,000 U) ENVASE CON FRASCO AMPULA Y JERINGA PRELLENADA CON 10 ML DE AGUA  INYECTABLE.",ENV,1,JGO,50,miligramos,50,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
658,Grupo Nº 4: Dermatología,ISOTRETINOINA,4129,4129,4000041290000,040,000,4129,00,00,SI,Sustantiva,ISOTRETINOINA CAPSULA CADA CAPSULA CONTIENE: ISOTRETINOINA 20 MG ENVASE CON 30  CAPSULAS.,ENV,30,CAP,20,miligramos,600,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
776,Grupo Nº 4: Dermatología,BAÑO COLOIDE,801,0801,1000008010000,010,000,0801,00,00,SI,Sustantiva,BAÑO COLOIDE POLVO CADA GRAMO CONTIENE: HARINA DE SOYA 965 MG (CONTENIDO PROTEICO 45%) POLIVIDONA 20 MG ENVASE CON UN SOBRE INDIVIDUAL DE 90 G.,ENV,1,SBR,90,gramos,90,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,VARIOS,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0
777,Grupo Nº 4: Dermatología,BAÑO COLOIDE,801,0801,1000008010103,010,000,0801,01,03,NO,Sustantiva,BAÑO COLOIDE POLVO CADA GRAMO CONTIENE: HARINA DE SOYA 965 MG (CONTENIDO PROTEICO 45%) POLIVIDONA 20 MG. ENVASE CON DOS SOBRES INDIVIDUALES DE 90 G.,ENV,2,SBR,90,gramos,180,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,VARIOS,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0
778,Grupo Nº 4: Dermatología,ÓXIDO DE ZINC,804,0804,1000008040000,010,000,0804,00,00,SI,"VALES,Sustantiva",OXIDO DE ZINC PASTA CADA 100 G CONTIENEN: OXIDO DE ZINC 25. 0 G ENVASE CON 30 G.,ENV,1,PZA,25,gramos,25,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,VARIOS,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0
779,Grupo Nº 4: Dermatología,FLUOCINOLONA,811,0811,1000008110000,010,000,0811,00,00,SI,VALES,FLUOCINOLONA CREMA CADA G CONTIENE: ACETONIDO DE FLUOCINOLONA 0.1 MG ENVASE CON 20 G.,ENV,1,TBO,0.1,miligramos,0.1,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIFLAMATORIOS_ESTEROIDEOS,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
780,Grupo Nº 4: Dermatología,HIDROCORTISONA,813,0813,1000008130000,010,000,0813,00,00,SI,"VALES,Sustantiva",HIDROCORTISONA CREMA CADA G CONTIENE: 17 BUTIRATO DE HIDROCORTISONA 1 MG ENVASE CON 15 G.,ENV,1,TBO,1,miligramos,1,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
781,Grupo Nº 4: Dermatología,BENZOILO,822,0822,1000008220000,010,000,0822,00,00,NO,"VALES,Sustantiva",BENZOILO. LOCION DERMICA O GEL DERMICO. CADA 100 MILILITROS O GRAMOS CONTIENEN:  PEROXIDO DE BENZOILO 5 G. ENVASE CON 30 ML.,ENV,30,ML.,5,gramos,5,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
782,Grupo Nº 4: Dermatología,BENZOILO,822,0822,1000008220100,010,000,0822,01,00,NO,"VALES,Sustantiva",BENZOILO LOCION DERMICA O GEL DERMICO CADA 100 MILILITROS O GRAMOS CONTIENEN: PEROXIDO DE BENZOILO 5 G ENVASE CON 50 ML,ENV,50,ML.,5,gramos,5,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
783,Grupo Nº 4: Dermatología,BENZOILO,822,0822,1000008220200,010,000,0822,02,00,SI,"VALES,Sustantiva",BENZOILO. LOCION DERMICA O GEL DERMICO. CADA 100 MILILITROS O GRAMOS CONTIENEN: PEROXIDO DE BENZOILO 5 G. ENVASE CON 60 G.,ENV,60,GRO,5,gramos,300,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
784,Grupo Nº 4: Dermatología,ALANTOINA Y ALQUITRÁN DE HULLA,831,0831,1000008310000,010,000,0831,00,00,SI,Sustantiva,ALANTOINA Y ALQUITRAN DE HULLA SUSPENSION DERMICA CADA ML CONTIENE: ALANTOINA 20.0 MG ALQUITRAN DE HULLA 9.4 MG ENVASE CON 120 ML.,ENV,120,ML.,29.4,miligramos,29.4,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
785,Grupo Nº 4: Dermatología,BENCILO,861,0861,1000008610000,010,000,0861,00,00,SI,"VALES,Sustantiva",BENCILO EMULSION DERMICA CADA ML CONTIENE: BENZOATO DE BENCILO 300 MG ENVASE CON 120 ML.,ENV,120,ML.,300,miligramos,300,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
786,Grupo Nº 4: Dermatología,ALIBOUR,871,0871,1000008710000,010,000,0871,00,00,SI,"VALES,Sustantiva",ALIBOUR POLVO CADA GRAMO CONTIENE: SULFATO DE COBRE 177.0 MG SULFATO DE ZINC 619.5 MG ALCANFOR 26.5 MG ENVASE CON 12 SOBRES CON 2.2 G.,ENV,12,SBR,823,miligramos,9876,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
787,Grupo Nº 4: Dermatología,CLIOQUINOL,872,0872,1000008720000,010,000,0872,00,00,SI,"VALES,Sustantiva",CLIOQUINOL CREMA CADA G CONTIENE: CLIOQUINOL 30 MG ENVASE CON 20 G.,ENV,1,TBO,30,miligramos,30,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIMICOTICOS_SISTEMICOS_Y_TOPICOS,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
788,Grupo Nº 4: Dermatología,MICONAZOL,891,0891,1000008910000,010,000,0891,00,00,SI,"VALES,Consumo en demanda",MICONAZOL CREMA CADA GRAMO CONTIENE: NITRATO DE MICONAZOL 20 MG ENVASE CON 20 G.,ENV,1,ENV,20,miligramos,20,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIMICOTICOS_SISTEMICOS_Y_TOPICOS,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
789,Grupo Nº 4: Dermatología,PODOFILINA,901,0901,1000009010000,010,000,0901,00,00,SI,"VALES,Sustantiva",PODOFILINA SOLUCION DERMICA CADA ML CONTIENE: RESINA DE PODOFILINA 250 MG ENVASE CON 5 ML.,ENV,1,ENV,250,miligramos,250,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
790,Grupo Nº 4: Dermatología,FLUOROURACILO,903,0903,1000009030000,010,000,0903,00,00,SI,"VALES,Sustantiva",FLUOROURACILO CREMA O UNGUENTO CADA GRAMO CONTIENE: 5- FLUOROURACILO 50 MG ENVASE CON 20 G.,ENV,1,ENV,50,miligramos,50,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
791,Grupo Nº 4: Dermatología,ÁCIDO RETINOICO,904,0904,1000009040000,010,000,0904,00,00,SI,"VALES,Sustantiva",ACIDO RETINOICO CREMA CADA 100 GRAMOS CONTIENEN: ACIDO RETINOICO 0.05 G ENVASE CON 20 G.,ENV,1,TBO,0.05,gramos,0.05,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,VARIOS,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0
1020,Grupo Nº 4: Dermatología,SULFADIAZINA DE PLATA,4126,4126,1000041260000,010,000,4126,00,00,SI,Sustantiva,SULFADIAZINA DE PLATA CREMA CADA 100 GRAMOS CONTIENE: SULFADIAZINA DE PLATA MICRONIZADA 1 G ENVASE CON 375 G.,ENV,1,PZA,3.75,gramos,3.75,gramos,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1021,Grupo Nº 4: Dermatología,PIMECROLIMUS,4131,4131,1000041310002,010,000,4131,00,02,NO,"Sustantiva,VALES",PIMECROLIMUS. CREMA. CADA 100 G CONTIENE: PIMECROLIMUS 1 G. ENVASE CON 15 G.,ENV,15,CHO,1,gramos,15,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1022,Grupo Nº 4: Dermatología,PIMECROLIMUS,4131,4131,1000041310100,010,000,4131,01,00,SI,"Sustantiva,VALES",PIMECROLIMUS CREMA CADA 100 G CONTIENE: PIMECROLIMUS 1 G ENVASE CON 30 G.,ENV,30,GRO,1,gramos,30,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1023,Grupo Nº 4: Dermatología,IMIQUIMOD,4140,4140,1000041400000,010,000,4140,00,00,SI,"Sustantiva,VALES","IMIQUIMOD CREMA AL 5% CADA SOBRE CONTIENE: IMIQUIMOD 12.5 MG ENVASE CON 12 SOBRES, QUE CONTIENEN 250 MG DE CREMA.",ENV,12,SBR,250,miligramos,3000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1284,Grupo Nº 4: Dermatología,METOXALENO,5126,5126,1000051260000,010,000,5126,00,00,SI,Sustantiva,METOXALENO CAPSULA O TABLETA CADA CAPSULA O TABLETA CONTIENE: METOXALENO 10 MG  ENVASE CON 30 CAPSULAS O TABLETAS.,ENV,30,C.T,10,miligramos,300,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1285,Grupo Nº 4: Dermatología,"ALANTOINA, ALQUITRÁN DE HULLA Y CLIOQUINOL",5132,5132,1000051320000,010,000,5132,00,00,SI,Sustantiva,"ALANTOINA, ALQUITRAN DE HULLA Y CLIOQUINOL CREMA CADA 100 GRAMOS CONTIENEN:  ALANTOINA 0.2 G SOLUCION DE ALQUITRAN DE HULLA 5.0 G CLIOQUINOL 3.0 G ENVASE  CON 60 G.",ENV,1,ENV,8.2,gramos,8.2,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1286,Grupo Nº 4: Dermatología,"ALANTOINA, ALQUITRÁN DE HULLA Y CLIOQUINOL",5132,5132,1000051320100,010,000,5132,01,00,NO,Sustantiva,"ALANTOINA, ALQUITRAN DE HULLA Y CLIOQUINOL. CREMA. CADA 100 GRAMOS CONTIENEN: ALANTOINA 0.2 G. SOLUCION DE ALQUITRAN DE HULLA 5.0 G. CLIOQUINOL 3.0 G. ENVASE CON 150 G.",ENV,150,F.A,9.3,gramos,1395,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
175,Grupo Nº 5: Endocrinología y Metabolismo,GALSULFASA,5543,5543,1000055430000,010,000,5543,00,00,SI,Catálogo II -- GEEL,GALSULFASA SOLUCION INYECTABLE CADA FRASCO AMPULA CONTIENE: GALSULFASA 5 MG  ENVASE CON UN FRASCO AMPULA CON 5 ML (1 MG/ML).,ENV,1,F.A,5,miligramos,5,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
179,Grupo Nº 5: Endocrinología y Metabolismo,IMIGLUCERASA,5545,5545,1000055450000,010,000,5545,00,00,SI,Catálogo II -- GEEL,IMIGLUCERASA SOLUCION INYECTABLE CADA FRASCO AMPULA CON POLVO CONTIENE:  IMIGLUCERASA 400 U ENVASE CON FRASCO AMPULA CON POLVO LIOFILIZADO.,ENV,1,F.A,400,U,400,U,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
180,Grupo Nº 5: Endocrinología y Metabolismo,AGALSIDASA BETA,5546,5546,1000055460000,010,000,5546,00,00,SI,Catálogo II -- GEEL,AGALSIDASA BETA SOLUCION INYECTABLE CADA FRASCO AMPULA CON POLVO O LIOFILIZADO  CONTIENE: AGALSIDASA BETA 35 MG ENVASE CON FRASCO AMPULA CON POLVO  LIOFILIZADO.,ENV,1,F.A,35,miligramos,35,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
181,Grupo Nº 5: Endocrinología y Metabolismo,LARONIDASA,5547,5547,1000055470000,010,000,5547,00,00,SI,"Catálogo II -- GEEL,Uso Hospitalario, Endocrinología y Metabolismo",LARONIDASA SOLUCION INYECTABLE CADA FRASCO AMPULA CONTIENE: LARONIDASA 2.9 MG  (500 U) ENVASE CON FRASCO AMPULA CON 5 ML (2.9 MG O 500 U).,ENV,1,F.A,2.9,miligramos,2.9,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
182,Grupo Nº 5: Endocrinología y Metabolismo,ALGLUCOSIDASA ALFA,5548,5548,1000055480000,010,000,5548,00,00,SI,Catálogo II -- GEEL,ALGLUCOSIDASA ALFA SOLUCION INYECTABLE CADA FRASCO AMPULA CON POLVO CONTIENE:  ALGLUCOSIDASA ALFA 50 MG ENVASE CON FRASCO AMPULA CON POLVO LIOFILIZADO.,ENV,1,F.A,50,miligramos,50,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
183,Grupo Nº 5: Endocrinología y Metabolismo,AGALSIDASA ALFA,5549,5549,1000055490000,010,000,5549,00,00,SI,Catálogo II -- GEEL,AGALSIDASA ALFA SOLUCION INYECTABLE CADA FRASCO AMPULA CONTIENE: AGALSIDASA  ALFA 3.5 MG ENVASE CON FRASCO AMPULA CON 3.5 ML (1 MG/ML).,ENV,1,F.A,3.5,miligramos,3.5,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
184,Grupo Nº 5: Endocrinología y Metabolismo,IDURSULFASA,5550,5550,1000055500000,010,000,5550,00,00,SI,Catálogo II -- GEEL,IDURSULFASA SOLUCION INYECTABLE CADA FRASCO AMPULA CONTIENE: IDURSULFASA 6 MG  ENVASE CON FRASCO AMPULA CON 3 ML (6 MG/3 ML).,ENV,1,F.A,6,miligramos,6,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
189,Grupo Nº 5: Endocrinología y Metabolismo,LANREOTIDO,5610,5610,1000056100002,010,000,5610,00,02,NO,"Entrega hospitalaria,Entrega hospitalaria",LANREOTIDO. SOLUCION INYECTABLE. CADA JERINGA PRELLENADA CONTIENE: ACETATO DE LANREOTIDO EQUIVALENTE A 90 MG DE LANREOTIDO. ENVASE CON UNA JERINGA PRELLENADA CON 0.3 ML.,ENV,1,JGA,90,miligramos,90,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
190,Grupo Nº 5: Endocrinología y Metabolismo,LANREOTIDO,5610,5610,1000056100100,010,000,5610,01,00,SI,"Entrega hospitalaria,Entrega hospitalaria",LANREOTIDO SOLUCION INYECTABLE CADA JERINGA PRELLENADA CONTIENE: ACETATO DE LANREOTIDO EQUIVALENTE A  90 MG DE LANREOTIDO. ENVASE CON UNA JERINGA PRELLENADA DE 0.5 ML CON DISPOSITIVO DE SEGURIDAD.,ENV,1,JGA,90,miligramos,90,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
191,Grupo Nº 5: Endocrinología y Metabolismo,LANREOTIDO,5611,5611,1000056110002,010,000,5611,00,02,NO,"Entrega hospitalaria,Entrega hospitalaria",LANREOTIDO. SOLUCION INYECTABLE. CADA JERINGA PRELLENADA CONTIENE: ACETATO DE LANREOTIDO EQUIVALENTE A 120 MG DE LANREOTIDO. ENVASE CON UNA JERINGA PRELLENADA CON 0.5 ML.,ENV,1,JGA,120,miligramos,120,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
192,Grupo Nº 5: Endocrinología y Metabolismo,LANREOTIDO,5611,5611,1000056110100,010,000,5611,01,00,SI,"Entrega hospitalaria,Entrega hospitalaria",LANREOTIDO SOLUCION INYECTABLE CADA JERINGA PRELLENADA CONTIENE: ACETATO DE LANREOTIDO EQUIVALENTE A 120 MG DE LANREOTIDO. ENVASE CON UNA JERINGA PRELLENADA DE 0.5 ML CON DISPOSITIVO DE SEGURIDAD.,ENV,1,JGA,120,miligramos,120,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
193,Grupo Nº 5: Endocrinología y Metabolismo,TALIGLUCERASA ALFA,5614,5614,1000056140000,010,000,5614,00,00,SI,Catálogo II -- GEEL,TALIGLUCERASA ALFA. SOLUCION INYECTABLE CADA FRASCO AMPULA CON LIOFILIZADO  CONTIENE: TALIGLUCERASA ALFA 200 U. ENVASE CON FRASCO AMPULA CON POLVO  LIOFILIZADO.,ENV,1,F.A,200,U,200,U,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
194,Grupo Nº 5: Endocrinología y Metabolismo,VELAGLUCERASA ALFA,5615,5615,1000056150000,010,000,5615,00,00,SI,Catálogo II -- GEEL,VELAGLUCERASA ALFA. SOLUCION INYECTABLE. CADA FRASCO AMPULA CON LIOFILIZADO  CONTIENE: VELAGLUCERASA ALFA DE 400 U. ENVASE CON FRASCO AMPULA CON  LIOFILIZADO.,ENV,1,F.A,400,U,400,U,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
204,Grupo Nº 5: Endocrinología y Metabolismo,DESMOPRESINA,5690,5690,1000056900000,010,000,5690,00,00,SI,Sustantiva,"DESMOPRESINA, TABLETA. CADA TABLETA CONTIENE: ACETATO DE DESMOPRESINA  EQUIVALENTE A 60 MICROGRAMOS DE DESMOPRESINA. ENVASE CON 30 TABLETAS",ENV,30,TAB,60,microgramos,1800,microgramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
205,Grupo Nº 5: Endocrinología y Metabolismo,DESMOPRESINA,5691,5691,1000056910000,010,000,5691,00,00,SI,Sustantiva,"DESMOPRESINA, TABLETA. CADA TABLETA CONTIENE: ACETATO DE DESMOPRESINA  EQUIVALENTE A 120 MICROGRAMOS DE DESMOPRESINA. ENVASE CON 30 TABLETAS.",ENV,30,TAB,120,microgramos,3600,microgramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
237,Grupo Nº 5: Endocrinología y Metabolismo,CARBONATO DE CALCIO / VITAMINA D,6000,6000,1000060000000,010,000,6000,00,00,SI,Sustantiva -- Eficiencia terapeutica P - 17%,CARBONATO DE CALCIO / VITAMINA D3. TABLETA. CADA TABLETA CONTIENE: CARBONATO DE CALCIO 1666.670 MG. EQUIVALENTE A 600 MG DE CALCIO COLECALCIFEROL 6.2 MG  EQUIVALENTE A 400 UI DE VITAMINA D3. ENVASE CON 30 TABLETAS.,ENV,30,TAB,600,miligramos,18000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
265,Grupo Nº 5: Endocrinología y Metabolismo,AGALSIDASA BETA,6116,6116,1000061160000,010,000,6116,00,00,SI,,AGALSIDASA BETA. SOLUCION INYECTABLE. CADA FRASCO AMPULA CON POLVO LIOFILIZADO CONTIENE: AGALSIDASA BETA 5 MG. ENVASE CON FRASCO AMPULA CON POLVO LIOFILIZADO.,ENV,1,F.A,5,miligramos,5,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
468,Grupo Nº 5: Endocrinología y Metabolismo,PREDNISOLONA,2482,2482,1000024820000,010,000,2482,00,00,SI,"VALES,Sustantiva",PREDNISOLONA SOLUCION ORAL CADA 100 ML CONTIENEN: FOSFATO SODICO DE  PREDNISOLONA EQUIVALENTE A 100 MG DE PREDNISOLONA. ENVASE CON FRASCO DE 100 ML  Y VASO GRADUADO DE 20 ML.,ENV,1,ENV,100,miligramos,100,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
726,Grupo Nº 5: Endocrinología y Metabolismo,PREDNISONA,472,0472,1000004720000,010,000,0472,00,00,SI,"VALES,Sustantiva",PREDNISONA TABLETA CADA TABLETA CONTIENE: PREDNISONA 5 MG ENVASE CON 20 TABLETAS.,ENV,20,TAB,5,miligramos,100,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIFLAMATORIOS_ESTEROIDEOS,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
727,Grupo Nº 5: Endocrinología y Metabolismo,PREDNISONA,473,0473,1000004730000,010,000,0473,00,00,SI,"VALES,Sustantiva",PREDNISONA TABLETA CADA TABLETA CONTIENE: PREDNISONA 50 MG ENVASE CON 20 TABLETAS.,ENV,20,TAB,50,miligramos,1000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
729,Grupo Nº 5: Endocrinología y Metabolismo,METILPREDNISOLONA,476,0476,1000004760000,010,000,0476,00,00,SI,Entrega hospitalaria,METILPREDNISOLONA SOLUCION INYECTABLE CADA FRASCO AMPULA CON LIOFILIZADO CONTIENE SUCCINATO SODICO DE METILPREDNISOLONA EQUIVALENTE A 500 MG DE METILPREDNISOLONA. ENVASE CON 50 FRASCOS AMPULA Y 50 AMPOLLETAS CON 8 ML DE,ENV,50,JGO,500,miligramos,25000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
774,Grupo Nº 5: Endocrinología y Metabolismo,BEZAFIBRATO,655,0655,1000006550000,010,000,0655,00,00,SI,"VALES,Consumo en demanda",BEZAFIBRATO TABLETA CADA TABLETA CONTIENE: BEZAFIBRATO 200 MG ENVASE CON 30 TABLETAS.,ENV,30,TAB,200,miligramos,6000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,HIPOLIPEMIANTES,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0
775,Grupo Nº 5: Endocrinología y Metabolismo,PRAVASTATINA,657,0657,1000006570000,010,000,0657,00,00,SI,"VALES,Consumo en demanda",PRAVASTATINA TABLETA CADA TABLETA CONTIENE: PRAVASTATINA SODICA 10 MG ENVASE CON 30 TABLETAS.,ENV,30,TAB,10,miligramos,300,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,HIPOLIPEMIANTES,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0
793,Grupo Nº 5: Endocrinología y Metabolismo,CALCIO,1006,1006,1000010060000,010,000,1006,00,00,SI,"VALES,Sustantiva -- Eficiencia terapeutica P - 83%",CALCIO COMPRIMIDO EFERVESCENTE CADA COMPRIMIDO CONTIENE: LACTATO GLUCONATO DE CALCIO 2.94 G CARBONATO DE CALCIO 300 MG EQUIVALENTE A 500 MG DE CALCIO IONIZABLE. ENVASE CON 12 COMPRIMIDOS.,ENV,12,COM,500,miligramos,6000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,FARMACOS_UTILIZADOS_EN_NEFROLOGIA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0
794,Grupo Nº 5: Endocrinología y Metabolismo,LEVOTIROXINA,1007,1007,1000010070000,010,000,1007,00,00,SI,"VALES,Sustantiva",LEVOTIROXINA TABLETA CADA TABLETA CONTIENE: LEVOTIROXINA SODICA EQUIVALENTE A 100 MICROGRAMOS DE LEVOTIROXINA SODICA ANHIDRA. ENVASE CON 100 TABLETAS.,ENV,100,TAB,100,microgramos,10000,microgramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,FARMACOS_UTILIZADOS_EN_HIPOTIROIDISMO,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0
795,Grupo Nº 5: Endocrinología y Metabolismo,TIAMAZOL,1022,1022,1000010220000,010,000,1022,00,00,SI,"VALES,Sustantiva",TIAMAZOL TABLETA CADA TABLETA CONTIENE: TIAMAZOL 5 MG ENVASE CON 20 TABLETAS.,ENV,20,TAB,5,miligramos,100,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,FARMACOS_UTILIZADOS_EN_HIPERTIROIDISMO,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0
796,Grupo Nº 5: Endocrinología y Metabolismo,GLIBENCLAMIDA,1042,1042,1000010420000,010,000,1042,00,00,SI,"VALES,Consumo en demanda",GLIBENCLAMIDA TABLETA CADA TABLETA CONTIENE: GLIBENCLAMIDA 5 MG ENVASE CON 50 TABLETAS.,ENV,50,TAB,5,miligramos,250,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIDIABETICOS,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
797,Grupo Nº 5: Endocrinología y Metabolismo,INSULINA HUMANA,1050,1050,1000010500002,010,000,1050,00,02,NO,"VALES,Sustantiva -- Eficiencia terapeutica C - 75%",INSULINA HUMANA. SUSPENSION INYECTABLE ACCION INTERMEDIA NPH. CADA ML CONTIENE: INSULINA HUMANA ISOFANA (ORIGEN ADN RECOMBINANTE) 100 UI O INSULINA ZINC ISOFANA HUMANA (ORIGEN ADN RECOMBINANTE) 100 UI. ENVASE CON UN FRASCO AMPULA,ENV,1,FCO,100,UI,100,UI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIDIABETICOS,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
798,Grupo Nº 5: Endocrinología y Metabolismo,INSULINA HUMANA,1050,1050,1000010500100,010,000,1050,01,00,SI,"VALES,Sustantiva -- Eficiencia terapeutica C - 75%",INSULINA HUMANA ACCION INTERMEDIA NPH SUSPENSION INYECTABLE ACCION INTERMEDIA NPH CADA ML CONTIENE: INSULINA HUMANA ISOFANA (ORIGEN ADN RECOMBINANTE) 100 UI O INSULINA ZINC ISOFANA HUMANA (ORIGEN ADN RECOMBINANTE) 100 UI ENVASE CON UN,ENV,1,FAJ,100,UI,100,UI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIDIABETICOS,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
799,Grupo Nº 5: Endocrinología y Metabolismo,INSULINA HUMANA,1050,1050,1000010500102,010,000,1050,01,02,NO,"VALES,Sustantiva -- Eficiencia terapeutica C - 75%",INSULINA HUMANA. SUSPENSION INYECTABLE ACCION INTERMEDIA NPH. CADA ML CONTIENE: INSULINA HUMANA ISOFANA (ORIGEN ADN RECOMBINANTE) 100 UI O INSULINA ZINC ISOFANA HUMANA (ORIGEN ADN RECOMBINANTE) 100 UI. ENVASE CON UN FRASCO AMPULA,ENV,1,F.A,100,UI,100,UI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIDIABETICOS,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
800,Grupo Nº 5: Endocrinología y Metabolismo,INSULINA HUMANA,1051,1051,1000010510000,010,000,1051,00,00,NO,"VALES,Sustantiva",INSULINA HUMANA. SOLUCION INYECTABLE ACCION RAPIDA REGULAR. CADA ML CONTIENE: INSULINA HUMANA (ORIGEN ADN RECOMBINANTE) 100 UI O INSULINA ZINC ISOFANA HUMANA (ORIGEN ADN RECOMBINANTE) 100 UI. ENVASE CON UN FRASCO AMPULA CON 5 ML.,ENV,1,FCO,100,UI,100,UI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
801,Grupo Nº 5: Endocrinología y Metabolismo,INSULINA HUMANA,1051,1051,1000010510100,010,000,1051,01,00,SI,"VALES,Sustantiva",INSULINA HUMANA ACCION RAPIDA REGULAR SOLUCION INYECTABLE ACCION RAPIDA REGULAR CADA ML CONTIENE: INSULINA HUMANA (ORIGEN ADN RECOMBINANTE) 100 UI O INSULINA ZINC ISOFANA HUMANA (ORIGEN ADN RECOMBINANTE) 100 UI. ENVASE CON UN FRASCO,ENV,1,FAJ,100,UI,100,UI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
802,Grupo Nº 5: Endocrinología y Metabolismo,TESTOSTERONA,1061,1061,1000010610000,010,000,1061,00,00,SI,"VALES,Sustantiva",TESTOSTERONA SOLUCION INYECTABLE CADA AMPOLLETA CONTIENE: ENANTATO DE  TESTOSTERONA 250 MG ENVASE CON AMPOLLETA CON 1 ML.,ENV,1,AMP,250,miligramos,250,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
803,Grupo Nº 5: Endocrinología y Metabolismo,GONADOTROFINA CORIÓNICA,1081,1081,1000010810000,010,000,1081,00,00,NO,Sustantiva,GONADOTROFINA CORIONICA SOLUCION INYECTABLE CADA FRASCO AMPULA O AMPOLLETA CON LIOFILIZADO CONTIENE: GONADOTROFINA CORIONICA 5 000 UI ENVASE CON 1 FRASCO AMPULA Y AMPOLLETA CON 2 ML DE DILUYENTE.,ENV,1,AFA,5000,UI,5000,UI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
804,Grupo Nº 5: Endocrinología y Metabolismo,GONADOTROFINA CORIÓNICA,1081,1081,1000010810100,010,000,1081,01,00,SI,Sustantiva,GONADOTROFINA CORIONICA SOLUCION INYECTABLE CADA FRASCO AMPULA O AMPOLLETA CON LIOFILIZADO CONTIENE: GONADOTROFINA CORIONICA 5 000 UI ENVASE CON 1 O 3 AMPOLLETAS O FRASCOS VIALES Y 1 O 3 AMPOLLETAS CON 1 ML DE DILUYENTE,ENV,1,JGO,5000,UI,5000,UI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
805,Grupo Nº 5: Endocrinología y Metabolismo,GONADOTROFINA CORIÓNICA,1081,1081,1000010810200,010,000,1081,02,00,NO,Sustantiva,GONADOTROFINA CORIONICA. SOLUCION INYECTABLE. CADA FRASCO AMPULA CON LIOFILIZADO CONTIENE: GONADOTROFINA CORIONICA 250 MICROGRAMOS. ENVASE CON 1 FRASCO AMPULA CON LIOFILIZADO Y FRASCO AMPULA O AMPOLLETA CON 1 ML DE,ENV,1,JGO,250,microgramos,250,microgramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
809,Grupo Nº 5: Endocrinología y Metabolismo,CALCITRIOL,1095,1095,1000010950000,010,000,1095,00,00,SI,"VALES,Sustantiva",CALCITRIOL CAPSULA DE GELATINA BLANDA CADA CAPSULA CONTIENE: CALCITRIOL 0.25 MICROGRAMOS ENVASE CON 50 CAPSULAS.,ENV,50,CAP,0.25,microgramos,12.5,microgramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,FARMACOS_UTILIZADOS_EN_NEFROLOGIA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0
811,Grupo Nº 5: Endocrinología y Metabolismo,DESMOPRESINA,1097,1097,1000010970000,010,000,1097,00,00,SI,"VALES,Sustantiva",DESMOPRESINA SOLUCION NASAL CADA ML CONTIENE: ACETATO DE DESMOPRESINA EQUIVALENTE A 89 MICROGRAMOS DE DESMOPRESINA. ENVASE NEBULIZADOR CON 2.5 ML.,ENV,1,ENV,89,microgramos,89,microgramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
813,Grupo Nº 5: Endocrinología y Metabolismo,DESMOPRESINA,1099,1099,1000010990000,010,000,1099,00,00,SI,"VALES,Entrega hospitalaria,Entrega hospitalaria",DESMOPRESINA TABLETA CADA TABLETA CONTIENE: ACETATO DE DESMOPRESINA EQUIVALENTE A 178 MICROGRAMOS DE DESMOPRESINA. ENVASE CON 30 TABLETAS.,ENV,30,TAB,178,microgramos,5340,microgramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
814,Grupo Nº 5: Endocrinología y Metabolismo,DESMOPRESINA,1099,1099,1000010990002,010,000,1099,00,02,NO,"VALES,Entrega hospitalaria,Entrega hospitalaria",DESMOPRESINA. TABLETA. CADA TABLETA CONTIENE: ACETATO DE DESMOPRESINA 0.2 MG EQUIVALENTE A 178 MICROGRAMOS DE DESMOPRESINA. ENVASE CON 30 TABLETAS.,ENV,30,TAB,178,microgramos,5340,microgramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
933,Grupo Nº 5: Endocrinología y Metabolismo,DEXAMETASONA,3432,3432,1000034320000,010,000,3432,00,00,SI,"Sustantiva,VALES",DEXAMETASONA TABLETA CADA TABLETA CONTIENE DEXAMETASONA 0.5 MG ENVASE CON 30  TABLETAS.,ENV,30,TAB,0.5,miligramos,15,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIFLAMATORIOS_ESTEROIDEOS,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
934,Grupo Nº 5: Endocrinología y Metabolismo,METILPREDNISOLONA,3433,3433,1000034330000,010,000,3433,00,00,SI,Sustantiva,METILPREDNISOLONA SUSPENSION INYECTABLE CADA ML CONTIENE: ACETATO DE  METILPREDNISOLONA 40 MG UN FRASCO AMPULA CON 2 ML.,ENV,1,F.A,40,miligramos,40,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIFLAMATORIOS_ESTEROIDEOS,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
992,Grupo Nº 5: Endocrinología y Metabolismo,EZETIMIBA,4024,4024,1000040240000,010,000,4024,00,00,NO,"Sustantiva,VALES",EZETIMIBA. TABLETA. CADA TABLETA CONTIENE: EZETIMIBA 10 MG. ENVASE CON 7 TABLETAS.,ENV,7,TAB,10,miligramos,70,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,HIPOLIPEMIANTES,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0
993,Grupo Nº 5: Endocrinología y Metabolismo,EZETIMIBA,4024,4024,1000040240100,010,000,4024,01,00,NO,"Sustantiva,VALES",EZETIMIBA. TABLETA. CADA TABLETA CONTIENE: EZETIMIBA 10 MG. ENVASE CON 10 TABLETAS.,ENV,10,TAB,10,miligramos,100,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,HIPOLIPEMIANTES,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0
994,Grupo Nº 5: Endocrinología y Metabolismo,EZETIMIBA,4024,4024,1000040240200,010,000,4024,02,00,NO,"Sustantiva,VALES",EZETIMIBA. TABLETA. CADA TABLETA CONTIENE: EZETIMIBA 10 MG. ENVASE CON 14 TABLETAS.,ENV,14,TAB,10,miligramos,140,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,HIPOLIPEMIANTES,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0
995,Grupo Nº 5: Endocrinología y Metabolismo,EZETIMIBA,4024,4024,1000040240300,010,000,4024,03,00,NO,"Sustantiva,VALES",EZETIMIBA. TABLETA. CADA TABLETA CONTIENE: EZETIMIBA 10 MG. ENVASE CON 21 TABLETAS.,ENV,21,TAB,10,miligramos,210,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,HIPOLIPEMIANTES,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0
996,Grupo Nº 5: Endocrinología y Metabolismo,EZETIMIBA,4024,4024,1000040240400,010,000,4024,04,00,SI,"Sustantiva,VALES",EZETIMIBA TABLETA CADA TABLETA CONTIENE: EZETIMIBA 10 MG ENVASE CON 28 TABLETAS.,ENV,28,TAB,10,miligramos,280,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,HIPOLIPEMIANTES,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0
997,Grupo Nº 5: Endocrinología y Metabolismo,EZETIMIBA,4024,4024,1000040240500,010,000,4024,05,00,NO,"Sustantiva,VALES",EZETIMIBA. TABLETA. CADA TABLETA CONTIENE: EZETIMIBA 10 MG. ENVASE CON 30 TABLETAS.,ENV,30,TAB,10,miligramos,300,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,HIPOLIPEMIANTES,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0
1030,Grupo Nº 5: Endocrinología y Metabolismo,"INSULINA LISPRO, LISPRO PROTAMINA",4148,4148,1000041480002,010,000,4148,00,02,NO,"Sustantiva -- Eficiencia terapeutica C - 5%,VALES","INSULINA LISPRO, LISPRO PROTAMINA. SUSPENSION INYECTABLE. CADA ML CONTIENE: INSULINA LISPRO (ORIGEN ADN RECOMBINANTE) 25 UI INSULINA LISPRO PROTAMINA (ORIGEN ADN RECOMBINANTE) 75 UI. ENVASE CON DOS CARTUCHOS CON 3 ML.",ENV,2,CHO,100,UI,200,UI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIDIABETICOS,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1031,Grupo Nº 5: Endocrinología y Metabolismo,"INSULINA LISPRO, LISPRO PROTAMINA",4148,4148,1000041480100,010,000,4148,01,00,SI,"Sustantiva -- Eficiencia terapeutica C - 5%,VALES","INSULINA LISPRO, LISPRO PROTAMINA.  SUSPENSION INYECTABLE. CADA ML CONTIENE: INSULINA LISPRO (ORIGEN ADN RECOMBINANTE) 25 UI INSULINA LISPRO PROTAMINA (ORIGEN ADN RECOMBINANTE) 75 UI. ENVASE CON UN FRASCO AMPULA CON 10ML.",ENV,1,F.A,100,UI,100,UI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIDIABETICOS,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1032,Grupo Nº 5: Endocrinología y Metabolismo,PIOGLITAZONA,4149,4149,1000041490000,010,000,4149,00,00,SI,"Sustantiva -- Eficiencia terapeutica D - 70%,VALES",PIOGLITAZONA TABLETA CADA TABLETA CONTIENE: CLORHIDRATO DE PIOGLITAZONA EQUIVALENTE A 15 MG DE PIOGLITAZONA. ENVASE CON 7 TABLETAS.,ENV,7,TAB,15,miligramos,105,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIDIABETICOS,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1033,Grupo Nº 5: Endocrinología y Metabolismo,ROSIGLITAZONA,4150,4150,1000041500000,010,000,4150,00,00,NO,Sustantiva -- Eficiencia terapeutica D - 30%,ROSIGLITAZONA. TABLETA. CADA TABLETA CONTIENE: MALEATO DE ROSIGLITAZONA EQUIVALENTE A 4 MG DE ROSIGLITAZONA. ENVASE CON 14 TABLETAS.,ENV,14,TAB,4,miligramos,56,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIDIABETICOS,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1034,Grupo Nº 5: Endocrinología y Metabolismo,ROSIGLITAZONA,4150,4150,1000041500100,010,000,4150,01,00,SI,Sustantiva -- Eficiencia terapeutica D - 30%,ROSIGLITAZONA TABLETA CADA TABLETA CONTIENE: MALEATO DE ROSIGLITAZONA EQUIVALENTE A 4 MG DE ROSIGLITAZONA ENVASE CON 28 TABLETAS.,ENV,28,TAB,4,miligramos,112,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIDIABETICOS,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1037,Grupo Nº 5: Endocrinología y Metabolismo,INSULINA HUMANA,4157,4157,1000041570000,010,000,4157,00,00,SI,Sustantiva,INSULINA HUMANA DE ACCION INTERMEDIA LENTA SUSPENSION INYECTABLE ACCION INTERMEDIA LENTA CADA ML CONTIENE: INSULINA ZINC COMPUESTA HUMANA (ORIGEN ADN RECOMBINANTE) 100 UI ENVASE CON UN FRASCO AMPULA CON 10 ML.,ENV,1,F.A,100,UI,100,UI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1038,Grupo Nº 5: Endocrinología y Metabolismo,INSULINA HUMANA,4157,4157,1000041570002,010,000,4157,00,02,NO,Sustantiva,INSULINA HUMANA SUSPENSION INYECTABLE ACCION INTERMEDIA LENTA CADA ML CONTIENE: INSULINA ZINC COMPUESTA HUMANA (ORIGEN ADN RECOMBINANTE) 100 UI ENVASE CON UN FRASCO AMPULA CON 10 ML.,ENV,1,F.A,100,UI,100,UI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1039,Grupo Nº 5: Endocrinología y Metabolismo,INSULINA GLARGINA,4158,4158,1000041580000,010,000,4158,00,00,SI,"Sustantiva -- Eficiencia terapeutica C - 20%,VALES",INSULINA GLARGINA SOLUCION INYECTABLE CADA ML DE SOLUCION CONTIENE: INSULINA GLARGINA 3.64 MG. EQUIVALENTE A 100 UI DE INSULINA HUMANA. ENVASE CON UN FRASCO AMPULA CON 10 ML.,ENV,1,ENV,3.64,miligramos,3.64,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIDIABETICOS,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1040,Grupo Nº 5: Endocrinología y Metabolismo,INSULINA GLARGINA,4158,4158,1000041580100,010,000,4158,01,00,NO,"Sustantiva -- Eficiencia terapeutica C - 20%,VALES","INSULINA GLARGINA. SOLUCION INYECTABLE, CADA MILILITRO CONTIENE: INSULINA GLARGINA 3.64 MG EQUIVALENTE A 100.0 UI. ENVASE CON 5 CARTUCHOS DE VIDRIO CON 3 ML EN DISPOSITIVO DESECHABLE",ENV,5,CHO,3.64,miligramos,18.2,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIDIABETICOS,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1041,Grupo Nº 5: Endocrinología y Metabolismo,INSULINA GLARGINA,4158,4158,1000041580102,010,000,4158,01,02,NO,"Sustantiva -- Eficiencia terapeutica C - 20%,VALES","INSULINA GLARGINA. SOLUCION INYECTABLE, CADA MILILITRO CONTIENE: INSULINA GLARGINA 3.64 MG EQUIVALENTE A 100.0 UI DE INSULINA HUMANA. ENVASE CON 5 CARTUCHOS DE VIDRIO CON 3 ML EN DISPOSITIVO DESECHABLE.",ENV,5,CHO,3.64,miligramos,18.2,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIDIABETICOS,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1042,Grupo Nº 5: Endocrinología y Metabolismo,FLUDROCORTISONA,4160,4160,1000041600000,010,000,4160,00,00,SI,Sustantiva,FLUDROCORTISONA COMPRIMIDO CADA COMPRIMIDO CONTIENE: ACETATO DE FLUDROCORTISONA 0.1 MG ENVASE CON 100 COMPRIMIDOS.,ENV,100,TAB,0.1,miligramos,10,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1044,Grupo Nº 5: Endocrinología y Metabolismo,INSULINA LISPRO,4162,4162,1000041620000,010,000,4162,00,00,SI,"Sustantiva,VALES",INSULINA LISPRO SOLUCION INYECTABLE. CADA ML CONTIENE: INSULINA LISPRO (ORIGEN  ADN RECOMBINANTE) 100 UI ENVASE CON UN FRASCO AMPULA CON 10 ML.,ENV,1,F.A,100,UI,100,UI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIDIABETICOS,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1237,Grupo Nº 5: Endocrinología y Metabolismo,DEFLAZACORT,4505,4505,1000045050000,010,000,4505,00,00,SI,"VALES,Sustantiva",DEFLAZACORT TABLETA CADA TABLETA CONTIENE: DEFLAZACORT 6 MG ENVASE CON 20  TABLETAS.,ENV,20,TAB,6,miligramos,120,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1238,Grupo Nº 5: Endocrinología y Metabolismo,DEFLAZACORT,4507,4507,1000045070000,010,000,4507,00,00,SI,"VALES,Sustantiva",DEFLAZACORT TABLETA CADA TABLETA CONTIENE: DEFLAZACORT 30 MG ENVASE CON 10  TABLETAS.,ENV,10,TAB,30,miligramos,300,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1280,Grupo Nº 5: Endocrinología y Metabolismo,ATORVASTATINA,5106,5106,1000051060000,010,000,5106,00,00,SI,"VALES,Consumo en demanda",ATORVASTATINA TABLETA CADA TABLETA CONTIENE: ATORVASTATINA CALCICA TRIHIDRATADA  EQUIVALENTE A 20 MG DE ATORVASTATINA. ENVASE CON 10 TABLETAS.,ENV,10,TAB,20,miligramos,200,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,HIPOLIPEMIANTES,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0
1287,Grupo Nº 5: Endocrinología y Metabolismo,CALCITONINA,5161,5161,1000051610000,010,000,5161,00,00,SI,Sustantiva,CALCITONINA SOLUCION INYECTABLE CADA AMPOLLETA O FRASCO AMPULA CON SOLUCION O LIOFILIZADO CONTIENE: CALCITONINA SINTETICA DE SALMON 50 UI ENVASE CON 5 AMPOLLETAS O FRASCOS AMPULA CON DILUYENTE.,ENV,5,JGO,50,UI,250,UI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1288,Grupo Nº 5: Endocrinología y Metabolismo,CALCITONINA,5161,5161,1000051610100,010,000,5161,01,00,NO,Sustantiva,CALCITONINA. SOLUCION INYECTABLE. CADA AMPOLLETA O FRASCO AMPULA CON SOLUCION O LIOFILIZADO CONTIENE: CALCITONINA SINTETICA DE SALMON 50 UI. ENVASE CON 6 AMPOLLETAS O FRASCOS AMPULA CON DILUYENTE.,ENV,6,AFA,50,UI,300,UI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1289,Grupo Nº 5: Endocrinología y Metabolismo,CALCITONINA,5161,5161,1000051610200,010,000,5161,02,00,NO,Sustantiva,CALCITONINA. SOLUCION INYECTABLE. CADA AMPOLLETA O FRASCO AMPULA CON SOLUCION O LIOFILIZADO CONTIENE: CALCITONINA SINTETICA DE SALMON 50 UI. ENVASE CON 12 AMPOLLETAS O FRASCOS AMPULA CON DILUYENTE.,ENV,12,AFA,50,UI,600,UI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1290,Grupo Nº 5: Endocrinología y Metabolismo,SOMATROPINA,5163,5163,1000051630000,010,000,5163,00,00,SI,Sustantiva,SOMATROPINA SOLUCION INYECTABLE CADA FRASCO AMPULA CON LIOFILIZADO CONTIENE:  SOMATROPINA BIOSINTETICA 1.33 MG EQUIVALENTE A 4 UI ENVASE CON FRASCO AMPULA Y  FRASCO AMPULA O AMPOLLETA CON 1 O 2 ML DE DILUYENTE.,ENV,1,JGO,1.33,miligramos,1.33,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1291,Grupo Nº 5: Endocrinología y Metabolismo,TESTOSTERONA,5164,5164,1000051640000,010,000,5164,00,00,SI,Sustantiva,TESTOSTERONA CAPSULA CADA CAPSULA CONTIENE: UNDECANOATO DE TESTOSTERONA 40 MG  ENVASE CON 30 CAPSULAS.,ENV,30,CAP,40,miligramos,1200,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1292,Grupo Nº 5: Endocrinología y Metabolismo,TESTOSTERONA,5164,5164,1000051640100,010,000,5164,01,00,NO,Sustantiva,TESTOSTERONA. CAPSULA. CADA CAPSULA CONTIENE: UNDECANOATO DE TESTOSTERONA 40 MG. ENVASE CON 60 CAPSULAS.,ENV,60,CAP,40,miligramos,2400,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1293,Grupo Nº 5: Endocrinología y Metabolismo,METFORMINA,5165,5165,1000051650000,010,000,5165,00,00,SI,"VALES,Consumo en demanda",METFORMINA TABLETA CADA TABLETA CONTIENE: CLORHIDRATO DE METFORMINA 850 MG  ENVASE CON 30 TABLETAS.,ENV,30,TAB,850,miligramos,25500,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIDIABETICOS,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1294,Grupo Nº 5: Endocrinología y Metabolismo,ACARBOSA,5166,5166,1000051660000,010,000,5166,00,00,SI,"VALES,Sustantiva",ACARBOSA TABLETA CADA TABLETA CONTIENE: ACARBOSA 50 MG ENVASE CON 30 TABLETAS.,ENV,30,COM,50,miligramos,1500,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIDIABETICOS,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1295,Grupo Nº 5: Endocrinología y Metabolismo,SOMATROPINA,5167,5167,1000051670000,010,000,5167,00,00,SI,Sustantiva,"SOMATROPINA SOLUCION INYECTABLE CADA CARTUCHO CON DOS COMPARTIMIENTOS UNO CON LIOFILIZADO CONTIENE: SOMATROPINA 5.3 MG EQUIVALENTE A 16 UI Y OTRO CON EL DILUYENTE.ENVASE CON UN CARTUCHO CON DOS COMPARTIMIENTOS, UNO CON LIOFILIZADO",ENV,1,ENV,5.3,miligramos,5.3,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1296,Grupo Nº 5: Endocrinología y Metabolismo,SOMATROPINA,5167,5167,1000051670100,010,000,5167,01,00,NO,Sustantiva,SOMATROPINA SOLUCION INYECTABLE CADA CARTUCHO CON DOS COMPARTIMIENTOS UNO CON LIOFILIZADO CONTIENE: SOMATROPINA 5.3 MG EQUIVALENTE A 16 UI Y OTRO CON EL DILUYENTE. ENVASE CON FRASCO AMPULA CON LIOFILIZADO Y AMPOLLETA CON 2 ML DE,ENV,1,ENV,5.3,miligramos,5.3,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1297,Grupo Nº 5: Endocrinología y Metabolismo,DESMOPRESINA,5169,5169,1000051690000,010,000,5169,00,00,SI,"Entrega hospitalaria,Uso Hospitalario, Endocrinología y Metabolismo",DESMOPRESINA SOLUCION INYECTABLE CADA AMPOLLETA CONTIENE: ACETATO DE  DESMOPRESINA 15 MICROGRAMOS ENVASE CON 5 AMPOLLETAS CON UN ML.,ENV,5,AMP,15,microgramos,75,microgramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1298,Grupo Nº 5: Endocrinología y Metabolismo,OCTREOTIDA,5171,5171,1000051710000,010,000,5171,00,00,NO,"Entrega hospitalaria,Entrega hospitalaria,Entrega hospitalaria","OCTREOTIDA SUSPENSION INYECTABLE CADA FRASCO AMPULA CONTIENE: ACETATO DE OCTREOTIDA EQUIVALENTE A 20 MG DE OCTREOTIDA. ENVASE CON UN FRASCO AMPULA Y DOS AMPOLLETAS CON DILUYENTE,",ENV,1,ENV,20,miligramos,20,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1299,Grupo Nº 5: Endocrinología y Metabolismo,OCTREOTIDA,5171,5171,1000051710100,010,000,5171,01,00,SI,"Entrega hospitalaria,Entrega hospitalaria,Entrega hospitalaria","OCTREOTIDA. SUSPENSION INYECTABLE, CADA FRASCO AMPULA CONTIENE: ACETATO DE OCTREOTIDA EQUIVALENTE A 20 MG DE OCTREOTIDA. ENVASE CON UN FRASCO AMPULA Y UNA JERINGA PRELLENADA CON 2.5 ML DE DILUYENTE.",ENV,1,JGO,20,miligramos,20,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1300,Grupo Nº 5: Endocrinología y Metabolismo,OCTREOTIDA,5171,5171,1000051710200,010,000,5171,02,00,NO,"Entrega hospitalaria,Entrega hospitalaria,Entrega hospitalaria","OCTREOTIDA. SUSPENSION INYECTABLE, CADA FRASCO AMPULA CONTIENE: ACETATO DE OCTREOTIDA EQUIVALENTE A 20 MG DE OCTREOTIDA. ENVASE CON UN FRASCO AMPULA Y UNA JERINGA PRELLENADA CON 2 ML DE DILUYENTE.",ENV,1,JGO,20,miligramos,20,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,MEROPENEM,5292,5292,1000052920000,010,000,5292,00,00,SI,"Sustantiva,Uso Hospitalario, Enfermedades Infecciosas y Parasitarias,Uso Hospitalario, Enfermedades Infecciosas y Parasitarias",MEROPENEM SOLUCION INYECTABLE CADA FRASCO AMPULA CON POLVO CONTIENE: MEROPENEM  TRIHIDRATADO EQUIVALENTE A 1 G DE MEROPENEM. ENVASE CON 1 FRASCO AMPULA.,ENV,1,F.A,1,gramos,1,gramos,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
2,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,MEROPENEM,5292,5292,1000052920100,010,000,5292,01,00,NO,"Sustantiva,Uso Hospitalario, Enfermedades Infecciosas y Parasitarias,Uso Hospitalario, Enfermedades Infecciosas y Parasitarias",MEROPENEM. SOLUCION INYECTABLE. CADA FRASCO AMPULA CON POLVO CONTIENE: MEROPENEM TRIHIDRATADO EQUIVALENTE A 1 G DE MEROPENEM. ENVASE CON 10 FRASCOS AMPULA.,ENV,10,F.A,1,gramos,10,gramos,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
3,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,ESTAVUDINA,5293,5293,1000052930000,010,000,5293,00,00,SI,Sin programa definido,ESTAVUDINA CAPSULA CADA CAPSULA CONTIENE: ESTAVUDINA 15 MG ENVASE CON 60  CAPSULAS.,ENV,60,CAP,15,miligramos,900,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
4,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,ESTAVUDINA,5294,5294,1000052940000,010,000,5294,00,00,SI,"Antirretrovirales,Sustantiva -- VIH",ESTAVUDINA CAPSULA CADA CAPSULA CONTIENE: ESTAVUDINA 40 MG ENVASE CON 60  CAPSULAS.,ENV,60,CAP,40,miligramos,2400,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
5,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,CEFEPIMA,5295,5295,1000052950000,010,000,5295,00,00,NO,Sustantiva,CEFEPIMA. SOLUCION INYECTABLE. CADA FRASCO AMPULA CONTIENE: CLORHIDRATO MONOHIDRATADO DE CEFEPIMA EQUIVALENTE A 1 G DE CEFEPIMA. ENVASE CON UN FRASCO AMPULA Y AMPOLLETA CON 3 ML DE DILUYENTE.,ENV,1,JGO,1,gramos,1,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
6,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,CEFEPIMA,5295,5295,1000052950100,010,000,5295,01,00,SI,Sustantiva,CEFEPIMA SOLUCION INYECTABLE CADA FRASCO AMPULA CONTIENE: CLORHIDRATO  MONOHIDRATADO DE CEFEPIMA EQUIVALENTE A 1 G DE CEFEPIMA. ENVASE CON UN FRASCO  AMPULA Y AMPOLLETA CON 10 ML DE DILUYENTE.,ENV,1,JGO,1,gramos,1,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
7,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,NEVIRAPINA,5296,5296,1000052960000,010,000,5296,00,00,SI,"Antirretrovirales,Sustantiva -- VIH",NEVIRAPINA TABLETA CADA TABLETA CONTIENE: NEVIRAPINA 200 MG ENVASE CON 60  TABLETAS.,ENV,60,TAB,200,miligramos,12000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
8,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,NEVIRAPINA,5296,5296,1000052960100,010,000,5296,01,00,NO,"Antirretrovirales,Sustantiva -- VIH",NEVIRAPINA. TABLETA. CADA TABLETA CONTIENE: NEVIRAPINA 200 MG. ENVASE CON 100 TABLETAS.,ENV,100,TAB,200,miligramos,20000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
9,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,EFAVIRENZ,5298,5298,1000052980000,010,000,5298,00,00,SI,Sin programa definido,EFAVIRENZ CAPSULA CADA CAPSULA CONTIENE: EFAVIRENZ 200 MG ENVASE CON 90  CAPSULAS.,ENV,90,CAP,200,miligramos,18000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
10,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,NITROFURANTOÍNA,5302,5302,1000053020000,010,000,5302,00,00,SI,"VALES,Sustantiva",NITROFURANTOINA SUSPENSION ORAL CADA 100 ML CONTIENEN: NITROFURANTOINA 500 MG  ENVASE CON 120 ML (25 MG/5 ML).,FCO,120,ML.,500,miligramos,500,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
18,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,CASPOFUNGINA,5313,5313,1000053130000,010,000,5313,00,00,SI,"Entrega hospitalaria,Uso Hospitalario, Enfermedades Infecciosas y Parasitarias",CASPOFUNGINA SOLUCION INYECTABLE CADA FRASCO AMPULA CON POLVO CONTIENE: ACETATO  DE CASPOFUNGINA EQUIVALENTE A 50 MG DE CASPOFUNGINA. ENVASE CON FRASCO AMPULA  CON POLVO PARA 10.5 ML (5 MG/ML).,ENV,1,ENV,50,miligramos,50,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
19,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,CASPOFUNGINA,5314,5314,1000053140000,010,000,5314,00,00,SI,"Entrega hospitalaria,Uso Hospitalario, Enfermedades Infecciosas y Parasitarias",CASPOFUNGINA SOLUCION INYECTABLE CADA FRASCO AMPULA CON POLVO CONTIENE: ACETATO  DE CASPOFUNGINA EQUIVALENTE A 70 MG DE CASPOFUNGINA. ENVASE CON FRASCO AMPULA  CON POLVO PARA 10.5 ML (7 MG/ML).,ENV,1,ENV,70,miligramos,70,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
20,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,VORICONAZOL,5315,5315,1000053150000,010,000,5315,00,00,SI,"Sustantiva -- Eficiencia terapeutica H - 2%,Uso Hospitalario, Enfermedades Infecciosas y Parasitarias",VORICONAZOL SOLUCION INYECTABLE CADA FRASCO AMPULA CON LIOFILIZADO CONTIENE:  VORICONAZOL 200 MG ENVASE CON UN FRASCO AMPULA CON LIOFILIZADO.,ENV,1,ENV,200,miligramos,200,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
21,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,VORICONAZOL,5317,5317,1000053170000,010,000,5317,00,00,SI,Sustantiva,VORICONAZOL TABLETA CADA TABLETA CONTIENE: VORICONAZOL 50 MG ENVASE CON 14  TABLETAS.,ENV,14,TAB,50,miligramos,700,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
22,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,VORICONAZOL,5318,5318,1000053180000,010,000,5318,00,00,SI,,VORICONAZOL TABLETA CADA TABLETA CONTIENE: VORICONAZOL 200 MG ENVASE CON 14  TABLETAS.,ENV,14,TAB,200,miligramos,2800,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
23,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,DIDANOSINA,5321,5321,1000053210000,010,000,5321,00,00,SI,Sin programa definido,DIDANOSINA CAPSULA CON GRANULOS CON CAPA ENTERICA CADA CAPSULA CON GRANULOS CON  CAPA ENTERICA CONTIENE: DIDANOSINA 200 MG ENVASE CON 30 CAPSULAS.,ENV,30,CAP,200,miligramos,6000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
24,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,DIDANOSINA,5322,5322,1000053220000,010,000,5322,00,00,SI,Antirretrovirales,DIDANOSINA CAPSULA CON GRANULOS CON CAPA ENTERICA CADA CAPSULA CON GRANULOS CON  CAPA ENTERICA CONTIENE: DIDANOSINA 250 MG ENVASE CON 30 CAPSULAS.,ENV,30,CAP,250,miligramos,7500,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
25,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,DIDANOSINA,5323,5323,1000053230000,010,000,5323,00,00,SI,"Sustantiva -- VIH,Antirretrovirales",DIDANOSINA CAPSULA CON GRANULOS CON CAPA ENTERICA CADA CAPSULA CON GRANULOS CON  CAPA ENTERICA CONTIENE: DIDANOSINA 400 MG ENVASE CON 30 CAPSULAS.,ENV,30,CAP,400,miligramos,12000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
26,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,MARAVIROC,5324,5324,1000053240000,010,000,5324,00,00,SI,"Catálogo II -- GERA,Antirretrovirales",MARAVIROC TABLETA. CADA TABLETA CONTIENE: MARAVIROC 150 MG ENVASE CON 60  TABLETAS.,ENV,60,TAB,150,miligramos,9000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
27,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,MARAVIROC,5325,5325,1000053250000,010,000,5325,00,00,SI,"Antirretrovirales,Catálogo II -- GERA",MARAVIROC TABLETA. CADA TABLETA CONTIENE: MARAVIROC 300 MG. ENVASE CON 60  TABLETAS.,ENV,60,TAB,300,miligramos,18000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
28,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,PENTAMIDINA,5328,5328,1000053280000,010,000,5328,00,00,SI,Sin programa definido,PENTAMIDINA SOLUCION INYECTABLE CADA FRASCO AMPULA CON LIOFILIZADO CONTIENE:  ISETIONATO DE PENTAMIDINA 300 MG ENVASE CON UN FRASCO AMPULA.,ENV,1,F.A,300,miligramos,300,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
203,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,RIFAXIMINA,5671,5671,1000056710000,010,000,5671,00,00,SI,Sustantiva,RIFAXIMINA. TABLETA. CADA TABLETA CONTIENE: RIFAXIMINA 200 MG. ENVASE CON 28 TABLETAS.,ENV,28,TAB,200,miligramos,5600,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
223,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,DARUNAVIR,5860,5860,1000058600000,010,000,5860,00,00,SI,,DARUNAVIR. TABLETA. CADA TABLETA CONTIENE: ETANOLATO DE DARUNAVIR EQUIVALENTE A 400 MG DE DARUNAVIR. ENVASE CON 60 TABLETAS.,ENV,60,TAB,400,miligramos,24000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
224,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,DARUNAVIR,5860,5860,1000058600100,010,000,5860,01,00,NO,,DARUNAVIR. TABLETA. CADA TABLETA CONTIENE: DARUNAVIR 400 MG. ENVASE CON 60 TABLETAS.,ENV,60,TAB,400,miligramos,24000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
225,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,DARUNAVIR,5861,5861,1000058610000,010,000,5861,00,00,SI,Sin programa definido,DARUNAVIR TABLETA. CADA TABLETA CONTIENE: ETANOLATO DE DARUNAVIR EQUIVALENTE A 75 MG. DE DARUNAVIR.,ENV,480,TAB,75,miligramos,36000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
226,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,DARUNAVIR,5862,5862,1000058620000,010,000,5862,00,00,SI,"Catálogo II -- GERA,Antirretrovirales",DARUNAVIR TABLETA. CADA TABLETA CONTIENE: ETANOLATO DE DARUNAVIR EQUIVALENTE A 150 MG. DE DARUNAVIR.,ENV,240,TAB,150,miligramos,36000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
228,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,RIBAVIRINA,5920,5920,1000059200000,010,000,5920,00,00,SI,Sustantiva,RIBAVIRINA CAPSULA CADA CAPSULA CONTIENE: RIBAVIRINA 200 MG ENVASE CON 90 CAPSULAS.,ENV,90,CAP,200,miligramos,18000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
229,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,RIBAVIRINA,5920,5920,1000059200100,010,000,5920,01,00,NO,Sustantiva,RIBAVIRINA. TABLETA CADA TABLETA CONTIENE: RIBAVIRINA 200 MG. ENVASE CON 168 TABLETAS.,ENV,168,TAB,200,miligramos,33600,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
239,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,DOLUTEGRAVIR,6010,6010,1000060100001,010,000,6010,00,01,SI,"Catálogo II -- GERA,Antirretrovirales",DOLUTEGRAVIR. TABLETA. CADA TABLETA CONTIENE: DOLUTEGRAVIR SODICO EQUIVALENTE A 50 MG DE DOLUTEGRAVIR. ENVASE CON 30 TABLETAS.,ENV,30,TAB,50,miligramos,1500,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
254,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,"OMBITASVIR, PARITAPREVIR, RITONAVIR Y DASABUVIR",6041,6041,1000060410000,010,000,6041,00,00,SI,Catálogo II -- GEMHEC,"OMBITASVIR, PARITAPREVIR, RITONAVIR Y DASABUVIR. TABLETA. CADA TABLETA CONTIENE: OMBITASVIR 12.5 MG PARITAPREVIR 75.0 MG RITONAVIR 50.0 MG. CADA TABLETA CONTIENE: DASABUVIR 250.0 MG. ENVASE CON 4 CAJAS CADA UNA CON 7",ENV,1,ENV,387.5,miligramos,387.5,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
257,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,"SOFOSBUVIR, LEDIPASVIR",6052,6052,1000060520000,010,000,6052,00,00,SI,Catálogo II -- GEMHEC,"SOFOSBUVIR, LEDIPASVIR. TABLETA. CADA TABLETA CONTIENE: SOFOSBUVIR 400 MG LEDIPASVIR 90 MG. ENVASE CON 28 TABLETAS.",ENV,28,TAB,490,miligramos,13720,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
261,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,ETRAVIRINA,6074,6074,1000060740000,010,000,6074,00,00,SI,,ETRAVIRINA. TABLETA. CADA TABLETA CONTIENE: ETRAVIRINA 200 MG. ENVASE CON 60 TABLETAS.,ENV,60,TAB,200,miligramos,12000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
264,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,DARUNAVIR / COBICISTAT,6098,6098,1000060980000,010,000,6098,00,00,SI,,DARUNAVIR / COBICISTAT. TABLETA. CADA TABLETA CONTIENE: ETANOLATO DE DARUNAVIR EQUIVALENTE A 800 MG DE DARUNAVIR. COBICISTAT EN DIOXIDO DE SILICIO EQUIVALENTE A 150 MG DE COBICISTAT. ENVASE CON 30 TABLETAS.,ENV,30,TAB,950,miligramos,28500,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
266,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,ZIDOVUDINA,6121,6121,1000061210000,010,000,6121,00,00,SI,,ZIDOVUDINA. SOLUCION INYECTABLE. CADA FRASCO AMPULA CONTIENE: ZIDOVUDINA 200 MG. ENVASE CON 5 FRASCOS AMPULA (200 MG/20 ML).,ENV,5,F.A,200,miligramos,1000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
267,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,ELVITEGRAVIR / COBICISTAT / EMTRICITABINA / TENOFOVIR,6126,6126,1000061260000,010,000,6126,00,00,SI,Sustantiva -- VIH,ELVITEGRAVIR / COBICISTAT / EMTRICITABINA / TENOFOVIR. TABLETA. CADA TABLETA CONTIENE: ELVITEGRAVIR 150 MG. COBICISTAT 150 MG. TENOFOVIR DISOPROXIL FUMARATO 300 MG,ENV,30,TAB,600,miligramos,18000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
268,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,"SOFOSBUVIR, VELPATASVIR",6131,6131,1000061310000,010,000,6131,00,00,SI,Catálogo II -- GEMHEC,"SOFOSBUVIR, VELPATASVIR. TABLETA. CADA TABLETA CONTIENE: SOFOSBUVIR 400 MG. VELPATASVIR 100 MG.",ENV,28,TAB,500,miligramos,14000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
271,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,GLECAPREVIR/PIBRENTASVIR,6164,6164,1000061640000,010,000,6164,00,00,SI,Catálogo II -- GEMHEC,"GLECAPREVIR/PIBRENTASVIR. TABLETA. CADA TABLETA CONTIENE: GLECAPREVIR 100 MG. PIBRENTASVIR 40 MG. ENVASE CON 4 CAJAS, CADA UNA CON 7 TIRAS CON 3 TABLETAS CADA UNA.",ENV,4,CJA,100,miligramos,400,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
359,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,AMIKACINA,1956,1956,1000019560000,010,000,1956,00,00,SI,Sustantiva,AMIKACINA SOLUCION INYECTABLE CADA AMPOLLETA O FRASCO AMPULA CONTIENE: SULFATO DE AMIKACINA EQUIVALENTE A 500 MG DE AMIKACINA. ENVASE CON 1 AMPOLLETA O FRASCO AMPULA CON 2 ML.,ENV,1,AFA,500,miligramos,500,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIBIOTICOS,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
360,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,AMIKACINA,1956,1956,1000019560100,010,000,1956,01,00,NO,Sustantiva,AMIKACINA. SOLUCION INYECTABLE. CADA AMPOLLETA O FRASCO AMPULA CONTIENE: SULFATO DE AMIKACINA EQUIVALENTE A 500 MG DE AMIKACINA. ENVASE CON 2 AMPOLLETAS O FRASCO AMPULA CON 2 ML.,ENV,1,ENV,500,miligramos,500,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIBIOTICOS,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
361,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,AMIKACINA,1957,1957,1000019570000,010,000,1957,00,00,SI,"VALES,Sustantiva",AMIKACINA SOLUCION INYECTABLE CADA AMPOLLETA O FRASCO AMPULA CONTIENE: SULFATO DE AMIKACINA EQUIVALENTE A 100 MG DE AMIKACINA. ENVASE CON 1 AMPOLLETA O FRASCO AMPULA CON 2 ML.,ENV,1,AFA,100,miligramos,100,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
362,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,AMIKACINA,1957,1957,1000019570100,010,000,1957,01,00,NO,"VALES,Sustantiva",AMIKACINA. SOLUCION INYECTABLE. CADA AMPOLLETA O FRASCO AMPULA CONTIENE: SULFATO DE AMIKACINA EQUIVALENTE A 100 MG DE AMIKACINA. ENVASE CON 2 AMPOLLETAS O FRASCO AMPULA CON 2 ML.,ENV,1,ENV,100,miligramos,100,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
363,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,AZITROMICINA,1969,1969,1000019690000,010,000,1969,00,00,NO,"VALES,Sustantiva",AZITROMICINA. TABLETA. CADA TABLETA CONTIENE: AZITROMICINA DIHIDRATADA EQUIVALENTE A 500 MG DE AZITROMICINA. ENVASE CON 3 TABLETAS.,ENV,3,TAB,500,miligramos,1500,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
364,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,AZITROMICINA,1969,1969,1000019690100,010,000,1969,01,00,SI,"VALES,Sustantiva",AZITROMICINA TABLETA CADA TABLETA CONTIENE: AZITROMICINA DIHIDRATADA EQUIVALENTE A 500 MG DE AZITROMICINA ENVASE CON 4 TABLETAS.,ENV,4,TAB,500,miligramos,2000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
365,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,ERITROMICINA,1971,1971,1000019710000,010,000,1971,00,00,SI,"VALES,Programa de Planificación Familiar,Sustantiva",ERITROMICINA CAPSULA O TABLETA CADA CAPSULA O TABLETA CONTIENE: ESTEARATO DE ERITROMICINA EQUIVALENTE A 500 MG DE ERITROMICINA. ENVASE CON 20 CAPSULAS O TABLETAS.,ENV,20,C.T,500,miligramos,10000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIBIOTICOS,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
366,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,ERITROMICINA,1972,1972,1000019720000,010,000,1972,00,00,SI,"VALES,Sustantiva",ERITROMICINA SUSPENSION ORAL CADA 5 ML CONTIENEN: ESTEARATO O ETILSUCCINATO O ESTOLATO DE ERITROMICINA EQUIVALENTE A 250 MG DE ERITROMICINA. ENVASE CON POLVO PARA 100 ML Y DOSIFICADOR.,ENV,1,ENV,250,miligramos,250,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
367,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,CLINDAMICINA,1973,1973,1000019730000,010,000,1973,00,00,SI,Sustantiva,CLINDAMICINA SOLUCION INYECTABLE CADA AMPOLLETA CONTIENE: FOSFATO DE CLINDAMICINA EQUIVALENTE A 300 MG DE CLINDAMICINA. ENVASE AMPOLLETA CON 2 ML.,ENV,1,AMP,300,miligramos,300,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIBIOTICOS,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
368,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,TETRACICLINA,1981,1981,1000019810000,010,000,1981,00,00,SI,"VALES,Sustantiva",TETRACICLINA TABLETA O CAPSULA CADA TABLETA O CAPSULA CONTIENE: CLORHIDRATO DE TETRACICLINA 250 MG ENVASE CON 10 TABLETAS O CAPSULAS.,ENV,10,C.T,250,miligramos,2500,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
369,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,CLORANFENICOL,1991,1991,1000019910000,010,000,1991,00,00,SI,Sustantiva,CLORANFENICOL CAPSULA CADA CAPSULA CONTIENE: CLORANFENICOL 500 MG ENVASE CON 20 CAPSULAS.,ENV,20,CAP,500,miligramos,10000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
370,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,CLORANFENICOL,1992,1992,1000019920000,010,000,1992,00,00,SI,Sustantiva,CLORANFENICOL SOLUCION INYECTABLE CADA FRASCO AMPULA CON POLVO CONTIENE: SUCCINATO SODICO DE CLORANFENICOL EQUIVALENTE A 1 G DE CLORANFENICOL. ENVASE CON UN FRASCO AMPULA CON DILUYENTE DE 5 ML.,ENV,1,ENV,1,gramos,1,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
371,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,AMFOTERICINA B O ANFOTERICINA B,2012,2012,1000020120002,010,000,2012,00,02,SI,"Sustantiva,Uso Hospitalario, Enfermedades Infecciosas y Parasitarias",AMFOTERICINA B O ANFOTERICINA B. SOLUCION INYECTABLE CADA FRASCO AMPULA CON POLVO CONTIENE: AMFOTERICINA B O ANFOTERICINA B 50 MG. ENVASE CON UN FRASCO AMPULA.,ENV,1,F.A,50,miligramos,50,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
372,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,KETOCONAZOL,2016,2016,1000020160000,010,000,2016,00,00,SI,Sustantiva,KETOCONAZOL TABLETA. CADA TABLETA CONTIENE: KETOCONAZOL 200 MG. ENVASE CON 10 TABLETAS.,ENV,10,TAB,200,miligramos,2000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIMICOTICOS_SISTEMICOS_Y_TOPICOS,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
373,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,ITRACONAZOL,2018,2018,1000020180000,010,000,2018,00,00,SI,"VALES,Sustantiva",ITRACONAZOL CAPSULA CADA CAPSULA CONTIENE: ITRACONAZOL 100 MG ENVASE CON 15 CAPSULAS.,ENV,15,CAP,100,miligramos,1500,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIMICOTICOS_SISTEMICOS_Y_TOPICOS,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
374,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,CLOROQUINA,2030,2030,1000020300000,010,000,2030,00,00,SI,Sustantiva,CLOROQUINA TABLETA CADA TABLETA CONTIENE: FOSFATO DE CLOROQUINA EQUIVALENTE A 150 MG DE CLOROQUINA. ENVASE CON 1 000 TABLETAS.,ENV,1000,TAB,150,miligramos,150000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
375,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,CLOROQUINA,2030,2030,1000020300100,010,000,2030,01,00,NO,Sustantiva,CLOROQUINA. TABLETA CADA TABLETA CONTIENE: FOSFATO DE CLOROQUINA EQUIVALENTE A 150 MG. DE CLOROQUINA.,ENV,30,TAB,150,miligramos,4500,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
376,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,PRIMAQUINA,2031,2031,1000020310000,010,000,2031,00,00,SI,Sustantiva,PRIMAQUINA TABLETA CADA TABLETA CONTIENE: FOSFATO DE PRIMAQUINA EQUIVALENTE A 5 MG DE PRIMAQUINA. ENVASE CON 20 TABLETAS.,ENV,20,TAB,5,miligramos,100,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
377,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,PRIMAQUINA,2032,2032,1000020320000,010,000,2032,00,00,SI,Sustantiva,PRIMAQUINA TABLETA CADA TABLETA CONTIENE: FOSFATO DE PRIMAQUINA EQUIVALENTE A 15 MG DE PRIMAQUINA. ENVASE CON 20 TABLETAS.,ENV,20,TAB,15,miligramos,300,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
378,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,PRAZICUANTEL,2040,2040,1000020400000,010,000,2040,00,00,SI,Sustantiva,PRAZICUANTEL TABLETA CADA TABLETA CONTIENE: PRAZICUANTEL 600 MG ENVASE CON 25  TABLETAS.,ENV,25,TAB,600,miligramos,15000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
379,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,TINIDAZOL,2042,2042,1000020420000,010,000,2042,00,00,SI,Sustantiva,TINIDAZOL TABLETA CADA TABLETA CONTIENE: TINIDAZOL 500 MG ENVASE CON 8 TABLETAS.,ENV,8,TAB,500,miligramos,4000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
384,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,AMOXICILINA,2127,2127,1000021270000,010,000,2127,00,00,SI,"VALES,Sustantiva",AMOXICILINA SUSPENSION ORAL CADA FRASCO CON POLVO CONTIENE: AMOXICILINA  TRIHIDRATADA EQUIVALENTE A 7.5 G DE AMOXICILINA. ENVASE CON POLVO PARA 75 ML  (500 MG/5 ML).,ENV,1,ENV,500,miligramos,500,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIBIOTICOS,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
385,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,AMOXICILINA,2128,2128,1000021280000,010,000,2128,00,00,SI,"VALES,Sustantiva",AMOXICILINA CAPSULA CADA CAPSULA CONTIENE: AMOXICILINA TRIHIDRATADA EQUIVALENTE  A 500 MG DE AMOXICILINA. ENVASE CON 12 CAPSULAS.,ENV,12,CAP,500,miligramos,6000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
386,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,AMOXICILINA,2128,2128,1000021280100,010,000,2128,01,00,NO,"VALES,Sustantiva",AMOXICILINA. CAPSULAS. CADA CAPSULA CONTIENE: AMOXICILINA TRIHIDRATADA  EQUIVALENTE A 500 MG DE AMOXICILINA. ENVASE CON 15 CAPSULAS.,CJA,15,CAP,500,miligramos,7500,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
387,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,AMOXICILINA – ACIDO CLAVULÁNICO,2129,2129,1000021290000,010,000,2129,00,00,SI,"VALES,Sustantiva","AMOXICILINA -ACIDO CLAVULANICO SUSPENSION ORAL CADA FRASCO CON POLVO CONTIENE:  AMOXICILINA TRIHIDRATADA EQUIVALENTE A 1.5 G DE AMOXICILINA. CLAVULANATO DE  POTASIO EQUIVALENTE A 375 MG DE ACIDO CLAVULANICO. ENVASE CON 60 ML, CADA 5 ML",ENV,1,ENV,1.875,miligramos,1.875,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
388,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,AMOXICILINA – ACIDO CLAVULÁNICO,2130,2130,1000021300002,010,000,2130,00,02,SI,"Sustantiva,Uso Hospitalario, Enfermedades Infecciosas y Parasitarias",AMOXICILINA – ACIDO CLAVULANICO. SOLUCION INYECTABLE. CADA FRASCO AMPULA CON POLVO CONTIENE: AMOXICILINA SODICA EQUIVALENTE A 500 MG DE AMOXICILINA. CLAVULANATO DE POTASIO EQUIVALENTE A 100 MG DE ACIDO CLAVULANICO. ENVASE CON UN,ENV,1,F.A,600,miligramos,600,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
389,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,CLARITROMICINA,2132,2132,1000021320000,010,000,2132,00,00,SI,"VALES,Sustantiva",CLARITROMICINA TABLETA CADA TABLETA CONTIENE: CLARITROMICINA 250 MG ENVASE CON  10 TABLETAS.,ENV,10,TAB,250,miligramos,2500,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIBIOTICOS,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
390,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,CLINDAMICINA,2133,2133,1000021330000,010,000,2133,00,00,SI,"VALES,Sustantiva",CLINDAMICINA CAPSULA CADA CAPSULA CONTIENE: CLORHIDRATO DE CLINDAMICINA  EQUIVALENTE A 300 MG DE CLINDAMICINA. ENVASE CON 16 CAPSULAS.,ENV,16,CAP,300,miligramos,4800,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
391,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,FLUCONAZOL,2135,2135,1000021350000,010,000,2135,00,00,SI,Sustantiva -- Eficiencia terapeutica H - 98%,FLUCONAZOL SOLUCION INYECTABLE CADA FRASCO AMPULA CONTIENE: FLUCONAZOL 100 MG  ENVASE CON UN FRASCO AMPULA CON 50 ML (2 MG/ML).,ENV,1,F.A,100,miligramos,100,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
392,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,RIBAVIRINA,2139,2139,1000021390000,010,000,2139,00,00,SI,Sustantiva,RIBAVIRINA CAPSULA CADA CAPSULA CONTIENE: RIBAVARINA 400 MG ENVASE CON 12  CAPSULAS.,ENV,12,CAP,400,miligramos,4800,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
425,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,AMOXICILINA – ACIDO CLAVULÁNICO,2230,2230,1000022300000,010,000,2230,00,00,SI,"VALES,Sustantiva",AMOXICILINA -ACIDO CLAVULANICO TABLETA CADA TABLETA CONTIENE: AMOXICILINA TRIHIDRATADA EQUIVALENTE A 500 MG DE AMOXILINA. CLAVULANATO DE POTASIO EQUIVALENTE A 125 MG DE ACIDO CLAVULANICO. ENVASE CON 12 TABLETAS.,ENV,12,TAB,625,miligramos,7500,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
426,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,AMOXICILINA – ACIDO CLAVULÁNICO,2230,2230,1000022300100,010,000,2230,01,00,NO,"VALES,Sustantiva",AMOXICILINA - ACIDO CLAVULANICO. TABLETA. CADA TABLETA CONTIENE: AMOXICILINA TRIHIDRATADA EQUIVALENTE A 500 MG. DE AMOXILINA CLAVULANATO DE POTASIO EQUIVALENTE A 125 MG. DE ACIDO CLAVULANICO. ENVASE CON 16 TABLETAS.,ENV,16,TAB,625,miligramos,10000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
440,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,METENAMINA,2333,2333,1000023330000,010,000,2333,00,00,SI,Sustantiva,METENAMINA TABLETA CADA TABLETA CONTIENE: HIPURATO DE METENAMINA 500 MG ENVASE  CON 30 TABLETAS.,ENV,30,TAB,500,miligramos,15000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
451,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,ESTREPTOMICINA,2403,2403,1000024030000,010,000,2403,00,00,SI,Sustantiva,ESTREPTOMICINA SOLUCION INYECTABLE EL FRASCO AMPULA CON POLVO CONTIENE: SULFATO  DE ESTREPTOMICINA EQUIVALENTE A 1 G DE ESTREPTOMICINA. ENVASE CON UN FRASCO  AMPULA Y DILUYENTE CON 2 ML.,ENV,1,JGO,1,gramos,1,gramos,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
452,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,ISONIAZIDA,2404,2404,1000024040000,010,000,2404,00,00,SI,Sustantiva,ISONIAZIDA TABLETA CADA TABLETA CONTIENE: ISONIAZIDA: 100 MG ENVASE CON 200  TABLETAS.,ENV,200,TAB,100,miligramos,20000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
453,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,ETAMBUTOL,2405,2405,1000024050000,010,000,2405,00,00,SI,Sustantiva,ETAMBUTOL TABLETA CADA TABLETAS CONTIENE: CLORHIDRATO DE ETAMBUTOL 400 MG  ENVASE CON 50 TABLETAS.,ENV,50,TAB,400,miligramos,20000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
454,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,RIFAMPICINA,2409,2409,1000024090000,010,000,2409,00,00,SI,Sustantiva,"RIFAMPICINA CAPSULA, COMPRIMIDO O TABLETA RECUBIERTA. CADA CAPSULA, COMPRIMIDO O TABLETA RECUBIERTA CONTIENE: RIFAMPICINA 300 MG ENVASE CON 1000 CAPSULAS, COMPRIMIDOS O TABLETAS RECUBIERTAS.",ENV,1000,C.C,300,miligramos,300000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
455,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,RIFAMPICINA,2409,2409,1000024090100,010,000,2409,01,00,NO,Sustantiva,"RIFAMPICINA. CAPSULA, COMPRIMIDO O TABLETA RECUBIERTA. CADA CAPSULA, COMPRIMIDO O TABLETA RECUBIERTA CONTIENE: RIFAMPICINA 300 MG A. ENVASE CON 120 CAPSULAS, COMPRIMIDOS O TABLETAS RECUBIERTAS.",ENV,120,TCC,300,miligramos,36000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
456,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,RIFAMPICINA,2410,2410,1000024100000,010,000,2410,00,00,SI,Sustantiva,RIFAMPICINA SUSPENSION ORAL CADA 5 ML CONTIENEN: RIFAMPICINA 100 MG ENVASE CON  120 ML Y DOSIFICADOR.,ENV,1,ENV,100,miligramos,100,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
457,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,PIRAZINAMIDA,2413,2413,1000024130000,010,000,2413,00,00,SI,Sustantiva,PIRAZINAMIDA TABLETA CADA TABLETA CONTIENE: PIRAZINAMIDA 500 MG ENVASE CON 50  TABLETAS.,ENV,50,TAB,500,miligramos,25000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
458,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,RIFAMPICINA-ISONIAZIDA-PIRAZINAMIDA,2414,2414,1000024140000,010,000,2414,00,00,SI,Sustantiva,RIFAMPICINA –ISONIAZIDA -PIRAZINAMIDA TABLETA O GRAGEA CADA TABLETA O GRAGEA CONTIENE: RIFAMPICINA 150 MG ISONIAZIDA 75 MG PIRAZINAMIDA 400 MG ENVASE CON 240 TABLETAS O GRAGEAS.,ENV,240,C.G,625,miligramos,150000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
459,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,ISONIAZIDA Y RIFAMPICINA,2415,2415,1000024150000,010,000,2415,00,00,SI,Sustantiva,ISONIAZIDA -RIFAMPICINA COMPRIMIDO O CAPSULA CADA COMPRIMIDO O CAPSULA  CONTIENE: ISONIAZIDA 200 MG RIFAMPICINA 150 MG ENVASE CON 120 COMPRIMIDOS O  CAPSULAS.,ENV,120,C.C,350,miligramos,42000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
460,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,ISONIAZIDA Y RIFAMPICINA,2417,2417,1000024170000,010,000,2417,00,00,SI,Sustantiva -- Tuberculosis,ISONIAZIDA -RIFAMPICINA TABLETA RECUBIERTA CADA TABLETA RECUBIERTA CONTIENE:  ISONIAZIDA 400 MG RIFAMPICINA 300 MG ENVASE CON 90 TABLETAS RECUBIERTAS.,ENV,90,TAB,700,miligramos,63000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
461,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,"ISONIAZIDA, RIFAMPICINA, PIRAZINAMIDA, ETAMBUTOL",2418,2418,1000024180000,010,000,2418,00,00,SI,Sustantiva -- Tuberculosis,ISONIAZIDA -RIFAMPICINA-PIRAZINAMIDA -ETAMBUTOL TABLETA CADA TABLETA CONTIENE:  ISONIAZIDA 75 MG RIFAMPICINA 150 MG PIRAZINAMIDA 400 MG CLORHIDRATO DE  ETAMBUTOL 300 MG ENVASE CON 240 TABLETAS.,ENV,240,TAB,925,miligramos,222000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
475,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,NITAZOXANIDA,2519,2519,1000025190000,010,000,2519,00,00,SI,"VALES,Sustantiva",NITAZOXANIDA TABLETA CADA TABLETA CONTIENE: NITAZOXANIDA 200 MG ENVASE CON 6  TABLETAS.,ENV,6,TAB,200,miligramos,1200,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
477,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,NITAZOXANIDA,2523,2523,1000025230000,010,000,2523,00,00,SI,"VALES,Sustantiva",NITAZOXANIDA GRAGEA O TABLETA RECUBIERTA CADA GRAGEA O TABLETA RECUBIERTA CONTIENE: NITAZOXANIDA 500 MG ENVASE CON 6 GRAGEAS O TABLETAS RECUBIERTAS.,ENV,6,T.G,500,miligramos,3000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIBIOTICOS,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
478,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,NITAZOXANIDA,2523,2523,1000025230102,010,000,2523,01,02,NO,"VALES,Sustantiva",NITAZOXANIDA. GRAGEA O TABLETA RECUBIERTA. CADA GRAGEA O TABLETA RECUBIERTA CONTIENE: NITAZOXANIDA 500 MG. ENVASE CON 10 GRAGEAS O TABLETAS RECUBIERTAS.,ENV,10,T.G,500,miligramos,5000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIBIOTICOS,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
479,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,NITAZOXANIDA,2523,2523,1000025230200,010,000,2523,02,00,NO,"VALES,Sustantiva",NITAZOXANIDA. GRAGEA O TABLETA RECUBIERTA. CADA GRAGEA O TABLETA RECUBIERTA CONTIENE: NITAZOXANIDA 500 MG. ENVASE CON 14 GRAGEAS O TABLETAS RECUBIERTAS.,ENV,14,T.G,500,miligramos,7000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIBIOTICOS,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
792,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,DAPSONA,906,0906,1000009060000,010,000,0906,00,00,SI,,DAPSONA TABLETA CADA TABLETA CONTIENE: DAPSONA 100 MG ENVASE CON 1000 TABLETAS.,ENV,1000,TAB,100,miligramos,100000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
842,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,METRONIDAZOL,1308,1308,1000013080000,010,000,1308,00,00,NO,"VALES,Sustantiva",METRONIDAZOL. TABLETAS. CADA TABLETA CONTIENE: METRONIDAZOL 500 MG. ENVASE CON 20 TABLETAS.,ENV,20,TAB,500,miligramos,10000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIBIOTICOS,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
843,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,METRONIDAZOL,1308,1308,1000013080100,010,000,1308,01,00,SI,"VALES,Sustantiva",METRONIDAZOL TABLETA CADA TABLETA CONTIENE: METRONIDAZOL 500 MG ENVASE CON 30 TABLETAS.,ENV,30,TAB,500,miligramos,15000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIBIOTICOS,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
844,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,METRONIDAZOL,1309,1309,1000013090000,010,000,1309,00,00,SI,"Sustantiva,Uso Hospitalario, Enfermedades Infecciosas y Parasitarias",METRONIDAZOL SOLUCION INYECTABLE CADA AMPOLLETA O FRASCO AMPULA CONTIENE: METRONIDAZOL 200 MG ENVASE CON 2 AMPOLLETAS O FRASCOS AMPULA CON 10 ML.,ENV,2,AMP,200,miligramos,400,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
845,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,METRONIDAZOL,1310,1310,1000013100000,010,000,1310,00,00,SI,"VALES,Sustantiva",METRONIDAZOL SUSPENSION ORAL CADA 5 ML CONTIENEN: BENZOILO DE METRONIDAZOL EQUIVALENTE A 250 MG DE METRONIDAZOL. ENVASE CON 120 ML Y DOSIFICADOR.,ENV,120,ML.,250,miligramos,250,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
846,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,METRONIDAZOL,1311,1311,1000013110000,010,000,1311,00,00,SI,"Sustantiva,Uso Hospitalario, Enfermedades Infecciosas y Parasitarias",METRONIDAZOL SOLUCION INYECTABLE CADA 100 ML CONTIENEN: METRONIDAZOL 500 MG ENVASE CON 100 ML.,ENV,1,ENV,500,miligramos,500,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
847,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,QUINFAMIDA,1314,1314,1000013140000,010,000,1314,00,00,SI,"VALES,Sustantiva",QUINFAMIDA TABLETA CADA TABLETA CONTIENE: QUINFAMIDA 300 MG ENVASE CON UNA TABLETA.,ENV,1,TAB,300,miligramos,300,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
848,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,ALBENDAZOL,1344,1344,1000013440000,010,000,1344,00,00,SI,"VALES,Consumo en demanda",ALBENDAZOL TABLETA CADA TABLETA CONTIENE: ALBENDAZOL 200 MG ENVASE CON 2 TABLETAS.,ENV,2,TAB,200,miligramos,400,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIBIOTICOS,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
849,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,ALBENDAZOL,1345,1345,1000013450000,010,000,1345,00,00,SI,"VALES,Sustantiva -- Meta médica",ALBENDAZOL SUSPENSION ORAL CADA FRASCO CONTIENE: ALBENDAZOL 400 MG ENVASE CON 20 ML.,ENV,20,ML.,400,miligramos,400,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
910,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,TRIMETOPRIMA-SULFAMETOXAZOL,1903,1903,1000019030000,010,000,1903,00,00,SI,"VALES,Programa de Planificación Familiar,Sustantiva",TRIMETOPRIMA -SULFAMETOXAZOL COMPRIMIDO O TABLETA CADA COMPRIMIDO O TABLETA CONTIENE: TRIMETOPRIMA 80 MG SULFAMETOXAZOL 400 MG ENVASE CON 20 COMPRIMIDOS O TABLETAS.,ENV,20,TAB,480,miligramos,9600,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIBIOTICOS,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
911,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,TRIMETOPRIMA-SULFAMETOXAZOL,1904,1904,1000019040000,010,000,1904,00,00,SI,"VALES,Sustantiva",TRIMETOPRIMA -SULFAMETOXAZOL SUSPENSION ORAL CADA 5 ML CONTIENEN: TRIMETOPRIMA 40 MG SULFAMETOXAZOL 200 MG ENVASE CON 120 ML Y DOSIFICADOR.,ENV,120,ML.,240,miligramos,240,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
912,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,NITROFURANTOÍNA,1911,1911,1000019110000,010,000,1911,00,00,SI,"VALES,Sustantiva",NITROFURANTOINA CAPSULA CADA CAPSULA CONTIENE: NITROFURANTOINA 100 MG ENVASE  CON 40 CAPSULAS.,ENV,40,CAP,100,miligramos,4000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIBIOTICOS,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
913,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,BENCILPENICILINA SÓDICA CRISTALINA,1921,1921,1000019210000,010,000,1921,00,00,SI,Sustantiva,"BENCILPENICILINA SODICA CRISTALINA SOLUCION INYECTABLE CADA FRASCO AMPULA CON  POLVO CONTIENE: BENCILPENICILINA SODICA CRISTALINA EQUIVALENTE A 1000 000 UI  DE BENCILPENICILINA. ENVASE CON UN FRASCO AMPULA, CON O SIN 2 ML DE DILUYENTE.",ENV,1,ENV,1000000,UI,1000000,UI,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
914,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,BENCILPENICILINA PROCAÍNICA CON BENCILPENICILINA CRISTALINA,1923,1923,1000019230000,010,000,1923,00,00,SI,"VALES,Sustantiva",BENCILPENICILINA PROCAINICA CON BENCILPENICILINA CRISTALINA SUSPENSION INYECTABLE CADA FRASCO AMPULA CON POLVO CONTIENE: BENCILPENICILINA PROCAINICA EQUIVALENTE A 300 000 UI DE BENCILPENICILINA BENCILPENICILINA CRISTALINA,ENV,1,ENV,300000,UI,300000,UI,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
915,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,BENCILPENICILINA PROCAÍNICA CON BENCILPENICILINA CRISTALINA,1924,1924,1000019240000,010,000,1924,00,00,SI,"VALES,Sustantiva",BENCILPENICILINA PROCAINICA CON BENCILPENICILINA CRISTALINA. SUSPENSION INYECTABLE. CADA FRASCO AMPULA CON POLVO CONTIENE: BENCILPENICILINA PROCAINICA EQUIVALENTE A 600 000 UI DE BENCILPENICILINA. BENCILPENICILINA CRISTALINA,ENV,1,ENV,600000,UI,600000,UI,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIBIOTICOS,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
916,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,BENZATINA BENCILPENICILINA,1925,1925,1000019250000,010,000,1925,00,00,SI,"VALES,Sustantiva",BENZATINA BENCILPENICILINA SUSPENSION INYECTABLE CADA FRASCO AMPULA CON POLVO  CONTIENE: BENZATINA BENCILPENICILINA EQUIVALENTE A 1 200 000 UI DE  BENCILPENICILINA. ENVASE CON UN FRASCO AMPULA Y 5 ML DE DILUYENTE.,ENV,1,ENV,120000,UI,120000,UI,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIBIOTICOS,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
917,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,DICLOXACILINA,1926,1926,1000019260000,010,000,1926,00,00,SI,"Sustantiva,Programa de Planificación Familiar",DICLOXACILINA CAPSULA O COMPRIMIDO CADA CAPSULA O COMPRIMIDO CONTIENE:  DICLOXACILINA SODICA 500 MG ENVASE CON 20 CAPSULAS O COMPRIMIDOS.,ENV,20,C.C,500,miligramos,10000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIBIOTICOS,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
918,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,DICLOXACILINA,1927,1927,1000019270000,010,000,1927,00,00,SI,Sustantiva,DICLOXACILINA SUSPENSION ORAL CADA 5 ML CONTIENEN: DICLOXACILINA SODICA 250 MG ENVASE CON POLVO PARA 60 ML Y DOSIFICADOR.,ENV,60,ML.,250,miligramos,250,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
919,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,DICLOXACILINA,1928,1928,1000019280000,010,000,1928,00,00,SI,"Sustantiva,Programa de Planificación Familiar",DICLOXACILINA SOLUCION INYECTABLE CADA FRASCO AMPULA CON POLVO CONTIENE: DICLOXACILINA SODICA EQUIVALENTE A 250 MG DE DICLOXACILINA. ENVASE FRASCO AMPULA Y 5 ML DE DILUYENTE.,ENV,1,JGO,250,miligramos,250,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
920,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,AMPICILINA,1929,1929,1000019290000,010,000,1929,00,00,SI,"VALES,Programa de Planificación Familiar,Sustantiva",AMPICILINA TABLETA O CAPSULA CADA TABLETA O CAPSULA CONTIENE: AMPICILINA ANHIDRA O AMPICILINA TRIHIDRATADA EQUIVALENTE A 500 MG DE AMPICILINA. ENVASE CON 20 TABLETAS O CAPSULAS.,ENV,20,C.T,500,miligramos,10000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIBIOTICOS,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
921,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,AMPICILINA,1930,1930,1000019300000,010,000,1930,00,00,SI,"VALES,Sustantiva",AMPICILINA SUSPENSION ORAL CADA 5 ML CONTIENEN: AMPICILINA TRIHIDRATADA EQUIVALENTE A 250 MG DE AMPICILINA. ENVASE CON POLVO PARA 60 ML Y DOSIFICADOR.,ENV,60,ML.,250,miligramos,250,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
922,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,AMPICILINA,1931,1931,1000019310000,010,000,1931,00,00,SI,"Sustantiva,Programa de Planificación Familiar",AMPICILINA SOLUCION INYECTABLE CADA FRASCO AMPULA CON POLVO CONTIENE: AMPICILINA SODICA EQUIVALENTE A 500 MG DE AMPICILINA. ENVASE CON UN FRASCO AMPULA Y 2 ML DE DILUYENTE.,ENV,1,JGO,500,miligramos,500,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIBIOTICOS,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
923,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,BENCILPENICILINA SÓDICA CRISTALINA,1933,1933,1000019330000,010,000,1933,00,00,SI,Sustantiva,BENCILPENICILINA SODICA CRISTALINA SOLUCION INYECTABLE CADA FRASCO AMPULA CON POLVO CONTIENE: BENCILPENICILINA SODICA CRISTALINA EQUIVALENTE A 5 000 000 UI DE BENCILPENICILINA. ENVASE CON UN FRASCO AMPULA.,ENV,1,ENV,5000000,UI,5000000,UI,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
924,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,CEFOTAXIMA,1935,1935,1000019350000,010,000,1935,00,00,SI,Sustantiva,CEFOTAXIMA SOLUCION INYECTABLE CADA FRASCO AMPULA CON POLVO CONTIENE: CEFOTAXIMA SODICA EQUIVALENTE A 1 G DE CEFOTAXIMA. ENVASE CON UN FRASCO AMPULA Y 4 ML DE DILUYENTE.,ENV,1,ENV,1,gramos,1,gramos,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
925,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,CEFTRIAXONA,1937,1937,1000019370000,010,000,1937,00,00,SI,Sustantiva,CEFTRIAXONA SOLUCION INYECTABLE CADA FRASCO AMPULA CON POLVO CONTIENE: CEFTRIAXONA SODICA EQUIVALENTE A 1 G DE CEFTRIAXONA. ENVASE CON UN FRASCO AMPULA Y 10 ML DE DILUYENTE.,ENV,1,JGO,1,gramos,1,gramos,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
926,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,BENCILPENICILINA BENZATÍNICA COMPUESTA,1938,1938,1000019380000,010,000,1938,00,00,SI,"VALES,Sustantiva",BENCILPENICILINA BENZATINICA COMPUESTA SUSPENSION INYECTABLE CADA FRASCO AMPULA CON POLVO CONTIENE: BENZATINA BENCILPENICILINA EQUIVALENTE A 600 000 UI DE BENCILPENICILINA BENCILPENICILINA PROCAINICA EQUIVALENTE A 300 000 UI DE,ENV,1,ENV,900000,UI,900000,UI,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
927,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,DOXICICLINA,1940,1940,1000019400000,010,000,1940,00,00,SI,"VALES,Sustantiva",DOXICICLINA CAPSULA O TABLETA CONTIENE: HICLATO DE DOXICICLINA EQUIVALENTE A 100 MG DE DOXICILINA. ENVASE CON 10 CAPSULAS O TABLETAS.,ENV,10,CAP,100,miligramos,1000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
928,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,DOXICICLINA,1940,1940,1000019400002,010,000,1940,00,02,NO,"VALES,Sustantiva",DOXICICLINA. CAPSULA O TABLETA. CADA CAPSULA O TABLETA CONTIENE: HICLATO DE DOXICICLINA EQUIVALENTE A 100 MG DE DOXICILINA. ENVASE CON 10 CAPSULAS O TABLETAS.,ENV,10,C.T,100,miligramos,1000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
929,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,GENTAMICINA,1954,1954,1000019540000,010,000,1954,00,00,SI,Sustantiva,GENTAMICINA SOLUCION INYECTABLE CADA AMPOLLETA CONTIENE: SULFATO DE GENTAMICINA EQUIVALENTE A 80 MG DE GENTAMICINA. ENVASE CON AMPOLLETA CON 2 ML.,ENV,1,AMP,80,miligramos,80,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
930,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,GENTAMICINA,1955,1955,1000019550000,010,000,1955,00,00,SI,Sustantiva,GENTAMICINA SOLUCION INYECTABLE CADA AMPOLLETA CONTIENE: SULFATO DE GENTAMICINA EQUIVALENTE A 20 MG DE GENTAMICINA BASE. ENVASE CON AMPOLLETA CON 2 ML.,ENV,1,AMP,20,miligramos,20,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1052,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,NEOMICINA,4176,4176,1000041760000,010,000,4176,00,00,SI,"Sustantiva,VALES",NEOMICINA CAPSULA O TABLETA CADA TABLETA O CAPSULA CONTIENE: SULFATO DE NEOMICINA EQUIVALENTE A 250 MG DE NEOMICINA. ENVASE CON 10 CAPSULAS O TABLETAS.,ENV,10,T.C,250,miligramos,2500,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1107,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,LEVOFLOXACINO,4249,4249,1000042490000,010,000,4249,00,00,SI,"Sustantiva -- Eficiencia terapeutica J - 90%,Uso Hospitalario, Enfermedades Infecciosas y Parasitarias",LEVOFLOXACINO SOLUCION INYECTABLE CADA ENVASE CONTIENE: LEVOFLOXACINO HEMIHIDRATADO EQUIVALENTE A 500 MG DE LEVOFLOXACINO. ENVASE CON 100 ML.,ENV,1,ENV,500,miligramos,500,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1111,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,VANCOMICINA,4251,4251,1000042510000,010,000,4251,00,00,SI,"Sustantiva -- Eficiencia terapeutica G - 90%,Uso Hospitalario, Enfermedades Infecciosas y Parasitarias",VANCOMICINA SOLUCION INYECTABLE CADA FRASCO AMPULA CON POLVO CONTIENE: CLORHIDRATO DE VANCOMICINA EQUIVALENTE A 500 MG DE VANCOMICINA. ENVASE CON UN FRASCO AMPULA.,ENV,1,F.A,500,miligramos,500,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1112,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,MOXIFLOXACINO,4252,4252,1000042520000,010,000,4252,00,00,SI,"VALES,Sustantiva -- Eficiencia terapeutica K - 10%",MOXIFLOXACINO TABLETA CADA TABLETA CONTIENE: CLORHIDRATO DE MOXIFLOXACINO EQUIVALENTE A 400 MG DE MOXIFLOXACINO. ENVASE CON 7 TABLETAS.,ENV,7,TAB,400,miligramos,2800,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1113,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,MOXIFLOXACINO,4253,4253,1000042530000,010,000,4253,00,00,SI,"Sustantiva -- Eficiencia terapeutica J - 10%,Uso Hospitalario, Enfermedades Infecciosas y Parasitarias",MOXIFLOXACINO SOLUCION INYECTABLE CADA 100 ML CONTIENEN: CLORHIDRATO DE MOXIFLOXACINO EQUIVALENTE A 160 MG DE MOXIFLOXACINO. ENVASE CON BOLSA FLEXIBLE O FRASCO AMPULA CON 250 ML (400 MG).,ENV,1,ENV,400,miligramos,400,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1114,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,CEFTAZIDIMA,4254,4254,1000042540000,010,000,4254,00,00,SI,Sustantiva,CEFTAZIDIMA SOLUCION INYECTABLE CADA FRASCO AMPULA CON POLVO CONTIENE: CEFTAZIDIMA PENTAHIDRATADA EQUIVALENTE A 1 G DE CEFTAZIDIMA. ENVASE CON UN FRASCO AMPULA Y 3 ML DE DILUYENTE.,ENV,1,F.A,1,gramos,1,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1115,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,CIPROFLOXACINO,4255,4255,1000042550000,010,000,4255,00,00,SI,"VALES,Programa de Planificación Familiar,Consumo en demanda",CIPROFLOXACINO CAPSULA O TABLETA CADA CAPSULA O TABLETA CONTIENE: CLORHIDRATO DE CIPROFLOXACINO MONOHIDRATADO EQUIVALENTE A 250 MG DE CIPROFLOXACINO. ENVASE CON 8 CAPSULAS O TABLETAS.,ENV,8,C.T,250,miligramos,2000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIBIOTICOS,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1116,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,TALIDOMIDA,4256,4256,1000042560000,010,000,4256,00,00,SI,"VALES,Sustantiva",TALIDOMIDA TABLETA O CAPSULA CADA TABLETA O CAPSULA CONTIENE: TALIDOMIDA 100 MG ENVASE CON 50 TABLETAS O CAPSULAS.,ENV,50,C.T,100,miligramos,5000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1117,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,CIPROFLOXACINO,4258,4258,1000042580002,010,000,4258,00,02,SI,Sustantiva,CIPROFLOXACINO. SUSPENSION ORAL CADA 5 MILILITROS CONTIENEN: CLORHIDRATO DE CIPROFLOXACINO EQUIVALENTE A 250 MG DE CIPROFLOXACINO O CIPROFLOXACINO 250 MG ENVASE CON MICROESFERAS CON 5 G Y ENVASE CON DILUYENTE CON 93 ML.,JGO,1,JGO,250,miligramos,250,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1118,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,CIPROFLOXACINO,4259,4259,1000042590000,010,000,4259,00,00,SI,"Sustantiva,Uso Hospitalario, Enfermedades Infecciosas y Parasitarias",CIPROFLOXACINO SOLUCION INYECTABLE CADA 100 ML CONTIENE: LACTATO O CLORHIDRATO DE CIPROFLOXACINO EQUIVALENTE A 200 MG DE CIPROFLOXACINO. ENVASE CON 100 ML.,ENV,1,ENV,200,miligramos,200,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1119,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,NISTATINA,4260,4260,1000042600000,010,000,4260,00,00,SI,"VALES,Sustantiva",NISTATINA SUSPENSION ORAL CADA FRASCO CON POLVO CONTIENE: NISTATINA 2 400 000 UI ENVASE PARA 24 ML.,ENV,1,FCO,240000,UI,240000,UI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1120,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,ACICLOVIR,4263,4263,1000042630000,010,000,4263,00,00,SI,Sustantiva,ACICLOVIR COMPRIMIDO O TABLETA CADA COMPRIMIDO O TABLETA CONTIENE: ACICLOVIR 200 MG ENVASE CON 25 COMPRIMIDOS O TABLETAS.,ENV,25,COM,200,miligramos,5000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIBIOTICOS,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1121,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,ACICLOVIR,4264,4264,1000042640000,010,000,4264,00,00,SI,"Sustantiva,Uso Hospitalario, Enfermedades Infecciosas y Parasitarias",ACICLOVIR SOLUCION INYECTABLE CADA FRASCO AMPULA CON LIOFILIZADO CONTIENE: ACICLOVIR SODICO EQUIVALENTE A 250 MG DE ACICLOVIR. ENVASE CON 5 FRASCOS AMPULA.,ENV,5,F.A,250,miligramos,1250,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1122,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,ATAZANAVIR,4266,4266,1000042660000,010,000,4266,00,00,SI,"Antirretrovirales,Entrega hospitalaria",ATAZANAVIR CAPSULA CADA CAPSULA CONTIENE: SULFATO DE ATAZANAVIR EQUIVALENTE A 300 MG DE ATAZANAVIR. ENVASE CON 30 CAPSULAS.,ENV,30,CAP,300,miligramos,9000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1123,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,ATAZANAVIR,4267,4267,1000042670000,010,000,4267,00,00,SI,"Antirretrovirales,Entrega hospitalaria",ATAZANAVIR CAPSULA CADA CAPSULA CONTIENE: SULFATO DE ATAZANAVIR EQUIVALENTE A 200 MG DE ATAZANAVIR. ENVASE CON 60 CAPSULAS.,ENV,60,CAP,200,miligramos,12000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1124,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,LAMIVUDINA / ZIDOVUDINA,4268,4268,1000042680000,010,000,4268,00,00,SI,"Antirretrovirales,Sustantiva -- VIH",LAMIVUDINA -ZIDOVUDINA TABLETA CADA TABLETA CONTIENE: LAMIVUDINA 150 MG ZIDOVUDINA 300 MG ENVASE CON 60 TABLETAS.,ENV,60,TAB,450,miligramos,27000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1125,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,ENFUVIRTIDA,4269,4269,1000042690000,010,000,4269,00,00,NO,"Antirretrovirales,Catálogo II -- GERA",ENFUVIRTIDA SOLUCION INYECTABLE. CADA FRASCO AMPULA CON LIOFILIZADO CONTIENE: ENFUVIRTIDA 108 MG ENVASE CON 60 FRASCOS AMPULA CON LIOFILIZADO Y 60 FRASCOS AMPULA CON 1.1 ML DE AGUA INYECTABLE.,ENV,60,AFA,108,miligramos,6480,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1126,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,ENFUVIRTIDA,4269,4269,1000042690100,010,000,4269,01,00,SI,"Antirretrovirales,Catálogo II -- GERA","ENFUVIRTIDA SOLUCION INYECTABLE CADA FRASCO AMPULA CON LIOFILIZADO CONTIENE:  ENFUVIRTIDA 108 MG ENVASE CON 60 JERINGAS DE 3 ML, 60 JERINGAS DE 1 ML Y 180  TOALLITAS HUMEDECIDAS CON ALCOHOL.",ENV,60,JGA,108,miligramos,6480,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1127,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,LAMIVUDINA,4271,4271,1000042710000,010,000,4271,00,00,SI,"Antirretrovirales,Sustantiva -- VIH",LAMIVUDINA SOLUCION CADA 100 ML CONTIENEN: LAMIVUDINA 1 G ENVASE CON 240 ML Y DOSIFICADOR.,ENV,1,ENV,1,gramos,1,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1128,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,ABACAVIR,4272,4272,1000042720000,010,000,4272,00,00,SI,"Antirretrovirales,Antirretrovirales,Sustantiva -- VIH",ABACAVIR SOLUCION CADA 100 ML CONTIENEN: SULFATO DE ABACAVIR EQUIVALENTE A 2 G DE ABACAVIR. ENVASE CON UN FRASCO DE 240 ML Y PIPETA DOSIFICADORA.,ENV,1,JGO,2,gramos,2,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1129,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,ABACAVIR,4273,4273,1000042730000,010,000,4273,00,00,SI,Sustantiva -- VIH,ABACAVIR TABLETA CADA TABLETA CONTIENE: SULFATO DE ABACAVIR EQUIVALENTE A 300 MG DE ABACAVIR. ENVASE CON 60 TABLETAS.,ENV,60,TAB,300,miligramos,18000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1130,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,TIPRANAVIR,4274,4274,1000042740000,010,000,4274,00,00,SI,"Antirretrovirales,Catálogo II -- GERA",TIPRANAVIR CAPSULA CADA CAPSULA CONTIENE: TIPRANAVIR 250 MG ENVASE CON 120 CAPSULAS.,ENV,120,CAP,250,miligramos,30000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1131,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,EMTRICITABINA,4276,4276,1000042760000,010,000,4276,00,00,SI,"Antirretrovirales,Sustantiva -- VIH",EMTRICITABINA CAPSULA CADA CAPSULA CONTIENE: EMTRICITABINA 200 MG ENVASE CON 30 CAPSULAS.,ENV,30,CAP,200,miligramos,6000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1132,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,TENOFOVIR DISOPROXIL FUMARATO O TENOFOVIR,4277,4277,1000042770000,010,000,4277,00,00,SI,"Antirretrovirales,Entrega hospitalaria",TENOFOVIR DISOPROXIL FUMARATO O TENOFOVIR. TABLETA CADA TABLETA CONTIENE: TENOFOVIR DISOPROXIL FUMARATO 300 MG O TENOFOVIR DISOPROXIL FUMARATO 300 MG EQUIVALENTE A 245 MG DE TENOFOVIR DISOPROXILO ENVASE CON 30 TABLETAS.,ENV,30,TAB,300,miligramos,9000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1133,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,FOSAMPRENAVIR,4278,4278,1000042780000,010,000,4278,00,00,SI,"Antirretrovirales,Sustantiva -- VIH",FOSAMPRENAVIR TABLETA RECUBIERTA CADA TABLETA RECUBIERTA CONTIENE: FOSAMPRENAVIR CALCICO EQUIVALENTE A 700 MG DE FOSAMPRENAVIR ENVASE CON 60 TABLETAS RECUBIERTAS.,ENV,60,TAB,700,miligramos,42000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1135,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,GENTAMICINA-COLÁGENO,4280,4280,1000042800002,010,000,4280,00,02,NO,"Entrega hospitalaria,Uso Hospitalario, Enfermedades Infecciosas y Parasitarias,Uso Hospitalario, Enfermedades Infecciosas y Parasitarias,Entrega hospitalaria",GENTAMICINA-COLAGENO. IMPLANTE. CADA IMPLANTE CONTIENE: SULFATO DE GENTAMICINA EQUIVALENTE A 1.3 MG DE GENTAMICINA. COLAGENO DE TENDON BOVINO 2.8 MG. ENVASE CON 1 IMPLANTE DE 5 CM X 5 CM X 0.5 CM.,ENV,1,PZA,4.1,miligramos,4.1,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1136,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,GENTAMICINA-COLÁGENO,4280,4280,1000042800100,010,000,4280,01,00,SI,"Entrega hospitalaria,Uso Hospitalario, Enfermedades Infecciosas y Parasitarias,Uso Hospitalario, Enfermedades Infecciosas y Parasitarias,Entrega hospitalaria",GENTAMICINA COLAGENO IMPLANTE CADA IMPLANTE CONTIENE: SULFATO DE GENTAMICINA EQUIVALENTE A 1.3 MG DE GENTAMICINA. COLAGENO DE TENDON BOVINO 2.8 MG ENVASE CON 5 IMPLANTES DE 5 CM X 5 CM X 0.5 CM.,ENV,5,PZA,4.1,miligramos,20.5,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1137,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,GENTAMICINA-COLÁGENO,4281,4281,1000042810002,010,000,4281,00,02,NO,"Entrega hospitalaria,Uso Hospitalario, Enfermedades Infecciosas y Parasitarias,Uso Hospitalario, Enfermedades Infecciosas y Parasitarias,Entrega hospitalaria",GENTAMICINA-COLAGENO. IMPLANTE. CADA IMPLANTE CONTIENE: SULFATO DE GENTAMICINA EQUIVALENTE A 1.3 MG DE GENTAMICINA. COLAGENO DE TENDON BOVINO 2.8 MG. ENVASE CON 1 IMPLANTE DE 10 CM X 10 CM X 0.5 CM.,ENV,1,PZA,4.1,miligramos,4.1,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1138,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,GENTAMICINA-COLÁGENO,4281,4281,1000042810100,010,000,4281,01,00,SI,"Entrega hospitalaria,Uso Hospitalario, Enfermedades Infecciosas y Parasitarias,Uso Hospitalario, Enfermedades Infecciosas y Parasitarias,Entrega hospitalaria",GENTAMICINA COLAGENO CADA IMPLANTE CONTIENE: SULFATO DE GENTAMICINA EQUIVALENTE A 1.3 MG DE GENTAMICINA. COLAGENO DE TENDON BOVINO 2.8 MG ENVASE CON 5 IMPLANTES DE 10 CM X 10 CM X 0.5 CM.,ENV,5,PZA,4.1,miligramos,20.5,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1141,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,DARUNAVIR,4289,4289,1000042890000,010,000,4289,00,00,NO,"Antirretrovirales,Catálogo II -- GERA",DARUNAVIR TABLETA CADA TABLETA CONTIENE: ETANOLATO DE DARUNAVIR EQUIVALENTE A 600 MG DE DARUNAVIR ENVASE CON 60 TABLETAS.,ENV,60,TAB,600,miligramos,36000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1142,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,DARUNAVIR,4289,4289,1000042890100,010,000,4289,01,00,SI,"Antirretrovirales,Catálogo II -- GERA",DARUNAVIR. TABLETA. CADA TABLETA CONTIENE: DARUNAVIR 600 MG. ENVASE CON 60 TABLETAS.,ENV,60,TAB,600,miligramos,36000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1143,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,LINEZOLID,4290,4290,1000042900000,010,000,4290,00,00,SI,Entrega hospitalaria,LINEZOLID TABLETA CADA TABLETA CONTIENE: LINEZOLID 600 MG ENVASE CON 10 TABLETAS.,ENV,10,TAB,600,miligramos,6000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1144,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,LINEZOLID,4291,4291,1000042910000,010,000,4291,00,00,SI,"Sustantiva -- Eficiencia terapeutica G - 10%,Uso Hospitalario, Enfermedades Infecciosas y Parasitarias",LINEZOLID SOLUCION INYECTABLE CADA 100 ML CONTIENEN: LINEZOLID 200 MG ENVASE CON BOLSA CON 300 ML.,ENV,1,BSA,200,miligramos,200,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1147,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,LEVOFLOXACINO,4299,4299,1000042990000,010,000,4299,00,00,SI,Sustantiva -- Eficiencia terapeutica K - 90%,LEVOFLOXACINO TABLETA CADA TABLETA CONTIENE: LEVOFLOXACINO HEMIHIDRATADO EQUIVALENTE A 500 MG DE LEVOFLOXACINO. ENVASE CON 7 TABLETAS.,ENV,7,TAB,500,miligramos,3500,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1148,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,LEVOFLOXACINO,4300,4300,1000043000000,010,000,4300,00,00,SI,Sustantiva,LEVOFLOXACINO TABLETA CADA TABLETA CONTIENE: LEVOFLOXACINO HEMIHIDRATADO EQUIVALENTE A 750 MG DE LEVOFLOXACINO. ENVASE CON 7 TABLETAS.,ENV,7,TAB,750,miligramos,5250,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1190,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,ABACAVIR-LAMIVUDINA-ZIDOVUDINA,4368,4368,1000043680000,010,000,4368,00,00,SI,"Antirretrovirales,Sustantiva -- VIH",ABACAVIR -LAMIVUDINA -ZIDOVUDINA TABLETA CADA TABLETA CONTIENE: SULFATO DE  ABACAVIR EQUIVALENTE A 300 MG DE ABACAVIR. LAMIVUDINA 150 MG ZIDOVUDINA 300 MG  ENVASE CON 60 TABLETAS.,ENV,60,TAB,750,miligramos,45000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1191,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,EFAVIRENZ,4370,4370,1000043700000,010,000,4370,00,00,SI,"Antirretrovirales,Sustantiva -- VIH",EFAVIRENZ COMPRIMIDO RECUBIERTO CADA COMPRIMIDO CONTIENE: EFAVIRENZ 600 MG  ENVASE CON 30 COMPRIMIDOS RECUBIERTOS.,ENV,30,COM,600,miligramos,18000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1192,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,ABACAVIR-LAMIVUDINA,4371,4371,1000043710000,010,000,4371,00,00,SI,"Antirretrovirales,Sustantiva -- VIH",ABACAVIR-LAMIVUDINA TABLETA CADA TABLETA CONTIENE: SULFATO DE ABACAVIR  EQUIVALENTE A 600 MG DE ABACAVIR LAMIVUDINA 300 MG ENVASE CON 30 TABLETAS.,ENV,30,TAB,300,miligramos,9000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1193,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,VALGANCICLOVIR,4373,4373,1000043730000,010,000,4373,00,00,SI,"Antirretrovirales,Entrega hospitalaria",VALGANCICLOVIR. COMPRIMIDO. CADA COMPRIMIDO CONTIENE: CLORHIDRATO DE  VALGANCICLOVIR EQUIVALENTE A 450 MG DE VALGANCICLOVIR. ENVASE CON 60  COMPRIMIDOS.,ENV,60,COM,450,miligramos,27000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1194,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,ZANAMIVIR,4374,4374,1000043740001,010,000,4374,00,01,SI,Sin programa definido,"ZANAMIVIR. POLVO. CADA DOSIS DE POLVO CONTIENE: ZANAMIVIR 5 MG ENVASE CON 5 DISCOS DE ALUMINIO, CADA UNO CON 4 DOSIS DE 5 MG. Y UN DISPOSITIVO INHALADOR.",ENV,1,ENV,5,miligramos,5,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1195,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,ADEFOVIR,4375,4375,1000043750000,010,000,4375,00,00,SI,Sustantiva,ADEFOVIR TABLETA CADA TABLETA CONTIENE: DIPIVOXILO DE ADEFOVIR 10 MG ENVASE CON  30 TABLETAS.,ENV,30,TAB,10,miligramos,300,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1198,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,ENTECAVIR,4385,4385,1000043850000,010,000,4385,00,00,SI,Entrega hospitalaria,ENTECAVIR TABLETA CADA TABLETA CONTIENE: ENTECAVIR 0.50 MG ENVASE CON 30  TABLETAS.,ENV,30,TAB,0.5,miligramos,15,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1199,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,ENTECAVIR,4386,4386,1000043860002,010,000,4386,00,02,SI,Sustantiva,ENTECAVIR. TABLETA. CADA TABLETA CONTIENE: ENTECAVIR 1 MG. ENVASE CON 30 TABLETAS.,ENV,30,TAB,1,miligramos,30,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1200,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,EMTRICITABINA-TENOFOVIR,4396,4396,1000043960000,010,000,4396,00,00,SI,"Antirretrovirales,Entrega hospitalaria,Entrega hospitalaria,Entrega hospitalaria",EMTRICITABINA-TENOFOVIR DISOPROXIL FUMARATO TABLETA RECUBIERTA CADA TABLETA RECUBIERTA CONTIENE: TENOFOVIR DISOPROXIL FUMARATO 300 MG EQUIVALENTE A 245 MG DE TENOFOVIR DISOPROXIL EMTRICITABINA 200 MG ENVASE CON 30 TABLETAS,ENV,30,TAB,500,miligramos,15000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1201,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,EMTRICITABINA-TENOFOVIR,4396,4396,1000043960001,010,000,4396,00,01,NO,"Antirretrovirales,Entrega hospitalaria,Entrega hospitalaria,Entrega hospitalaria",EMTRICITABINA-TENOFOVIR. TABLETA. CADA TABLETA CONTIENE: TENOFOVIR DISOPROXIL FUMARATO EQUIVALENTE A 245 MG DE TENOFOVIR DISOPROXIL. EMTRICITABINA 200 MG. ENVASE CON 30 TABLETAS.,ENV,30,TAB,445,miligramos,13350,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1202,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,EMTRICITABINA-TENOFOVIR,4396,4396,1000043960100,010,000,4396,01,00,NO,"Antirretrovirales,Entrega hospitalaria,Entrega hospitalaria,Entrega hospitalaria",EMTRICITABINA-TENOFOVIR. TABLETA. CADA TABLETA CONTIENE: TENOFOVIR DISOPROXIL SUCCINATO EQUIVALENTE A 245 MG DE TENOFOVIR DISOPROXIL EMTRICITABINA 200 MG. ENVASE CON 30 TABLETAS.,ENV,30,TAB,445,miligramos,13350,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1254,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,TEICOPLANINA,4578,4578,1000045780000,010,000,4578,00,00,SI,"Sustantiva,Uso Hospitalario, Enfermedades Infecciosas y Parasitarias",TEICOPLANINA SOLUCION INYECTABLE EL FRASCO AMPULA CONTIENE: TEICOPLANINA 400 MG  ENVASE CON UN FRASCO AMPULA Y AMPOLLETA CON 3 ML DE DILUYENTE.,ENV,1,JGO,400,miligramos,400,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1255,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,OSELTAMIVIR,4582,4582,1000045820000,010,000,4582,00,00,SI,"VALES,Influenza -- sin CPM_V",OSELTAMIVIR CAPSULA CADA CAPSULA CONTIENE: OSELTAMIVIR 75.0 MG ENVASE CON 10  CAPSULAS.,ENV,10,CAP,75,miligramos,750,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1256,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,OSELTAMIVIR,4583,4583,1000045830000,010,000,4583,00,00,SI,Sin programa definido,OSELTAMIVIR CAPSULA CADA CAPSULA CONTIENE: FOSFATO DE OSELTAMIVIR EQUIVALENTE A 45 MG DE OSELTAMIVIR ENVASE CON 10 CAPSULAS.,ENV,10,CAP,45,miligramos,450,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1257,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,OSELTAMIVIR,4584,4584,1000045840000,010,000,4584,00,00,SI,Sin programa definido,OSELTAMIVIR CAPSULA CADA CAPSULA CONTIENE: FOSFATO DE OSELTAMIVIR EQUIVALENTE A 30 MG DE OSELTAMIVIR ENVASE CON 10 CAPSULAS,ENV,10,CAP,30,miligramos,300,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1258,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,OSELTAMIVIR,4585,4585,1000045850000,010,000,4585,00,00,SI,Sin programa definido,OSELTAMIVIR SUSPENSION CADA ENVASE CON 30 G DE POLVO CONTIENE: FOSFATO DE OSELTAMIVIR EQUIVALENTE A 0.9 G DE OSELTAMIVIR ENVASE CON 30 G. RECONSTITUIR CON 100 ML DE AGUA PARA FORMAR UNA SUSPENSION CONTENIENDO 900 MG/75 ML (12,ENV,30,GRO,30.9,gramos,927,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1259,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,TIGECICLINA,4590,4590,1000045900000,010,000,4590,00,00,SI,"Sustantiva,Uso Hospitalario, Enfermedades Infecciosas y Parasitarias",TIGECICLINA SOLUCION INYECTABLE CADA FRASCO AMPULA CON LIOFILIZADO CONTIENE:  TIGECICLINA 50 MG ENVASE CON UN FRASCO AMPULA.,ENV,1,F.A,50,miligramos,50,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1260,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,PIPERACILINA-TAZOBACTAM,4592,4592,1000045920000,010,000,4592,00,00,SI,"Sustantiva,Uso Hospitalario, Enfermedades Infecciosas y Parasitarias",PIPERACILINA –TAZOBACTAM SOLUCION INYECTABLE CADA FRASCO AMPULA CON POLVO  CONTIENE: PIPERACILINA SODICA EQUIVALENTE A 4 G DE PIPERACILINA. TAZOBACTAM  SODICO EQUIVALENTE A 500 MG DE TAZOBACTAM. ENVASE CON FRASCO AMPULA.,ENV,1,F.A,500,miligramos,500,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1345,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,TRIMETOPRIMA Y SULFAMETOXAZOL,5255,5255,1000052550000,010,000,5255,00,00,SI,"Sustantiva,Uso Hospitalario, Enfermedades Infecciosas y Parasitarias",TRIMETOPRIMA -SULFAMETOXAZOL SOLUCION INYECTABLE CADA AMPOLLETA CONTIENE:  TRIMETOPRIMA 160 MG SULFAMETOXAZOL 800 MG ENVASE CON 6 AMPOLLETAS CON 3 ML.,ENV,6,AMP,960,miligramos,5760,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1346,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,CEFALOTINA,5256,5256,1000052560000,010,000,5256,00,00,SI,Sustantiva,CEFALOTINA SOLUCION INYECTABLE CADA FRASCO AMPULA CON POLVO CONTIENE:  CEFALOTINA SODICA EQUIVALENTE A 1 G DE CEFALOTINA. ENVASE CON UN FRASCO AMPULA  Y 5 ML DE DILUYENTE.,ENV,1,JGO,1,gramos,1,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1348,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,NEVIRAPINA,5259,5259,1000052590000,010,000,5259,00,00,SI,"Antirretrovirales,Sustantiva -- VIH",NEVIRAPINA SUSPENSION CADA 100 MILILITROS CONTIENEN: NEVIRAPINA HEMIHIDRATADA  EQUIVALENTE A 1 G DE NEVIRAPINA ENVASE CON 240 ML CON DOSIFICADOR.,ENV,1,ENV,1,gramos,1,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1349,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,PIRIMETAMINA,5261,5261,1000052610000,010,000,5261,00,00,SI,Sustantiva,PIRIMETAMINA TABLETA CADA TABLETA CONTIENE: PIRIMETAMINA 25 MG ENVASE CON 30  TABLETAS.,ENV,30,TAB,25,miligramos,750,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1350,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,CEFUROXIMA,5264,5264,1000052640002,010,000,5264,00,02,NO,Sustantiva,CEFUROXIMA. SOLUCION O SUSPENSION INYECTABLE. CADA FRASCO AMPULA CON POLVO CONTIENE: CEFUROXIMA SODICA EQUIVALENTE A 750 MG DE CEFUROXIMA. ENVASE CON UN FRASCO AMPULA Y ENVASE CON 3 ML DE DILUYENTE.,ENV,1,JGO,750,miligramos,750,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1351,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,CEFUROXIMA,5264,5264,1000052640100,010,000,5264,01,00,SI,Sustantiva,CEFUROXIMA. SOLUCION O SUSPENSION INYECTABLE. CADA FRASCO AMPULA CON POLVO CONTIENE: CEFUROXIMA SODICA EQUIVALENTE A 750 MG DE CEFUROXIMA. ENVASE CON UN FRASCO AMPULA Y ENVASE CON 5 ML DE DILUYENTE.,ENV,1,JGO,750,miligramos,750,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1352,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,CEFUROXIMA,5264,5264,1000052640200,010,000,5264,02,00,NO,Sustantiva,CEFUROXIMA SOLUCION O SUSPENSION INYECTABLE CADA FRASCO AMPULA CON POLVO CONTIENE: CEFUROXIMA SODICA EQUIVALENTE A 750 MG DE CEFUROXIMA. ENVASE CON UN FRASCO AMPULA Y ENVASE CON 10 ML DE DILUYENTE.,ENV,1,JGO,750,miligramos,750,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1353,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,IMIPENEM Y CILASTATINA,5265,5265,1000052650002,010,000,5265,00,02,SI,"Sustantiva,Uso Hospitalario, Enfermedades Infecciosas y Parasitarias,Uso Hospitalario, Enfermedades Infecciosas y Parasitarias",IMIPENEM Y CILASTATINA. SOLUCION INYECTABLE. CADA FRASCO AMPULA CON POLVO CONTIENE: IMIPENEM MONOHIDRATADO EQUIVALENTE A 500 MG DE IMIPENEM. CILASTATINA SODICA EQUIVALENTE A 500 MG DE CILASTATINA. ENVASE CON UN FRASCO AMPULA.,ENV,1,F.A,500,miligramos,500,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1354,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,IMIPENEM Y CILASTATINA,5265,5265,1000052650100,010,000,5265,01,00,NO,"Sustantiva,Uso Hospitalario, Enfermedades Infecciosas y Parasitarias,Uso Hospitalario, Enfermedades Infecciosas y Parasitarias",IMIPENEM Y CILASTATINA. SOLUCION INYECTABLE. CADA FRASCO AMPULA CON POLVO CONTIENE: IMIPENEM MONOHIDRATADO EQUIVALENTE A 500 MG DE IMIPENEM. CILASTATINA SODICA EQUIVALENTE A 500 MG DE CILASTATINA. ENVASE CON 25 FRASCOS AMPULA.,ENV,25,F.A,500,miligramos,12500,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1355,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,FLUCONAZOL,5267,5267,1000052670000,010,000,5267,00,00,SI,"VALES,Sustantiva -- Eficiencia terapeutica J - 98%",FLUCONAZOL CAPSULA O TABLETA CADA CAPSULA O TABLETA CONTIENE: FLUCONAZOL 100 MG  ENVASE CON 10 CAPSULAS O TABLETAS.,ENV,10,CAP,100,miligramos,1000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1356,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,GANCICLOVIR,5268,5268,1000052680000,010,000,5268,00,00,SI,"Sustantiva,Uso Hospitalario, Enfermedades Infecciosas y Parasitarias",GANCICLOVIR SOLUCION INYECTABLE CADA FRASCO AMPULA CON LIOFILIZADO CONTIENE:  GANCICLOVIR SODICO EQUIVALENTE A 500 MG DE GANCICLOVIR. ENVASE CON UN FRASCO  AMPULA Y UNA AMPOLLETA CON 10 ML DE DILUYENTE.,ENV,1,JGO,500,miligramos,500,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1357,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,ZIDOVUDINA,5273,5273,1000052730000,010,000,5273,00,00,SI,"Antirretrovirales,Sustantiva -- VIH",ZIDOVUDINA SOLUCION ORAL CADA 100 ML CONTIENEN: ZIDOVUDINA 1 G ENVASE CON 240  ML.,ENV,1,ENV,1,gramos,1,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1358,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,ZIDOVUDINA,5274,5274,1000052740000,010,000,5274,00,00,SI,"Antirretrovirales,Sustantiva -- VIH",ZIDOVUDINA CAPSULA CADA CAPSULA CONTIENE: ZIDOVUDINA 250 MG ENVASE CON 30  CAPSULAS.,ENV,30,CAP,250,miligramos,7500,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1359,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,ETRAVIRINA,5275,5275,1000052750000,010,000,5275,00,00,SI,"Catálogo II -- GERA,Antirretrovirales",ETRAVIRINA TABLETA CADA TABLETA CONTIENE: ETRAVIRINA 100 MG ENVASE CON 120  TABLETAS.,ENV,120,TAB,100,miligramos,12000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1360,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,LOPINAVIR-RITONAVIR,5276,5276,1000052760000,010,000,5276,00,00,SI,"Antirretrovirales,Entrega hospitalaria",LOPINAVIR-RITONAVIR SOLUCION CADA 100 ML CONTIENEN: LOPINAVIR 8.0 G RITONAVIR  2.0 G ENVASE FRASCO AMBAR CON 160 ML Y DOSIFICADOR.,ENV,1,ENV,10,gramos,10,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1361,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,TEICOPLANINA,5278,5278,1000052780000,010,000,5278,00,00,SI,"Sustantiva,Uso Hospitalario, Enfermedades Infecciosas y Parasitarias",TEICOPLANINA SOLUCION INYECTABLE CADA FRASCO AMPULA CON POLVO CONTIENE:  TEICOPLANINA 200 MG ENVASE CON UN FRASCO AMPULA Y DILUYENTE CON 3 ML.,ENV,1,ENV,200,miligramos,200,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1362,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,INDINAVIR,5279,5279,1000052790000,010,000,5279,00,00,SI,Sustantiva -- VIH,INDINAVIR CAPSULA CADA CAPSULA CONTIENE: SULFATO DE INDINAVIR EQUIVALENTE A 400  MG DE INDINAVIR. ENVASE CON 180 CAPSULAS.,ENV,180,CAP,400,miligramos,72000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1363,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,RALTEGRAVIR,5280,5280,1000052800000,010,000,5280,00,00,SI,"Catálogo II -- GERA,Antirretrovirales",RALTEGRAVIR COMPRIMIDO CADA COMPRIMIDO CONTIENE: RALTEGRAVIR POTASICO  EQUIVALENTE A 400 MG DE RALTEGRAVIR ENVASE CON 60 COMPRIMIDOS.,ENV,60,COM,400,miligramos,24000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1364,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,RITONAVIR,5281,5281,1000052810000,010,000,5281,00,00,NO,"Antirretrovirales,Sustantiva -- VIH",RITONAVIR. CAPSULA O TABLETA. CADA CAPSULA O TABLETA CONTIENE RITONAVIR 100 MG  2 ENVASES CON 84 CAPSULAS CADA UNO.,ENV,1,ENV,100,miligramos,100,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1365,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,RITONAVIR,5281,5281,1000052810100,010,000,5281,01,00,SI,"Antirretrovirales,Sustantiva -- VIH",RITONAVIR. CAPSULA O TABLETA. CADA CAPSULA O TABLETA CONTIENE RITONAVIR 100 MG. ENVASE CON 30 TABLETAS.,ENV,30,TAB,100,miligramos,3000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1366,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,LAMIVUDINA,5282,5282,1000052820000,010,000,5282,00,00,NO,"Antirretrovirales,Sustantiva -- VIH",LAMIVUDINA. TABLETA. CADA TABLETA CONTIENE: LAMIVUDINA 150 MG. ENVASE CON 30 TABLETAS.,ENV,30,TAB,150,miligramos,4500,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1367,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,LAMIVUDINA,5282,5282,1000052820100,010,000,5282,01,00,SI,"Antirretrovirales,Sustantiva -- VIH",LAMIVUDINA TABLETA CADA TABLETA CONTIENE: LAMIVUDINA 150 MG ENVASE CON 60  TABLETAS.,ENV,60,TAB,150,miligramos,9000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1368,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,CEFEPIMA,5284,5284,1000052840000,010,000,5284,00,00,SI,Sustantiva,CEFEPIMA SOLUCION INYECTABLE EL FRASCO AMPULA CONTIENE: CLORHIDRATO  MONOHIDRATADO DE CEFEPIMA EQUIVALENTE A 500 MG DE CEFEPIMA. ENVASE CON UN  FRASCO AMPULA Y AMPOLLETA CON 5 ML DE DILUYENTE.,ENV,1,ENV,500,miligramos,500,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1369,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,LOPINAVIR-RITONAVIR,5286,5286,1000052860000,010,000,5286,00,00,SI,"Antirretrovirales,Sustantiva -- VIH",LOPINAVIR-RITONAVIR TABLETA CADA TABLETA CONTIENE: LOPINAVIR 100 MG RITONAVIR   25 MG ENVASE CON 60 TABLETAS.,ENV,60,TAB,125,miligramos,7500,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1370,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,LOPINAVIR-RITONAVIR,5288,5288,1000052880000,010,000,5288,00,00,SI,"Antirretrovirales,Entrega hospitalaria",LOPINAVIR-RITONAVIR TABLETA CADA TABLETA CONTIENE: LOPINAVIR 200 MG RITONAVIR  50 MG ENVASE CON 120 TABLETAS.,ENV,120,TAB,250,miligramos,30000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1371,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,SAQUINAVIR,5290,5290,1000052900000,010,000,5290,00,00,SI,"Antirretrovirales,Entrega hospitalaria",SAQUINAVIR COMPRIMIDO CADA COMPRIMIDO CONTIENE: MESILATO DE SAQUINAVIR  EQUIVALENTE A 500 MG DE SAQUINAVIR ENVASE CON 120 COMPRIMIDOS.,ENV,120,COM,500,miligramos,60000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1372,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,MEROPENEM,5291,5291,1000052910000,010,000,5291,00,00,SI,"Sustantiva,Uso Hospitalario, Enfermedades Infecciosas y Parasitarias,Uso Hospitalario, Enfermedades Infecciosas y Parasitarias",MEROPENEM SOLUCION INYECTABLE CADA FRASCO AMPULA CON POLVO CONTIENE: MEROPENEM  TRIHIDRATADO EQUIVALENTE A 500 MG DE MEROPENEM. ENVASE CON 1 FRASCO AMPULA.,ENV,1,F.A,500,miligramos,500,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1373,Grupo Nº 6: Enfermedades Infecciosas y Parasitarias,MEROPENEM,5291,5291,1000052910100,010,000,5291,01,00,NO,"Sustantiva,Uso Hospitalario, Enfermedades Infecciosas y Parasitarias,Uso Hospitalario, Enfermedades Infecciosas y Parasitarias",MEROPENEM. SOLUCION INYECTABLE. CADA FRASCO AMPULA CON POLVO CONTIENE: MEROPENEM TRIHIDRATADO EQUIVALENTE A 500 MG DE MEROPENEM. ENVASE CON 10 FRASCOS AMPULA.,ENV,10,F.A,500,miligramos,5000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
197,Grupo Nº 7: Enfermedades Inmunoalérgicas,INMUNOGLOBULINA HUMANA NORMAL SUBCUTÁNEA,5642,5642,1000056420000,010,000,5642,00,00,SI,Sin programa definido,INMUNOGLOBULINA HUMANA NORMAL SUBCUTANEA. SOLUCION INYECTABLE CADA FRASCO AMPULA CONTIENE: INMUNOGLOBULINA HUMANA NORMAL 3300 MG. ENVASE CON UN FRASCO AMPULA CON 20 ML.,ENV,1,F.A,3300,miligramos,3300,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
200,Grupo Nº 7: Enfermedades Inmunoalérgicas,FLUTICASONA,5646,5646,1000056460000,010,000,5646,00,00,SI,"VALES,Sustantiva -- Eficiencia terapeutica E - 49%","FLUTICASONA, SUSPENSION EN AEROSOL NASAL. CADA DISPARO PROPORCIONA: FUROATO DE  FLUTICASONA 27.5 MICROGRAMOS. ENVASE CON 120 DISPAROS.",ENV,120,DPS,27.5,microgramos,3300,microgramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
206,Grupo Nº 7: Enfermedades Inmunoalérgicas,INMUNOGLOBULINA HUMANA,5696,5696,1000056960000,010,000,5696,00,00,SI,"Sin programa definido,Uso Hospitalario, Enfermedades Inmunoalérgicas",INMUNOGLOBULINA HUMANA. SOLUCION INYECTABLE. CADA FRASCO AMPULA CONTIENE: INMUNOGLOBULINA HUMANA NORMAL ENDOVENOSA 2.5 G. ENVASE CON UN FRASCO AMPULA  CON 25 ML.,ENV,1,F.A,2.5,gramos,2.5,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
207,Grupo Nº 7: Enfermedades Inmunoalérgicas,INMUNOGLOBULINA HUMANA,5697,5697,1000056970000,010,000,5697,00,00,SI,"Uso Hospitalario, Enfermedades Inmunoalérgicas",INMUNOGLOBULINA HUMANA. SOLUCION INYECTABLE. CADA FRASCO AMPULA CONTIENE: INMUNOGLOBULINA HUMANA NORMAL ENDOVENOSA 5.0 G. ENVASE CON UN FRASCO AMPULA  CON 50 ML.,ENV,1,F.A,5,gramos,5,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
208,Grupo Nº 7: Enfermedades Inmunoalérgicas,INMUNOGLOBULINA HUMANA,5698,5698,1000056980000,010,000,5698,00,00,SI,"Sustantiva,Uso Hospitalario, Enfermedades Inmunoalérgicas",INMUNOGLOBULINA HUMANA. SOLUCION INYECTABLE. CADA FRASCO AMPULA CONTIENE: INMUNOGLOBULINA HUMANA NORMAL ENDOVENOSA 10.0 G. ENVASE CON UN FRASCO AMPULA  CON 100 ML.,ENV,1,F.A,10,gramos,10,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
393,Grupo Nº 7: Enfermedades Inmunoalérgicas,BETAMETASONA,2141,2141,1000021410000,010,000,2141,00,00,SI,Sustantiva,BETAMETASONA SOLUCION INYECTABLE CADA AMPOLLETA O FRASCO AMPULA CONTIENE:  FOSFATO SODICO DE BETAMETASONA 5.3 MG EQUIVALENTE A 4 MG DE BETAMETASONA.  ENVASE CON UN FRASCO AMPULA O UNA AMPOLLETA CON 1 ML.,ENV,1,AFA,4,miligramos,4,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
394,Grupo Nº 7: Enfermedades Inmunoalérgicas,LORATADINA,2144,2144,1000021440000,010,000,2144,00,00,SI,"VALES,Consumo en demanda",LORATADINA TABLETA O GRAGEA CADA TABLETA O GRAGEA CONTIENEN: LORATADINA 10 MG  ENVASE CON 20 TABLETAS O GRAGEAS.,ENV,20,T.G,10,miligramos,200,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIALERGICOS,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
395,Grupo Nº 7: Enfermedades Inmunoalérgicas,LORATADINA,2145,2145,1000021450000,010,000,2145,00,00,SI,"VALES,Sustantiva",LORATADINA JARABE CADA 100 ML CONTIENEN: LORATADINA 100 MG ENVASE CON 60 ML Y  DOSIFICADOR.,FCO,1,FCO,100,miligramos,100,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
553,Grupo Nº 7: Enfermedades Inmunoalérgicas,EPINASTINA,3143,3143,1000031430000,010,000,3143,00,00,SI,"Sustantiva,VALES",EPINASTINA TABLETA CADA TABLETA CONTIENE: CLORHIDRATO DE EPINASTINA 20 MG  ENVASE CON 10 TABLETAS.,ENV,10,TAB,20,miligramos,200,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIALERGICOS,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
554,Grupo Nº 7: Enfermedades Inmunoalérgicas,FEXOFENADINA,3146,3146,1000031460000,010,000,3146,00,00,SI,Sustantiva,FEXOFENADINA COMPRIMIDO CADA COMPRIMIDO CONTIENE: CLORHIDRATO DE FEXOFENADINA  180 MG ENVASE CON 10 COMPRIMIDOS.,ENV,10,COM,180,miligramos,1800,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
555,Grupo Nº 7: Enfermedades Inmunoalérgicas,LEVOCETIRIZINA,3150,3150,1000031500001,010,000,3150,00,01,SI,Sustantiva,LEVOCETIRIZINA TABLETA CADA TABLETA CONTIENE: DICLORHIDRATO DE LEVOCETIRIZINA 5  MG ENVASE CON 20 TABLETAS.,ENV,20,TAB,5,miligramos,100,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
606,Grupo Nº 7: Enfermedades Inmunoalérgicas,HIDROXIZINA,409,0409,4000004090000,040,000,0409,00,00,SI,"VALES,Sustantiva",HIDROXIZINA GRAGEA O TABLETA CADA GRAGEA O TABLETA CONTIENE: CLORHIDRATO DE  HIDROXIZINA 10 MG ENVASE CON 30 GRAGEAS O TABLETAS.,ENV,30,GRA,10,miligramos,300,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIALERGICOS,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
705,Grupo Nº 7: Enfermedades Inmunoalérgicas,CLORFENAMINA,402,0402,1000004020000,010,000,0402,00,00,SI,"VALES,Sustantiva",CLORFENAMINA TABLETA CADA TABLETA CONTIENE: MALEATO DE CLORFENAMINA 4.0 MG ENVASE CON 20 TABLETAS.,ENV,20,TAB,4,miligramos,80,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIALERGICOS,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
706,Grupo Nº 7: Enfermedades Inmunoalérgicas,DIFENHIDRAMINA,405,0405,1000004050000,010,000,0405,00,00,SI,"VALES,Sustantiva",DIFENHIDRAMINA JARABE CADA 100 MILILITROS CONTIENEN: CLORHIDRATO DE DIFENHIDRAMINA 250 MG ENVASE CON 60 ML.,ENV,60,ML.,250,miligramos,250,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIALERGICOS,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
707,Grupo Nº 7: Enfermedades Inmunoalérgicas,DIFENHIDRAMINA,406,0406,1000004060000,010,000,0406,00,00,SI,Sustantiva,DIFENHIDRAMINA SOLUCION INYECTABLE CADA FRASCO AMPULA CONTIENE: CLORHIDRATO DE DIFENHIDRAMINA 100 MG ENVASE CON FRASCO AMPULA DE 10 ML.,ENV,1,F.A,100,miligramos,100,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
708,Grupo Nº 7: Enfermedades Inmunoalérgicas,CLORFENAMINA,408,0408,1000004080000,010,000,0408,00,00,SI,"VALES,Sustantiva",CLORFENAMINA JARABE CADA MILILITRO CONTIENE: MALEATO DE CLORFENAMINA 0.5 MG ENVASE CON 60 ML.,ENV,60,ML.,0.5,miligramos,0.5,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
724,Grupo Nº 7: Enfermedades Inmunoalérgicas,KETOTIFENO,463,0463,1000004630000,010,000,0463,00,00,SI,"VALES,Sustantiva",KETOTIFENO SOLUCION ORAL CADA 100 ML CONTIENEN: FUMARATO ACIDO DE KETOTIFENO EQUIVALENTE A 20 MG DE KETOTIFENO. ENVASE CON 120 ML Y DOSIFICADOR.,ENV,120,ML.,20,miligramos,20,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,BRONCODILATADORES_Y_EXPECTORANTES,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
725,Grupo Nº 7: Enfermedades Inmunoalérgicas,CROMOGLICATO DE SODIO,464,0464,1000004640000,010,000,0464,00,00,SI,Sustantiva,CROMOGLICATO DE SODIO SUSPENSION AEROSOL CADA INHALADOR CONTIENEN: CROMOGLICATO DISODICO 560 MG ENVASE CON ESPACIADOR PARA 112 DOSIS DE 5 MG.,ENV,1,ENV,560,miligramos,560,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
728,Grupo Nº 7: Enfermedades Inmunoalérgicas,HIDROCORTISONA,474,0474,1000004740000,010,000,0474,00,00,SI,Sustantiva,HIDROCORTISONA SOLUCION INYECTABLE CADA FRASCO AMPULA CONTIENE: SUCCINATO SODICO DE HIDROCORTISONA EQUIVALENTE A 100 MG DE HIDROCORTISONA. ENVASE CON 50 FRASCOS AMPULA Y 50 AMPOLLETAS CON 2 ML DE DILUYENTE.,ENV,50,JGO,100,miligramos,5000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIFLAMATORIOS_ESTEROIDEOS,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1024,Grupo Nº 7: Enfermedades Inmunoalérgicas,MOMETASONA,4141,4141,1000041410000,010,000,4141,00,00,SI,"Sustantiva -- Eficiencia terapeutica E - 50%,VALES",MOMETASONA SUSPENSION PARA INHALACION CADA 100 ML CONTIENE: FUROATO DE MOMETASONA MONOHIDRATADA EQUIVALENTE A 0.050 G DE FUROATO DE MOMETASONA ANHIDRA ENVASE NEBULIZADOR CON 18 ML Y VALVULA DOSIFICADORA (140,ENV,1,ENV,0.05,gramos,0.05,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIFLAMATORIOS_ESTEROIDEOS,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1025,Grupo Nº 7: Enfermedades Inmunoalérgicas,MOMETASONA,4141,4141,1000041410001,010,000,4141,00,01,NO,"Sustantiva -- Eficiencia terapeutica E - 50%,VALES",MOMETASONA SUSPENSION PARA INHALACION CADA 100 ML CONTIENE: FUROATO DE MOMETASONA MONOHIDRATADA EQUIVALENTE A 0.050 G DE FUROATO DE MOMETASONA ANHIDRO ENVASE NEBULIZADOR CON 18 ML Y VALVULA DOSIFICADORA (140 NEBULIZACIONES DE 50,ENV,1,ENV,0.05,gramos,0.05,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIFLAMATORIOS_ESTEROIDEOS,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1331,Grupo Nº 7: Enfermedades Inmunoalérgicas,INMUNOGLOBULINA G NO MODIFICADA,5240,5240,1000052400000,010,000,5240,00,00,SI,"Uso Hospitalario, Enfermedades Inmunoalérgicas,Uso Hospitalario, Enfermedades Inmunoalérgicas",INMUNOGLOBULINA G NO MODIFICADA SOLUCION INYECTABLE. CADA FRASCO AMPULA CON LIOFILIZADO O SOLUCION CONTIENEN: INMUNOGLOBULINA G NO MODIFICADA 6 G. ENVASE CON UN FRASCO AMPULA CON 120 ML.,ENV,1,F.A,6,gramos,6,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1332,Grupo Nº 7: Enfermedades Inmunoalérgicas,INMUNOGLOBULINA G NO MODIFICADA,5240,5240,1000052400100,010,000,5240,01,00,NO,"Uso Hospitalario, Enfermedades Inmunoalérgicas,Uso Hospitalario, Enfermedades Inmunoalérgicas",INMUNOGLOBULINA G NO MODIFICADA SOLUCION INYECTABLE. CADA FRASCO AMPULA CON LIOFILIZADO O SOLUCION CONTIENEN: INMUNOGLOBULINA G NO MODIFICADA 6 G. ENVASE CON FRASCO AMPULA Y FRASCO CON 200 ML DE DILUYENTE. CON EQUIPO DE PERFUSION,ENV,1,EQP,6,gramos,6,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1333,Grupo Nº 7: Enfermedades Inmunoalérgicas,INMUNOGLOBULINA G NO MODIFICADA,5244,5244,1000052440001,010,000,5244,00,01,SI,"Uso Hospitalario, Enfermedades Inmunoalérgicas,Uso Hospitalario, Enfermedades Inmunoalérgicas",INMUNOGLOBULINA G NO MODIFICADA. SOLUCION INYECTABLE. 5 G. ENVASE CON UN FRASCO AMPULA CON 100 ML.,ENV,100,ML.,5,gramos,5,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1334,Grupo Nº 7: Enfermedades Inmunoalérgicas,INMUNOGLOBULINA G NO MODIFICADA,5244,5244,1000052440002,010,000,5244,00,02,NO,"Uso Hospitalario, Enfermedades Inmunoalérgicas,Uso Hospitalario, Enfermedades Inmunoalérgicas",INMUNOGLOBULINA G NO MODIFICADA. SOLUCION INYECTABLE CADA FRASCO AMPULA CONTIENE: INMUNOGLOBULINA G NO. MODIFICADA 5 G. ENVASE CON UN FRASCO AMPULA CON 100 ML.,ENV,100,ML.,5,gramos,5,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1335,Grupo Nº 7: Enfermedades Inmunoalérgicas,INMUNOGLOBULINA G NO MODIFICADA,5244,5244,1000052440102,010,000,5244,01,02,NO,"Uso Hospitalario, Enfermedades Inmunoalérgicas,Uso Hospitalario, Enfermedades Inmunoalérgicas",INMUNOGLOBULINA G NO MODIFICADA. SOLUCION INYECTABLE. CADA FRASCO AMPULA CONTIENE: INMUNOGLOBULINA G NO MODIFICADA 5 G. ENVASE CON UN FRASCO AMPULA CON  LIOLIFILIZADO Y FRASCO AMPULA CON 90 A 100 ML DE DILUYENTE.,ENV,1,ENV,5,gramos,5,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
396,Grupo Nº 8: Gastroenterología,RANITIDINA,2151,2151,1000021510000,010,000,2151,00,00,SI,"VALES,Sustantiva",RANITIDINA JARABE CADA 10 ML CONTIENE: CLORHIDRATO DE RANITIDINA 150 MG ENVASE  CON 200 ML.,ENV,1,ENV,150,miligramos,150,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
429,Grupo Nº 8: Gastroenterología,CINITAPRIDA,2247,2247,1000022470000,010,000,2247,00,00,SI,"VALES,Sustantiva",CINITAPRIDA COMPRIMIDO CADA COMPRIMIDO CONTIENE BITARTRATO DE CINITAPRIDA  EQUIVALENTE A 1 MG DE CINITAPRIDA. ENVASE CON 25 COMPRIMIDOS.,ENV,25,COM,1,miligramos,25,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
815,Grupo Nº 8: Gastroenterología,BUTILHIOSCINA O HIOSCINA,1206,1206,1000012060000,010,000,1206,00,00,SI,"VALES,Programa de Planificación Familiar,Consumo en demanda",BUTILHIOSCINA GRAGEA O TABLETA. CADA GRAGEA O TABLETA CONTIENE: BROMURO DE BUTILHIOSCINA 10 MG ENVASE CON 10 GRAGEAS O TABLETAS.,ENV,10,GRA,10,miligramos,100,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIULCEROSOS_Y_PROTECTORES_DE_LA_MUCOSA_GASTRICA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
816,Grupo Nº 8: Gastroenterología,BUTILHIOSCINA O HIOSCINA,1206,1206,1000012060002,010,000,1206,00,02,NO,"VALES,Programa de Planificación Familiar,Consumo en demanda",BUTILHIOSCINA O HIOSCINA. GRAGEA O TABLETA. CADA GRAGEA O TABLETA CONTIENE: BROMURO DE BUTILHIOSCINA O BUTILBROMURO DE HIOSCINA 10 MG. ENVASE CON 10 GRAGEAS O TABLETAS.,ENV,10,T.G,10,miligramos,100,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIULCEROSOS_Y_PROTECTORES_DE_LA_MUCOSA_GASTRICA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
817,Grupo Nº 8: Gastroenterología,BUTILHIOSCINA O HIOSCINA,1207,1207,1000012070000,010,000,1207,00,00,SI,Sustantiva,BUTILHIOSCINA SOLUCION INYECTABLE CADA AMPOLLETA CONTIENE: BROMURO DE BUTILHIOSCINA 20 MG ENVASE CON 3 AMPOLLETAS DE 1 ML.,ENV,3,AMP,20,miligramos,60,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
818,Grupo Nº 8: Gastroenterología,BUTILHIOSCINA O HIOSCINA,1207,1207,1000012070002,010,000,1207,00,02,NO,Sustantiva,BUTILHIOSCINA O HIOSCINA. SOLUCION INYECTABLE. CADA AMPOLLETA CONTIENE: BROMURO DE BUTILHIOSCINA O BUTILBROMURO DE HIOSCINA 20 MG. ENVASE CON 3 AMPOLLETAS DE 1 ML.,ENV,3,AMP,20,miligramos,60,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
819,Grupo Nº 8: Gastroenterología,PINAVERIO,1210,1210,1000012100000,010,000,1210,00,00,SI,"VALES,Consumo en demanda",PINAVERIO TABLETA CADA TABLETA CONTIENE: BROMURO DE PINAVERIO 100 MG ENVASE CON 14 TABLETAS.,ENV,14,TAB,100,miligramos,1400,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIULCEROSOS_Y_PROTECTORES_DE_LA_MUCOSA_GASTRICA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
820,Grupo Nº 8: Gastroenterología,PINAVERIO,1210,1210,1000012100100,010,000,1210,01,00,NO,"VALES,Consumo en demanda",PINAVERIO. TABLETA. CADA TABLETA CONTIENE: BROMURO DE PINAVERIO 100 MG. ENVASE CON 28 TABLETAS.,ENV,28,TAB,100,miligramos,2800,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIULCEROSOS_Y_PROTECTORES_DE_LA_MUCOSA_GASTRICA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
821,Grupo Nº 8: Gastroenterología,ALUMINIO,1221,1221,1000012210000,010,000,1221,00,00,SI,"VALES,Sustantiva",ALUMINIO TABLETA CADA TABLETA CONTIENE: HIDROXIDO DE ALUMINIO 200 MG ENVASE CON 50 TABLETAS.,ENV,50,TAB,200,miligramos,10000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
822,Grupo Nº 8: Gastroenterología,ALUMINIO,1222,1222,1000012220000,010,000,1222,00,00,SI,"VALES,Sustantiva",ALUMINIO SUSPENSION ORAL CADA 100 ML CONTIENEN: HIDROXIDO DE ALUMINIO 7 G ENVASE CON 240 ML Y DOSIFICADOR (350 MG/5 ML).,ENV,1,ENV,7,gramos,7,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
823,Grupo Nº 8: Gastroenterología,ALUMINIO Y MAGNESIO,1223,1223,1000012230000,010,000,1223,00,00,SI,"VALES,Sustantiva",ALUMINIO Y MAGNESIO TABLETA MASTICABLE CADA TABLETA MASTICABLE CONTIENE: HIDROXIDO DE ALUMINIO 200 MG HIDROXIDO DE MAGNESIO 200 MG O TRISILICATO DE MAGNESIO: 447.3 MG ENVASE CON 50 TABLETAS MASTICABLES.,ENV,50,TAB,400,miligramos,20000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
824,Grupo Nº 8: Gastroenterología,ALUMINIO Y MAGNESIO,1224,1224,1000012240000,010,000,1224,00,00,SI,"VALES,Sustantiva",ALUMINIO Y MAGNESIO SUSPENSION ORAL CADA 100 ML CONTIENEN: HIDROXIDO DE ALUMINIO 3.7 G HIDROXIDO DE MAGNESIO 4.0 G O TRISILICATO DE MAGNESIO: 8.9 G ENVASE CON 240 ML Y DOSIFICADOR.,ENV,240,ML.,7.7,gramos,7.7,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIULCEROSOS_Y_PROTECTORES_DE_LA_MUCOSA_GASTRICA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
825,Grupo Nº 8: Gastroenterología,RANITIDINA,1233,1233,1000012330000,010,000,1233,00,00,SI,"VALES,Consumo en demanda",RANITIDINA GRAGEA O TABLETA CADA GRAGEA O TABLETA CONTIENE: CLORHIDRATO DE RANITIDINA EQUIVALENTE A 150 MG DE RANITIDINA. ENVASE CON 20 GRAGEAS O TABLETAS.,ENV,20,T.G,150,miligramos,3000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIULCEROSOS_Y_PROTECTORES_DE_LA_MUCOSA_GASTRICA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
826,Grupo Nº 8: Gastroenterología,RANITIDINA,1234,1234,1000012340003,010,000,1234,00,03,NO,Sustantiva,RANITIDINA. SOLUCION INYECTABLE. CADA AMPOLLETA CONTIENE: CLORHIDRATO DE RANITIDINA EQUIVALENTE A 50 MG DE RANITIDINA. ENVASE CON 5 AMPOLLETAS DE 2 ML.,ENV,5,AMP,50,miligramos,250,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
827,Grupo Nº 8: Gastroenterología,RANITIDINA,1234,1234,1000012340100,010,000,1234,01,00,SI,Sustantiva,RANITIDINA SOLUCION INYECTABLE CADA AMPOLLETA CONTIENE: CLORHIDRATO DE RANITIDINA EQUIVALENTE A 50 MG DE RANITIDINA. ENVASE CON 5 AMPOLLETAS DE 5 ML.,ENV,5,AMP,50,miligramos,250,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
828,Grupo Nº 8: Gastroenterología,METOCLOPRAMIDA,1241,1241,1000012410000,010,000,1241,00,00,SI,Sustantiva,METOCLOPRAMIDA SOLUCION INYECTABLE CADA AMPOLLETA CONTIENE: CLORHIDRATO DE METOCLOPRAMIDA 10 MG ENVASE CON 6 AMPOLLETAS DE 2 ML.,ENV,6,AMP,10,miligramos,60,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
829,Grupo Nº 8: Gastroenterología,METOCLOPRAMIDA,1242,1242,1000012420000,010,000,1242,00,00,SI,"VALES,Consumo en demanda",METOCLOPRAMIDA TABLETA CADA TABLETA CONTIENE: CLORHIDRATO DE METOCLOPRAMIDA 10 MG ENVASE CON 20 TABLETAS.,ENV,20,TAB,10,miligramos,200,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIULCEROSOS_Y_PROTECTORES_DE_LA_MUCOSA_GASTRICA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
830,Grupo Nº 8: Gastroenterología,METOCLOPRAMIDA,1243,1243,1000012430000,010,000,1243,00,00,SI,Sustantiva,METOCLOPRAMIDA SOLUCION CADA ML CONTIENE: CLORHIDRATO DE METOCLOPRAMIDA 4 MG ENVASE FRASCO GOTERO CON 20 ML.,ENV,20,ML.,4,miligramos,4,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
831,Grupo Nº 8: Gastroenterología,MESALAZINA,1244,1244,1000012440000,010,000,1244,00,00,SI,"VALES,Entrega hospitalaria",MESALAZINA SUSPENSION RECTAL CADA 100 ML CONTIENE: MESALAZINA 6.667 G ENVASE CON 7 ENEMAS DE 60 ML.,ENV,7,PZA,6.667,gramos,46.669,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,FARMACOS_MODIFICADORES_DE_LA_ENFERMEDAD,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0
832,Grupo Nº 8: Gastroenterología,BISMUTO,1263,1263,1000012630000,010,000,1263,00,00,SI,Sustantiva,BISMUTO SUSPENSION ORAL CADA 100 ML CONTIENEN: SUBSALICILATO DE BISMUTO 1.750 G ENVASE CON 240 ML.,ENV,240,ML.,1.75,gramos,1.75,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
833,Grupo Nº 8: Gastroenterología,SENÓSIDOS A-B,1270,1270,1000012700000,010,000,1270,00,00,SI,Sustantiva,SENOSIDOS A-B SOLUCION ORAL. CADA 100 ML CONTIENEN: CONCENTRADO DE SEN EQUIVALENTE A 200 MG DE SENOSIDOS A Y B. ENVASE CON 75 ML. O ENVASE CON SOBRE CON POLVO Y FRASCO CON 75 ML DE SOLUCION PARA RECONSTITUIR.,ENV,1,ENV,200,miligramos,200,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIULCEROSOS_Y_PROTECTORES_DE_LA_MUCOSA_GASTRICA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
834,Grupo Nº 8: Gastroenterología,SENÓSIDOS A-B,1270,1270,1000012700002,010,000,1270,00,02,NO,Sustantiva,SENOSIDOS A-B. SOLUCION ORAL. CADA 100 ML CONTIENEN: CONCENTRADO DE SEN EQUIVALENTE A 200 MG DE SENÓSIDOS A Y B. ENVASE CON 75 ML.,ENV,75,ML.,200,miligramos,200,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIULCEROSOS_Y_PROTECTORES_DE_LA_MUCOSA_GASTRICA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
835,Grupo Nº 8: Gastroenterología,SENÓSIDOS A-B,1270,1270,1000012700100,010,000,1270,01,00,NO,Sustantiva,SENOSIDOS A-B. SOLUCION ORAL. CADA 100 ML CONTIENEN: CONCENTRADO DE SEN EQUIVALENTE A 200 MG DE SENOSIDOS A Y B. ENVASE CON SOBRE CON POLVO Y FRASCO CON 75 ML DE SOLUCION PARA RECONSTITUIR.,ENV,1,SBR,200,miligramos,200,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIULCEROSOS_Y_PROTECTORES_DE_LA_MUCOSA_GASTRICA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
836,Grupo Nº 8: Gastroenterología,PLÁNTAGO PSYLLIUM,1271,1271,1000012710000,010,000,1271,00,00,SI,"VALES,Sustantiva",PLANTAGO PSYLLIUM POLVO CADA 100 G CONTIENEN: POLVO DE CASCARA DE SEMILLA DE PLANTAGO PSYLLIUM 49.7 G ENVASE CON 400 G.,ENV,400,GRO,49.7,gramos,19880,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIULCEROSOS_Y_PROTECTORES_DE_LA_MUCOSA_GASTRICA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
837,Grupo Nº 8: Gastroenterología,SENÓSIDOS A-B,1272,1272,1000012720000,010,000,1272,00,00,SI,"VALES,Consumo en demanda",SENOSIDOS A-B TABLETA CADA TABLETA CONTIENE: CONCENTRADOS DE SEN DESECADOS 187 MG (NORMALIZADO A 8.6 MG DE SENOSIDOS A-B). ENVASE CON 20 TABLETAS.,ENV,20,TAB,187,miligramos,3740,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
838,Grupo Nº 8: Gastroenterología,ACEITE DE RICINO,1273,1273,1000012730000,010,000,1273,00,00,SI,Sustantiva,ACEITE DE RICINO SOLUCION CADA ENVASE CONTIENE: ACEITE DE RICINO ENVASE CON 70 ML.,ENV,70,ML.,70,mililitros,70,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
839,Grupo Nº 8: Gastroenterología,MAGNESIO,1275,1275,1000012750000,010,000,1275,00,00,SI,"VALES,Sustantiva",MAGNESIO SUSPENSION ORAL CADA 100 ML CONTIENEN: HIDROXIDO DE MAGNESIO 8.5 G ENVASE CON 120 ML. (425 MG/5 ML).,ENV,120,ML.,8.5,gramos,8.5,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
840,Grupo Nº 8: Gastroenterología,FOSFATO Y CITRATO DE SODIO,1277,1277,1000012770000,010,000,1277,00,00,SI,Sustantiva,FOSFATO Y CITRATO DE SODIO SOLUCION CADA 100 ML CONTIENEN: FOSFATO MONOSODICO 12 G CITRATO DE SODIO 10 G ENVASE CON 133 ML Y CANULA RECTAL.,ENV,133,ML.,22,gramos,22,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
841,Grupo Nº 8: Gastroenterología,GLICEROL,1278,1278,1000012780000,010,000,1278,00,00,SI,"VALES,Sustantiva",GLICEROL SUPOSITORIO CADA SUPOSITORIO CONTIENE: GLICEROL 2.632 G ENVASE CON 6 SUPOSITORIOS.,ENV,6,SUP,2.632,gramos,15.792,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
850,Grupo Nº 8: Gastroenterología,LIDOCAÍNA - HIDROCORTISONA,1363,1363,1000013630000,010,000,1363,00,00,SI,"VALES,Sustantiva",LIDOCAINA -HIDROCORTISONA UNGÜENTO CADA 100 GRAMOS CONTIENE: LIDOCAINA 5 G ACETATO DE HIDROCORTISONA 0.25 G SUBACETATO DE ALUMINIO 3.50 G OXIDO DE ZINC 18 G ENVASE CON 20 G Y APLICADOR.,ENV,1,ENV,20,gramos,20,gramos,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIULCEROSOS_Y_PROTECTORES_DE_LA_MUCOSA_GASTRICA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
851,Grupo Nº 8: Gastroenterología,LIDOCAÍNA - HIDROCORTISONA,1364,1364,1000013640000,010,000,1364,00,00,SI,"VALES,Sustantiva",LIDOCAINA -HIDROCORTISONA SUPOSITORIO CADA SUPOSITORIO CONTIENE: LIDOCAINA 60 MG ACETATO DE HIDROCORTISONA 5 MG OXIDO DE ZINC 400 MG SUBACETATO DE ALUMINIO 50 MG ENVASE CON 6 SUPOSITORIOS.,ENV,6,SUP,515,miligramos,3090,miligramos,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIULCEROSOS_Y_PROTECTORES_DE_LA_MUCOSA_GASTRICA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1010,Grupo Nº 8: Gastroenterología,RESINA DE COLESTIRAMINA,4112,4112,1000041120000,010,000,4112,00,00,SI,"Sustantiva,VALES",RESINA DE COLESTIRAMINA POLVO CADA SOBRE CONTIENE: RESINA DE COLESTIRAMINA 4 G ENVASE CON 50 SOBRES.,ENV,50,SBR,4,gramos,200,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1011,Grupo Nº 8: Gastroenterología,POLIDOCANOL,4113,4113,1000041130000,010,000,4113,00,00,SI,"Sustantiva,Uso Hospitalario, Gastroenterología",POLIDOCANOL SOLUCION INYECTABLE CADA ML CONTIENE: POLIDOCANOL 30 MG ENVASE CON UN FRASCO AMPULA CON 30 ML.,ENV,1,F.A,30,miligramos,30,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1050,Grupo Nº 8: Gastroenterología,MESALAZINA,4175,4175,1000041750000,010,000,4175,00,00,SI,"Sustantiva,VALES",MESALAZINA SUPOSITORIO CADA SUPOSITORIO CONTIENE: MESALAZINA 1 G ENVASE CON 14 SUPOSITORIOS.,ENV,14,SUP,1,gramos,14,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1051,Grupo Nº 8: Gastroenterología,MESALAZINA,4175,4175,1000041750100,010,000,4175,01,00,NO,"Sustantiva,VALES",MESALAZINA. SUPOSITORIO. CADA SUPOSITORIO CONTIENE: MESALAZINA 1 G. ENVASE CON 28 SUPOSITORIOS.,ENV,28,SUP,1,gramos,28,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1053,Grupo Nº 8: Gastroenterología,LOPERAMIDA,4184,4184,1000041840000,010,000,4184,00,00,SI,"Sustantiva,VALES","LOPERAMIDA COMPRIMIDO, TABLETA O GRAGEA CADA COMPRIMIDO, TABLETAS O GRAGEA CONTIENE: CLORHIDRATO DE LOPERAMIDA 2 MG ENVASE CON 12 COMPRIMIDOS, TABLETAS O GRAGEAS.",ENV,12,C.G,2,miligramos,24,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIULCEROSOS_Y_PROTECTORES_DE_LA_MUCOSA_GASTRICA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1054,Grupo Nº 8: Gastroenterología,ÁCIDO URSODEOXICÓLICO,4185,4185,1000041850000,010,000,4185,00,00,SI,"Sustantiva,VALES",ACIDO URSODEOXICOLICO CAPSULA CADA CAPSULA CONTIENE: ACIDO URSODEOXICOLICO 250 MG ENVASE CON 50 CAPSULAS.,ENV,50,CAP,250,miligramos,12500,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1055,Grupo Nº 8: Gastroenterología,ÁCIDO URSODEOXICÓLICO,4185,4185,1000041850100,010,000,4185,01,00,NO,"Sustantiva,VALES",ACIDO URSODEOXICOLICO. CAPSULA. CADA CAPSULA CONTIENE: ACIDO URSODEOXICOLICO 250 MG. ENVASE CON 60 CAPSULAS.,ENV,60,CAP,250,miligramos,15000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1056,Grupo Nº 8: Gastroenterología,MESALAZINA,4186,4186,1000041860002,010,000,4186,00,02,SI,"Sustantiva,VALES",MESALAZINA GRAGEA CON CAPA ENTERICA O TABLETA DE LIBERACION PROLONGADA CADA GRAGEA CON CAPA ENTERICA O TABLETA DE LIBERACION PROLONGADA CONTIENE MESALAZINA 500 MG ENVASE CON 30 GRAGEAS CON CAPA ENTERICA O TABLETAS DE LIBERACION,ENV,30,T.G,500,miligramos,15000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1057,Grupo Nº 8: Gastroenterología,MESALAZINA,4186,4186,1000041860104,010,000,4186,01,04,NO,"Sustantiva,VALES",MESALAZINA GRAGEA CON CAPA ENTERICA O TABLETA DE LIBERACION PROLONGADA CADA GRAGEA CON CAPA ENTERICA O TABLETA DE LIBERACION PROLONGADA CONTIENE MESALAZINA 500 MG ENVASE CON 40 GRAGEAS CON CAPA ENTERICA O TABLETAS DE LIBERACION,ENV,40,T.G,500,miligramos,20000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1058,Grupo Nº 8: Gastroenterología,MESALAZINA,4186,4186,1000041860203,010,000,4186,02,03,NO,"Sustantiva,VALES",MESALAZINA GRAGEA CON CAPA ENTERICA O TABLETA DE LIBERACION PROLONGADA CADA GRAGEA CON CAPA ENTERICA O TABLETA DE LIBERACION PROLONGADA CONTIENE MESALAZINA 500 MG ENVASE CON 50 GRAGEAS CON CAPA ENTERICA O TABLETAS DE LIBERACION,ENV,50,T.G,500,miligramos,25000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1059,Grupo Nº 8: Gastroenterología,MESALAZINA,4186,4186,1000041860303,010,000,4186,03,03,NO,"Sustantiva,VALES",MESALAZINA GRAGEA CON CAPA ENTERICA O TABLETA DE LIBERACION PROLONGADA CADA GRAGEA CON CAPA ENTERICA O TABLETA DE LIBERACION PROLONGADA CONTIENE MESALAZINA 500 MG ENVASE CON 60 GRAGEAS CON CAPA ENTERICA O TABLETAS DE LIBERACION,ENV,60,T.G,500,miligramos,30000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1060,Grupo Nº 8: Gastroenterología,MESALAZINA,4186,4186,1000041860403,010,000,4186,04,03,NO,"Sustantiva,VALES",MESALAZINA GRAGEA CON CAPA ENTERICA O TABLETA DE LIBERACION PROLONGADA CADA GRAGEA CON CAPA ENTERICA O TABLETA DE LIBERACION PROLONGADA CONTIENE MESALAZINA 500 MG ENVASE CON 100 GRAGEAS CON CAPA ENTERICA O TABLETAS DE LIBERACION,ENV,100,T.G,500,miligramos,50000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1061,Grupo Nº 8: Gastroenterología,MESALAZINA,4186,4186,1000041860502,010,000,4186,05,02,NO,"Sustantiva,VALES",MESALAZINA. TABLETA DE LIBERACION RETARDADA. CADA TABLETA DE LIBERACION RETARDADA CONTIENE: MESALAZINA 500 MG. ENVASE CON 30 TABLETAS DE LIBERACION RETARDADA.,ENV,30,TAB,500,miligramos,15000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1062,Grupo Nº 8: Gastroenterología,MESALAZINA,4186,4186,1000041860602,010,000,4186,06,02,NO,"Sustantiva,VALES",MESALAZINA. TABLETA DE LIBERACION RETARDADA. CADA TABLETA DE LIBERACION RETARDADA CONTIENE: MESALAZINA 500 MG. ENVASE CON 40 TABLETAS DE LIBERACION RETARDADA.,ENV,40,TAB,500,miligramos,20000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1063,Grupo Nº 8: Gastroenterología,MESALAZINA,4186,4186,1000041860702,010,000,4186,07,02,NO,"Sustantiva,VALES",MESALAZINA. TABLETA DE LIBERACION RETARDADA. CADA TABLETA DE LIBERACION RETARDADA CONTIENE: MESALAZINA 500 MG. ENVASE CON 60 TABLETAS DE LIBERACION RETARDADA.,ENV,60,TAB,500,miligramos,30000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1064,Grupo Nº 8: Gastroenterología,MESALAZINA,4189,4189,1000041890000,010,000,4189,00,00,SI,"Sustantiva,VALES",MESALAZINA SUPOSITORIO CADA SUPOSITORIO CONTIENE: MESALAZINA 250 MG ENVASE CON 30 SUPOSITORIOS.,CJA,30,SUP,250,miligramos,7500,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1065,Grupo Nº 8: Gastroenterología,PANCREATINA,4190,4190,1000041900000,010,000,4190,00,00,SI,"Sustantiva,VALES","PANCREATINA CAPSULA (CON MICROESFERAS ACIDO RESISTENTES) CADA CAPSULA CONTIENE PANCREATINA 150 MG CON: LIPASA. NO MENOS DE 10,000 UNIDADES USP ENVASE CON 50 CAPSULAS.",ENV,50,CAP,150,miligramos,7500,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1066,Grupo Nº 8: Gastroenterología,POLIETILENGLICOL,4191,4191,1000041910000,010,000,4191,00,00,SI,Sustantiva,POLIETILENGLICOL POLVO CADA SOBRE CONTIENE: POLIETILENGLICOL 3350 105 G ENVASE CON 4 SOBRES.,ENV,4,SBR,105,gramos,420,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1236,Grupo Nº 8: Gastroenterología,SULFASALAZINA,4504,4504,1000045040000,010,000,4504,00,00,SI,"VALES,Sustantiva",SULFASALAZINA TABLETA CON CAPA ENTERICA CADA TABLETA CON CAPA ENTERICA  CONTIENE: SULFASALAZINA 500 MG ENVASE CON 60 TABLETAS CON CAPA ENTERICA.,ENV,60,TAB,500,miligramos,30000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,FARMACOS_MODIFICADORES_DE_LA_ENFERMEDAD,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1301,Grupo Nº 8: Gastroenterología,SUCRALFATO,5176,5176,1000051760000,010,000,5176,00,00,SI,"VALES,Sustantiva",SUCRALFATO TABLETA CADA TABLETA CONTIENE: SUCRALFATO 1 G ENVASE CON 40  TABLETAS.,ENV,40,TAB,1,gramos,40,gramos,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIULCEROSOS_Y_PROTECTORES_DE_LA_MUCOSA_GASTRICA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1302,Grupo Nº 8: Gastroenterología,OCTREOTIDA,5181,5181,1000051810000,010,000,5181,00,00,SI,Sustantiva,OCTREOTIDA SOLUCION INYECTABLE CADA FRASCO AMPULA CONTIENE: OCTREOTIDA 1 MG ENVASE CON UN FRASCO AMPULA CON 5 ML.,ENV,1,F.A,1,miligramos,1,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1303,Grupo Nº 8: Gastroenterología,PANTOPRAZOL O RABEPRAZOL U OMEPRAZOL,5186,5186,1000051860000,010,000,5186,00,00,NO,"VALES,Consumo en demanda",PANTOPRAZOL O RABEPRAZOL U OMEPRAZOL. TABLETA O GRAGEA O CAPSULA. CADA TABLETA O GRAGEA O CAPSULA CONTIENE: PANTOPRAZOL 40 MG O RABEPRAZOL SODICO 20 MG U OMEPRAZOL 20 MG. ENVASE CON 7 TABLETAS O GRAGEAS O CAPSULAS.,ENV,7,TGC,40,miligramos,280,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIULCEROSOS_Y_PROTECTORES_DE_LA_MUCOSA_GASTRICA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1304,Grupo Nº 8: Gastroenterología,PANTOPRAZOL O RABEPRAZOL U OMEPRAZOL,5186,5186,1000051860100,010,000,5186,01,00,SI,"VALES,Consumo en demanda",PANTOPRAZOL O RABEPRAZOL U OMEPRAZOL TABLETA O GRAGEA O CAPSULA CADA TABLETA O  GRAGEA O CAPSULA CONTIENE: PANTOPRAZOL 40 MG O RABEPRAZOL SODICO 20 MG U  OMEPRAZOL 20 MG ENVASE CON 14 TABLETAS O GRAGEAS O CAPSULAS.,ENV,14,TGC,40,miligramos,560,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIULCEROSOS_Y_PROTECTORES_DE_LA_MUCOSA_GASTRICA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1305,Grupo Nº 8: Gastroenterología,PANTOPRAZOL O RABEPRAZOL U OMEPRAZOL,5186,5186,1000051860200,010,000,5186,02,00,NO,"VALES,Consumo en demanda",PANTOPRAZOL O RABEPRAZOL U OMEPRAZOL. TABLETA O GRAGEA O CAPSULA. CADA TABLETA O GRAGEA O CAPSULA CONTIENE: PANTOPRAZOL 40 MG O RABEPRAZOL SODICO 20 MG U OMEPRAZOL 20 MG. ENVASE CON 28 TABLETAS O GRAGEAS O CAPSULAS.,ENV,28,TGC,40,miligramos,1120,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIULCEROSOS_Y_PROTECTORES_DE_LA_MUCOSA_GASTRICA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1306,Grupo Nº 8: Gastroenterología,OMEPRAZOL O PANTOPRAZOL,5187,5187,1000051870000,010,000,5187,00,00,SI,"Sustantiva,Uso Hospitalario, Gastroenterología",OMEPRAZOL O PANTOPRAZOL SOLUCION INYECTABLE CADA FRASCO AMPULA CON LIOFILIZADO  CONTIENE: OMEPRAZOL SODICO EQUIVALENTE A 40 MG DE OMEPRAZOL. O PANTOPRAZOL  SODICO EQUIVALENTE A 40 MG DE PANTOPRAZOL. ENVASE CON UN FRASCO AMPULA CON,ENV,1,F.A,40,miligramos,40,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1307,Grupo Nº 8: Gastroenterología,TERLIPRESINA,5191,5191,1000051910000,010,000,5191,00,00,SI,"Sustantiva,Uso Hospitalario, Gastroenterología,Uso Hospitalario, Gastroenterología,Uso Hospitalario, Gastroenterología",TERLIPRESINA SOLUCION INYECTABLE CADA FRASCO AMPULA CON LIOFILIZADO CONTIENE: ACETATO DE TERLIPRESINA 1.00 MG EQUIVALENTE A 0.86 MG DE TERLIPRESINA ENVASE CON UN FRASCO AMPULA CON LIOFILIZADO Y UNA AMPOLLETA CON 5 ML DE DILUYENTE.,ENV,1,JGO,1.86,miligramos,1.86,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1308,Grupo Nº 8: Gastroenterología,TERLIPRESINA,5191,5191,1000051910100,010,000,5191,01,00,NO,"Sustantiva,Uso Hospitalario, Gastroenterología,Uso Hospitalario, Gastroenterología,Uso Hospitalario, Gastroenterología",TERLIPRESINA. SOLUCION INYECTABLE CADA FRASCO AMPULA O AMPOLLETA CON SOLUCION  CONTIENE: ACETATO DE TERLIPRESINA 1 MG EQUIVALENTE A 0.85 MG DE TERLIPRESINA.  ENVASE CON 1 FRASCO AMPULA O AMPOLLETA CON 8.5 ML.,ENV,1,FCO,1.85,microgramos,1.85,microgramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1309,Grupo Nº 8: Gastroenterología,TERLIPRESINA,5191,5191,1000051910200,010,000,5191,02,00,NO,"Sustantiva,Uso Hospitalario, Gastroenterología,Uso Hospitalario, Gastroenterología,Uso Hospitalario, Gastroenterología",TERLIPRESINA. SOLUCION INYECTABLE CADA FRASCO AMPULA O AMPOLLETA CON SOLUCION  CONTIENE: ACETATO DE TERLIPRESINA 1 MG EQUIVALENTE A 0.85 MG DE TERLIPRESINA.  ENVASE CON 5 FRASCOS AMPULA O AMPOLLETAS CON 8.5 ML.,ENV,5,FCO,1.85,microgramos,9.25,microgramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1314,Grupo Nº 8: Gastroenterología,PEGINTERFERÓN ALFA,5221,5221,1000052210000,010,000,5221,00,00,SI,Entrega hospitalaria,PEGINTERFERON ALFA. SOLUCION INYECTABLE. CADA PLUMA PRECARGADA CON LIOFILIZADO CONTIENE: PEGINTERFERON ALFA-2B 80 MICROGRAMOS. ENVASE CON UNA PLUMA PRECARGADA Y UN CARTUCHO CON 0.5 ML DE DILUYENTE.,ENV,1,ENV,80,microgramos,80,microgramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1315,Grupo Nº 8: Gastroenterología,PEGINTERFERÓN ALFA,5222,5222,1000052220000,010,000,5222,00,00,SI,Entrega hospitalaria,PEGINTERFERON ALFA. SOLUCION INYECTABLE. CADA PLUMA PRECARGADA CON LIOFILIZADO CONTIENE: PEGINTERFERON ALFA-2B 120 MICROGRAMOS. ENVASE CON UNA PLUMA PRECARGADA Y UN CARTUCHO CON 0.5 ML DE DILUYENTE.,ENV,1,JGO,120,microgramos,120,microgramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1316,Grupo Nº 8: Gastroenterología,PEGINTERFERÓN ALFA,5223,5223,1000052230003,010,000,5223,00,03,NO,"Entrega hospitalaria,Entrega hospitalaria,Entrega hospitalaria",PEGINTERFERON ALFA. SOLUCION INYECTABLE. CADA FRASCO AMPULA CONTIENE: PEGINTERFERON ALFA-2A 180 MICROGRAMOS. ENVASE CON UN FRASCO AMPULA DE 1 ML.,ENV,1,F.A,180,microgramos,180,microgramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1317,Grupo Nº 8: Gastroenterología,PEGINTERFERÓN ALFA,5223,5223,1000052230103,010,000,5223,01,03,SI,"Entrega hospitalaria,Entrega hospitalaria,Entrega hospitalaria",PEGINTERFERON ALFA SOLUCION INYECTABLE CADA FRASCO AMPULA O JERINGA O PLUMA PRECARGADA CONTIENE: PEGINTERFERON ALFA-2 A 180 MICROGRAMOS. ENVASE CON UNA JERINGA PRECARGADA DE 0.5 ML.,ENV,1,JGA,180,microgramos,180,microgramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1318,Grupo Nº 8: Gastroenterología,PEGINTERFERÓN ALFA,5223,5223,1000052230104,010,000,5223,01,04,NO,"Entrega hospitalaria,Entrega hospitalaria,Entrega hospitalaria",PEGINTERFERON ALFA SOLUCION INYECTABLE CADA JERINGA PRECARGADA CONTIENE: PEGINTERFERON ALFA-2 A 180 MICROGRAMOS. ENVASE CON UNA JERINGA PRECARGADA DE 0.5 ML.,ENV,1,JGA,180,microgramos,180,microgramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1319,Grupo Nº 8: Gastroenterología,PEGINTERFERÓN ALFA,5223,5223,1000052230200,010,000,5223,02,00,NO,"Entrega hospitalaria,Entrega hospitalaria,Entrega hospitalaria",PEGINTERFERON ALFA SOLUCION INYECTABLE CADA PLUMA PRECARGADA CONTIENE: PEGINTERFERON ALFA-2A 180 MICROGRAMOS. ENVASE CON UNA PLUMA PRECARGADA DE 0.5 ML.,ENV,1,PLU,180,microgramos,180,microgramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1320,Grupo Nº 8: Gastroenterología,PEGINTERFERÓN ALFA,5224,5224,1000052240000,010,000,5224,00,00,SI,Entrega hospitalaria,PEGINTERFERON ALFA. SOLUCION INYECTABLE. CADA PLUMA PRECARGADA CON LIOFILIZADO  CONTIENE: PEGINTERFERON ALFA-2B 100 MICROGRAMOS. ENVASE CON UNA PLUMA  PRECARGADA Y UN CARTUCHO CON 0.5 ML DE DILUYENTE.,ENV,1,JGO,100,microgramos,100,microgramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
238,Grupo Nº 9: Gineco-obstetricia,DIENOGEST,6001,6001,1000060010001,010,000,6001,00,01,SI,Sustantiva,DIENOGEST. TABLETA. CADA TABLETA CONTIENE: DIENOGEST 2 MG. ENVASE CON 28 TABLETAS.,ENV,28,TAB,2,miligramos,56,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
240,Grupo Nº 9: Gineco-obstetricia,MISOPROSTOL,6012,6012,1000060120000,010,000,6012,00,00,SI,,MISOPROSTOL. TABLETA. CADA TABLETA CONTIENE: MISOPROSTOL 200 MICROGRAMOS. ENVASE CON 1 TABLETA.,ENV,1,TAB,200,microgramos,200,microgramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
241,Grupo Nº 9: Gineco-obstetricia,MISOPROSTOL,6012,6012,1000060120101,010,000,6012,01,01,NO,,MISOPROSTOL. TABLETA. CADA TABLETA CONTIENE: MISOPROSTOL 200 MICROGRAMOS. ENVASE CON 2 TABLETAS.,ENV,2,TAB,200,microgramos,400,microgramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
242,Grupo Nº 9: Gineco-obstetricia,MISOPROSTOL,6012,6012,1000060120201,010,000,6012,02,01,NO,,MISOPROSTOL. TABLETA. CADA TABLETA CONTIENE: MISOPROSTOL 200 MICROGRAMOS. ENVASE CON 4 TABLETAS.,ENV,4,TAB,200,microgramos,800,microgramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
243,Grupo Nº 9: Gineco-obstetricia,MISOPROSTOL,6012,6012,1000060120301,010,000,6012,03,01,NO,,MISOPROSTOL. TABLETA. CADA TABLETA CONTIENE: MISOPROSTOL 200 MICROGRAMOS. ENVASE CON 8 TABLETAS.,ENV,8,TAB,200,microgramos,1600,microgramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
244,Grupo Nº 9: Gineco-obstetricia,MISOPROSTOL,6012,6012,1000060120401,010,000,6012,04,01,NO,,MISOPROSTOL. TABLETA. CADA TABLETA CONTIENE: MISOPROSTOL 200 MICROGRAMOS. ENVASE CON 12 TABLETAS.,ENV,12,TAB,200,microgramos,2400,microgramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
252,Grupo Nº 9: Gineco-obstetricia,MIFEPRISTONA,6034,6034,1000060340000,010,000,6034,00,00,SI,,MIFEPRISTONA. TABLETA. CADA TABLETA CONTIENE: MIFEPRISTONA 200 MG. ENVASE CON UNA TABLETA.,ENV,1,TAB,200,miligramos,200,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
421,Grupo Nº 9: Gineco-obstetricia,TIBOLONA,2207,2207,1000022070002,010,000,2207,00,02,NO,"VALES,Sustantiva",TIBOLONA. TABLETAS. CADA TABLETA CONTIENE: TIBOLONA 2.5 MG. ENVASE CON 28 TABLETAS.,ENV,28,TAB,2.5,miligramos,70,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
422,Grupo Nº 9: Gineco-obstetricia,TIBOLONA,2207,2207,1000022070100,010,000,2207,01,00,SI,"VALES,Sustantiva",TIBOLONA TABLETA CADA TABLETA CONTIENE: TIBOLONA 2.5 MG ENVASE CON 30 TABLETAS.,ENV,30,TAB,2.5,miligramos,75,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
536,Grupo Nº 9: Gineco-obstetricia,MEDROXIPROGESTERONA,3044,3044,1000030440000,010,000,3044,00,00,SI,"Sustantiva,VALES",MEDROXIPROGESTERONA TABLETA CADA TABLETA CONTIENE: ACETATO DE  MEDROXIPROGESTERONA 10 MG ENVASE CON 10 TABLETAS.,ENV,10,TAB,10,miligramos,100,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
537,Grupo Nº 9: Gineco-obstetricia,MEDROXIPROGESTERONA,3045,3045,1000030450000,010,000,3045,00,00,SI,"Sustantiva,Programa de Planificación Familiar,VALES",MEDROXIPROGESTERONA SUSPENSION INYECTABLE CADA FRASCO AMPULA O JERINGA  PRELLENADA CONTIENE: ACETATO DE MEDROXIPROGESTERONA 150 MG ENVASE CON UNA  FRASCO AMPULA O JERINGA PRELLENADA DE 1 ML.,ENV,1,FAJ,150,miligramos,150,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
566,Grupo Nº 9: Gineco-obstetricia,INDOMETACINA,3412,3412,1000034120000,010,000,3412,00,00,SI,"VALES,Sustantiva",INDOMETACINA SUPOSITORIO CADA SUPOSITORIO CONTIENE: INDOMETACINA 100 MG ENVASE  CON 6 SUPOSITORIOS.,ENV,6,SUP,100,miligramos,600,miligramos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIINFLAMATORIOS_NO_ESTEROIDEOS,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
567,Grupo Nº 9: Gineco-obstetricia,INDOMETACINA,3412,3412,1000034120100,010,000,3412,01,00,NO,"VALES,Sustantiva",INDOMETACINA. SUPOSITORIO. CADA SUPOSITORIO CONTIENE: INDOMETACINA 100 MG. ENVASE CON 15 SUPOSITORIOS.,ENV,15,SUP,100,miligramos,1500,miligramos,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIINFLAMATORIOS_NO_ESTEROIDEOS,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
609,Grupo Nº 9: Gineco-obstetricia,ERGOMETRINA,1544,1544,4000015440000,040,000,1544,00,00,SI,Sustantiva,ERGOMETRINA (ERGONOVINA) SOLUCION INYECTABLE CADA AMPOLLETA CONTIENE: MALEATO DE ERGOMETRINA 0.2 MG ENVASE CON 50 AMPOLLETAS DE 1 ML.,ENV,50,AMP,0.25,miligramos,12.5,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
610,Grupo Nº 9: Gineco-obstetricia,ERGOMETRINA,1544,1544,4000015440002,040,000,1544,00,02,NO,Sustantiva,ERGOMETRINA SOLUCION INYECTABLE CADA AMPOLLETA CONTIENE: MALEATO DE ERGOMETRINA 0.2 MG ENVASE CON 50 AMPOLLETAS DE 1 ML.,ENV,50,AMP,0.25,miligramos,12.5,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
806,Grupo Nº 9: Gineco-obstetricia,DANAZOL,1093,1093,1000010930000,010,000,1093,00,00,SI,Sustantiva,DANAZOL CAPSULA O COMPRIMIDO CADA CAPSULA O COMPRIMIDO CONTIENE: DANAZOL 100 MG ENVASE CON 50 CAPSULAS O COMPRIMIDOS.,ENV,50,C.C,100,miligramos,5000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
807,Grupo Nº 9: Gineco-obstetricia,CABERGOLINA,1094,1094,1000010940000,010,000,1094,00,00,SI,"VALES,Sustantiva",CABERGOLINA TABLETA CADA TABLETA CONTIENE: CABERGOLINA 0.5 MG ENVASE CON 2 TABLETAS.,ENV,2,TAB,0.5,miligramos,1,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
808,Grupo Nº 9: Gineco-obstetricia,CABERGOLINA,1094,1094,1000010940100,010,000,1094,01,00,NO,"VALES,Sustantiva",CABERGOLINA. TABLETAS. CADA TABLETA CONTIENE: CABERGOLINA 0.5 MG. ENVASE CON 4 TABLETAS.,ENV,4,TAB,0.5,miligramos,2,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
810,Grupo Nº 9: Gineco-obstetricia,BROMOCRIPTINA,1096,1096,1000010960000,010,000,1096,00,00,SI,Sustantiva,BROMOCRIPTINA TABLETA CADA TABLETA CONTIENE: MESILATO DE BROMOCRIPTINA EQUIVALENTE A 2.5 MG DE BROMOCRIPTINA. ENVASE CON 14 TABLETAS.,ENV,14,TAB,2.5,miligramos,35,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
853,Grupo Nº 9: Gineco-obstetricia,ESTRÓGENOS CONJUGADOS,1501,1501,1000015010000,010,000,1501,00,00,SI,Sustantiva,ESTROGENOS CONJUGADOS GRAGEA O TABLETA CADA GRAGEA O TABLETA CONTIENE: ESTROGENOS CONJUGADOS DE ORIGEN EQUINO 0.625 MG ENVASE CON 42 GRAGEAS O TABLETAS.,ENV,42,T.G,0.625,miligramos,26.25,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,HORMONALES,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0
854,Grupo Nº 9: Gineco-obstetricia,ESTRÓGENOS CONJUGADOS,1506,1506,1000015060000,010,000,1506,00,00,SI,"VALES,Sustantiva",ESTROGENOS CONJUGADOS CREMA VAGINAL CADA 100 G CONTIENE: ESTROGENOS CONJUGADOS DE ORIGEN EQUINO 62.5 MG ENVASE CON 43 G Y APLICADOR.,ENV,1,ENV,43,gramos,43,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,HORMONALES,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0
855,Grupo Nº 9: Gineco-obstetricia,ESTRÓGENOS CONJUGADOS Y MEDROXIPROGESTERONA,1508,1508,1000015080000,010,000,1508,00,00,SI,Sustantiva,ESTROGENOS CONJUGADOS Y MEDROXIPROGESTERONA GRAGEA CADA GRAGEA CONTIENE: ESTROGENOS CONJUGADOS DE ORIGEN EQUINO 0.625 MG ACETATO DE MEDROXIPROGESTERONA 2.5 MG ENVASE CON 28 GRAGEAS.,ENV,28,GRA,3.125,miligramos,87.5,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
856,Grupo Nº 9: Gineco-obstetricia,CIPROTERONA-ETINILESTRADIOL,1511,1511,1000015110000,010,000,1511,00,00,SI,"VALES,Sustantiva",CIPROTERONA-ETINILESTRADIOL GRAGEA CADA GRAGEA CONTIENE: ACETATO DE CIPROTERONA 2 MG ETINILESTRADIOL 0.035 MG ENVASE CON 21 GRAGEAS.,ENV,21,GRA,2.035,miligramos,42.735,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
857,Grupo Nº 9: Gineco-obstetricia,"ESTRADIOL, DROSPIRENONA",1516,1516,1000015160000,010,000,1516,00,00,SI,,"ESTRADIOL, DROSPIRENONA. COMPRIMIDO. CADA COMPRIMIDO CONTIENE: ESTRADIOL HEMIHIDRATADO EQUIVALENTE A 1 MG. DE ESTRADIOL. DROSPIRENONA 2 MG. ENVASE CON 28 COMPRIMIDOS.",ENV,28,COM,3,miligramos,84,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
858,Grupo Nº 9: Gineco-obstetricia,CLORMADINONA,1521,1521,1000015210000,010,000,1521,00,00,SI,Sustantiva,CLORMADINONA TABLETA CADA TABLETA CONTIENE: ACETATO DE CLORMADINONA 2 MG ENVASE CON 10 TABLETAS.,ENV,10,TAB,2,miligramos,20,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
860,Grupo Nº 9: Gineco-obstetricia,CLOMIFENO,1531,1531,1000015310000,010,000,1531,00,00,SI,Sustantiva,CLOMIFENO TABLETA CADA TABLETA CONTIENE: CITRATO DE CLOMIFENO 50 MG ENVASE CON 10 TABLETAS.,ENV,10,TAB,50,miligramos,500,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
861,Grupo Nº 9: Gineco-obstetricia,CARBETOCINA,1541,1541,1000015410002,010,000,1541,00,02,SI,Sustantiva,CARBETOCINA SOLUCION INYECTABLE CADA AMPOLLETA O FRASCO AMPULA CONTIENE: CARBETOCINA 100 MICROGRAMOS ENVASE CON UNA AMPOLLETA O FRASCO AMPULA.,ENV,1,AFA,100,microgramos,100,microgramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
862,Grupo Nº 9: Gineco-obstetricia,CARBETOCINA,1541,1541,1000015410100,010,000,1541,01,00,NO,Sustantiva,CARBETOCINA SOLUCION INYECTABLE CADA AMPOLLETA O FRASCO AMPULA CONTIENE: CARBETOCINA 100 MICROGRAMOS ENVASE CON 5 AMPOLLETA O FRASCO AMPULA.,ENV,5,AFA,100,microgramos,500,microgramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
863,Grupo Nº 9: Gineco-obstetricia,CARBETOCINA,1541,1541,1000015410201,010,000,1541,02,01,NO,Sustantiva,CARBETOCINA SOLUCION INYECTABLE CADA AMPOLLETA O FRASCO AMPULA CONTIENE: CARBETOCINA 100 MG. ENVASE CON UN FRASCO AMPULA Y UN FILTRO DE INFUSION DE 0.45 MICRAS.,ENV,1,ENV,100,miligramos,100,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
864,Grupo Nº 9: Gineco-obstetricia,OXITOCINA,1542,1542,1000015420000,010,000,1542,00,00,SI,"Sustantiva,Uso Hospitalario, Gineco-obstetricia",OXITOCINA. SOLUCION INYECTABLE CADA AMPOLLETA CONTIENE: OXITOCINA: 5 UI ENVASE CON 50 AMPOLLETAS CON 1 ML.,ENV,50,AMP,5,UI,250,UI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
866,Grupo Nº 9: Gineco-obstetricia,ATOSIBÁN,1546,1546,1000015460000,010,000,1546,00,00,SI,"Sustantiva,Uso Hospitalario, Gineco-obstetricia",ATOSIBAN SOLUCION INYECTABLE CADA FRASCO AMPULA CONTIENE: ATOSIBAN 37.5 MG ENVASE CON 5.0 ML.,ENV,1,ENV,37.4,miligramos,37.4,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
867,Grupo Nº 9: Gineco-obstetricia,ORCIPRENALINA,1551,1551,1000015510000,010,000,1551,00,00,SI,"Sustantiva,Uso Hospitalario, Gineco-obstetricia",ORCIPRENALINA SOLUCION INYECTABLE CADA AMPOLLETA CONTIENE: SULFATO DE ORCIPRENALINA 0.5 MG ENVASE CON 3 AMPOLLETAS CON 1 ML.,ENV,3,AMP,0.5,miligramos,1.5,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
868,Grupo Nº 9: Gineco-obstetricia,ORCIPRENALINA,1552,1552,1000015520000,010,000,1552,00,00,SI,Sustantiva,ORCIPRENALINA TABLETA CADA TABLETA CONTIENE: SULFATO DE ORCIPRENALINA 20 MG ENVASE CON 30 TABLETAS.,ENV,30,TAB,20,miligramos,600,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
869,Grupo Nº 9: Gineco-obstetricia,METRONIDAZOL,1561,1561,1000015610000,010,000,1561,00,00,SI,Sustantiva,METRONIDAZOL OVULO O TABLETA VAGINAL CADA OVULO O TABLETA CONTIENE: METRONIDAZOL 500 MG ENVASE CON 10 OVULOS O TABLETAS.,ENV,10,T.O,500,miligramos,5000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
870,Grupo Nº 9: Gineco-obstetricia,NITROFURAL,1562,1562,1000015620000,010,000,1562,00,00,SI,"VALES,Sustantiva",NITROFURAL OVULO CADA OVULO CONTIENE: NITROFURAL 6 MG ENVASE CON 6 OVULOS.,ENV,6,OVU,6,miligramos,36,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIBIOTICOS,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
871,Grupo Nº 9: Gineco-obstetricia,NISTATINA,1566,1566,1000015660000,010,000,1566,00,00,SI,"VALES,Sustantiva",NISTATINA OVULO O TABLETA VAGINAL CADA OVULO O TABLETA CONTIENE: NISTATINA 100 000 UI ENVASE CON 12 OVULOS O TABLETAS.,ENV,12,T.O,100000,UI,1200000,UI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ANTIMICOTICOS_SISTEMICOS_Y_TOPICOS,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
872,Grupo Nº 9: Gineco-obstetricia,INMUNOGLOBULINA ANTI D,1591,1591,1000015910000,010,000,1591,00,00,SI,Entrega hospitalaria,INMUNOGLOBULINA ANTI D SOLUCION INYECTABLE CADA FRASCO AMPULA O JERINGA PRELLENADA CONTIENE: INMUNOGLOBULINA ANTI D 0.300 MG ENVASE CON UN FRASCO AMPULA CON O SIN DILUYENTE O UNA JERINGA O UNA AMPOLLETA.,ENV,1,ENV,0.3,miligramos,0.3,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1026,Grupo Nº 9: Gineco-obstetricia,FOLITROPINA BETA,4142,4142,1000041420000,010,000,4142,00,00,SI,Sustantiva,FOLITROPINA BETA SOLUCION INYECTABLE CADA FRASCO AMPULA CON SOLUCION CONTIENE: FOLITROPINA BETA 50 UI ENVASE CON UN FRASCO AMPULA CON 0.5 ML.,ENV,1,F.A,50,UI,50,UI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1027,Grupo Nº 9: Gineco-obstetricia,LUTROPINA ALFA,4145,4145,1000041450000,010,000,4145,00,00,SI,Sustantiva,LUTROPINA ALFA SOLUCION INYECTABLE CADA FRASCO AMPULA CON LIOFILIZADO CONTIENE: LUTROPINA ALFA 75 UI ENVASE CON 1 FRASCO AMPULA Y 1 AMPOLLETA O FRASCO AMPULA CON 1 ML DE DILUYENTE.,ENV,1,ENV,75,UI,75,UI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1028,Grupo Nº 9: Gineco-obstetricia,LUTROPINA ALFA,4145,4145,1000041450101,010,000,4145,01,01,NO,Sustantiva,LUTROPINA ALFA. SOLUCION INYECTABLE. CADA FRASCO AMPULA CON LIOFILIZADO CONTIENE: LUTROPINA ALFA 75 UI. ENVASE CON 3 FRASCOS AMPULA Y 3 AMPOLLETAS O FRASCOS AMPULA CON 1 ML DE DILUYENTE.,ENV,3,JGO,75,UI,225,UI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1029,Grupo Nº 9: Gineco-obstetricia,LUTROPINA ALFA,4145,4145,1000041450202,010,000,4145,02,02,NO,Sustantiva,LUTROPINA ALFA. SOLUCION INYECTABLE. CADA FRASCO AMPULA CON LIOFILIZADO CONTIENE: LUTROPINA ALFA 75 UI. ENVASE CON 10 FRASCOS AMPULA Y 10 AMPOLLETAS O FRASCOS AMPULA CON 1 ML DE DILUYENTE.,ENV,10,JGO,75,UI,750,UI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1035,Grupo Nº 9: Gineco-obstetricia,GONADOTROFINAS POSTMENOPÁUSICAS HUMANAS,4155,4155,1000041550000,010,000,4155,00,00,NO,Sustantiva,GONADOTROFINAS POSTMENOPAUSICAS HUMANAS. SOLUCION INYECTABLE. CADA FRASCO AMPULA CON LIOFILIZADO CONTIENE: HORMONA ESTIMULANTE DEL FOLICULO (FSH) 75 UI HORMONA LUTEINIZANTE (LH) 75 UI. ENVASE CON 3 FRASCOS AMPULA Y 3 AMPOLLETAS CON,ENV,3,JGO,75,UI,225,UI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1036,Grupo Nº 9: Gineco-obstetricia,GONADOTROFINAS POSTMENOPÁUSICAS HUMANAS,4155,4155,1000041550100,010,000,4155,01,00,SI,Sustantiva,GONADOTROFINAS POSTMENOPAUSICAS HUMANAS SOLUCION INYECTABLE CADA FRASCO AMPULA CON LIOFILIZADO CONTIENE: HORMONA ESTIMULANTE DEL FOLICULO (FSH) 75 UI HORMONA LUTEINIZANTE (LH) 75 UI ENVASE CON 5 FRASCOS AMPULA Y 5 AMPOLLETAS CON 1 ML DE,ENV,5,JGO,150,UI,750,UI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1043,Grupo Nº 9: Gineco-obstetricia,ÁCIDO ALENDRÓNICO,4161,4161,1000041610000,010,000,4161,00,00,SI,"Sustantiva,VALES",ACIDO ALENDRONICO TABLETA O COMPRIMIDO CADA TABLETA O COMPRIMIDO CONTIENE ALENDRONATO DE SODIO EQUIVALENTE A 10 MG DE ACIDO ALENDRONICO. ENVASE CON 30 TABLETAS O COMPRIMIDOS.,ENV,30,T.C,10,miligramos,300,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1045,Grupo Nº 9: Gineco-obstetricia,RALOXIFENO,4163,4163,1000041630000,010,000,4163,00,00,NO,"Sustantiva,VALES",RALOXIFENO TABLETA CADA TABLETA CONTIENE: CLORHIDRATO DE RALOXIFENO 60 MG ENVASE CON 14 TABLETAS.,ENV,14,TAB,60,miligramos,840,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,FARMACOS_UTILIZADOS_EN_OSTEOPOROSIS,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0
1046,Grupo Nº 9: Gineco-obstetricia,RALOXIFENO,4163,4163,1000041630100,010,000,4163,01,00,SI,"Sustantiva,VALES",RALOXIFENO TABLETA CADA TABLETA CONTIENE: CLORHIDRATO DE RALOXIFENO 60 MG ENVASE CON 28 TABLETAS.,ENV,28,TAB,60,miligramos,1680,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,FARMACOS_UTILIZADOS_EN_OSTEOPOROSIS,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0
1047,Grupo Nº 9: Gineco-obstetricia,ÁCIDO ALENDRÓNICO,4164,4164,1000041640000,010,000,4164,00,00,SI,"Sustantiva,VALES",ACIDO ALENDRONICO TABLETA O COMPRIMIDO CADA TABLETA O COMPRIMIDO CONTIENE: ALENDRONATO DE SODIO EQUIVALENTE A 70 MG DE ACIDO ALENDRONICO. ENVASE CON 4 TABLETAS O COMPRIMIDOS.,ENV,4,T.C,70,miligramos,280,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1048,Grupo Nº 9: Gineco-obstetricia,ÁCIDO RISEDRÓNICO,4166,4166,1000041660000,010,000,4166,00,00,SI,Sustantiva,ACIDO RISEDRONICO GRAGEA O TABLETA CADA GRAGEA O TABLETA CONTIENE: RISEDRONATO SODICO 5 MG ENVASE CON 28 GRAGEAS O TABLETAS.,ENV,28,T.G,5,miligramos,140,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,FARMACOS_UTILIZADOS_EN_OSTEOPOROSIS,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0
1049,Grupo Nº 9: Gineco-obstetricia,ÁCIDO RISEDRÓNICO,4167,4167,1000041670000,010,000,4167,00,00,SI,"Sustantiva,VALES",ACIDO RISEDRONICO GRAGEA O TABLETA CADA GRAGEA O TABLETA CONTIENE: RISEDRONATO SODICO 35 MG ENVASE CON 4 GRAGEAS O TABLETAS.,ENV,4,T.G,35,miligramos,140,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1068,Grupo Nº 9: Gineco-obstetricia,DINOPROSTONA,4203,4203,1000042030000,010,000,4203,00,00,SI,Sustantiva,DINOPROSTONA GEL CADA JERINGA CONTIENE: DINOPROSTONA 0.5 MG ENVASE CON JERINGA Y CANULA.,ENV,1,JGO,0.5,miligramos,0.5,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1072,Grupo Nº 9: Gineco-obstetricia,PROGESTERONA,4215,4215,1000042150000,010,000,4215,00,00,SI,Sustantiva,PROGESTERONA GEL CADA 100 G CONTIENEN: PROGESTERONA 1.0 G ENVASE CON 80 G DE GEL CON REGLA DOSIFICADORA.,ENV,1,ENV,80,gramos,80,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1310,Grupo Nº 9: Gineco-obstetricia,FOLITROPINA ALFA,5206,5206,1000052060000,010,000,5206,00,00,NO,Sustantiva,FOLITROPINA BETA O FOLITROPINA ALFA SOLUCION INYECTABLE CADA AMPOLLETA O FRASCO  AMPULA CON LIOFILIZADO CONTIENE: HORMONA ESTIMULANTE DEL FOLICULO RECOMBINANTE  O FOLITROPINA BETA (FSH RECOMBINANTE) 75 UI O FOLITROPINA ALFA 75 UI (5.5,ENV,1,FAJ,75,UI,75,UI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1311,Grupo Nº 9: Gineco-obstetricia,FOLITROPINA ALFA,5206,5206,1000052060100,010,000,5206,01,00,SI,Sustantiva,FOLITROPINA BETA O FOLITROPINA ALFA SOLUCION INYECTABLE CADA AMPOLLETA O FRASCO AMPULA CON LIOFILIZADO CONTIENE: HORMONA ESTIMULANTE DEL FOLICULO RECOMBINANTE O FOLITROPINA BETA (FSH RECOMBINANTE) 75 UI O FOLITROPINA ALFA 75 UI (5.5,ENV,1,ENV,75,UI,75,UI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1312,Grupo Nº 9: Gineco-obstetricia,FOLITROPINA ALFA,5206,5206,1000052060102,010,000,5206,01,02,NO,Sustantiva,FOLITROPINA ALFA O FOLITROPINA BETA. SOLUCION INYECTABLE. CADA AMPOLLETA O FRASCO AMPULA CON LIOFILIZADO CONTIENE: HORMONA ESTIMULANTE DEL FOLICULO RECOMBINANTE O FOLITROPINA BETA (FSH RECOMBINANTE) 75 UI O FOLITROPINA ALFA 75,ENV,1,ENV,75,UI,75,UI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1313,Grupo Nº 9: Gineco-obstetricia,FOLITROPINA ALFA,5206,5206,1000052060200,010,000,5206,02,00,NO,Sustantiva,FOLITROPINA ALFA O FOLITROPINA BETA. SOLUCION INYECTABLE. CADA PLUMA PRECARGADA CONTIENE: FOLITROPINA ALFA 450 UI (33 MICROGRAMOS). ENVASE CON UNA PLUMA PRECARGADA CON 0.75 ML [450 UI (33 MICROGRAMOS)/0.75 ML] Y 12 AGUJAS ESTERILES,ENV,1,ENV,33,microgramos,33,microgramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
53,,,5379,5379,1000053790000,010,000,5379,00,00,SI,"Sin programa definido,Uso Hospitalario, Nutriología",ZINC SOLUCION INYECTABLE CADA AMPOLLETA CONTIENE: SULFATO DE ZINC  HEPTAHIDRATADO EQUIVALENTE A 5 MG DE ZINC ELEMENTAL. ENVASE CON 25 AMPOLLETAS  DE 3 ML.,ENV,25,AMP,5,miligramos,125,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
54,,,5381,5381,1000053810000,010,000,5381,00,00,SI,"Sustantiva,Uso Hospitalario, Nutriología",OLIGOMETALES ENDOVENOSOS. SOLUCION INYECTABLE CADA 100 ML. CONTIENEN:CLORURO DE ZINC 55.0 MG SULFATO CUPRICO PENTAHIDRATADO 16.9 MG SULFATO DE MANGANESO 38.10 MG. YODURO DE SODIO 1.30 MG. FLUORURO DE SODIO 14.0 MG. CLORURO DE SODIO,ENV,10,F.A,125.3,miligramos,1253,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
55,,,5382,5382,1000053820000,010,000,5382,00,00,SI,"Sustantiva,Uso Hospitalario, Nutriología",LIPIDOS INTRAVENOSOS (LIPIDOS DE CADENA LARGA AL 20%; SOYA O SOYA / CARTAMO) EMULSION INYECTABLE(LIPIDOS DE CADENA LARGA AL 20%; SOYA O SOYA / CARTAMO) CADA 100 ML CONTIENEN: ACEITE DE SOYA 20 G O MEZCLA DE ACEITE DE SOYA - ACEITE,ENV,1,ENV,20,gramos,20,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
56,,,5382,5382,1000053820002,010,000,5382,00,02,NO,"Sustantiva,Uso Hospitalario, Nutriología",LIPIDOS INTRAVENOSOS. EMULSION INYECTABLE (LIPIDOS DE CADENA LARGA AL 20 %; SOYA O SOYA / CARTAMO). CADA 100 ML CONTIENEN: ACEITE DE SOYA 20 G. O MEZCLA DE ACEITE DE SOYA ?ACEITE DE CARTAMO 10 G/10 G. CADA ML PROPORCIONA 2 KCAL. ENVASE,ENV,500,ML.,20,gramos,20,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
57,,,5383,5383,1000053830000,010,000,5383,00,00,SI,Sustantiva,VITAMINAS (POLIVITAMINAS) Y MINERALES JARABE CADA 5 ML CONTIENEN: VITAMINA D2 200 UI VITAMINA E 15.0 MG VITAMINA C 60.0 MG TIAMINA 1.05 MG RIBOFLAVINA 1.2 MG PIRIDOXINA 1.05 MG CIANOCOBALAMINA 4.5 MG NICOTINAMIDA 13.5 MG HIERRO,ENV,1,ENV,96.3,miligramos,96.3,miligramos,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
58,,,5383,5383,1000053830002,010,000,5383,00,02,NO,Sustantiva,MULTIVITAMINAS (POLIVITAMINAS) Y MINERALES. JARABE. CADA 5 ML CONTIENEN: VITAMINA A 2 500 UI. VITAMINA D2 200 UI. VITAMINA E 15.0 MG. VITAMINA C 60.0 MG. TIAMINA 1.05 MG. RIBOFLAVINA 1.2 MG. PIRIDOXINA 1.05 MG. CIANOCOBALAMINA,ENV,240,ML.,78.3,miligramos,78.3,miligramos,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
59,,,5384,5384,1000053840000,010,000,5384,00,00,SI,"Sustantiva,Uso Hospitalario, Nutriología",MULTIVITAMINAS SOLUCION INYECTABLE ADULTO CADA FRASCO AMPULA CON LIOFILIZADO CONTIENE: RETINOL (VITAMINA A) 3300.0 U COLECALCIFEROL (VITAMINA D3) 200.0 U ACETATO DE TOCOFEROL (VITAMINA E) 10.0 U NICOTINAMIDA 40.0 MG RIBOFLAVINA 3.6,ENV,1,JGO,3510,UI,3510,UI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
60,,,5385,5385,1000053850000,010,000,5385,00,00,SI,"Sustantiva,Uso Hospitalario, Nutriología,Uso Hospitalario, Nutriología,Uso Hospitalario, Nutriología","MULTIVITAMINAS SOLUCION INYECTABLE INFANTIL CADA FRASCO AMPULA CON  LIOFILIZADOCONTIENE: RETINOL (VITAMINA A) 2000.0 UI, COLECALCIFEROL (VITAMINA  D TRES) 200.0 UI, ACETATO DE ALFA TOCOFEROL (VITAMINA E) 7.0 UI, NICOTINAMIDA",ENV,1,ENV,2207,UI,2207,UI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
61,,,5385,5385,1000053850103,010,000,5385,01,03,NO,"Sustantiva,Uso Hospitalario, Nutriología,Uso Hospitalario, Nutriología,Uso Hospitalario, Nutriología","MULTIVITAMINAS. SOLUCION INYECTABLE INFANTIL. CADA FRASCO AMPULA CON LIOFILIZADO CONTIENE: RETINOL (VITAMINA A) 2000.0 UI, COLECALCIFEROL (VITAMINA D TRES) 200.0 UI, ACETATO DE ALFA TOCOFEROL (VITAMINA E) 7.0 UI, NICOTINAMIDA",ENV,1,JGO,2207,UI,2207,UI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
62,,,5385,5385,1000053850203,010,000,5385,02,03,NO,"Sustantiva,Uso Hospitalario, Nutriología,Uso Hospitalario, Nutriología,Uso Hospitalario, Nutriología","MULTIVITAMINAS. SOLUCION INYECTABLE INFANTIL. CADA FRASCO AMPULA CON LIOFILIZADO CONTIENE: RETINOL (VITAMINA A) 2000.0 UI, COLECALCIFEROL (VITAMINA D TRES) 200.0 UI, ACETATO DE ALFA TOCOFEROL (VITAMINA E) 7.0 UI, NICOTINAMIDA",ENV,1,JGO,2207,UI,2207,UI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
64,,,5391,5391,1000053910000,010,000,5391,00,00,SI,"VALES,Sustantiva",DIETA POLIMERICA SIN FIBRA SUSPENSION ORAL O ENTERAL ENVASE CON 236 A 250 ML.,ENV,1,ENV,250,mililitros,250,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
65,,,5391,5391,1000053910002,010,000,5391,00,02,NO,"VALES,Sustantiva","DIETA POLIMERICA SIN FIBRA. SUSPENSION ORAL O ENTERAL. CADA 100 ML CONTIENEN (MINIMO-MAXIMO): PROTEINAS 3.6-4 G, LIPIDOS 3.4-3.92 G, HIDRATOS DE CARBONO 12.72-13.8 G, VITAMINA A 264.2-400 U.I., VITAMINA D 21.1-28 U.I., VITAMINA E",ENV,1,ENV,100,mililitros,100,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
66,,,5392,5392,1000053920000,010,000,5392,00,00,SI,"VALES,Sustantiva",DIETA POLIMERICA CON FIBRA SUSPENSION ORAL O ENTERAL ENVASE CON 236 A 250 ML.,ENV,1,ENV,250,mililitros,250,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,FORMULAS_NUTRICIONALES_COMPLETAS,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0
67,,,5392,5392,1000053920002,010,000,5392,00,02,NO,"VALES,Sustantiva","DIETA POLIMERICA CON FIBRA. SUSPENSION ORAL O ENTERAL. CADA 100 ML CONTIENEN (MINIMO-MAXIMO): PROTEINAS 3.69-3.74 G, LIPIDOS 3.45-3.56 G, HIDRATOS DE CARBONO 11.90-15 G, FIBRA DIETARIA TOTAL 1.25-1.35 G, VITAMINA A 359.3-400 UI,",ENV,1,ENV,100,mililitros,100,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,FORMULAS_NUTRICIONALES_COMPLETAS,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0
68,,,5393,5393,1000053930000,010,000,5393,00,00,SI,"Sustantiva,Uso Hospitalario, Nutriología",AMINOACIDOS ENRIQUECIDOS CON AMINOACIDOS DE CADENA RAMIFICADA SOLUCION INYECTABLE. CADA 100 ML CONTIENEN: PRESENTACION 500 ML,ENV,500,ML.,500,mililitros,500,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
69,,,5393,5393,1000053930002,010,000,5393,00,02,NO,"Sustantiva,Uso Hospitalario, Nutriología","AMINOACIDOS ENRIQUECIDOS CON AMINOACIDOS DE CADENA RAMIFICADA. SOLUCION INYECTABLE. CADA 100 ML CONTIENE (MINIMO-MAXIMO): L- ISOLEUCINA 700-1380 MG, L- LEUCINA 1100-1580 MG, L- LISINA 265-690 MG, L- METIONINA 110-450 MG, L-",ENV,500,ML.,500,mililitros,500,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
70,,,5397,5397,1000053970101,010,000,5397,01,01,NO,,"FORMULA O DIETA INMUNORREGULADORA. POLVO O SUSPENSION ORAL. CONTENIDO EN 100 ML: ENERGIA: MINIMO 100.00 KILOCALORIAS, MAXIMO 150 KILOCALORIAS; PROTEINAS: MINIMO 5.60 GRAMOS, MAXIMO 9.63 GRAMOS; HIDRATOS DE CARBONO: MINIMO 12.00 GRAMOS,",ENV,1,ENV,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
71,,,5400,5400,1000054000000,010,000,5400,00,00,SI,Sustantiva,FORMULA DE INICIO LIBRE DE FENILALANINA POLVO ENVASE: LATA O SOBRE. CON MEDIDA DOSIFICADORA,ENV,1,ENV,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
72,,,5400,5400,1000054000002,010,000,5400,00,02,NO,Sustantiva,"FORMULA DE INICIO LIBRE DE FENILALANINA. POLVO. EN CADA 100 G CONTENIDO EN (MINIMO-MAXIMO): ENERGIA 470-550 KCAL, PROTEINA 12.50-17.00 G, HIDRATOS DE CARBONO 50.00-60.00 G, LIPIDOS 20.00-26.00 G, L-ALANINA 0-1.50 G, L-ARGININA 0",ENV,1,ENV,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
73,,,5401,5401,1000054010000,010,000,5401,00,00,SI,Sustantiva,FORMULA DE SEGUIMIENTO LIBRE DE FENILALANINA POLVO ENVASE: LATA O SOBRE. CON MEDIDA DOSIFICADORA,ENV,1,ENV,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
74,,,5401,5401,1000054010002,010,000,5401,00,02,NO,Sustantiva,"FORMULA DE SEGUIMIENTO LIBRE DE FENILALANINA. POLVO. EN CADA 100 G CONTENIDO EN (MINIMO-MAXIMO): ENERGIA 300-420 KCAL, PROTEINA 20.00-35.00 G, HIDRATOS DE CARBONO 30.00-65.00 G, LIPIDOS 0.10-15.00 G, L-ALANINA 0-2.00 G, L-ARGININA 0-",ENV,1,ENV,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
75,,,5402,5402,1000054020000,010,000,5402,00,00,SI,Sustantiva,FORMULA LIBRE DE FENILALANINA PARA ADOLESCENTE Y ADULTO POLVO ENVASE: LATA O SOBRE CON MEDIDA DOSIFICADORA,ENV,1,ENV,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
76,,,5402,5402,1000054020002,010,000,5402,00,02,NO,Sustantiva,"FORMULA LIBRE DE FENILALANINA PARA ADOLESCENTE Y ADULTO. POLVO. EN CADA 100 G CONTENIDO EN: ENERGIA 297 KCAL, PROTEINA 39 G, HIDRATOS DE CARBONO 34 G, LIPIDOS <0.5 G, L-ALANINA 1.7 G, L-ARGININA 3.2 G, L-ACIDO ASPARTICO 3 G, L-",ENV,1,ENV,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
77,,,5403,5403,1000054030000,010,000,5403,00,00,SI,Sustantiva,"ALIMENTO MEDICO PARA PACIENTES CON TRASTORNO DEL CICLO DE LA UREA, RECIEN NACIDO A 7 AÑOS 11 MESES DE EDAD POLVO ENVASE: LATA CON MEDIDA DOSIFICADORA.",LTA,1,LTA,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
78,,,5403,5403,1000054030002,010,000,5403,00,02,NO,Sustantiva,"ALIMENTO MEDICO PARA PACIENTES CON TRASTORNO DEL CICLO DE LA UREA, RECIEN NACIDOS A 7 AÑOS 11 MESES DE EDAD. POLVO. CADA 100 G CONTIENE (MINIMO-MAXIMO): ENERGIA 500.00-510.00 KCAL, PROTEINA 6.50-7.50 G, HIDRATOS DE CARBONO 57.00-",LTA,1,LTA,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
79,,,5404,5404,1000054040000,010,000,5404,00,00,SI,Sustantiva,"ALIMENTO MEDICO PARA PACIENTES CON TRASTORNO DEL CICLO DE LA UREA, DE 8 AÑOS O MAYORES Y ADULTOS POLVO ENVASE: LATA CON MEDIDA DOSIFICADORA",LTA,1,LTA,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
80,,,5404,5404,1000054040002,010,000,5404,00,02,NO,Sustantiva,"ALIMENTO MEDICO PARA PACIENTES CON TRASTORNO DEL CICLO DE LA UREA, DE 8 AÑOS O MAYORES Y ADULTOS. POLVO. CADA 100 G CONTIENE (MINIMO-MAXIMO): ENERGIA 360.00- 440.00 KCAL, PROTEINA 8.20-25.00 G, HIDRATOS DE CARBONO 45.00-71.00 G, LIPIDOS",LTA,1,LTA,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
81,,,5405,5405,1000054050000,010,000,5405,00,00,SI,Sustantiva,"ALIMENTO MEDICO PARA PACIENTES CON ACIDEMIA METILMALONICA Y PROPIONICA, DE RECIEN NACIDOS A 7 AÑOS 11 MESES DE EDAD POLVO ENVASE: LATA CON MEDIDA DOSIFICADORA.",LTA,1,LTA,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
82,,,5405,5405,1000054050002,010,000,5405,00,02,NO,Sustantiva,"ALIMENTO MEDICO PARA PACIENTES CON ACIDEMIA METILMALONICA Y PROPIONICA, DE RECIEN NACIDOS A 7 AÑOS 11 MESES DE EDAD. POLVO. CADA 100 G CONTIENE (MINIMO- MAXIMO): ENERGIA 350.00-500.00 KCAL, PROTEINA 15.00-25.00 G, HIDRATOS DE",LTA,1,LTA,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
83,,,5406,5406,1000054060000,010,000,5406,00,00,SI,Sustantiva,"ALIMENTO MEDICO PARA PACIENTES CON ACIDEMIA METILMALONICA Y PROPIONICA, DE 8 AÑOS O MAYORES Y ADULTOS POLVO ENVASE: LATA CON MEDIDA DOSIFICADORA.",LTA,1,LTA,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
84,,,5406,5406,1000054060002,010,000,5406,00,02,NO,Sustantiva,"ALIMENTO MEDICO PARA PACIENTES CON ACIDEMIA METILMALONICA Y PROPIONICA, DE 8 AÑOS O MAYORES Y ADULTOS. POLVO. CADA 100 G CONTIENE (MINIMO-MAXIMO): ENERGIA 340.00-410.00 KCAL, HIDRATOS DE CARBONO 35.00-59.00 G, LIPIDOS 0-13.00 G,",LTA,1,LTA,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
85,,,5407,5407,1000054070000,010,000,5407,00,00,SI,Sustantiva,"ALIMENTO MEDICO PARA PACIENTES CON ENFERMEDAD DE ORINA DE JARABE DE MAPLE (ARCE), DE RECIEN NACIDOS A 7 AÑOS 11 MESES DE EDAD POLVO ENVASE: LATA CON MEDIDA DOSIFICADORA.",LTA,1,LTA,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
86,,,5407,5407,1000054070002,010,000,5407,00,02,NO,Sustantiva,"ALIMENTO MEDICO PARA PACIENTES CON ENFERMEDAD DE ORINA DE JARABE DE MAPLE (ARCE), DE RECIEN NACIDOS A 7 AÑOS 11 MESES DE EDAD. POLVO. CADA 100 G CONTIENE (MINIMO-MAXIMO): ENERGIA 350.00-500.00 KCAL, PROTEINA 15.00-25.00 G, HIDRATOS",LTA,1,LTA,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
87,,,5408,5408,1000054080000,010,000,5408,00,00,SI,Sustantiva,"ALIMENTO MEDICO PARA PACIENTES CON ENFERMEDAD DE ORINA DE JARABE DE MAPLE (ARCE), DE 8 AÑOS O MAYORES Y ADULTOS POLVO ENVASE: LATA CON MEDIDA DOSIFICADORA.",LTA,1,LTA,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
88,,,5408,5408,1000054080002,010,000,5408,00,02,NO,Sustantiva,"ALIMENTO MEDICO PARA PACIENTES CON ENFERMEDAD DE ORINA DE JARABE DE MAPLE (ARCE), DE 8 AÑOS O MAYORES Y ADULTOS. POLVO. CADA 100 G CONTIENE (MINIMO MAXIMO): ENERGIA 340.00-410.00 KCAL, PROTEINA 24.00-39.00 G, HIDRATOS DE",LTA,1,LTA,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
89,,,5409,5409,1000054090000,010,000,5409,00,00,SI,Sin programa definido,"ALIMENTO MEDICO PARA PACIENTES CON HOMOCISTINURIA, RECIEN NACIDOS A 7 AÑOS 11 MESES DE EDAD POLVO ENVASE: LATA CON MEDIDA DOSIFICADORA.",LTA,1,LTA,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
90,,,5409,5409,1000054090002,010,000,5409,00,02,NO,Sin programa definido,"ALIMENTO MEDICO PARA PACIENTES CON HOMOCISTINURIA, RECIEN NACIDOS A 7 AÑOS 11 MESES DE EDAD. POLVO. CADA 100 G CONTIENE (MINIMO-MAXIMO): ENERGIA 350.00- 500.00 KCAL, PROTEINA 15.00-28.60 G, HIDRATOS DE CARBONO 51.00-62.00 G, LIPIDOS",LTA,1,LTA,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
91,,,5410,5410,1000054100000,010,000,5410,00,00,SI,Sustantiva,"ALIMENTO MEDICO PARA PACIENTES CON HOMOCISTINURIA, DE 8 AÑOS O MAYORES Y ADULTOS POLVO ENVASE: LATA CON MEDIDA DOSIFICADORA",LTA,1,LTA,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
92,,,5410,5410,1000054100002,010,000,5410,00,02,NO,Sustantiva,"ALIMENTO MEDICO PARA PACIENTES CON HOMOCISTINURIA, DE 8 AÑOS O MAYORES Y ADULTOS. POLVO. CADA 100 G CONTIENE (MINIMO-MAXIMO): ENERGIA 340.00-410.00 KCAL, PROTEINA 22.00-39.00 G, HIDRATOS DE CARBONO 35.00-61.00 G, LIPIDOS 0-",LTA,1,LTA,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
93,,,5411,5411,1000054110000,010,000,5411,00,00,SI,Sin programa definido,ALIMENTO MEDICO PARA MENORES DE UN AÑO CON ACIDEMIA ISOVALERICA Y OTROS TRASTORNOS DEL METABOLISMO DE LA LEUCINA POLVO. CONTENIDO EN: ENVASE,ENV,1,ENV,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
94,,,5411,5411,1000054110001,010,000,5411,00,01,NO,Sin programa definido,"ALIMENTO MEDICO PARA MENORES DE UN AÑO CON ACIDEMIA ISOVALERICA Y OTROS TRASTORNOS DEL METABOLISMO DE LA LEUCINA. POLVO. EN CADA 100 G CONTENIDO EN (MINIMO-MAXIMO): ENERGIA 475-500 KCAL, PROTEINA 13.00-16.20 G, CARNITINA 0-900",ENV,1,ENV,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
95,,,5412,5412,1000054120000,010,000,5412,00,00,SI,Sustantiva,ALIMENTO MEDICO PARA NIÑOS DE 1 A 8 AÑOS CON ACIDEMIA ISOVALERICA Y OTROS TRASTORNOS DEL METABOLISMO DE LA LEUCINA POLVO. CONTENIDO EN: ENVASE,ENV,1,ENV,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
96,,,5412,5412,1000054120001,010,000,5412,00,01,NO,Sustantiva,"ALIMENTO MEDICO PARA NIÑOS DE 1 A 8 AÑOS CON ACIDEMIA ISOVALERICA Y OTROS TRASTORNOS DEL METABOLISMO DE LA LEUCINA. POLVO. EN CADA 100 G CONTENIDO EN (MINIMO-MAXIMO): ENERGIA 309-500 KCAL, PROTEINA 16.2-30.00 G, CARNITINA 0-1800",ENV,1,ENV,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
97,,,5413,5413,1000054130000,010,000,5413,00,00,SI,Sin programa definido,ALIMENTO MEDICO PARA NIÑOS DE 8 AÑOS A ADULTOS CON ACIDEMIA ISOVALERICA Y OTROS TRASTORNOS DEL METABOLISMO DE LA LEUCINA POLVO. CONTENIDO EN: ENVASE,ENV,1,ENV,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
98,,,5413,5413,1000054130001,010,000,5413,00,01,NO,Sin programa definido,"ALIMENTO MEDICO PARA NIÑOS DE 8 AÑOS A ADULTOS CON ACIDEMIA ISOVALERICA Y OTROS TRASTORNOS DEL METABOLISMO DE LA LEUCINA. POLVO. EN CADA 100 G CONTENIDO EN (MINIMO-MAXIMO): ENERGIA 297-500 KCAL, PROTEINA 16.2-39.00 G, CARNITINA 0-1800",ENV,1,ENV,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
309,,,3803,3803,2000038030000,020,000,3803,00,00,NO,,VACUNA ANTIPOLIOMIELITICA INACTIVADA SUSPENSION INYECTABLE CADA DOSIS DE 0.5 ML CONTIENE: POLIOVIRUS INACTIVADOS: CEPA MAHONEY TIPO 1 40 UNIDADES DE ANTIGENO D CEPA MEF 1 TIPO 2 8 UNIDADES DE ANTIGENO D CEPA SAUKETT TIPO 3 32 UNIDADES,ENV,1,ENV,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
345,,,3835,3835,2000038350000,020,000,3835,00,00,SI,,VITAMINA A SOLUCION CADA DOSIS CONTIENE: PALMITATO DE VITAMINA A (RETINOL) 200  000 UI ENVASE CON 25 DOSIS.,ENV,25,DSS,200000,UI,5000000,UI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
346,,,3835,3835,2000038350100,020,000,3835,01,00,NO,,"VITAMINA A. SOLUCION CADA DOSIS CONTIENE: PALMITATO DE VITAMINA A (RETINOL) 200  000 UI, ENVASE CON 50 DOSIS.",ENV,50,DSS,200000,UI,10000000,UI,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
352,,,3851,3851,2000038510000,020,000,3851,00,00,NO,,"VACUNA SIN ADYUVANTE. ES UNA MEZCLA DE SOLUCION SALINA TAMPONADA CON FOSFATOS DE 15 MCG DE HEMAGLUTININA (HA) CON INFLUENZA A CALIFORNIA/07/2009 H1N1, CONCENTRADOS Y PURIFICADOS POR FORMALDEHIDO, DERIVADA POR DOSIS DE 0.5 ML. SE",FCO,10,DSS,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
403,,,2169,2169,1000021690000,010,000,2169,00,00,SI,Sustantiva,LEVOCARNITINA. SOLUCION INYECTABLE CADA AMPOLLETA CONTIENE: LEVOCARNITINA 1 G ENVASE CON 5 AMPOLLETAS DE 5 ML.,ENV,5,AMP,1,gramos,5,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
404,,,2169,2169,1000021690100,010,000,2169,01,00,NO,Sustantiva,LEVOCARNITINA SOLUCION INYECTABLE. CADA AMPOLLETA CONTIENE: LEVOCARNITINA 1 G. ENVASE CON 25 AMPOLLETAS DE 5 ML.,CJA,25,AMP,1,gramos,25,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
405,,,2169,2169,1000021690200,010,000,2169,02,00,NO,Sustantiva,LEVOCARNITINA. SOLUCION INYECTABLE. CADA AMPOLLETA CONTIENE: LEVOCARNITINA 1 G. ENVASE CON 50 AMPOLLETAS DE 5 ML.,ENV,50,AMP,1,gramos,50,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
406,,,2171,2171,1000021710000,010,000,2171,00,00,SI,Sustantiva,LEVOCARNITINA. TABLETA MASTICABLE CADA TABLETA CONTIENE: LEVOCARNITINA 1 G  ENVASE CON 20 TABLETAS.,ENV,20,TAB,1,gramos,20,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
448,,,2364,2364,1000023640000,010,000,2364,00,00,SI,"Sin programa definido,Uso Hospitalario, Nefrología y Urología",SOLUCION PARA DIALISIS PERITONEAL CON ICODEXTRINA SOLUCION CADA 100 ML  CONTIENEN: ICODEXTRINA 7.5000 G CLORURO DE SODIO 0.5400 G LACTATO DE SODIO  0.4500 G CLORURO DE CALCIO DIHIDRATADO 0.0257 G CLORURO DE MAGNESIO,ENV,1,ENV,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
471,,,2512,2512,1000025120000,010,000,2512,00,00,NO,"Sustantiva,Uso Hospitalario, Nutriología,Uso Hospitalario, Nutriología,Uso Hospitalario, Nutriología,Uso Hospitalario, Nutriología",AMINOACIDOS CRISTALINOS SOLUCION INYECTABLE AL 10% PEDIATRICOS PRESENTACION DE 250 ML.,ENV,250,ML.,250,mililitros,250,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
472,,,2512,2512,1000025120002,010,000,2512,00,02,NO,"Sustantiva,Uso Hospitalario, Nutriología,Uso Hospitalario, Nutriología,Uso Hospitalario, Nutriología,Uso Hospitalario, Nutriología","AMINOACIDOS CRISTALINOS. SOLUCION INYECTABLE AL 10% PEDIATRICOS. CADA 100 ML CONTIENE: L - ISOLEUCINA 670 - 820 MG, L - LEUCINA 1000 - 1400 MG, L - LISINA 670 - 1100 MG, L - METIONINA 220 - 340 MG, L - FENILALANINA 420 - 650 MG, L -",ENV,250,ML.,250,mililitros,250,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
473,,,2512,2512,1000025120100,010,000,2512,01,00,SI,"Sustantiva,Uso Hospitalario, Nutriología,Uso Hospitalario, Nutriología,Uso Hospitalario, Nutriología,Uso Hospitalario, Nutriología",AMINOACIDOS CRISTALINOS SOLUCION INYECTABLE AL 10% PEDIATRICOS PRESENTACION DE 500 ML.,ENV,500,ML.,500,mililitros,500,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
474,,,2512,2512,1000025120103,010,000,2512,01,03,NO,"Sustantiva,Uso Hospitalario, Nutriología,Uso Hospitalario, Nutriología,Uso Hospitalario, Nutriología,Uso Hospitalario, Nutriología","AMINOACIDOS CRISTALINOS. SOLUCION INYECTABLE AL 10% PEDIATRICOS. CADA 100 ML CONTIENE: L - ISOLEUCINA 670 - 820 MG, L - LEUCINA 1000 - 1400 MG, L - LISINA 670 - 1100 MG, L - METIONINA 220 - 340 MG, L - FENILALANINA 420 - 650 MG, L -",ENV,500,ML.,500,mililitros,500,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
494,,,2707,2707,1000027070000,010,000,2707,00,00,SI,"Sustantiva,VALES",ACIDO ASCORBICO TABLETA CADA TABLETA CONTIENE: ACIDO ASCORBICO 100 MG ENVASE  CON 20 TABLETAS.,ENV,20,TAB,100,miligramos,2000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,VITAMINICOS,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1
495,,,2714,2714,1000027140000,010,000,2714,00,00,SI,"VALES,Consumo en demanda","COMPLEJO B CADA TABLETA, COMPRIMIDO O CAPSULA CONTIENE: MONONITRATO O CLORHIDRATO DE TIAMINA 100 MG CLORHIDRATO DE PIRIDOXINA 5 MG CIANOCOBALAMINA 50 MICROGRAMOS ENVASE CON 30 TABLETAS, COMPRIMIDOS O CAPSULAS.",ENV,30,TAB,105.05,miligramos,3151.5,miligramos,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,VITAMINICOS,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1
496,,,2714,2714,1000027140004,010,000,2714,00,04,NO,"VALES,Consumo en demanda","COMPLEJO B. TABLETA, COMPRIMIDO O CAPSULA. CADA TABLETA, COMPRIMIDO O CAPSULA CONTIENE: MONONITRATO O CLORHIDRATO DE TIAMINA 100 MG CLORHIDRATO DE PIRIDOXINA 5 MG CIANOCOBALAMINA 50 MICROGRAMOS ENVASE CON 30 TABLETAS, COMPRIMIDOS O",ENV,30,TCC,105.05,miligramos,3151.5,miligramos,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,VITAMINICOS,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1
497,,,2715,2715,1000027150000,010,000,2715,00,00,NO,"Sustantiva,VALES",VITAMINA E GRAGEA O CAPSULA CADA GRAGEA O CAPSULA CONTIENE: VITAMINA E 400 MG ENVASE CON 100 GRAGEAS O CAPSULAS.,ENV,100,G.C,400,miligramos,40000,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,VITAMINICOS,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1
498,,,2715,2715,1000027150100,010,000,2715,01,00,SI,"Sustantiva,VALES",VITAMINA E GRAGEA O CAPSULA CADA GRAGEA O CAPSULA CONTIENE: VITAMINA E 400 MG ENVASE CON 99 GRAGEAS O CAPSULAS.,ENV,99,G.C,400,miligramos,39600,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,VITAMINICOS,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1
499,,,2736,2736,1000027360000,010,000,2736,00,00,NO,"Sustantiva,VALES",DIETA ELEMENTAL. POLVO ENVASE CON 6 SOBRES CON 79.5 A 80.4 G CADA UNO.,ENV,6,SBR,79.5,gramos,477,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
500,,,2736,2736,1000027360002,010,000,2736,00,02,NO,"Sustantiva,VALES","DIETA ELEMENTAL. POLVO. CADA 100 G O CADA 100 ML CONTENIDO EN (MINIMO-MAXIMO): ENERGIA 373.00-386.00 O 99.00-103.45 KCAL, HIDRATOS DE CARBONO 71.00-78.50 O 19.00-21.04 G, PROTEINAS 14.25-17.00 O 3.80-4.75 G, GRASAS 1.00-2.50 O 0.27-",ENV,6,SBR,100,gramos,600,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
501,,,2736,2736,1000027360100,010,000,2736,01,00,SI,"Sustantiva,VALES",DIETA ELEMENTAL. POLVOENVASE CON 10 SOBRES CON 79.5 A 80.4 G CADA UNO.,ENV,1,ENV,79.5,gramos,79.5,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
502,,,2736,2736,1000027360102,010,000,2736,01,02,NO,"Sustantiva,VALES","DIETA ELEMENTAL. POLVO. CADA 100 G O CADA 100 ML CONTENIDO EN (MINIMO-MAXIMO): ENERGIA 373.00-386.00 O 99.00-103.45 KCAL, HIDRATOS DE CARBONO 71.00-78.50 O 19.00-21.04 G, PROTEINAS 14.25-17.00 O 3.80-4.75 G, GRASAS 1.00-2.50 O 0.27-",ENV,10,SBR,100,gramos,1000,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
503,,,2737,2737,1000027370001,010,000,2737,00,01,SI,"Sustantiva,Uso Hospitalario, Nutriología","AMINOACIDOS CON ELECTROLITOS SOLUCION INYECTABLE AL 8.5% CADA 100 ML. CONTIENE L-ISOLEUCINA UNIDAD EN MILIGRAMOS: MINIMO 400, MAXIMO 620. L-LEUCINA UNIDAD EN MILIGRAMOS: MINIMO 520, MAXIMO 810. L-LISINA UNIDAD EN MILIGRAMOS: MINIMO 490,",ENV,500,ML.,500,mililitros,500,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
504,,,2738,2738,1000027380000,010,000,2738,00,00,SI,"Sustantiva,Uso Hospitalario, Nutriología","AMINOACIDOS CRISTALINOS. SOLUCION INYECTABLE AL 10% - ADULTOS. CADA 100 MILILITROS CONTIENEN: L- ISOLEUCINA, UNIDAD DE MEDIDA: MG, CANTIDAD MINIMA EN CADA 100 ML: 490, CANTIDAD MAXIMA EN CADA 100 ML: 720; L- LEUCINA, UNIDAD DE",ENV,1,ENV,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
505,,,2738,2738,1000027380002,010,000,2738,00,02,NO,"Sustantiva,Uso Hospitalario, Nutriología","AMINOACIDOS CRISTALINOS. SOLUCION INYECTABLE AL 10% ADULTOS. CADA 100 ML CONTIENE (MINIMO-MAXIMO): L- ISOLEUCINA 490-720 MG, L- LEUCINA 719-940 MG, L- LISINA 599-720 MG, L- METIONINA 294-440 MG, L- FENILALANINA 440-845 MG, L-",ENV,500,ML.,500,mililitros,500,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
506,,,2739,2739,1000027390000,010,000,2739,00,00,SI,"Sustantiva,VALES","DIETA POLIMERICA A BASE DE CASEINATO DE CALCIO. POLVO. CADA 100 GRAMOS CONTIENE: HIDRATOS DE CARBONO, UNIDAD DE MEDIDA: G, MINIMO 58.50, MAXIMO 68.00; PROTEINA, UNIDAD DE MEDIDA: G, MINIMO 15.80, MAXIMO 17.50; HISTIDINA,",ENV,1,ENV,100,gramos,100,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
507,,,2739,2739,1000027390002,010,000,2739,00,02,NO,"Sustantiva,VALES","DIETA POLIMERICA A BASE DE CASEINATO DE CALCIO O PROTEINAS, GRASAS, VITAMINAS, MINERALES. POLVO. CADA 100 GRAMOS CONTIENE: HIDRATOS DE CARBONO 58.50-68.00 G, PROTEINA 15.80-17.50 G, HISTIDINA 0.40-0.5600 G, ISOLEUCINA 0.7035-1.0135 G,",ENV,1,ENV,100,gramos,100,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
508,,,2740,2740,1000027400000,010,000,2740,00,00,SI,"Sustantiva,Uso Hospitalario, Nutriología",LIPIDOS INTRAVENOSOS (LIPIDOS DE CADENA MEDIANA Y LARGA AL 20%; SOYA / TRIGLICERIDOS) EMULSION INYECTABLE (LIPIDOS DE CADENA MEDIANA Y LARGA AL 20%; SOYA / TRIGLICERIDOS) CADA 1000 ML CONTIENEN: ACEITE DE SOYA 100 G,ENV,1,ENV,100,gramos,100,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
509,,,2740,2740,1000027400002,010,000,2740,00,02,NO,"Sustantiva,Uso Hospitalario, Nutriología",LIPIDOS INTRAVENOSOS EMULSIÓN INYECTABLE (LIPIDOS DE CADENA MEDIANA Y LARGA AL 20%; SOYA / TRIGLICERIDOS) CADA 1000 ML CONTIENEN: ACEITE DE SOYA 100 G TRIGLICERIDOS DE CADENA MEDIANA 100 G CADA ML PROPORCIONA 1.9 KCAL. ENVASE CON,ENV,500,ML.,500,mililitros,500,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
510,,,2744,2744,1000027440101,010,000,2744,01,01,NO,,"LIPIDOS. EMULSION INYECTABLE, (LIPIDOS DE CADENA LARGA AL 20%) CADA 100 ML CONTIENEN: ACEITE DE OLIVA 16 G, ACEITE DE SOYA 4 G.",ENV,500,ML.,500,mililitros,500,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
511,,,2745,2745,1000027450000,010,000,2745,00,00,SI,"Sustantiva,Uso Hospitalario, Nutriología,Uso Hospitalario, Nutriología",LIPIDOS INTRAVENOSOS: ACEITE DE PESCADO (ACIDOS GRASOS) EMULSION INYECTABLE  CADA 100 ML CONTIENEN: ACEITE DE PESCADO 10.0 G ENVASE CON 50 ML.,ENV,50,ML.,50,mililitros,50,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
512,,,2745,2745,1000027450100,010,000,2745,01,00,NO,"Sustantiva,Uso Hospitalario, Nutriología,Uso Hospitalario, Nutriología",LIPIDOS INTRAVENOSOS: ACEITE DE PESCADO (ACIDOS GRASOS). EMULSION INYECTABLE .CADA 100 ML CONTIENEN: ACEITE DE PESCADO 10.0 G. ENVASE CON 100 ML.,ENV,100,MG.,100,mililitros,100,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
574,,,3,0003,3000000030003,030,000,0003,00,03,SI,"VALES,Sustantiva",SUCEDANEO DE LECHE HUMANA DE PRETERMINO. POLVO. KILOCALORIAS. 100 G MINIMO 400 KCAL MAXIMO 525 KCAL. 100 KCAL MINIMO 100.0 KCAL MAXIMO 100.0 KCAL. 100 ML MINIMO 64 KCAL MAXIMO 85 KCAL. LIPIDOS. 100 G MINIMO 19.2 G MAXIMO 31.5 G. 100,ENV,1,ENV,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
575,,,3,0003,3000000030004,030,000,0003,00,04,NO,"VALES,Sustantiva","SUCEDANEO DE LECHE HUMANA DE PRETERMINO. POLVO. EN CADA 100 G 100 KCAL 100 ML CONTENIDO EN (MINIMO-MAXIMO): KILOCALORIAS 400-525 100.0-100.0 64-85 KCAL, LIPIDOS 19.2-31.5 4.80-6.00 3.072-5.1 G, ACIDO LINOLEICO 1200-7350 300.00-",ENV,1,ENV,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
576,,,11,0011,3000000110004,030,000,0011,00,04,SI,"VALES,Sustantiva","FORMULA PARA LACTANTES (SUCEDANEO DE LECHE HUMANA DE TERMINO). POLVO O LIQUIDO. ENERGIA: 100ML 60 KCAL - 70 KCAL, ENERGIA: 100ML 250 KJ - 295 KJ, VITAMINAS: VITAMINA A (EXPRESADOS EN RETINOL): 100KCAL 200 U.I. O 60 MICROGRAMOS - 600",ENV,1,ENV,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
577,,,11,0011,3000000110102,030,000,0011,01,02,NO,"VALES,Sustantiva","FORMULA PARA LACTANTES (SUCEDANEO DE LECHE HUMANA DE TERMINO). POLVO O LIQUIDO. ENERGIA: 100ML 60 KCAL - 70 KCAL, ENERGIA: 100ML 250 KJ - 295 KJ, VITAMINAS: VITAMINA A (EXPRESADOS EN RETINOL): 100KCAL 200 U.I. O 60 MICROGRAMOS - 600",ENV,1,ENV,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
578,,,12,0012,3000000120002,030,000,0012,00,02,SI,"VALES,Sustantiva",SUCEDANEO DE LECHE HUMANA DE TERMINO SIN LACTOSA. POLVO. KILOCALORIAS. 100 G MINIMO 502.0 MAXIMO 522.0 100 KCAL MINIMO 100.00 MAXIMO 100.00 100 ML MINIMO 66.66 MAXIMO 68.00 LIPIDOS. 100 G MINIMO 25.0 G MAXIMO 28.0 G. 100 KCAL MINIMO,ENV,1,ENV,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
579,,,13,0013,3000000130000,030,000,0013,00,00,NO,"VALES,Sustantiva","FORMULA DE PROTEINA EXTENSAMENTE HIDROLIZADA. POLVO. CONTENIDO EN NUTRIMENTOS: KILOCALORIAS.- EN CADA 100 GRAMOS MINIMO 457.0, MAXIMO 523.00, EN CADA 100 KILOCALORIAS MINIMO 100.00, MAXIMO 100.00, EN CADA 100 MILILITROS MINIMO",ENV,1,ENV,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
580,,,13,0013,3000000130003,030,000,0013,00,03,SI,"VALES,Sustantiva","FORMULA PARA LACTANTES CON NECESIDADES ESPECIALES DE NUTRICION CON PROTEINA EXTENSAMENTE HIDROLIZADA. POLVO O LIQUIDO. ENERGIA: 100ML 60 KCAL - 85 KCAL, ENERGIA: 100ML 250 KJ - 355 KJ, VITAMINAS: VITAMINA A: 100KCAL 200 U.I. O 60",ENV,1,ENV,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
581,,,13,0013,3000000130102,030,000,0013,01,02,NO,"VALES,Sustantiva","FORMULA PARA LACTANTES CON NECESIDADES ESPECIALES DE NUTRICION CON PROTEINA EXTENSAMENTE HIDROLIZADA. POLVO O LIQUIDO. ENERGIA: 100ML 60 KCAL - 85 KCAL, ENERGIA: 100ML 250 KJ - 355 KJ, VITAMINAS: VITAMINA A: 100KCAL 200 U.I. O 60",ENV,1,ENV,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
582,,,14,0014,3000000140005,030,000,0014,00,05,SI,"VALES,Sustantiva","FORMULA DE CONTINUACION. POLVO O LIQUIDO. ENERGIA: 100ML 60 KCAL - 85 KCAL, ENERGIA: 100ML 250 KJ - 355 KJ, VITAMINAS: VITAMINA A: 100KCAL 250 U.I. O 75 MICROGRAMOS EXPRESADOS EN RETINOL - 750 U.I. O 225 MICROGRAMOS EXPRESADOS EN",ENV,1,ENV,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
583,,,14,0014,3000000140102,030,000,0014,01,02,NO,"VALES,Sustantiva","FORMULA DE CONTINUACION. POLVO O LIQUIDO. ENERGIA: 100ML 60 KCAL - 85 KCAL, ENERGIA: 100ML 250 KJ - 355 KJ, VITAMINAS: VITAMINA A: 100KCAL 250 U.I. O 75 MICROGRAMOS EXPRESADOS EN RETINOL - 750 U.I. O 225 MICROGRAMOS EXPRESADOS EN",ENV,1,ENV,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
584,,,21,0021,3000000210002,030,000,0021,00,02,SI,"VALES,Sustantiva",FORMULA DE PROTEINA AISLADA DE SOYA. POLVO. KILOCALORIAS. 100 G MINIMO 515.0 KCAL MAXIMO 524.00 KCAL. 100 KCAL MINIMO 60.00 KCAL MAXIMO 70.00 KCAL. 100 ML MINIMO 66.67 KCAL MAXIMO 68.00 KCAL. LIPIDOS. 100 G MINIMO 20.00 G MAXIMO 28.30,ENV,1,ENV,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
585,,,5234,5234,3000052340000,030,000,5234,00,00,SI,Sustantiva,D-BIOTINA COMPRIMIDOS CADA COMPRIMIDO CONTIENE: D-BIOTINA 5 MG ENVASE CON 30  COMPRIMIDOS.,ENV,30,COM,5,miligramos,150,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
586,,,5234,5234,3000052340101,030,000,5234,01,01,NO,Sustantiva,D-BIOTINA. CAPSULAS. CADA CAPSULA CONTIENE: D-BIOTINA 5 MG. ENVASE CON 60 CAPSULAS.,ENV,60,CAP,5,miligramos,300,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
587,,,5394,5394,3000053940003,030,000,5394,00,03,SI,Sustantiva,"FORMULA PARA LACTANTES CON NECESIDADES ESPECIALES DE NUTRICION CON PROTEINA EXTENSAMENTE HIDROLIZADA Y TRIGLICERIDOS DE CADENA MEDIA. POLVO O LIQUIDO. ENERGIA: 100ML 60 KCAL - 85 KCAL, ENERGIA: 100ML 250 KJ - 355KJ, VITAMINAS:",ENV,1,ENV,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
588,,,5394,5394,3000053940100,030,000,5394,01,00,NO,Sustantiva,"FORMULA PARA LACTANTES CON NECESIDADES ESPECIALES DE NUTRICION CON PROTEINA EXTENSAMENTE HIDROLIZADA Y TRIGLICERIDOS DE CADENA MEDIA. POLVO O LIQUIDO. ENERGIA: 100ML 60 KCAL - 85 KCAL, ENERGIA: 100ML 250 KJ - 355KJ, VITAMINAS:",ENV,1,ENV,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
589,,,5398,5398,3000053980000,030,000,5398,00,00,NO,"VALES,Sustantiva","FORMULA CON PROTEINAS A BASE DE AMINOACIDOS. POLVO. CONTENIDO: KILOCALORIAS EN KILOCALORIAS.- EN CADA 100 GRAMOS 475.00, EN CADA 100 MILILITROS 71.25, EN CADA 100 KILOCALORIAS 100.00; LIPIDOS EN GRAMOS.- EN CADA 100 GRAMOS 23.00, EN",ENV,1,ENV,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
590,,,5398,5398,3000053980003,030,000,5398,00,03,SI,"VALES,Sustantiva","FORMULA PARA LACTANTES CON NECESIDADES ESPECIALES DE NUTRICION A BASE DE AMINOACIDOS. POLVO. ENERGIA: 100ML 60 KCAL - 70 KCAL, ENERGIA: 100ML 250 KJ - 295 KJ, VITAMINAS: VITAMINA A: 100KCAL 200 U.I. O 60 MICROGRAMOS EXPRESADOS EN",ENV,1,ENV,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
591,,,5398,5398,3000053980100,030,000,5398,01,00,NO,"VALES,Sustantiva","FORMULA PARA LACTANTES CON NECESIDADES ESPECIALES DE NUTRICION A BASE DE AMINOACIDOS. POLVO. ENERGIA: 100ML 60 KCAL - 70 KCAL, ENERGIA: 100ML 250 KJ - 295 KJ, VITAMINAS: VITAMINA A: 100KCAL 200 U.I. O 60 MICROGRAMOS EXPRESADOS EN",ENV,400,GRO,60,microgramos,60,microgramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
592,,,5951,5951,3000059510000,030,000,5951,00,00,SI,Sin programa definido,"FORMULA DE PROTEINA HIDROLIZADA DE ARROZ ETAPA 2. POLVO. CONTENIDO EN: ENERGIA* POR 100 KCAL 100 KCAL. POR 100 G DE POLVO 484 KCAL, PROTEINAS POR 100 KCAL 3,1 G. POR 100 G DE POLVO 15,0 G, HIDRATOS DE CARBONO POR 100 KCAL 11,7 G. POR 100",ENV,1,ENV,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
593,,,5952,5952,3000059520000,030,000,5952,00,00,SI,Sin programa definido,"FORMULA DE PROTEINA HIDROLIZADA DE ARROZ ETAPA 1. POLVO. CONTENIDO EN: ENERGIA* POR 100 KCAL 100 KCAL. POR 100 G DE POLVO 504 KCAL, PROTEINAS POR 100 KCAL 2,4 G. POR 100 G DE POLVO 12,0 G, HIDRATOS DE CARBONO POR 100 KCAL 11,3 G. POR 100",ENV,1,ENV,,,,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
607,,,425,0425,4000004250001,040,000,0425,00,01,NO,,PSEUDOEFEDRINA. TABLETAS. CADA TABLETA CONTIENE: CLORHIDRATO DE PSEUDOEFEDRINA 60 MG.,ENV,10,TAB,60,miligramos,600,miligramos,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
608,,,434,0434,4000004340001,040,000,0434,00,01,NO,,"PSEUDOEFEDRINA, JARABE, 600 MILIGRAMOS/100 MILILITROS. FRASCO CON 120 MILILITROS.",ENV,1,ENV,120,mililitros,120,mililitros,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
638,,,3245,3245,4000032450202,040,000,3245,02,02,NO,,PERFENAZINA 4. GRAGEAS O TABLETAS. CADA GRAGEA O TABLETA CONTIENE: PERFENAZINA 4 MG. ENVASE CON 30.,ENV,30,T.G,4,miligramos,120,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
648,,,3311,3311,4000033110101,040,000,3311,01,01,NO,,"MOCLOBEMIDA, COMPRIMIDOS CON 150 MILIGRAMOS.",ENV,30,COM,150,miligramos,4500,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
670,,,5476,5476,4000054760001,040,000,5476,00,01,NO,Sustantiva,LEVOMEPROMAZINA. SOLUCION INYECTABLE. CADA AMPOLLETA CONTIENE: CLORHIDRATO DE LEVOMEPROMAZINA EQUIVALENTE A 25 MG. DE LEVOMEPROMAZINA. AMPOLLETA DE 1 ML.,ENV,10,AMP,25,miligramos,250,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
672,,,22,0022,1000000220000,010,000,0022,00,00,SI,"VALES,Sustantiva",CASEINATO DE CALCIO POLVO CADA 100 G CONTIENEN: PROTEINAS 86.0 A 90.0 G GRASAS 0.0 A 2.0 G MINERALES 3.8 A 6.0 G HUMEDAD 0.0 A 6.2 G ENVASE CON 100 G.,ENV,1,PZA,100,gramos,100,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,VITAMINICOS,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1
673,,,22,0022,1000000220003,010,000,0022,00,03,NO,"VALES,Sustantiva",CASEINATO DE CALCIO POLVO CADA 100 G CONTIENEN: PROTEINAS 86.0 A 90.0 G GRASAS 0.0 A 2.0 G MINERALES 3.8 A 6.0 G HUMEDAD 0.0 A 6.2 G ENVASE CON 100 G.,ENV,100,GRO,100,gramos,10000,gramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,VITAMINICOS,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1
769,,,641,0641,1000006410202,010,000,0641,02,02,NO,,"DEXTRAN SOLUCION INYECTABLE. CADA 100 ML CONTIENEN: DEXTRAN (40 000) 10 G GLUCOSA 5 G, ENVASE CON 500 ML.",ENV,500,ML.,500,mililitros,500,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
812,,,1098,1098,1000010980000,010,000,1098,00,00,SI,"VALES,Sustantiva",VITAMINAS A.C.D SOLUCION CADA ML CONTIENE: PALMITATO DE RETINOL 7000 A 9000 UI; ACIDO ASCORBICO 80 A 125 MG; COLECALCIFEROL 1400 A 1800 UI; ENVASE CON 15 ML.,FCO,15,ML.,15,mililitros,15,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
852,,,1489,1489,1000014890201,010,000,1489,02,01,NO,,"ESTROGENOS CONJUGADOS DE ORIGEN VEGETAL. GRAGEAS O TABLETAS, CADA GRAGEA O TABLETA CONTIENE: ESTROGENOS CONJUGADOS DE ORIGEN VEGETAL 0.625 MG.",ENV,42,T.G,0.625,miligramos,26.25,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
859,,,1522,1522,1000015220301,010,000,1522,03,01,NO,,"HIDROXIPROGESTERONA CAPROATO DE, SOLUCION INYECTABLE, CADA AMPOLLETA CONTIENE: CAPROATO DE HIDROXIPROGESTERONA 250 MG. AMPOLLETA DE 1 ML.",ENV,1,AMP,250,miligramos,250,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
865,,,1545,1545,1000015450001,010,000,1545,00,01,NO,Sustantiva,ATOSIBAN. SOLUCION INYECTABLE. CADA FRASCO AMPULA CONTIENE: ATOSIBAN 6.75 MG. ENVASE CON 0.9 ML.,ENV,1,ENV,6.75,miligramos,6.75,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
878,,,1706,1706,1000017060000,010,000,1706,00,00,SI,Consumo en demanda,ACIDO FOLICO TABLETA CADA TABLETA CONTIENE: ACIDO FOLICO 5 MG ENVASE CON 20 TABLETAS.,ENV,20,TAB,5,miligramos,100,miligramos,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,FARMACOS_UTILIZADOS_EN_NEFROLOGIA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0
879,,,1706,1706,1000017060100,010,000,1706,01,00,NO,Consumo en demanda,ACIDO FOLICO. TABLETA. CADA TABLETA CONTIENE: ACIDO FOLICO 5 MG. ENVASE CON 92 TABLETAS.,ENV,92,TAB,5,miligramos,460,miligramos,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,FARMACOS_UTILIZADOS_EN_NEFROLOGIA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0
882,,,1711,1711,1000017110000,010,000,1711,00,00,SI,"VALES,Sustantiva -- Meta médica",ACIDO FOLICO TABLETA CADA TABLETA CONTIENE: ACIDO FOLICO 0.4 MG ENVASE CON 90 TABLETAS.,ENV,90,TAB,0.4,miligramos,36,miligramos,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,FARMACOS_UTILIZADOS_EN_NEFROLOGIA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0
883,,,1714,1714,1000017140000,010,000,1714,00,00,SI,"Sustantiva,Uso Hospitalario, Nutriología",SACARATO FERRICO SOLUCION INYECTABLE LA AMPOLLETA CONTIENE: COMPLEJO DE SACARATO DE OXIDO FERRICO EQUIVALENTE A 100 MG DE HIERRO ELEMENTAL. ENVASE CON 1 AMPOLLETA DE 5 ML.,ENV,1,AMP,100,miligramos,100,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1196,,,4376,4376,1000043760000,010,000,4376,00,00,SI,"VALES,Sustantiva","VITAMINAS (POLIVITAMINAS) Y MINERALES TABLETA, CAPSULA O GRAGEA CADA TABLETA,  CAPSULA O GRAGEA CONTIENE: CLORHIDRATO DE TIAMINA (VITAMINA B1) 5.0 A 10.0 MG  RIBOFLAVINA (VITAMINA B2) 2.5 A 10.0 MG CLORHIDRATO DE PIRIDOXINA (VITAMINA",ENV,30,TGC,20,miligramos,600,miligramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,VITAMINICOS,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1
1197,,,4378,4378,1000043780000,010,000,4378,00,00,SI,"Sustantiva,Uso Hospitalario, Nutriología",SELENIO SOLUCION INYECTABLE CADA ML CONTIENE SELENIO 40.0 MICROGRAMOS ENVASE  CON UN FRASCO AMPULA CON 10 ML.,ENV,1,F.A,40,microgramos,40,microgramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1230,,,4452,4452,1000044520401,010,000,4452,04,01,NO,,*****PASO A CLAVE 040 000 4452 00 01**** LORATADINA Y PSEUDOEFEDRINA. GRAGEA DE LIBERACION PROLONGADA. CADA GRAGEA CONTIENE: LORATADINA 5 MG. CLORHIDRATO O SULFATO DE PSEUDOEFEDRINA 120 MG.,ENV,10,GRA,125,microgramos,1250,microgramos,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1321,,,5229,5229,1000052290000,010,000,5229,00,00,SI,"Sustantiva,Uso Hospitalario, Nutriología",ACIDO ASCORBICO SOLUCION INYECTABLE CADA AMPOLLETA CONTIENE: ACIDO ASCORBICO 1  G ENVASE CON 6 AMPOLLETAS DE 10 ML.,ENV,6,AMP,10,mililitros,60,mililitros,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1322,,,5232,5232,1000052320000,010,000,5232,00,00,SI,Sustantiva,PIRIDOXINA TABLETA CADA TABLETA CONTIENE: PIRIDOXINA 300 MG ENVASE CON 10  TABLETAS.,ENV,10,COM,300,microgramos,3000,microgramos,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
